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ALOPECIA AREATA
P001
Hair follicle cycle and inflammatory infiltrate in alopecia areata at early stage
XT Zhang, Y Zhao, B Zhang, MZ Cai, YG Gong, T Ye and XQ Zhang The First Affiliated Hospital of
Sun Yat-Sen University of Medical Sciences, Guangzhou, China
Objective: To investigate the histopathological features including changing of hair follicle cycle and the
inflammatory infiltrate of lymphocytes, eosinophils, and mast cells in alopecia areata (AA).
Method: Clinical, laboratory, and pathological features of 136 patients with AA were
investigated.
Results: Follicular counts from biopsy specimens of the 136 patients showed largely decreased
anagen/telogen and terminal-vellus ratios. ‘‘Swarm-of-bees’’ peribulbar lymphoid infiltration existed
in 73.52% (100/136) of the patients, and those with it either had a shorter duration or had active hair
loss. Eosinophils were present in 47.8% (63/136) of cases in all stages of AA. Patients with diffuse type
were more likely to have eosinophilic infiltrate than those with other types of AA. Cell counts of mast
cells and the activated mast cell in AA lesions were more abundant in the deeper peri-follicular than
in the superficial peri-follicular area, but there was no difference between the peri-vascular deeper
and superficial parts of the dermis. Superficial peri-vascular and deeper peri-follicular mast cell counts
had a positive correlation with serum IgE level. Superficial peri-vascular mast cells and the activated
mast cell in AA lesions were found to be more abundant in patients in the active phase (P¼ 0.028,
0.004). The patients who had a ‘‘swarm-of-bees’’ peribulbar lymphoid infiltration had more mast cell
infiltration both in the superficial and deeper peri-vascular areas. The patients with higher peripheral
IgE level, as well as those with pigment casts in the follicular tract, had more activated mast cells in
the deeper peri-follicular area.
Conclusion: The presence of eosinophils, mast cells, and lymphocytes was found to be correlated
with disease severity and decrease of follicular terminal–vellus ratio. Also, the peri-vascular
infiltration of mast cells into the superficial dermis suggests that mast cells play an important role
in the pathological process of AA.
P002
Exomic sequencing of immune-related genes reveals novel candidate variants
associated with alopecia universalis
HH Ryu1, S Lee2,3, SH Paik1, SJ Jo1, J-S Seo2,3,4, J-I Kim2,3,4 and OS Kwon1,5,6 1Department of
Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Department
of Biomedical Sciences, Seoul National University Graduate School, Seoul, Republic of Korea;
3Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic
of Korea; 4Department of Biochemistry and Molecular Biology, Seoul National University College of
Medicine, Seoul, Republic of Korea; 5Laboratory of Cutaneous Aging and Hair Research, Clinical
Research Institute, Seoul National University Hospital, Seoul, Republic of Korea and 6Institute of
Dermatological Science, Seoul National University College of Medicine, Seoul, Republic of Korea
Alopecia areata (AA) is a common autoimmune disorder mostly presented as round patches of
hair loss and subclassified into alopecia totalis/alopecia universalis (AT/AU) based on the area of
alopecia. Although AA is relatively common, only 5% of AA patients progress to AT/AU, which
affect the whole scalp and whole body, respectively. To determine the genetic determinants of
this orphan disease, we undertook whole-exome sequencing of 6 samples from AU patients, and
26 variants in immune-related genes were selected as candidates. When an additional 14 AU
samples were genotyped for these candidates, 6 of them remained at the level of significance in
comparison with 155 Asian controls (Po1.92 103). Linkage disequilibrium was observed
between some of the most significant SNPs, including rs41559420 of HLA-DRB5 (Po0.001, OR
44.57) and rs28362679 of BTNL2 (Po0.001, OR 30.21). While BTNL2 was reported as a general
susceptibility gene of AA previously, HLA-DRB5 has not been implicated in AA. In addition, we
found several genetic variants in novel genes (HLA-DMB, TLR1, and PMS2) and discovered an
additional locus on HLA-A, a known susceptibility gene of AA. This study provides further
evidence for the association of previously reported genes with AA and novel findings such as
HLA-DRB5, which might represent a hidden culprit gene for AU.
P003
Association between IL16 gene polymorphisms and susceptibility to alopecia
areata in the Korean population
W-Y Sim1, J-H Chung2, Y-C Kye3 and B-L Lew1 1Kyunghee University Hospital at Gangdong,
Seoul, Republic of Korea; 2Kyung Hee University, Seoul, Republic of Korea and 3Korea
University, Seoul, Republic of Korea
Introduction: The pathogenesis of alopecia areata (AA) still remains unclear. However, several studies
have indicated that AA is an organ-specific autoimmune disease and that T cells, as well as certain
cytokines, such as IL-1b, IFN-g, and TNF-a, may play an important role in its development. It is known
that CD8þ T cells are the direct modulators of hair loss, while CD4þ cells play a classic ‘‘helper’’
role in AA onset. IL-16 plays a role in trafficking of several immune cells and may be a major
chemotactic signal for CD4þ cells. The aim of this study was to investigate the significance of IL16
gene polymorphisms in the susceptibility to AA and several phenotypes of AA.
Methods: We conducted a case–control association study of 228 AA patients and 270 matched healthy
controls. Genotype frequencies of four single-nucleotide polymorphisms (SNPs) in IL16 gene were
studied. Statistical analyses were performed according to onset age, presence of family history, clinical
subtypes of AA, and presence of nail involvement or body hair involvement.
Results: One SNP (rs17875491) of the IL16 gene showed significant difference between the AA
patients and control group. One SNP (rs11073001) of the IL16 gene showed significant difference
between the AA group with presence of family history and the AA group with absence of family
history. Strong LD blocks were formed between rs17875486 and rs17875491, and between
rs11073001 and rs1803275.
Conclusion: IL16 gene polymorphisms may contribute to the increased susceptibility to AA in the
Korean population, and IL16 gene polymorphisms may be associated with presence of family
history.
P004
Differences in comorbidity profiles between early-onset and late-onset alopecia
areata patients: a retrospective study of 871 Korean patients
B-K Kim, NR Lee, H Hong, NY Yoon, S-Y Ahn and W-S Lee Department of Dermatology and
Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju,
Republic of Korea
Alopecia areata (AA) is an autoimmune disease that presents as patchy, nonscarring hair loss,
affecting about 2% of the population. AA is thought to be frequently occurring in association with
other autoimmune diseases such as thyroid disorders and atopic disease. Also, several
epidemiologic studies have reported that onset before adolescence is more likely to be associated
with atopic disease as a comorbid disorder and a poorer prognosis. To compare the comorbidity
profiles of early-onset AA patients with late-onset AA patients, we divided 871 AA patients who
visited the Department of Dermatology of Yonsei Wonju Christian Hospital in the last 10 years
into two groups, on the basis of their onset ages. The early-onset AA group and late-onset group
comprised patients below 13 years old and older than 13 years, respectively. On reviewing their
histories of comorbid disorders and laboratory findings, past histories of hypertension, diabetes
mellitus, and thyroid diseases were significantly higher in the late-onset group, and probabilities
of abnormal hematologic tests, glucose, lipid profiles, and renal function tests were also
significantly higher in the late-onset group. However, these results may be considered to be
influenced by age. Interestingly, prevalence of atopic dermatitis, family history of AA, and
positivity of antinuclear antibodies (ANA) were significantly higher in the early-onset group. As a
result, it may be concluded that onset of AA before adolescence is significantly associated
with higher prevalence of atopic dermatitis, higher family history of AA, and higher positivity
of ANA.
P005
Non-scarring patch alopecia in patients with active systemic lupus erythematosus
differs from that of alopecia areata
Y Ye1, Y Zhao1, Y Gong1, X Zhang1, S Caulloo1, BZ Zhang1, Z Cai1, J Yang1, KJ McElwee2 and
X Zhang1 1Department of Dermatology, The First Affiliated Hospital of Sun Yat-sen University,
Guangzhou, China; 2Department of Dermatology and Skin Science and Vancouver Coastal
Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada
Background: Clinical features of non-scarring patch alopecia in patients with active systematic
lupus erythematosus (SLE) are similar to those of alopecia areata (AA).
Objectives: To identify the specific features of non-scarring patch alopecia in SLE and those of AA, in
order to correctly diagnose and treat SLE patients presented as non-scarring patch alopecia primarily.
Methods: Data including clinical, dermatoscopic, histopathological, and laboratory data from
patients with patch alopecia, including 21 active SLE patients and 21 AA patients, were
retrospectively analyzed and compared.
Results: The alopecia patches commonly presented as incomplete alopecia in the SLE group, but
complete alopecia in the AA group. Exclamation-mark hairs, black dots, broken hair, and yellow dots
were more common in AA patients, while hair shaft hypopigmentation and thinning, angiotelectasis,
peripilar sign, white dots, and honeycomb pigment pattern were more common in SLE patients.
Interfollicular polymorphous vessels were the most common presentation of angiotelectasis in the
alopecia region of SLE, while interfollicular arborizing vessels were observed more in the non-
alopecia region of SLE and alopecia region of AA. After treatment, increase in vellus hair was the
earliest feature that emerged in both groups, while hair shaft hypopigmentation was the earliest
feature that disappeared in SLE patients, and broken hair in AA patients. The prevalence of ANA,
dsDNA, AHA, AnuA, and decreased level of WBC was significantly higher in SLE patients than in AA
patients. The distinct histopathological changes of the alopecia region helped in differential diagnosis.
After treatment, no SLE patients had relapse of alopecia, while 41.7% of AA patients did.
Conclusion: Distinct clinical, dermoscopic, and histopathological features were found in the
alopecia region of SLE patients, in comparison to that of AA patients. Serological autoantibody
test is of value to confirm the differential diagnosis. Local angiotelectasis and vasculitis in vicinity
to hair follicles may be involved in the pathogenesis of alopecia in SLE.
P006
Early stage of alopecia areata is associated with T-cell infiltration, Th1/Th2
balance shift and epithelial apoptosis in the upper dermis
Y Zhao1, X Zhang1, KJ McElwee2, M Yu2 and X Zhang1 1First Affiliated Hospital of Sun Yat-sen
University, Guangzhou, China and 2Division of Dermatology, University of British Columbia,
Vancouver, Canada
Objective: To explore the mechanisms underlying the early stage of AA, focusing on T-cell
subpopulation and follicular apoptosis.
Materials and methods: Specimens were collected from 15 AA patients at early stage (p3
months, positive hair-pull test), 15 AA patients at late stage (43 months, negative hair-pull test) by
surgical dissection at the edge of the scalp lesion, and from the scalp of 13 normal controls.
Double staining of T-cell markers and apoptosis cell markers (Annexin V and Caspase 3) was
performed. Semi-quantitative RT–PCR assay was applied on both parts to detect mRNA expression
of Th1, Th2 cytokines, hair follicle cycle signaling molecules and apoptosis-associated factors.
Result: In early-stage AA patients, there was more intense perivascular and perifollicular CD3þ ,
CD4þ , CD8þ T lymphocyte infiltration than in late-stage AA patients and normal controls in the
upper dermis (Po0.05), but not in deep layer. Moreover, Caspase 3 and Annexin V-positive cells
were more in the upper perivascular and perifollicular areas (Po0.05), but less in the deep
perifollicular area (Po0.05) compared to late stage.
In contrast to normal controls, elevated mRNA levels of Annexin V, Caspase 3 and FAS were
observed in both the upper and deep layers of early-stage AA, with Annexin V and Caspase 3 also
upregulated in the deep layers of late cases. In contrast to the normal controls, in early stage, an
elevated mRNA expression of Th1 cytokines (IL-12, IFN-g) and a lower mRNA expression of Th2
cytokine IL-10 in the upper layer were observed, whereas mRNA expression of IL-10 in the deep
layer was similar to that in normal controls.
Conclusion: In the early stage of AA, Th1/Th2 balance shift, T-cell infiltration, and epithelial
apoptosis in the upper dermis were more obvious than in the deep layer. Therefore, more
functional study into inflammation in the superficial layer of the dermis is required in order to
further discern its link with follicular regression in AA.
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P007
Alopecia areata in the elderly: a 10-year retrospective study
JS Lee, KH Park, HJ Lim, YH Jang, WJ Lee, S-J Lee and DW Kim Department of Dermatology,
Kyungpook National University School of Medicine, Daegu, Republic of Korea
Aims: Alopecia areata (AA) is a well-known immune-mediated form of hair loss that usually
occurs in the young adults. AA in the elderly is relatively rare; therefore, little data have been
reported. The purpose of this study is to understand better the clinical characteristics of AA in the
elderly.
Methods: We performed a 10-year retrospective study of AA in the elderly who visited our
dermatologic clinic from January 2002 to December 2011. A clinical review of medical records
and subsequent telephone interviews were performed by dermatologists. The age of onset,
duration of disease, family history, past history, emotional stress before onset, AA type and
severity, ophiasis, nail changes, gray hair, coexisting systemic and/or dermatologic diseases,
therapeutic responses, and clinical courses were observed.
Results: Among 1761 patients who were newly diagnosed with AA, 61 patients (3.5%) were older
than 60 years of age at first visit. The oldest patient was 90 years old and the mean age was 71.
The duration from the recognition of initial hair loss to the time of the first visit was less than 6
months in 45.9% (28/61). There were 74.3% (26/35) of the patients with an extent of hair loss less
than 50% of the scalp. There was no statistically significant correlation between extent of AA and
graying (P¼0.679). Our study also demonstrated favorable therapeutic response, which was
found in 62.9% (22/35).
Conclusion: We observed various clinical characteristics of AA in the elderly. As a result, we
assumed that AA in the elderly showed mild disease severity. Large-scale studies are required to
validate our results.
P008
Diphencyprone (DPCP) in treatment of patchy alopecia areata (AA)
R Dhurat, P Pund and S Ghate LTM Medical College and General Hospital, Mumbai, India
Introduction: The effectiveness of DPCP in AA has been demonstrated in several studies with
variable response rates (5–85%), which has led to considerable speculation surrounding its
therapeutic value and efficacy.
Objectives: To assess the efficacy of DPCP in the treatment of AA.
Methodology: Forty-six subjects with mild-to-moderate AA having minimum two patches were
sensitized with 2% DPCP. During each weekly visit, patients were treated with gradually higher
concentrations of DPCP, which was applied to a single patch while another served as control. The
patients’ hair regrowth was graded as excellent (76–100%), good (51–75%), moderate (26–50%)
and mild (o25%) at months 3 and 6.
Results: Of the 46 patients, 20 were less than 10 years of age. Extent of AA was o25% in 30
subjects and 425% in 16. Thirty-nine subjects were available for analysis at 3 months and 29 at 6
months (no of dropouts: 17). At the end of 3 months, 15 subjects had good to excellent response,
7 had mild to moderate, and 16 had no response. At the end of 6 months, of the 29 subjects, 16
had good to excellent response, 10 had mild to moderate, and 3 had no response, giving an
efficacy rate (excellentþ good) of 55% (16/29).
At 6 months, the response in 18 subjects with o25% AA was good to excellent in 9 and mild to
moderate in 7; that in 11 subjects with 425% AA was good to excellent in 7 and mild to
moderate in 3. On the control patch in 29 subjects, seven showed spontaneous hair growth.
Common side effects were redness, itching, blisters, occipital lymphadenopathy, severe eczema,
and hyperpigmentation.
Conclusion: DPCP is an effective treatment in patchy AA. A long period of therapy is needed and
it will increase the percentage of responders.
P009
Efficacy and tolerability of medium-dose oral prednisolone pulse therapy over 4–8
weeks in alopecia areata-an update with 53 cases
A Miesel, TW Fischer and D Zillikens Department of Dermatology, Allergology and Venerology,
University Hospital of Luebeck, Luebeck, Germany
Alopecia areata (AA) is a common disease with limited effective therapeutic options, so
identification of a stage-adapted, effective, safe, pragmatic, and time-saving therapy is still
needed. A monocenter retrospective, clinical outcome study of oral medium-dose prednisolone
pulse therapy was performed in 52 patients (53 treatments; mean age 43 years; 37 female, 15
male) with active AA (33 AA multilocularis, 19 AA of different type). A continuous, specific
therapy scheme was defined over 4 weeks, starting with 50 mg prednisolone per day, descending
to 10 mg daily. Upon positive response after 4 weeks, continuation of treatment up to a total of 8
weeks, with 2 weeks of 20 and 10 mg per day, respectively, was performed. Negativation of pull-
test and hair re-growth were defined as response criteria. After 4 weeks, the pull-test turned
negative in 48% and after 8 weeks in 50% of treated patients. Hair re-growth was observed in
60% after 4 weeks and in 81% after 8 weeks. About 60% of the patients showed no side effects,
while 34% showed gentle to slight side effects like sweating, slight body weight or blood pressure
increase, stomach acidity, itching, or acne. Moderate side effects (weakness, hot flush, sleep
disturbance) occurred in 3.8%. One patient (1.8%) showed severe side effects (vomiting and loss
of power). However, all side effects resolved after therapy end. In conclusion, the presented
protocol of oral medium-dose prednisolone pulse therapy of up to 8 weeks is a successful therapy
with high responding rates and relatively small side effects and therefore represents an effective,
safe, and time-saving treatment option in AA patients.
P010
Optimization of severe forms’ treatment of alopecia areata using corticosteroids
A Gadzhigoroeva Moscow Dermatology and Cosmetology Center of Science and Practice,
Moscow, Russian Federation
Aim: To optimize the treatment of severe forms of AA.
Study material: 49 patients with AA, phenotypes S2–S5, male 9, female 40, age 18–56 years.
Compared methods of treatment: 1st group: 27 patients treated with prednisolone given as
tablets. The starting dose depended on the weight of the patient: up to 60 kg 35 mg per day;
460 kg 40 mg per day.
2nd group: 22 patients treated with combined therapy of prednisolone 15 mg per day and
cyclosporine A 3.5 mg per kg of weight per day. The treatment lasted 4–6 months depending on
effect.
Results: Hair growth was observed after 2–3 weeks of treatment in group 1, and after 3–6 weeks
of treatment in group 2. The efficacy: no response: 1st group 2/27 (7.4%), 2nd group
2/22 (9%); partial response: 1st group 15/27 (55.6%), 2nd group 9/22 (41%); complete
response: 1st group 10/27 (37%), 2nd group 11/22 (50%). The effect was worse in patients
of both the groups who had an early disease onset (in the childhood), alopecia persisting for more
than 5 years, and more than four episodes of AA in the course of life. Side effects were most
frequently reported in the patients of group 1 compared with group 2. A weight gain of 2–8 kg (15/
27), steroid-induced acne (9/27), facial cushingoid with lipopexia in the area of the upper
shoulder girdle (4/27), and increased appetite (13/27) were observed only in group 1. Arterial
hypertension (1/22) and dysesthesia (12/22) were observed only in patients of group 2.
Hypertrichosis of the face and extremities were observed in 11.1% of patients in group 1 and
36.4% in group 2.
Conclusion: The combined therapy stimulates hair regrowth more effectively, because this is a
result of combined effects of the two drugs with pathogenetic activity against AA. The use of
suboptimal doses of prednisolone and cyclosporine A allows to minimize the side effects of either
drug and simultaneously extends the scope of pathogenetic treatment, which results in extended
remission.
P011
Statistical analysis of prognostic factors in patients with rapidly progressive
alopecia areata
M Uchiyama, C Egusa, A Hobo, R Irisawa, M Yamazaki and R Tsuboi Department of
Dermatology, Tokyo Medical University, Shinjuku-ku, Japan
Alopecia areata (AA) is a common acquired alopecia showing variable hair loss. Although various
prognostic factors have been reported, no evident factors for determining prognosis and
appropriate treatment are known. To identify prognostic factors in AA patients, especially those
with rapidly progressive AA (RPAA), defined as those with positive hair-pull test results across the
entire scalp on the first visit or with a history of onset or rapid worsening of hair loss across the
entire scalp within 6 months prior to first visit, 1,030 patients diagnosed with AA at Tokyo
Medical University Hospital were retrospectively examined for 3 years, and their prognosis was
assessed on the basis of various indices using multivariate analysis. Patients with regenerated
vellus hairs initially observed on hair loss areas showed a significantly higher improvement or
cure rate regardless of the type or severity of AA, including RPAA, assessed on the first visit. Early
onset was associated with a significantly lower cure rate, and long disease duration was
associated with a significantly higher risk of relapse among all AA patients.
RPAA patients tended to show a good prognosis regardless of treatment modality or the severity
on the first visit, and previous history of AA was significantly associated with a poor prognosis in
RPAA patients. Our study suggests that these variables can aid in predicting prognosis among
RPAA patients.
P012
Home treatment using diphencyclopropenone for alopecia areata: focused on
efficacy, safety, convenience, and economic feasibility
KH Song, SM Kim, J Park, SK Yun and HU Kim Department of Dermatology, Chonbuk National
University Medical School, Jeonju, Republic of Korea
Background: Diphencyclopropenone (DPCP) immunotherapy is effective for alopecia areata,
although there are some troubling side effects as DPCP is a potent contact sensitizer. Hence, most
of the DPCP immunotherapy is directly conducted by dermatologists at a hospital weekly.
However, frequent visiting to a hospital could result in considerable loss of time and money for
patients that lead to decline in quality of life.
Objective: The aim of this study was to evaluate the efficacy, safety, convenience, and economic
feasibility of DPCP home treatment.
Methods: A retrospective review was done for 87 patients with alopecia areata who received
home treatment at Chonbuk National University Hospital. The procedure for sensitization and
determination of optimal concentration was identical to that of conventional methods, which are
based on weekly visits to hospital. Afterward, having received education regarding application
methods and side effects, DPCP solutions were given to all the patients at each visit in order to let
them apply themselves at home. Follow-up at hospital was done monthly. We evaluated regrowth
of hair using SALT score, side effects, and patient’s quality-of-life questionnaire. The results were
compared with those of previously published papers in which DPCP immunotherapy was done at
hospitals.
Results: Seventy-one patients (81.6%) presented clinical response during treatment period, with
33 patients showing complete response. Overall regrowth rate using SALT score was 54%. Forty-
two patients (48.3%) experienced at least one complication, although there were no serious ones.
Average score of questionnaire obtained at the end of home treatment was lower than that
obtained during weekly visit to hospital; it signifies that home treatment is economic, convenient,
and improves quality of life.
Conclusions: Our clinical outcomes were similar to those of previous conventional methods.
Improvement in quality of life was shown through the questionnaire. Hence, home treatment of
DPCP immunotherapy could be recommendable for patients with alopecia areata.
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P013
Alopecia areata: a new treatment plan
A Alsantali Dermatology Department, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
Background: Many therapeutic modalities have been used to treat alopecia areata (AA), with
variable efficacy and safety profiles. If AA extent is more than 50%, topical immunotherapy with
diphenylcyclopropenone (DPCP) is the first therapeutic option. For poor responders to DPCP or
those who cannot use it, several review articles for AA therapy suggest topical minoxidil and
topical corticosteroids, but the yield of these topical agents in treatment of extensive AA is limited.
So what are the other therapeutic agents that can be used? Also, other treatment protocols suggest
the use of systemic corticosteroids, but we know that corticosteroids have a high relapse rate once
stopped.
Objective: There is a need to propose new therapeutic alternatives and a new treatment plan
based on the safety and efficacy profiles of the available therapies.
Method: We conducted a systematic review of clinical trials evaluating the available therapeutic
options for AA treatment.
Results: In this paper, the therapeutic agents are organized according to their efficacy and safety
profiles into first-line, second-line, and third-line options. If alopecia areata involves more than
50% of the scalp, topical immunotherapy with DPCP is the first therapeutic option recommended
by many experts in hair diseases. For patients who respond poorly to DPCP and those who cannot
use it, second-line therapies can be used. Second-line therapies include use sulfasalazine with or
without systemic corticosteroids and PUVA-turban. If these therapies fail or are not tolerated,
third-line therapeutic options can be discussed with patients. These agents include methotrexate
with or without a systemic corticosteroid, azathioprine, cyclosporine, and pulse therapy of
corticosteroids.
Conclusion: In this review, the therapeutic agents are organized according to their efficacy and
safety profiles into first-line, second-line, and third-line options. A suggested new AA treatment
plan is presented in a practical algorithmic approach.
P014
Clinical and epidemiological study of childhood alopecia in two pediatric
hospitals in Santiago, Chile
FA Mardones and A Cortes Department of Dermatology, University of Chile, Santiago, Chile
Background: Scalp hair loss in children is a relatively rare event with a negative impact on the
child’s psychosocial wellbeing. International studies of alopecia in the pediatric population have
reported multiple causes, usually acquired and non-scarring forms. Also, there may be etiologic
differences according to age groups. No clinical or epidemiological surveys have been done in
the pediatric population of Chile.
Objective: To describe the clinical and epidemiologic profile of alopecia in children from two
Chilean pediatric hospitals.
Methods: Retrospective and prospective analysis of clinical records from Roberto del Rio and Luis
Calvo Mackenna Children’s Hospitals between January 2007 and June 2010. Patients under 15
years of age with diagnosis of scarring and non-scarring alopecia were included. Clinical and
epidemiologic characteristics were recorded. Statistical analysis was performed using the SPSS
11.5 program.
Results: 345 clinical records were analyzed, 179 male (51.9%) and 166 female (48.1%). The
median age of patients was 72 months. Overall, most of the cases were acquired forms of
alopecia, 97.4% were non-scarring. The most common diagnoses were: alopecia areata (36.8%),
tinea capitis (21%), nevus sebaceous (13.2%), telogen effluvium (8.7%), and trichotillomania
(5.2%). Only telogen effluvium and loose anagen syndrome were statistically higher in girls.
According to age groups the principal causes were aplasia cutis and nevus sebaceous in
newborns; nevus sebaceous, alopecia areata, tinea capitis, and telogen effluvium in toddlers and
preschoolers; alopecia areata, tinea capitis, tellogen effluvium, and trichotillomania in school
years; and nevus sebaceous, alopecia areata, tellogen effluvium, and trichotillomania in
adolescents.
Conclusions: This is the first study of alopecia in the Chilean pediatric population. As in
international reports, most of the cases were acquired and non-scarring forms of hair loss. The
most prevalent causes were alopecia areata, tinea capitis, nevus sebaceous, telogen effluvium,
and trichotillomania. However, this may vary according to the age group analyzed.
P015
Alopecia areata and Down’s syndrome: a coincidence?
V Molho-Pessach1, Y Ramot2, A Tenenbaum3 and A Zlotogorski2 1Department of Dermatology
and the Center for Genetic Diseases of the Skin and Hair, Hadassah - Hebrew University Medical
Center, Jerusalem, Israel; 2Department of Dermatology and the Center for Genetic Diseases of the
Skin and Hair, Hadassah - Hebrew University Medical Center, Jerusalem, Israel and 3Pediatric
Department, Hadassah - Hebrew University Medical Center, Jerusalem, Israel
Alopecia areata (AA) is considered to be more frequent in patients with Down’s syndrome (DS) in
comparison to the general population. The increased prevalence rate implicated that a causative
gene for this condition is located on chromosome 21. Nevertheless, only a small number of
studies evaluated the link between these two conditions, and they differ in methodology and in
their outcomes. Most importantly, none of these surveys has checked the familial incidence of AA
in these cases. Since an increased familial incidence of AA in DS patients with AA would suggest
that the association with chromosome 21 is coincidental, we evaluated patients with DS from our
AA clinic. We found 14 DS patients with AA (age range 3–35 at examination), with a mean age at
onset of 6.8±5.1 (range, 1.5–16). Two patients suffered from alopecia universalis, one had
alopecia totalis, and the others (n¼11) had patch-type AA. One patient had celiac disease, one
had Graves’ disease, two had a history of hypothyroidism, and three had elevated TSH. Of note,
AA was reported in first- or second-degree relatives of eight patients (57%). In our series of
patients, the age of onset was lower than the reported age in the literature, but clinical phenotype
was not more severe than the normal population. DS patients are often under strict medical
surveillance, and under these conditions skin diseases, such as AA, are more often diagnosed and
reported. This may have resulted in a selection bias in previous reports linking DS to AA. The fact
that many patients had a positive family history of AA suggests that the association to
chromosome 21 might have been coincidental. Further studies are needed to clarify if indeed an
association between AA and DS exists.
P016
Quality of life in alopecia areata
N Teovska Mitrevska1,2 1Department of Dermatology, Re-Medika General Hospital, Skopje, The
Former Yugoslav Republic of Macedonia and 2Re-Medika General Hospital, Skopje, the Former
Yugoslav Republic of Macedonia
Quality of life (QL) is defined as individuals’ perceptions of their position in life in the context of
the culture and value systems in which they live and in relation to their goals, expectations,
standards, and concerns. This definition reflects the view that most dermatologic conditions do
not imply a direct threat to life, but their chronic and incurable character has a powerful negative
impact on the QL of afflicted patients. They affect patients in a multidimensional manner, ranging
from emotional to social interactions, symptoms, and functional impairment. Many skin-specific
QL measures have been developed, one of the first being the Dermatology Life Quality Index
(DLQI), developed in the UK in 1994 by Finlay et al. Measuring the impact of dermatologic
disease on QL allows patients to express their feelings and appreciate their physicians’ concerns
and improves doctor–patient communication. It also helps in disease management, including the
risk/benefit assessment of alternative therapeutic interventions.
Objective: To assess baseline QL in alopecia areata patients referred to a dermatology department
in Re-Medika hospital.
Methods: In order to measure the QL, DLQI survey (using the 10-item DLQI) was completed by
100 patients with alopecia areata (AA) during the period of January–November 2012. The DLQI
score in patients with AA was compared with that of other dermatology illnesses.
Results: This is the first study in Macedonia to evaluate the QL in patients with AA. Women with
AA had significantly higher mean DLQI scores than men. DLQI scores for AA were significantly
higher than in patients with androgenetic alopecia.
Conclusion: The first step of improvement of QL is establishing a good doctor–patient relationship
for the motivation of the therapy, especially in periods of insufficient success.
P017
Treatment of local forms of alopecia areata
A Gadzhigoroeva Moscow Dermatology and Cosmetology Center of Science and Practice,
Moscow, Russian Federation
Aim: To optimize treatment of patients with local forms of alopecia areata (AA) using
corticosteroids.
Study material: 96 patients with AA, phenotypes S1–S4; male 33, female 63, age 18–60.
Compared methods of treatment:
Group 1: N¼ 38. Intralesional injections of betamethasone dipropionate/betamethasone sodium
phosphate not more than 2 ml once in 4–5 weeks.
Group 2: N¼ 21. Clobetasol propionate 0.05% externally in the form of ointment to alopecia foci
with occlusion overnight during 6 days, with a break on the seventh day.
Group 3: N¼ 35. Clobetasol propionate ointment 0.05%  2 times daily, combined with 5%
minoxidil application after 30 min.
Duration of treatment: 2–4 months. Observation after treatment: 3 months.
Results: Efficacy of treatment. No response: group 1—6/38 (16%), group 2—3/21 (14%), group
3—1/35 (3%); partial response: group 1—11/38 (29%), group 2—5/21 (24%), group 3—12/35
(34%); complete response: group 1—21/38 (55%), group 2—13/21 (62%), group 3—22/35 (63%).
The effect in the first group depended on the alopecia area and was maximal for a single lesion
with area of 3–5 cm2. In the second and third groups, the sizes of lesion area did not affect the
treatment efficacy.
Efficacy of treatment is comparable to patients of the second and the third groups. But, the
frequency of inadequate treatment responses was lower in patients of the third group, and in this
group hair grew denser in foci, were thicker, and more pigmented as compared to the first and the
second subgroups.
Conclusion: Clobetasol propionate in ointment can also be successfully used for treatment
of subtotal or total forms of AA. Combined therapy using 5% minoxidil contributes to a more
rapid restoration of pigmented hair (in case of extensive areas of alopecia) and optimizes
treatment of AA.
P018
Association of alopecia areata with autoimmune diseases in Georgia
NT Lortkipanidze Department of Dermatology, S/R Dermatology and Venereology National
Center, Tbilisi, Georgia, USA
Aim: To identify the association of alopecia areata (AA) with other autoimmune diseases.
Methods: Nine hundred patients (100 SLE; 100 systemic scleroderma; 100 myasthenia; 200
psoriasis; 100 autoimmune thrombocytopenia; 300 chronic autoimmune thyroiditis (CAT)) were
screened to determine AA. Three hundred individuals were selected in the control group by
simple randomization method.
Results: In all groups prevalence of AA was higher than in controls, but significant difference
was observed only in the CAT group, with w2 value totalling 7.86; P¼ 0.005; odds ratio 12.46
(95% CI 1.68–258.18), where only extensive form of AA is much more frequent, than in control
(P¼ 0.025).
Conclusions: There is strong association between AA and most other autoimmune diseases, but
there was not enough evidence to prove this; we hence need more larger and stronger research in
future. It seems there is also association of the autoimmune process with hormonal dysfunction
and hypothyroidism in our case.
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Off the top of your head: what makes a wig work for alopecians?
KT Moore-Millar1, A Thomson1, JJ Liggat2, S Shilton3 and S Wiggins4 1DMEM, The University of
Strathclyde, Glasgow, UK; 2Pure & Applied Chemistry, The University of Strathclyde, Glasgow,
UK; 3Chemical & Process Engineering, The University of Strathclyde, Glasgow, UK and 4School
of Psychology, The University of Strathclyde, Glasgow, UK
Alopecia UK quote that 1.7% of the British population may experience alopecia areata during
their lifetime. A large percentage of this population chose to wear wigs to conceal their hair loss.
Since 2008 NHS Scotland has spent over d1 million per annum on the provision of wigs to
medical hair loss patients, including alopecia. However, little is known about the wig users’
experience or how it affects their body image and quality of life. This study has conducted pilot
focus groups, semi-structured interviews, online questionnaires, and physical testing of wig
materials to gain a holistic understanding of wig users’ experiences. The findings look at
identifying any relationship with fiber technology and personal experiences, and how wig design
could improve their quality of life.
P020
Low-dose diphenylcyclopropenone treatment in alopecia areata
B-K Kim, DI Keum, H Hong and W-S Lee Department of Dermatology and Institute of Hair and
Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
Objective: Diphenylcyclopropenone (DPCP) is the most commonly used contact sensitizer in the
immunotherapy of alopecia areata (AA). Despite its relatively good treatment response, the
common side effect of severe contact dermatitis with a current high sensitization dose of 1 or 2%
DPCP decreases the compliance of the patients, which eventually causes failure in consistency of
the treatment. We aim to investigate the effect of immunotherapy with low-dose DPCP for AA.
Methods: We reviewed the medical records of the patients who visited our hair clinic in the past
10 years. Among them, we enrolled 127 patients with AA who received immunotherapy with
low-dose DPCP for at least 3 months, which starts with 0.1% sensitization. From a week after
initial treatment, DPCP challenge starts with a dose of 0.01%, at increasing doses of 0.025, 0.05,
and 0.1%. Patients who received other treatments were excluded.
Results: Of all 127 patients, 19 (15%) patients showed mild improvement, 55 (43.3%) patients
showed moderate improvement, and 27 (21.3%) patients had great improvement. The average
duration of initial treatment response of each group was 7.71, 7.68, and 7.52 months,
respectively. There was no statistical significance with alopecia subtypes, past history, and
laboratory results in terms of treatment response. Ninety-eight (77.2%) patients were reported
with no side effects; 17 (13.4%) patients complained mild itching and 4 (3%) patients had
folliculitis; 2 (1.6%) patients were reported with scale and erythema. Other side effects of
moderate and severe itching, increased hair fall, rash, vesicles, and lymph node enlargement
were reported with one case each.
Conclusion: Low-dose DPCP can be used safely and effectively as the first-line immunotherapy
for AA.
P021
Analysis of personality traits in patients with alopecia areata
J-M Kim1 and M-B Kim2 1Department of Dermatology, Pusan National University, Busan,
Republic of Korea and 2Department of Dermatology, Pusan National University Hospital, Busan,
Republic of Korea
Although the pathophysiology of alopecia areata (AA) is not fully understood, biochemical
interaction between hair follicle and brain, when coping with psychological stress, has been
proposed as a possible cause of AA. Furthermore, hair loss could cause profound psychosocial
impact. Therefore, patients with AA have a higher prevalence of psychiatric morbidity and certain
personality traits. However, there are few studies on personality traits in patients with AA. Thus,
this study was aimed to clarify the personality difference in 100 patients with AA and a control
population using a structured questionnaire based on the NEO-Five Factor Inventory (FFI). This
study could provide more detailed information on the five basic personality factors: neurotism,
extraversion, openness, agreeableness, and conscientiousness. This study could also be helpful in
understanding the role of personality in pathophysiology and treatment of AA, as well as in giving
a new insight into the personality traits of patients with AA.
P022
Cases of alopecia areata where invasion of mast cell is remarkable around hair
follicles: including examination of our department’s experience cases
N Saito1, Y Amoh1, H Maejima1, N Sato1, K Katsuoka1 and M Asaya2 1Department of
Dermatology, Kitasato University School of Medicine, Sagamihara, Japan and 2Asaya
Dermatological Clinic, Sagamihara, Japan
In recent years it has been suggested that mast cell contributes to the clinical condition of
alopecia areata. Here we report one case of alopecia areata with remarkable mast cell invasion
around the hair follicles in histopathology. The case is a 48-year-old Japanese woman. She
noticed alopecia of the hair in the beginning of September 2012. She visited the Asaya
Dermatological Clinic, because the alopecia area was spread, and was then referred to our
department. She visited our department on November 7. She developed bronchial asthma and
urticaria on October 22. A hen-egg-size, irregular-shaped, and imperfect alopecia lesion was
visualized in her occipital area, and a thumb-caput-size, circular, perfect alopecia spot was
shown in the macula. Fortunetelling depilation characteristics were remarkable in and around
the alopecia spot and she experienced itching. On histopathology, telogen hairs with
cellular infiltration around the hair bulbs were visualized. We diagnosed it as alopecia areata
by its clinical features and histopathological image. Mast cells appeared in the infiltrate
cells around hair bulbs. In the upper part of the dermis, a lot of mast cells were shown
in the perivascular area. On blood examination, there was no eosinophilia, and the IgE
showed a slight increase. We performed treatment by topical application of steroid and oral
administration of an antihistamine and are currently observing an episode of care. We
investigated factors such as presence of a merger of allergic diseases, results of blood
examination, severity, and consequence of remarkable mast cell invasion observed on
histopathology in this alopecia areata patient.
P023
Reduced level of vitamin D in chronic/relapsing alopecia areata
R d’Ovidio1, M Vessio2 and FD d’Ovidio3 1AIDA, Bari, Italy; 2Divisione di Dermatologia,
Ospedale Generale Regionale ‘‘F.Miulli’’, Acquaviva delle Fonti- Bari, Italy and 3Department of
Statistics ‘C. Cecchi’, University of Bari, Bari, Italy
Current observations apparently link vitamin D deficiency to many autoimmune diseases. Data
are scarce on the vitamin D levels in alopecia areata, an autoimmune disease that, in our
published experience, shows seasonality in most of its remitting–relapsing forms, with a pick of
relapse in autumn–winter. Our results in this period demonstrate the presence of insufficiency of
25OH-D in many patients, independent of their clinical forms and correlated to the expected
increase of the PTH values. This could suggest the possible clinical utility of vitamin D in the
management of this highly frustrating disease.
P024
Alopecia areata in a patient with Turner’s syndrome
SY Kim, JH Lee, YM Lee, JH Lee, JH Lee and GM Kim St Vincent Hospital, Suwon, Republic of
Korea
Turner’s syndrome is a sex chromosomal abnormality characterized by gonadal failure, short
stature, skeletal, and medical anomalies. Turner’s syndrome is infrequently associated with
alopecia areata (present in 3% of cases, compared with 0.3% of controls) and more recently with
psoriasis (present in 17% of patients compared with 1.6% of controls). We report a first case of
alopecia areata in a patient with Turner’s syndrome in Korea.
An 11-year-old girl with Turner’s syndrome was referred to our department by the Department of
Pediatrics with four round-shaped, hair loss patches on the scalp that existed for 6 months. She
had taken human growth hormone and estradiol for short stature and sexual immaturation, which
did not provoke the onset of cutaneous disease. Her family history was non-contributory.
Histopathologic feature was mild lymphocyte infiltration around the lower portion of the follicles.
Dermoscopic findings were black dots, broken hairs, short vellus hair, and tapering hair.
Histologic and dermoscopic findings were consistent with alopecia areata. Local treatments with
low-dose intralesional triamcinolone acetonide had been carried out once weekly, but
therapeutic response was slow, like in other cases of alopecia areata in Turner’s syndrome
patients.
Alopecia areata occurring in Turner’s syndrome may indicate some genetic relationship and
could support the concept that these patients have the tendency to develop autoimmune or
immunological diseases.
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The effect of AIRE 207 polymorphism on AIRE transcriptional activity highlights
the potential role of AIRE in the pathogenesis of alopecia areata
TRJ Lovewell1, AJG Mcdonagh1, F Abu-Duhier2, M Azzouz3, AG Messenger1 and R Tazi-Ahnini1
1Infection and Immunity, University of Sheffield, Sheffield, UK; 2University of Tabuk, Tabuk,
Saudi Arabia; 3Department of Neuroscience, University of Sheffield, Sheffield, UK
Alopecia areata (AA) is an inflammatory hair-loss disorder characterized by the follicular
infiltration of CD4þ and CD8þ T cells and is considered a tissue-specific autoimmune disease.
AA is highly associated with autoimmune polyendocrine syndrome type 1 (APS-1), a disease
caused by the malfunction of the AIRE gene. AIRE is expressed in the thymus, particularly in
thymic medullary epithelial cells (mTECs), and is required for the ectopic expression of a diverse
range of peripheral tissue antigens (PTAs) by mTECs, conferring on them the ability to perform the
negative selection of T cells. The expression profile of PTAs is affected not only by AIRE
deficiency but also by variation of AIRE activity in the thymus. To elucidate the mechanism
underlying this, we screened 591 bp upstream of the AIRE transcription start site including the
AIRE minimal promoter region for SNPSs and identified two SNPs at positions 655 and 230.
To study the effect of these variants on AIRE promoter activity we generated a TEC 1A3 cell line
stably transfected with a single copy of the reporter vector. Relative promoter activity was
estimated by comparing the luciferase-specific activity for lysates of the different reporter cell
lines, including AIRE-655G AIRE-230C, AIRE-655G AIRE-230T, and AIRE-655A AIRE-230C. The
analysis showed that the commonest haplotype, AIRE-655G AIRE-230C, has the highest luciferase
activity (Po0.001), whereas AIRE-655G AIRE-230T has an activity-specific activity value that
approaches nil. This haplotype was not present in the homozygous state in 110 healthy
individuals, whereas 4 patients were homozygous for AIRE-655G AIRE-230T out of 172 patients
with sporadic AA genotyped for these variants. The AIRE-655G AIRE-230T genotype could
dramatically alter AIRE transcription, leading to the defective negative selection, and allowing
self-reactive immature T lymphocytes to escape clonal deletion, leading to the development of an
autoimmune response as observed in AA.
P026
Investigation of selected cytokine genes suggests that IL-2RA and the TNF/LTA
locus are risk factors for severe alopecia areata
S Redler1, F Albert1, F Brockschmidt1, C Herold2, S Hanneken3, S Eigelshoven3, K Giehl4, R
Kruse5, G Lutz6, H Wolff4, B Blaumeiser7, M Bo¨hm8, T Becker2, M No¨then1,9 and R Betz1
1Instiute of Human Genetics, University of Bonn, Bonn, Germany; 2German Center for Neuro-
degenerative Diseases (DZNE), University of Bonn, Bonn, Germany; 3Department of Dermato-
logy, University of Du¨sseldorf, Du¨sseldorf, Germany; 4Department of Dermatology, University
of Munich, Munich, Germany; 5Dermatological Practice, Paderborn, Germany; 6Dermatological
Practice, Wesseling, Germany; 7Department of Medical Genetics, University of Antwerp,
Antwerp, Belgium; 8Department of Dermatology, University of Mu¨nster, Mu¨nster, Germany and
9Department of Genomics Life & Brain Center, University of Bonn, Bonn, Germany
The hypothesis that AA is autoimmune in nature is supported by previous studies and a genome-
wide association study. These report association with specific HLA alleles, as well as genetic
variants of other genes implicated in autoimmunity, such as various cytokine genes. However,
most of the cytokine genes cannot yet be considered proven susceptibility loci, since many of
these association findings were derived from small patient samples. Accumulating knowledge of
shared pathways in autoimmune diseases and findings of association between AA and other
autoimmune disorders highlight the importance of investigating the role of other common
autoimmune susceptibility alleles in AA. We therefore genotyped variants of cytokine genes using
a sample of 768 AA patients and 658 controls of Central European origin. We genotyped 11
single-nucleotide polymorphisms (SNPs) from cytokine genes implicated in previous AA studies
using the MassARRAY system and a Sequenom Compact MALDI-TOF device. These genes were
IL-1B, IL-1A, IL-1RN, MIF, IFNG, and the TNF/LTA gene region. We also genotyped 15 SNPs
selected from cytokine genes that have shown significant association with other autoimmune
diseases. These genes were IL-10, IL-1F5, IL-12B, IL-6, IL-2, IL-23, IL-2RA, and IL-4R. Significant
association was found for two variants within both IL-2RA and TNF/LTA. In the overall sample,
the most significant results were obtained for the IL-2RA variant rs706778 (P¼0.00038) and the
TNF/LTA locus variant rs1800629 (P¼0.0017). In subgroup analyses, according to severity, age
of onset, and family history these effects were stronger in the severely affected patients, with the
lowest P-values being obtained for rs706778 (P¼ 3.8 106). Our results therefore point to the
involvement of IL-2RA and the TNF/LTA region in the aetiology of AA—in particular severe AA—
and provide further support for the hypothesis that AA is autoimmune in nature.
P027
Functional genomics and targeted next-generation sequencing point to ULBP6 as
a critical node in the NKG2D axis in alopecia areata
L Petukhova1, E Drill2, M Duvic3, M Hordinsky4, D Norris5, V Price6, R Clynes7 and AM
Christiano8 1Department of Dermatology and Epidemiology, Columbia University, New York,
USA; 2Department of Dermatology and Biostatistics, Columbia University, New York, USA;
3Department of Dermatology, MD Anderson, Houston, Texas, USA; 4Department of Dermatol-
ogy, University of Minnesota, Minneapolis, USA; 5Department of Dermatology, University of
Colorado, Denver, USA; 6Department of Dermatology, University of California, San Francisco,
San Francisco, California, USA; 7Department of Medicine and Dermatology, Columbia
University, New York, USA and 8Department of Dermatology and Genetics & Development,
Columbia University, New York, USA
Our GWAS study in alopecia areata (AA) first revealed a role for NKG2D ligands encoded by the
ULBP3/6 genes in disease pathogenesis, which we biologically validated by showing a marked
upregulation of ULBP3/6 and the presence of CD8þNKG2Dþ T cells surrounding lesional hair
follicles. These findings, together with the previous demonstration of MICA overexpression in AA hair
follicles, placed the NKG2D axis squarely at the center of AA pathogenesis, and invited a functional
genomics approach to uncover causal variants predisposing to disease. In order to interrogate the
distribution of genetic variants that reside within the NKG2D axis in AA, we first identified a
comprehensive list of NKG2D axis loci by constructing a genetic network of 65 genes from a database
of known and predicted protein interactions. Next, we performed whole-exome sequencing for 11
probands with severe AA from multiplex families from our linkage study and identified 280 variants
within 57 of 65 NKG2D axis genes. Of these, 50 variants result in a protein sequence change,
including 9 rare or novel mutations, which cluster in 7 genes, two of which reside within genomic
regions with evidence for linkage in AA. Unexpectedly, one of these genes is ULBP6, which was
previously identified in our GWAS (P¼ 5 1019). Given the convergence of linkage and GWAS
evidence at this locus, we next performed targeted sequencing of the ULBP3/6 region in 80 AA patients
using the Raindance platform and identified additional protein-coding variants that were reported to
have very low population frequencies (o0.007), but, strikingly, were strongly overrepresented at a
combined frequency of 10% among AA patients. The preponderance of rare, nonsynonomous variants
affecting critical protein domains suggests that ULBP6 is an essential node in the genetic architecture of
AA, and points to a role for variability in NKG2D-mediated cytotoxicity in disease pathogenesis.
P028
Next-generation T cell receptor sequencing for the identification and monitoring
of pathogenic T cells in alopecia areata
A de Jong1, A Jabbari1, Z Dai1, L Xing2, M Kurban1, B Thompson1, M Furniss1, J Mackay-Wiggan1,
AM Christiano1 and R Clynes2 1Dermatology, Columbia University, New York, USA and
2Department of Pathology, Columbia University, New York, USA
Alopecia areata (AA) is one of the most common autoimmune diseases, characterized by non-
scarring hair loss. T cells are considered the critical pathogenic cells, since they abundantly
infiltrate the hair follicles in AA, and are both necessary and sufficient to transfer disease in the
C3H/HeJ mouse model of AA. Next-generation T-cell receptor (TCR) sequencing provides a
platform to identify and track the frequency of pathogenic TCR clonotypes, representing a
functional biomarker of disease activity. Using this technique for TCR b-chain sequencing, we
have identified strikingly expanded T-cell clones in the lesional skin from five AA patients, which
represented up to 9.5% of the total TCR sequences, supporting an antigen-driven process in AA,
and providing evidence of dominant pathogenic T-cell clones. Comparative data from the C3H/
HeJ mouse model of AA also strongly support this notion, as identical TCR sequences were
dramatically expanded in new AA lesions of recipient mice grafted with lesional skin from the
same donor. In human AA patients, we found that some T-cell clones that were expanded in
affected skin also circulate at significant frequencies (40.1% of total blood sequences) in the
peripheral blood of the patient. By correlating the disease severity with the frequencies of
circulating pathogenic clones, we are now testing the hypothesis that circulating pathogenic TCR
frequency distinguishes patchy alopecia (AAP) and generalized alopecia (AU), and/or correlates
with baseline disease severity or disease trajectory. In a longitudinal study, we will determine if
increased circulating pathogenic TCR frequency precedes or occurs concomitantly with disease
progression. The unique accessibility of clonally expanded pathogenic T cells within the
hair follicle end organ represents an ideal clinical setting to examine the broad applicability of
next-generation sequencing to identify and track pathogenic TCR clonotypes in human
autoimmunity.
P029
Reversal of longstanding alopecia areata in C3H/HeJ mice using topical JAK
inhibitors
A Jabbari1, Z Dai1, L Xing2, A de Jong1, AM Christiano1,3 and R Clynes1,2,4 1Department of
Dermatology, Columbia University, New York, USA; 2Department of Pathology, Columbia
University, New York, USA; 3Department of Genetics & Development, Columbia University,
New York, USA and 4Department of Medicine, Columbia University, New York, USA
Alopecia areata (AA) is one of the most prevalent autoimmune diseases for which no
targeted therapy exists. T cells have been previously implicated in the disease process,
but the immune activation pathways and specific T-cell types involved have not been identified.
Guided by our GWAS studies implicating NKG2D ligands (NKG2DL) in human AA, here
we identify NKG2D-expressing CD8þ cytolytic T cells (CTLs) as the dominant immune
effectors in the C3H/HeJ mouse model, which were both necessary and sufficient for disease
induction. Moreover, we show that the NKG2DLs Rae1 and H60 are both upregulated in the AA
mouse hair follicle (HF). We interrogated the cytokine pathways involved in the AA inflam-
matory response, identifying a dominant IFNg signature as well as IL15. These two cytokines
conspire to induce the pathogenic AA Type 1 cytotoxic T cell inflammatory response.
IL15 produced by the HF promotes the activation of ‘‘NKtype’’ IFNg-producing CTLs. In turn,
IFNg produced by alopecic CTLs activates the HF, closing a pathogenic circle by upregulating HF
IL15, MHC molecules, and NKG2DLs, all of which target the HF for CTL attack. This type 1
cytotoxic pathway can be interrupted with either anticytokine biologics or small-molecule
inhibitors of their downstream effector JAK kinases. We demonstrate that both IL15 blocking
antibodies and systemic JAK inhibition prevent disease induction in grafted AA mice. Importantly,
two recently FDA-approved JAK inhibitors, tofacitinib (JAK3i) and ruxolitinib (JAK1/2i), that
inhibit signaling through the IL15 and IFNg receptors, respectively, have been topically
formulated and have demonstrated safety and efficacy in human psoriasis. We show that both
topical JAK inhibitors eliminate local CTLs and induce hair regrowth, durably reversing AA in
mice with established disease, thereby providing a strong rationale for their clinical evaluation
in human AA.
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Endogenous retinoids in the pathogenesis of alopecia areata
HB Everts1, KA Silva2, C Johnson1, B King2, JP Szatkiewicz2, S Kamdar2, DE Ong3, JL Napoli4,
J Wang4, LE King Jr5, DA Whiting6, KJ McElwee7, JP Sundberg2,5 and FJ Duncan1 1Department of
Human Nutrition, The Ohio State University, Columbus, Ohio, USA; 2The Jackson Laboratory,
Bar Harbor, Maine, USA; 3Department of Biochemistry, Vanderbilt University Medical Center,
Nashville, Tennessee, USA; 4University of California, Berkeley, Berkeley, California, USA;
5Department of Medicine (Dermatology), Vanderbilt University Medical Center, Nashville,
Tennessee, USA; 6Baylor Hair Research and Treatment Center, Dallas, Texas, USA and
7University of British Columbia, Vancouver, BC, Canada
Alopecia areata (AA) is an autoimmune disease that attacks anagen hair follicles. Gene array in
graft-induced C3H/HeJ mice revealed that genes involved in retinoic acid (RA) synthesis were
increased, while RA degradation genes were decreased in AA compared to sham controls. This
was confirmed by immunohistochemistry in biopsies from patients with AA and both mouse and
rat AA models. RA levels were also increased in C3H/HeJ mice with AA. C3H/HeJ mice were fed
a purified diet containing one of four levels of dietary vitamin A, or an unpurified diet 2 weeks
before grafting and disease progression followed. High vitamin A accelerated AA, while mice fed
no vitamin A had more severe disease by the end of the study. More hair follicles were in anagen
in mice fed high vitamin A. Both the number and localization of granzyme B-positive cells were
altered by vitamin A. Protein levels of IFNG were also the lowest and IL13 highest in mice fed
high vitamin A. Protein levels of IL10, IFNG, IL17, IL21, IL22, and PDL1 were reduced and
CXCL9 and CCL5 increased as the disease progressed, but no additional effects of vitamin A were
seen. Combined, these results suggest that vitamin A regulates both the hair cycle and immune
response to alter the progression of AA.
P031
Type I cytokines and chemokines are targetable immune pathways in alopecia
areata
Z Dai1, L Xing2, A Jabbari1, A de Jong1, AM Christiano1,3 and R Clynes1,2,4 1Department of
Dermatology, Columbia University, New York, USA; 2Department of Pathology, Columbia
University, New York, USA; 3Genetics & Development, Colub, New York, USA and 4Department
of Medicine, Columbia University, New York, USA
Alopecia areata (AA) is pathologically characterized as a ‘‘swarm of bees’’, with recruitment of T
cells around and invading the hair follicle. We recently defined the phenotype of these cells in the
C3H/HeJ alopecic mouse. These IFN-g-producing ‘‘NK-type’’ CD8 killer T cells infiltrate the hair
follicle, are massively expanded in the cutaneous lymph node, and are necessary and sufficient
for disease transfer in adoptive recipients. In alopecic mice, the inflammatory signature is
dominated by the Type I response, and the CXCL9-11 chemokines are among the most highly
upregulated genes in lesional skin. The FDA-approved small-molecule JAK1 inhibitor ruxolitinib,
which blocks IFN signaling, eliminated the Type I cytokine signature and durably reversed AA
development in mice with established disease when given topically. Interestingly, the CXCR3
receptor, known to bind these IFN-inducible chemokines, is upregulated on the key pathogenic
alopecic CTL effectors. To demonstrate whether CXCL9-11 chemokines were pathogenically
required, we treated mice with blocking antibodies to CXCR3. Importantly, CXCR3 blockade
prevented AA development in the AA graft model and notably abrogated the expansion of
CXCR3þ alopecic killer T cells in the skin and cutaneous lymph node. We show here using
transcriptional profiling of human and mouse alopecic skin that the IFN pathway is the dominant
signaling pathway involved in AA. Transcriptional profiles of 12 AA patients and 9 normal
controls show that IFN-inducible chemokines (CXCL9-11) are massively transcriptionally
upregulated in the skin of human AA lesions. Taken together, these data demonstrate proof-of-
principle of interfering with the Type I response in human AA, via blockade of IFN-inducible
chemokines. CXCR3 blockade could be approached clinically with either antibody or small-
molecule blockade, the latter being particularly intriguing as a topical therapeutic.
P032
Identification of autoantigen epitopes in alopecia areata
EH Wang1, JP Dutz1,2, J Shapiro2 and KJ McElwee1 1Department of Dermatology and Skin
Science, University of British Columbia, Vancouver, Canada and 2Department of Dermatology
and Skin Science, Vancouver General Hospital, Vancouver, Canada
Alopecia areata (AA) is believed to be an autoimmune disease that results in non-scarring,
inflammatory hair loss. Both CD4 and cytotoxic CD8 T cells (CTLs) have been found to be
important for the onset and progression of AA both in humans and in rodent AA models. Hair
follicular (HF) keratinocyte and/or melanocyte antigen epitopes are suspected as potential targets
of auto-reactive CTLs, but the specific epitopes have not yet been identified. We investigated the
potential for a panel of known epitopes, expressed by human HF keratinocytes and melanocytes,
to induce activation of CTLs. Peripheral blood mononuclear cell (PBMC) populations were
isolated from AA-affected and healthy subjects with HLA-A2 serotypes. PBMCs were cultured
with synthesized HLA-A2 restrictive peptide with specific sequences for trichohyalin, melanin,
MART-1, tyrosinase, tyrosinase-related protein-2 (TRP2), and GP-100. The frequency of CTL
activation in PBMC was measured by using enzyme-linked immunosorbent spot (ELISpot) assays,
where activated IFNgamma-secreting cells are visible as spots. Specific epitope cocktails derived
from trichohyalin, MART-1, and TRP2 induced significantly higher responses in human AA CTLs
compared to healthy controls. Investigation into CTL activation via single trichohyalin epitopes
showed highly variable results, suggesting patients with different stages of AA may have different
primary targets. AA-affected C3H/HeJ mouse lymph node cells (LNCs) showed significantly
higher responses to mouse antigen epitopes like keratin-16 (K16) and MART-1. However, in
contrast to human PBMCs, trichohyalin epitopes did not induce a significantly higher amount of
CTL activation in AA mouse LNCs, though the average response was greater than control mouse
LNCs. The data indicate that AA-affected subjects present with an increased frequency of CTLs
responsive to antigen epitopes originating from keratinocytes and melanocytes. Potentially,
trichohyalin, MART1, and K16 could be specific targets for CTLs that cause AA.
P033
Remission of longstanding alopecia universalis after HIV infection
Y Ramot1, T Tetro1, I Levi2 and A Zlotogorski1 1Department of Dermatology, Hadassah - Hebrew
University Medical Center, Jerusalem, Israel and 2Sheva Medical Center, Tel-Hashomer, Israel
Alopecia areata (AA) is a common disorder leading to non-scarring hair loss. Infrequently, the
disease may progress to alopecia universalis (AU), the most severe form of the disease, affecting
all scalp and body hair. AU is highly resistant to treatment, and only rarely spontaneous remission
occurs. Its exact pathogenesis is still obscure, although it was suggested to be an autoimmune-
mediated disease. Infection with human immunodeficiency virus (HIV) has been associated with
autoimmune diseases, and several reports described the induction of AA by HIV infection. We
report here a 46-year-old male patient with AU for 20 years, who experienced dramatic regrowth
of the scalp and body hair following infection with HIV. Hair growth increased with lowering of
CD4 counts, reaching a maximum of 90% regrowth of hair with CD4 counts of 400 cells mm3.
The patient did not have recurrence of hair loss after starting treatment for associated syphilis and
with increase in CD4 counts. To our knowledge, this is the first report of induction of hair growth
in an AA patient after HIV infection. This finding is especially noteworthy, considering that
remission occurred in longstanding AU, the most severe and recalcitrant form of AA. This report
raises interesting questions regarding AA pathogenesis, and emphasizes the importance of
systemic immune dysfunction for the induction of the disease. Further insight into the
pathogenesis of AA remission in HIV patients may help us elucidate the underlying mechanism
of AA in the general population.
P034
Correlation between serum thymus and activation-regulated chemokine (TARC),
and severity and activity in alopecia areata without active atopic symptom
S Inui, T Nakajima, F Noguchi and S Itami Department of Regenerative Dermatology, Osaka
University School of Medicine, Suita, Japan
Serum thymus and activation-regulated chemokine (TARC), a chemokine involved in Th2 cell
migration, is a good indicator of atopic dermatitis (AD) severity. Here, we report serum TARC in
our 130 alopecia areata (AA) patients without active atopic symptoms such as AD, allergic
rhinitis, conjunctivitis, and asthma. Patients with past history of AD who had only mild xerosis
were included, while those with eczematous lesions excluded. Using the SALT score the patients
were classified as follows: S0: no (n¼10); S1: 1–25% (n¼29); S2: 26–50% (n¼ 13); S3: 51–75%
(n¼ 10); S4: 76–99% (n¼ 8); S5: 100% scalp hair loss (n¼ 39), rapidly progressing diffuse type
(n¼ 6), and ophiasis type (n¼ 15). As a result, serum TARC was 302.3±90.7 pg ml1 in S0,
272.5±116.3 pg ml1 in S1, 310.8±119.0 pg ml1 in S2, 316.8±204.5 pg ml1 in S3,
431.9±407.4 pg ml1 in S4, 454.7±250.7 pg ml1 in S5, 663.3±490.7 pg ml1 in the diffuse
type, and 334.6±165.3 pg ml1 in the ophiasis type group. The serum TARC positively correlated
with the SALT grade (S1–S5) severity (Po0.001, Spearman rank-order correlation coefficient by
rank test). Moreover, when comparing serum TARC in the S2 and rapidly progressing diffuse type
with 26–50% scalp hair loss (703±537.8, n¼5), that in the latter was significantly higher
(Po0.05, Mann–Whitney’s U-test). On the other hand, there was no significant difference
between serum TARC in the S1 and 2 (284.4±117.1, n¼ 29) groups and ophiasis type with
1–50% scalp hair loss (349.5±172.7, n¼ 13). Further, immunohistochemical study using anti-
TARC and CD68 antibodies revealed that CD68-positive histiocytic cells produce TARC around
the AA hair follicles. Together, although AA is generally considered a Th1 disease, Th2 cells can
play some additional roles in severity and rapid progression of AA.
P035
An association study of alopecia areata using microsatellite markers within the
major histocompatibility complex
S Ikeda1, A Takagi1, E Komiyama1, N Yoshihara1, T Mabuchi2, Y Haida3, A Oka4 and A Ozawa2
1Department of Dermatology, Juntendo University Graduate School of Medicine, Tokyo, Japan;
2Department of Dermatology, Tokai University School of Medicine, Kanagawa, Japan;
3Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai
University School of Medicine, Kanagawa, Japan and 4The Institute of Medical Science, Tokai
University School of Medicine, Tokyo, Japan
Background: Many autoimmune diseases are associated with alleles of human leukocyte antigen
(HLA) genes within the MHC (major histocompatibility complex) region. Associations with
alopecia areata (AA) in HLA genes were also observed in different ethnic groups. However, the
alleles associated with AA and the loci were completely discordant, and AA susceptibility gene
within the MHC region has not been identified.
Objective: The aim in this study is to identify an AA susceptibility locus within the MHC region
using a Japanese population that has not been exploited for genetic association study of AA to
date.
Methods: We comprehensively selected 22 microsatellites spanning 2.4 Mbp (from HLA-E to
PSMB8) in the MHC region and genotyped 163 cases and 560 controls. To decide alleles of the
HLA-C locus, we used the LABType SSO typing test produced by ONE LAMBDA.
Results: The most significant association with AA was obtained for an allele (P¼1.45E05, OR:
3.25) of the D6S2811 locus that is 19.2 kb centromeric of the HLA-C gene within the HLA class I
region. This association was the most statistically significant one after Bonferroni’s correction
out of all the microsatellites that were analyzed. Moreover, our haplotype analysis demonstrated
that a haplotype strongly associated with AA (P¼ 3.28E05, OR: 3.75) was located around the
HLA-C locus.
Conclusion: Multiple studies showed that the AA susceptibility locus was located within the HLA
class II gene region in mainly European ancestry; however, our study showed a novel finding
different from these studies.
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Identification of gene expression biomarker signatures for use as an Alopecia
Areata Disease Activity Index (ALADIN)
JE Cerise1, A Jabbari1, M Duvic2, M Hordinsky3, D Norris4, V Price5, J Mackay-Wiggan1,
R Clynes1 and AM Christiano1 1Columbia University, New York, USA; 2MD Anderson Cancer
Center, Houston, Texas, USA; 3University of Minnesota, Minneapolis, Minnesota, USA;
4University of Colorado, Denver, Colorado, USA and 5University of California San Francisco,
San Francisco, California, USA
Alopecia areata (AA) is a highly prevalent autoimmune disease in which the hair follicle is
attacked by cytotoxic T lymphocytes. The accessibility of the target organ within skin biopsies has
provided us the opportunity to develop a novel disease activity score based on quantitative
composite gene expression signatures. Using both Affymetrix microarrays and RNA-Seq data
analyzed using Ingenuity Systems’ IPA, we identified two striking gene expression signatures in
total skin from both human AA and the C3H-HeJ mouse, namely the IFN response, including IFN-
gamma and IFN-inducible chemokines, and a cytotoxic T cell (CTL) signature including CD8 and
granzymes, implicating these effectors as the dominant inflammatory cells in AA pathogenesis. To
generate a functional biomarker from the AA transcriptome, we developed the Alopecia Areata
Disease Activity Index (ALADIN), a two-dimensional quantitative composite score. ALADIN was
derived from expression levels of representative genes from both the IFN and CTL pathways to
generate a measure of the distance of AA transcriptional levels from a baseline obtained from the
skin of healthy individuals. The ALADIN score reduces the complexity of the transcriptome into a
tractable bivariate index that can be used to quantitate and monitor patients’ disease status and
progression. We deployed ALADIN in our studies of mouse AA, and demonstrated that ALADIN
scores provide a quantitative measure of observed disease reversal, and ‘‘molecular distance to
skin homeostasis’’ during the course of successful prevention and treatment of disease. ALADIN is
currently being assessed in cross-sectional studies to validate its utility in human AA. We
anticipate that ALADIN will be useful as a dynamic functional biomarker to stratify and
longitudinally track patients enrolled in observational and interventional clinical studies.
P037
Alopecia areata in mice: is it a family affair?
JP Sundberg1,2, KA Silva1, VE Kennedy1, BA Sundberg1, LE King2 and A Berndt3 1Research and
Development, The Jackson Laboratory, Bar Harbor, Maine, USA; 2Department of Medicine,
Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA and
3Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Inbred mouse strains have been categorized into seven groups based on pedigree derivation and
haplotype analyses. Mice, as is also the case for other mammalian species including humans,
develop alopecia areata (AA). The C3H/HeJ inbred strain, a member of pedigree group 1, was the
first to be described with spontaneous AA. Subsequently, all C3H substrains as well as the closely
related CBA/J (also in group 1) carrying a mutation (Btkxid) causing a form of B-cell
immunodeficiency, were found to develop AA. A/J mice (also group 1) were later found to
develop a form of AA. In a massive aging phenotyping project, MRL/MpJ (group 1), SJL/J (group 2),
and SWR/J (group 2) were found to develop histological lesions consistent with AA. All six strains
are relatively closely related. Using genome-wide association mapping methods, candidate genes
were identified in the genetic intervals designated Alaa1, 2, and 4 but not in Alaa3 of the C3B6F2
quantitative trait loci (QTLs). Transporter 2, ATP-binding cassette, sub-family B (Tap2) was
confirmed in Alaa1, verifying earlier haplotype mapping studies. Additional candidate genes were
identified on mouse chromosomes 1, 2, 3, 5, 11, 12, and 18 confirming the complex genetic basis
of AA. Genetically closely related mouse strains have an AA phenotype and many of these genes
have been found in human AA genetic studies. These mice strains with an AA phenotype may be
useful to clarify the role of these genes in human AA in various ethnic groups.
ANDROGENETIC ALOPECIA
P038
Differential gene expression patterns in frontal and vertex scalp in men with
androgenetic alopecia-before and after the use of minoxidil topical foam
P Karnik1, M Consolo1, P Oyetakin-White1, E Baron1 and P Mirmirani2 1Case Western Reserve
University, Cleveland, Ohio, USA and 2The Permanente Medical Group, Vallejo, California, USA
The efficacy of 5% minoxidil topical foam (MTF) for hair regrowth in androgenetic alopecia
(AGA) has been well established; however, its mechanism of action is poorly understood. In this
double-blinded placebo-controlled prospective study, 16 healthy men aged 18–49 years with
Hamilton–Norwood type IV–V thinning were enrolled. Ten men used 5% MTF twice daily for 8
weeks and 6 used placebo. Scalp biopsies were taken from the leading edge of hair loss from the
frontal and vertex scalp at visit 0 and again after 8 weeks of active drug/placebo use. Microarray
analysis was performed on all available samples. A comparison of vertex scalp biopsy specimens
before and after use of MTF revealed the following upregulated genes: keratin-associated proteins
(KRTAP 13-2, KRTAP19-3, KRTAP19-5, KRTAP7-1, KRTAP8-1, KRTAP19-1) as well as non-
coding RNAs (SNORD116-22, SNORD25, SNORA5, VTRNA1-1). The downregulated genes
included: epidermal differentiation and keratinization genes including late cornified envelope
genes (LCE3D, LCE3E, LCE1C, LCE2A, LCE2C, LCE2D), small proline-rich proteins (SPRR2B,
SPRR2E, SPRR2G, SPRR2A), loricrin (LOR), fillagrin (FLG2), and cornefelin (CNFN). Inflammatory
genes (CCL18, S100A7, IL1F7, CD177) were also downregulated. These changes were not seen in
the placebo samples. Gene expression changes indicated that the frontal scalp was responsive to
minoxidil treatment in a manner similar to vertex scalp. These data suggest that the hair growth
properties of MTF may be mediated through increased production of hair keratin-associated
proteins, which are essential for the formation of a rigid and resistant hair shaft through their
extensive disulfide bond crosslinking with abundant cysteine residues of hair keratins. MTF also
reduces keratinization of the epidermis and inflammatory signals, which are known to be altered
in AGA. Further studies are needed to understand the potential role of non-coding RNAs in
follicular physiology. (This work was supported by an Independent Investigator grant form
Johnson & Johnson Consumer Companies, Inc.)
P039
What is the meaning of the ‘‘visible pigmented non-vellus hair count’’ in FDA-
approved clinical trial reports?
DJJ Van Neste1,2 and HD Rushton3 1Skinterface, Tournai, Belgium; 2Brussels’ Hair Clinic,
Brussels, Belgium and 3School of Pharmacy & Biomedical Sciences, University of Portsmouth,
Portsmouth, UK
During the past 30 years, the Canfield method was employed in minoxidil-Regaine/finasteride-
Propecia clinical trials. However, unlike EU-based methods, we are unaware of any published
critical validation data for this technique. This probably led to the Cochrane Review questioning
the efficacy of topical minoxidil therapy. Pooling the Canfield data as changes from baseline in
non-vellus hair counts between 16–48 weeks of treatment showed an increase of, respectively, 25
and 27 hair cm2 for 2 and 5% minoxidil. Taking þ 26 hair cm2 change as 100% therapeutic
response, it follows that the þ 14 hair cm2 increase obtained after using placebo lotion explains
about 50% of the measured effect. Therefore the calculated net therapeutic benefit (active minus
placebo) was þ 12 hair cm2. However, Canfield did not use immersion liquid before scalp hair
imaging, while studies that did so found a decrease in hair count with placebo lotion, pointing to
a confounder in Canfield’s method. Furthermore, in the absence of lotion, Canfield’s hair counts
in two international finasteride trials (pooled data 24–96 weeks) showed negative changes from
baseline with oral placebo, i.e.,5.7 and 8.1 hair cm2, with a net therapeutic benefit of þ24
and þ 16 hair cm2, respectively. This indicates that the application of lotions affects the visibility
of hair when employing the Canfield method. In our independent controlled study evaluating
Propecia, employing a calibrated contrast-enhanced phototrichogram (immersion fluid; hair
counted if thickness X30mm) involving 15 male subjects with randomized topical lotion (1 ml
per day) of either placebo (n¼8) or minoxidil 5% (n¼ 7), for 12 weeks, there was no statistically
significant change from baseline with Propeciaþplacebo (þ8 hair cm2), while a significant
increase of þ 40 hair cm2 was found with Propeciaþminoxidil 5%. We advise the use of
accurate validated methodologies to generate appropriate objective data!
P040
Pharmacodynamic of P-3074 (finasteride 0.25% topical solution) in subjects with
androgenetic alopecia
M Caserini1, R Palmieri1, M Radicioni2 and E Terragni2 1Polichem S.A., Lugano, Switzerland and
2Cross Research S.A., Arzo, Switzerland
A new proprietary topical formulation, P-3074, containing finasteride 0.25% as active ingredient
and hydroxypropyl-chitosan (HPCH) as film-forming agent, was developed for androgenetic
alopecia. The present study was aimed at investigating the pharmacodynamic profile of
finasteride in terms of dihydrotestosterone (DHT) concentrations in the scalp and in serum after
multiple topical application of P-3074 or oral finasteride intake in subjects with androgenetic
alopecia. Eighteen healthy men were randomly allocated to P-3074 or oral treatment after
providing written informed consent. Twelve volunteers applied P-3074 topical solution for 7
days: six subjects once daily (o.d.) in the morning and the others twice daily (b.i.d.) in the morning
and in the evening. The third group of six volunteers was administered 1 mg oral finasteride once
daily in the morning for 1 week. Scalp (vertex) biopsies were collected at baseline and 6 hours
after last dose administration, while serum samples were collected at baseline, before last
administration, and 6 and 12 hours after the last multiple dose. A marked decrease in scalp DHT
levels was observed: by 47.22% with P-3074 b.i.d., from 1.91 (±0.54) to 1.01 ng ml1 (±0.39),
by 71.20% with P-3074 o.d., from 1.52 (±0.41) to 0.44 ng ml1 (±0.08), and by 51.11% with
the oral formulation, from 1.39 (±0.25) to 0.68 ng ml1 (±0.34). Serum DHT was reduced by
69.3–74.0% with P-3074 b.i.d., 67.6–80.4% with P-3074 o.d., and 69.7–76.1% with the oral
formulation. These results showed a similar inhibition of serum DHT after 1 week of finasteride
administration with the three dose regimens and were consistent with the results obtained in a
previous P-3074 PK study. These findings show that DHT concentration in the scalp, after 7-day
treatment course of P-3074 o.d., was more reduced (about 40%) than after 1 mg oral finasteride
administration for the same treatment period.
P041
Genetic variations associated with efficacy of dutasteride, the dual 5a-reductase
inhibitor in the treatment of male pattern hair loss
SJ Jo1,2, A Rhie3,4, S Lee3,4, B-L Lew5, W-Y Sim5, KH Cho1,2, JH Chung1,2, J-I Kim3,4 and OS
Kwon1,2 1Department of Dermatology, Seoul National University College of Medicine, Seoul,
Republic of Korea; 2Institute of Human-Environment Interface Biology, Seoul National University
College of Medicine, Seoul, Republic of Korea; 3Genomic Medicine Institute, Medical Research
Center, Seoul National University, Seoul, Republic of Korea; 4Department of Biomedical
Sciences, Seoul National University Graduate School, Seoul, Republic of Korea and 5Department
of Dermatology, Kyunghee University College of Medicine, Seoul, Republic of Korea
Male pattern hair loss (MPHL) is an androgen-induced progressive hair loss caused by shortening
of anagen duration representing as miniaturization of involved hair follicles. A main treatment
target for MPHL is inhibition of 5a-reductase (5AR) because dihydrotestosterone (DHT), which is
converted from testosterone by 5AR in hair follicles and sebaceous glands, is the most responsible
androgen for MPHL. However, the effect of 5AR inhibition differs for each individual and the
genetic causes of the individual difference in the treatment efficacy have not been identified. In
this study, we aimed to search for exonic variants associated with response to dutasteride, a dual
inhibitor of type I and II 5AR. A total of 42 men with MPHL who had been treated with dutasteride
for 6 months were recruited and classified into good- (above the 75 percentile in efficacy, n¼ 10)
and poor-efficacy groups (below the 25 percentile in efficacy, n¼10) according to the change in
hair count after treatment. Quantitative regression analysis on all subjects yielded 16 single-
nucleotide variants (SNVs) to be associated (Po0.05), and quantitative regression analysis by
classifying good- and poor-responding groups left 10 SNVs out of 16. On treating the poor/good
responding groups as cases and controls, three SNVs were found significant to be associated. A
novel SNV (chr7:91763660:T4C) was located on 7q21.2, the first exon of CYP51A1. The others
were rs72623193 on 2q31 and rs1064796 on 19p13.12, and the associated genes were DHRS9
and CYP4F11, respectively. Our results suggested that CYP51A1, DHRS9, and CYP4F11 are
potential candidate genes associated with the efficacy of dutasteride on MPHL.
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Analysis of androgenetic alopecia in Amerindian people (mapuche) from Southern
Chile
FA Mardones, Y Valenzuela and V Zemelman Dermatology Department, University of Chile
Clinical Hospital, Santiago, Chile
Background: Androgenetic alopecia (AGA) is a common cause of hair loss in men and women.
Studies in Caucasian and Asian populations have established racial differences in prevalence and
clinical types of AGA. Investigators have suggested that native American (Amerindian)
populations would have a lower prevalence and less severe type of AGA.
Objective: To determine the prevalence and clinical patterns of AGA in adult males and females
in an Amerindian (mapuche) population of Chile.
Methods: Sample size was calculated using an estimated population proportion. Individuals
included adults with two or more surnames of mapuche origin who attended outpatient clinics for
general morbidity. Participants were excluded if they had scarring or other causes of non-scarring
alopecia or known triggering factors of effluvium. The Norwood-Hamilton and Ludwig
classifications were used for clinical pattern evaluation.
Results: 231 patients (88 males and 143 females) were evaluated, men averaging 46.2 years and women
40.7 years. The prevalence of men with AGA was 32.9% and that of women 8.29%. The percentage of
AGA increased with age: in the 20–29-year group, 6% affected males and none in females; in the 30–39-
year group, 10.5% affected males and 5% in females; in the 40–49-year group, 20% affected males and
7% in females; in the 50–59-year group, 21.4% affected males and 6% in females. In the sixth decade,
46.6% of men and 27% of women were affected. In subjects older than 70 years, all of the men and
42.8% of the women had AGA. Regarding the clinical pattern of AGA in men, 27.6% (8/29) had a female
pattern, 20.7% (6/29) had type IV, 17.2% (5/29) were types III vertex or VI, 10.3% (3/29) had type V, and
6.9% (2/29) had type VII. All of the women with AGA showed a female pattern classified as type I.
Conclusions: Chilean mapuche men and women showed a lower prevalence of AGA compared
to Caucasians, but higher than reported in Asian populations. Likewise, the prevalence of AGA in
our Amerindian population increased with age. Unlike Caucasian men, the female pattern was
the most common clinical pattern in mapuche men. As in Asian reports, Ludwig type I was the
most common pattern in mapuche women.
The similarities of AGA prevalence and clinical pattern of our study group with Asian studies may
support the genetic and anthropologist evidence of a common genetic link.
P043
Oxidative stress and cell senescence in androgenetic alopecia (AGA)
JH Upton1, A Bahta1, N Farjo2, B Farjo2, R Bhogal3 and MP Philpott1 1Centre for Cutaneous
Research, Queen Mary’s University of London, Whitechapel, UK; 2Farjo Medical Centre,
Manchester, UK and 3Unilever R&D, Colworth, UK
The hair follicle dermal papilla (DP) is essential for hair growth and is known to be a target tissue
for androgens. However, the mechanism for decreased hair growth in AGA is unknown. We have
shown that DP cells from balding scalp undergo premature senescence in vitro when compared to
matched DP cells from non-balding scalp, and that this is associated with upregulation of
p16INK4a and downregulation of BMI-1. Patient-matched DP cells from balding scalp have
significantly higher levels of reactive oxygen species (ROS), undergo fewer population doublings,
and have higher levels of cell senescence when cultured at 21% O2 compared to 2% O2, and
these differences correlate with changes in p16INK4a and BMI-1 expression. We also show that
growth factor secretion by the DP is affected by O2 culture conditions differently in balding and
non-balding DP cells. In addition, we show that the endogenous antioxidants catalase and total
glutathione exhibit increased expression in balding DP cells, or cells grown under 21% O2
conditions. Conversely, reduced glutathione was expressed at lower levels in balding DP cells
compared to non-balding DP cells when cultured under 2% O2. Oxygen conditions were also
found to alter DP cell motility, with greater motility observed at 2% O2 compared to 21% O2.
These data suggest that oxygen conditions significantly alter the function of DP cells and, by
extension, oxidative stress may exacerbate the onset of androgenic alopecia by affecting
senescence and DHT-induced TGF-b secretion, a known inducer of catagen and inhibitor of hair
follicle growth.
P044
The therapeutic potential of naturally immune privileged hair follicle cells
X Wang, J Hao, G Leung, T Breitkopf, Z Ao, G Warnock, J Shapiro and K McElwee University of
British Columbia, Vancouver, BC, Canada
Naturally immune privileged hair follicle cells have great potential for hair restoration and cell
transplantation. The objective of this study was to explore the potential of localized, non-toxic,
cell-based immune modulation as an alternative to current immunosuppressive regimens in
allogeneic tissue transplantation. Hair follicle–derived mesenchymal dermal sheath cells (DSCs)
possess innate immunosuppressive properties that could potentially be utilized to create localized
hyporesponsiveness in the context of allogeneic transplantation. Immune privilege-related gene
expression was evaluated in cultured human DSCs by using quantitative real-time PCR (q-PCR)
and western blot/ELISA, respectively. Immunomodulatory potential was characterized by using a
peripheral blood mononuclear cell (PBMC) proliferation/activation assay. Both program death
ligand 1 (PD-L1, 7.3±3.2-fold increase at mRNA level, n¼ 4) and transforming growth factor
beta 2 (TGF-b2, 6.3±3.0-fold increase at mRNA, n¼ 4) were upregulated, whereas interleukin 1
receptor antagonist (IL-1RA) and HLA-A, -B were downregulated in DSC (12.5±4.2, 2.8±0.8,
and 2±0.5 decrease, respectively) compared with non-follicular fibroblasts (FB). Activation of T
cells was measured by the production of IFN-g in the co-culture of PBMCs (as responders) and
allogenic human islets (as stimulators). The secretion of IFN-g from PBMCs was significantly
reduced in the presence of DSCs (23.0 vs. 5.7 pg ml1, Po0.01) or DSC-conditioned medium
(18.5 vs. 2.15 pg ml1, Po0.04) compared to FB. The data suggest a limited capacity of T-cell
activation in the presence of DSCs or their conditioned medium in response to alloantigen
stimulation. This study demonstrates that immune-privileged DSCs may create a localized
immunosuppressive microenvironment that may be exploited to reduce the need for chronic
systemic immunosuppression with drugs in clinical transplantation.
P045
Follicular unit extraction using the robot system (ARTAS) in an Asian population
J-W Shin1, J-Y Kim2 and CH Huh1 1Department of Dermatology, Seoul National University
Bundang Hospital, Seongnam, Republic of Korea and 2Mojelim Hair Clinic, Seoul, Republic of
Korea
Recently, follicular unit extraction (FUE) has become a popular harvesting method for hair
restoration. FUE provides many advantages over the strip method, including absence of linear
scar, much less pain, and short recovery time. However, FUE is a time-consuming, exhausting,
and technically more challenging job to doctors.
The ARTAS system (Restoration Robotics, Mountain View, CA) is an interactive, computer-
assisted, and physician-controlled robotic system for use with the FUE harvesting technique for
surgical hair restoration. Each follicular unit is digitally tracked, and removed in a random
fashion. The authors introduced the ARTAS system for the first time in Asia, and seek to share their
experiences of using this system in the Korean population in this paper.
In the Seoul National University Bundang Hospital, a total of 13 patients underwent FUE hair
restoration surgery using ARTAS system from September 2013 to December 2013. The mean age
of patients was 46.77±16.10 years. Twelve patients were male with androgenetic alopecia, and
the other one patient was female with female-type baldness. The mean number of punching done
by the ARTAS system for each patient was 1016.2±111.2. Transection rate ranged from 0.57 to
12%, with a mean value of 4.37±3.17%. No significant side effect or complication was detected
during and after the surgery. The surgeons felt much less fatigue compared with manual FUE
during the procedure and more precise extraction could be done all through the harvesting time.
The ARTAS system is a good advancement in FUE graft harvesting in terms of reducing surgeon’s fatigue
and improving graft quality. Unfortunately, there are no clinical or experimental Asian data about this
system yet. Further sharing of experiences and investigation for this system would be necessary in the future.
P046
Platelet-rich plasma promoting hair growth in human hair follicle dermal papilla
cells associated with VEGF and VEGFR-2
BJ Kim1,2, SY Kim1,2, TR Kwon1,2, YH Lee1, YS Song1,2, K Li1, YW Lee3, CH Huh4 and CK Hong1
1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of
Korea, 2Department of Convergence Medicine and Pharmaceutical Biosciences, Graduate
School, Chung-Ang University, Seoul, Republic of Korea, 3Department of Dermatology, Konkuk
University, College of Medicine, Seoul, Republic of Korea, 4Department of Dermatology, Seoul
National University Bundang Hospital, Seongnam, Republic of Korea
Aims: Autologous platelet-rich plasma (PRP) has been used to accelerate wound repair. It has
been reported that PRP contains various growth factors such as platelet-derived growth factors
(PDGF), transforming growth factors (TGF), fibroblast growth factors (FGF), and vascular
endothelial growth factors (VEGF). Previously, we have proposed that PRP promotes hair growth
in male-pattern baldness surgery. In this study, we investigated the effect of PRP in enhancing hair
growth on human hair dermal papilla (DP) cells.
Method: We assessed cell proliferation in cultured human DPCs by MTT assay and measured the
expression levels of VEGF, VEGFR-2, p63, Wnt5a, Wnt10b, and b-catenin by western blot analysis. This
research was supported by the Basic Science Research Program through the National Research Foundation
of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011–0008687).
Results: To elucidate this hair growth effect related to the proliferative effect of PRP on DP cells, we
treated human dermal papilla cells with PRP in a time- and dose-dependent manner. We showed
that PRP increased DP cell proliferation in a time- and dose-dependent manner. We further
evaluated the expression of VEGF and VEGFR-2 on human hair follicle DP cells. The expression of
VEGF and VEGFR-2 on DP cells was examined by western blot analysis. We found that PRP strongly
enhanced VEGF and VEGFR-2. We also found that PRP increased expression of b-catenin, Wnt5a,
and Wnt10b, a potent hair growth factor, and enhanced the level of p63, a stem cell factor.
Conclusions: These results suggest that the PRP hair growth effect in DP may result from
upregulation of b-catenin, Wnt5a, and Wnt10b expression due to increased levels of VEGF and
VEGF-R. Thus, our results provide support for possible therapeutic materials based on autologous
PRP to promote hair growth.
P047
Aspirin inhibits minoxidil-induced proliferation of human keratinocytes
A Monselise, G Leung, K Fraser, J Shapiro and KJ McElwee Department of Dermatology and Skin
Science, University of British Columbia, Vancouver, BC, Canada
Minoxidil is one of the most commonly used drugs for treating androgenetic alopecia, though its
exact mechanism of function is not well understood. A number of in vitro studies suggest it
involves the stimulation of cyclooxygenase1 (COX-1) activity, which increases prostaglandin E2
(PGE2) production, leading to a reversal of follicular miniaturization, and promotion of hair
follicles into the normal anagen phase of the hair cycle. However, approximately one-third of the
minoxidil users show no response to treatment and their hair loss progresses.
Aspirin, also known as acetylsalicylic acid (ASA), is a commonly used non-steroid anti-
inflammatory drug. It suppresses the synthesis of prostaglandins through irreversible inactivation
of cyclooxygenase enzymes, particularly COX-1. The regular use of a low-dose ASA is widely
accepted as a preventative measure against myocardial infarction (MI) and stroke for certain
subsets of the population in the United States and elsewhere. Estimates suggest that about one-
fifth of US adults take ASA daily or every other day.
In this in vitro study, the objective was to investigate the effect of the COX-1-suppressing property
of ASA on the COX-1-stimulating activity of minoxidil, mimicking the situation when both drugs
are taken concurrently. To evaluate the potency of minoxidil in keratinocyte proliferation in the
presence of ASA, human immortalized keratinocytes (HaCaT cells) were cultured in minoxidil
sulfate with increasing concentrations of ASA (1, 3, and 5 mM) for 72 h. Compared to respective
controls, the minoxidil sulfate growth-promoting effect on HaCat cells was significantly hindered
by the presence of ASA in a dose-dependent manner. This preliminary result concurs with our
speculation that ASA could diminish the minoxidil-induced hair growth response in some
minoxidil users. Further studies are needed to determine the effectiveness of minoxidil in those
who are concomitantly using ASA.
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Quantitative assessment of female-pattern hair loss by estimating the width of a
reshaped baldness area
P-K Hung1, W-H Hsieh2, R-Y Tsai3, C-W Kung1, H-W Fang4, C-M Chen1 and S-J Lin1 1Institute of
Biomedical Engineering, National Taiwan University, Taipei, Taiwan, Republic of China;
2Graduate Institution of Engineering Technology-Doctoral, National Taipei University of
Technology, Taipei, Taiwan, Republic of China; 3Department of Dermatology and Skin Laser
Center, Taipei Municipal Wan-Fang Hospital, Taipei Medical University, Taipei, Taiwan,
Republic of China and 4Institute of Chemical Engineering, National Taipei University of
Technology, Taipei, Taiwan, Republic of China
Aims: The Ludwig and Savin scale categorize the severity of female-pattern hair loss (FPHL), but it
is insufficient in describing patient progress. The appearance of baldness area should be clarified
with a quantitative parameter so that even a minor difference among individuals can be decently
detected and recorded for both follow-up assessment and treatment response.
Methods: Images of 44 FPHL patients with Savin scale stage I and II (from I-1 to II-2) were
enrolled, and every image was normalized before the segmentation of baldness area. With level-
set algorithm and principal component analysis, the baldness area was delineated and reshaped
to an equivalent ellipse. The minor axis of the ellipse, indicating the width of the baldness area,
was revealed. After estimating and declaring the appropriate interval of baldness width for each
Savin scale, the severity of FPHL can be more precisely described.
Results: The image normalization process was verified to reduce the diagnostic discrepancy
by 7.5% for physicians. With baldness width as the primary parameter, a stable diagnostic
accuracy (82%) was achieved, while the diagnostic accuracy of the four physicians ranged from
40 to 64%.
Conclusions: The image normalization is approved to reduce diagnostic discrepancy and
diagnosis of FPHL becomes a quantitative comparison of the baldness feature. By monitoring
minor changes of the same individual, a customized diagnosis of FPHL for both follow-up
assessment and treatment response can be facilitated in clinical practice.
P049
Racial differences of hair steroid profiling in male-pattern baldness between
Korean and Caucasian populations
B-L Lew1, Y-J Oh1, M-H Choi2, B-C Chung2 and W-Y Sim1 1Kyunghee University Hospital at
Gangdong, Seoul, Republic of Korea and 2University of Science and Technology, Seoul, Republic
of Korea
The hair loss in male-pattern baldness (MPB) is the result of miniaturization of the hair follicle and
shortening of the anagen phase of the hair growth cycle mediated by dihydrotestosterone (DHT),
which is metabolized from testosterone (T) and catalyzed by 5a-reductase. However, the
androgen activities in MPB within different racial groups are not completely understood. As
biological fluids demonstrate no correlation between androgen levels and MPB, steroids extracted
from the hair shaft were compared in balding and normal Korean and Caucasian subjects. Human
hair fibers were obtained by cutting the proximal part hair from the vertex and occipital scalp, and
the 12 steroid levels were evaluated in balding and normal Korean and Caucasian subjects. The
balding groups in both populations had significantly higher DHT and T levels than the control
groups. Balding Caucasians had twofold increased epitestosterone levels compared with normal
Caucasians, but only slight increases compared with normal Koreans. 5b-Dihydroprogesterone
levels were significantly increased in balding Koreans compared with normal Koreans, but were
not significantly different from those in the Caucasian groups. Both Korean groups had higher
vertex androgen levels than those of the Caucasian populations. However, levels of
pregnenolone, a DHEA, and A-dione precursor were markedly higher in the Caucasian groups
than in the Korean groups. For 5a-reductase, the metabolic ratio of DHT/T was increased slightly
in both balding populations. The activities of 3b-hydroxysteroid dehydrogenase showed racial
differences between normal and balding subjects. The quantitative results obtained from the
occipital hair were not consistent with those of the vertex hair. Our findings confirm the existence
of racial differences in hair steroid levels.
P050
Leukocyte telomere length is related to age but not to progression of androgenetic
alopecia in Japanese males
T Koyama1,2, K Kobayashi1,2, N Wakisaka1,3, N Hirayama1,4, S Konishi1,5, Y Nakamizo1,5,
K Takeda1 and M Kawakami1 1NPO Future Medical Laboratory, Tokyo, Japan; 2Josai Clinic,
Tokyo, Japan; 3Wakisaka Clinic Osaka, Osaka, Japan; 4AAC Clinic Nagoya, Nagoya, Japan and
5Josai Clinic Fukuoka, Fukuoka, Japan
Background: Androgenetic alopecia (AGA) is strongly related to aging. Leukocyte telomere length
shortens over time and it is known as a parameter of biological aging. We assessed the association
of leukocyte telomere length with the progression of AGA.
Methods: Median terminal restriction fragment length as average telomere size was compared in
the leukocyte DNA of 23 males, 20–35 years old (mean±SE: 28.5±4.3 years), with healthy hair (I
in Hamilton–Norwood classification), and 23 age-matched males (28.0±4.7 years) with AGA (IV
and V in Hamilton–Norwood classification) by using the TeloTAGGG Telomere Length Assay kit
(Roche, Mannheim, Germany) according to the manufacturer’s instructions.
Results: Median telomere length between AGA males and healthy-hair males did not show
significant difference (8.27±0.58 vs. 8.23±0.62, P¼ 0.78). Moreover, we compared the median
telomere length between 30–35-year-old males (n¼ 22, 32.4±1.6 years old) and 20–29-year-old
males (n¼ 24, 24.6±2.5 years old) to evaluate the association of telomere length with age. The
length in 30–35-year-old males was significantly shorter than that in 20–29-year-old males
(7.84±0.35 vs. 8.63±0.35, Po0.001).
Conclusion: We demonstrated that the telomere length of leukocytes is associated with age, but
not with progression of AGA in Japanese males. It is the first report on telomere length in
leukocytes in AGA.
P051
Why care about linear hair growth rates (LHGR)?
DJJ Van Neste1,2 1Skinterface, Tournai, Belgium and 2Brussels’ Hair Clinic, Brussels, Belgium
We found a positive correlation between hair thickness (mm) and linear hair growth rates (LHGR;
mm per 24 hours) as well as in vivo on the scalp of humans and scalp grafts maintained of nude
mice (Ann NY Acad Sci 642: 480–482, 1991). Because uncertainties subsist in the technology
(micrometry) and time window (30 days supposed continuous growth between clipping sessions
for length measurement), especially with shorter hair cycling, we wished to control such
information with up-to-date methods.
We used the contrast-enhanced phototrichogram method with exogen collection (CE-PTG-EC), an
accurate technology (www.skinterface.be) for hair growth and thickness measurement. Sites on
the top of the head were investigated in male subjects: 13 healthy controls and two groups of
patients with male-pattern hair loss (MPHL; 39 (IHN 08 study) and 22 (P22 12 study) subjects,
respectively, with Hamilton III–V patterns).
We confirm that there is a statistically significant (ANOVA;Po0.0001) correlation between
thickness and rate of growth in all tested subjects. In MPHL there were statistically significant and
systematic slower growth rates in hair p80 mm ranging from 18 to 7%. There was a non-
significant difference between controls and MPHL with a range of 4 to þ6% for thicker hair
(+480 mm).
The reduced LHGR, together with reduced thickness, shorter duration of anagen, and
increased ‘‘lag’’ between cycling phases, might contribute to the global impression of decreased
cumulative growth and time-related difference in terms of reduction of hair volume on the top of
the head as compared with the crown. This finding further explains why after 2 to 3 months
patients become usually unhappy with their hairstyle and ask for ‘‘equalizing’’ the hair mass with
a haircut!
More investigations on linear hair growth rate in individual patients might shed some light in
terms of severity of hair loss and/or response to treatment.
P052
Observation of hair characteristics in the so-called ‘permanent zone of scalp’
containing part of the occipital and temporal areas according to BASP and
Norwood–Hamilton classification in an Asian population with androgenetic
alopecia
JY Kim, JS Kim, J Gye, S Namkoong, SP Hong, M Kim and BC Park Department of Dermatology,
Dankook University College of Medicine, Cheonan, Republic of Korea
Aims: Since previous studies reported the hair characteristics of a normal population, differences
were noticed in practical use on treating alopecia patients. In addition, the hairs of occipital and
temporal scalp are known to persist in androgenic alopecia patients, but there are no data about
the follicular changes of the patients on such anatomical areas.
Methods: Our center divided 200 participants according to the BASP and Norwood–
Hamilton classification, and analyzed the hairs of the occiput and 2 sites of the temporal
regions with noninvasive digital phototrichogram. We examined hair density, numbers of
follicular unit, ratio of compound/single hairs, hair diameters, and the ratio of terminal/vellus
hairs.
Results: According to the BASP classification, statistical decrease of hair density was shown in the
anterior aspect of the temporal region among U type and other groups of BASP (Po0.05),
although the hair densities of the occipital areas were statistically insignificant among the BASP
subtypes. The diameters of hairs showed definite differences between U type and M, V, F types in
all anatomical regions. The ratio of compound/single hairs and of terminal/vellus hairs was
statistically insignificant.
Among the Norwood–Hamilton subtypes, only hair thickness in the temporal region showed
statistically significant change as the disease reached the most severe form.
Finally, the age factor was divided into five groups (o30, 30–39, 40–49, 50–59, and X60 years
old). Statistically significant differences were observed in the hair density of the temporal region,
measured above the ear helix, and in the hair thickness of the temporal regions (Po0.05). Patients
over 60 showed looser and thinner hairs than the younger population.
Conclusions: According to this observation, hair density and hair thickness of known permanent
scalp regions showed significant differences depending on the severity, the BASP subtypes, and
age in Asian people with male-pattern baldness.
P053
Epidemiologic and clinical profiles of Korean androgenetic alopecia patients
S-Y Park, H Hong, DI Keum and W-S Lee Department of Dermatology and Institute of Hair
and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic
of Korea
Objectives: Androgenetic alopecia (AGA) is the most common form of hair loss. Previously,
several studies had investigated the epidemiologic characteristics of AGA. The objective of this
study was to evaluate the clinical features, medical history, and family history of AGA patients in
Korea.
Methods: A total of 1,320 patients were enrolled. The demographics, past medical history, and
past history of alopecia were investigated with medical records, laboratory results, and
interviews.
Results: There were 862 male patients and 490 female patients (M:F¼1.7:1). The most prevalent
age groups were the patients in their thirties (24.8%) and forties (20.8%). About 14% of the
patients had a family history of AGA. Three hundred ninety patients were assessed by Basic and
Specific (BASP) classification. The M type (55.9%) was the most common basic type and V type
was the most common specific type. In all, 18.5% of the patients already had past history of
medical problems. The most commonly associated diseases were hypertension (HTN) (13.8%),
followed by diabetes mellitus (DM) (8.0%) and hypercholesterolemia (3.4%). Serum cholesterol,
triglyceride, and glucose levels were increased in 24.1%, 12.9%, and 24.7% of the patients,
respectively.
Conclusion: The prevalence of HTN, DM, and hypercholesterolemia did not show significant
difference compared to the prevalences in the general population. These findings are different
from previous studies conducted in individuals of Caucasian ethnicity, which showed a higher
prevalence of associated diseases (HTN, DM, hypercholesterolemia) in AGA patients. We assume
that these findings may be related to racial characteristics.
www.jidonline.org 1399
ABSTRACTS
P054
An epidemiologic study of androgenetic alopecia using the basic and specific
(BASP) classification in 3,114 Korean patients
CK Hong, IK Yeo and IP Son Department of Dermatology, Chung-Ang University College of
Medicine, Seoul, Republic of Korea
Background: Androgenetic alopecia (AGA) is the most common type of hair loss characterized by
the transformation of terminal scalp hair into vellus hair. The epidemiology of AGA is not fully
understood. A strong genetic basis has long been identified, while little is known of its non-
genetic causes.
Objective: We investigated the clinical status using the Basic and Specific (BASP) classification
and some environmental factors.
Methods: We examined 3,114 Korean AGA patients who visited 1 of 17 dermatologic clinics in
South Korea from March 2011 to February 2012. Epidemiologic data were collected using a
standard questionnaire.
Results: According to the basic type of the BASP classification, type M was the most common in
both male (82.2%) and female (52.7%) patients. Type F was observed in 24.2% of Korean males
with AGA. No associations were seen between eating or sleeping habits and severity of hair loss.
However, drinking and smoking were associated with the severity of AGA in male patients. We
observed that patients with a family history had more advanced types of hair loss in both genders.
Moreover, the age of onset of AGA in male patients with a family history was earlier than in male
patients without a family history.
Conclusions: Although there is very little evidence for environmental influences on AGA, the
present study showed an association between hair loss severity and environmental factors, such
as smoking and drinking. Also, the associations of family history with a higher degree of severity
in hair loss and with the age of onset were observed.
P055
Investigator-initiated double-blind, two-armed, placebo-controlled, randomized
clinical trial with an open-label extension phase, to investigate the efficacy of 5%
Minoxidil topical foam twice daily in men with androgenetic alopecia in the
fronto-temporal and vertex regions regarding hair volume over 24/52 weeks
K Hillmann1, N Garcia Bartels1, A Stroux2, D Canfield3 and U Blume-Peytavi1 1Charite´-
Universita¨tsmedizin Berlin, Clinical Research Center for Hair and Skin Science, Department of
Dermatology and Allergy, Berlin, Germany; 2Charite´-Universita¨tsmedizin Berlin, Institute for
Biometry and Clinical Epidemiology, Berlin, Germany and 3Canfield Scientific Inc., Fairfield,
California, USA
Background: 5% minoxidil topical foam (5%MTF) twice daily has shown effectiveness in male
androgenetic alopecia (AGA) in the vertex area over 16 weeks of application. No long-term data
on the efficacy of 5% MTF exist. Furthermore, there are little data on the efficacy of minoxidil in
the fronto-temporal region in men with AGA.
Objectives: To assess the efficacy of twice daily application of 5% MTF compared with placebo
in the fronto-temporal region of male patients with AGA after 16 and 24 weeks, as well as to gain
long-term data on the efficacy and safety of 5% MTF BID in the fronto-temporal compared with
the vertex region, over a period of 52 weeks.
Methods: Seventy male patients with moderate AGA (Hamilton–Norwood IIIvertex–VI) were
included. 5% MTF or placebo foam was applied twice daily for 24 weeks in the vertex and fronto-
temporal regions, with changeover to a 28-week open-label phase with application of 5% MTF
for all subjects. Measurements of non-vellus target area hair count (TAHC), non-vellus target area
hair width (TAHW), global expert panel rating, and subject’s rating were performed.
Results: Results were analyzed after 16 and 52 weeks. TAHC in the fronto-temporal area
increased significantly at both time points compared to baseline (16 weeks: Po0.0005; 52 weeks:
Po0.02). TAHW in the fronto-temporal and vertex regions showed a significant increase in both
areas after 16 (Po0.0005) and 52 weeks (P¼ 0.04). The occurrence of local intolerances and
adverse events was similar in both groups. No major adverse events were recorded.
Conclusions: This is the first study proving the efficacy of 5% MTF twice daily in the fronto-
temporal region. 5% MTF is a safe and effective treatment in men affected by moderate stages of
AGA in the fronto-temporal and vertex areas over 52 weeks. (This work was supported by an
Independent Investigator grant form Johnson & Johnson Consumer Companies, Inc.)
P056
Systemic growth factor treatment on the patients with androgenetic alopecia
BI Ro Department of Dermatology, Myongji Hospital/Kwandong University College of Medicine,
Koyang-si, Republic of Korea
Background: Among the various stimulants of treatment in androgenetic alopecia (AGA), growth
factor is known as an effective agent in hair regeneration. Systemic growth factor (SGF) is mainly
composed of b-fibroblast growth factor (b-FGF), vascular endothelial growth factor (VEGF),
insulin-like growth factor-1 (IGF-1), and others.
Purpose: The aim of this study is to evaluate the efficacy of systemic growth factor treatment in
patients with AGA.
Methods: SGFs were topically applied using medical devices containing a microneedle and by
electroporation in a 2–4-week interval. The efficacy was evaluated by phototrichogram and digital
photograph analysis after 10 times of treatment within 6 months. In total 116 patients, aged
between 19 and 60 years, were enrolled (MPHL II–V: 54 patients, FPHL I and II: 62 patients)
through 12 months, from October 2011 to September 2012.
Results: Phototrichogram showed 9.85% increase in hair density and 9.11% increase in hair
thickness. In hair density, 30.1% showed 5–10% increase, and 25% of the patients showed more
than 15% increase. In hair thickness, 35.3% presented 0–5% increase, and 21.5% patients
presented more than 15% increase. MPHL cases were more effective than FPHL. Adverse effect
was not observed except for a mild tingling sensation.
Conclusion: Systemic growth factor therapy is effective and safe for the treatment of AGA and this
will be one of the treatment options for AGA.
P057
Male and female androgenetic alopecia indications for minoxidil, PRP, and
follicles unit transplantation according to the phototrichogram and the
multifactorial classification
P Bouhanna Hospital Saint-Louis, Paris, France
Introduction: It is known that hair growth is influenced by several parameters. Therefore, any
alopecia consultation justifies a good clinical examination and a full evaluation analysis to
establish a reliable diagnosis that is a prerequisite for any treatment.
Objective: The Dynamic Multifactorial Classification with various parameters that can be
quantitated and computerized allows a precise evaluation of parameters such as fixed distances of
the face, measurements of the balding area and the hairy area, scalp laxity and thickness, and
covering power of hair. This includes density, caliber, shape, length, growth rate, and hair color.
The digitalized phototrichogram allows a precise hair count for density and anagen–telogen ratio.
Results: All these measures proved to be efficient during the fluctuations of various parameters in
hormonal, finasteride, minoxidil, and platelet-rich plasma (PRP) treatments. It also helped to
determine precisely the surgical indications of hair transplant and allowed the best choice
between the follicular unit extraction (FUE) or the follicular unit long hair (FUL) and the stage
of maximal baldness according to a better assessment of the baldness evolution during the
patient’s life.
Conclusion: This approach will lead to a better evaluation of the evolution of androgenetic
alopecia in both sexes, either spontaneously or under medical and surgical treatments.
P058
A randomized, double-blind, and placebo-controlled 12-month efficacy study of
CG 210 on hair diameter in male alopecia subjects already using Finasteride 1mg
A Takeda1, S Harti2, J Liu2, L Zhang3 and A Sato4 1School of Medicine, Kitasato University,
Kanagawa, Japan; 2Legacy Healthcare, Lausanne, Switzerland; 3Legacy Healthcare, Lausanne,
Switzerland and 4Tokyo Memorial Clinic, Tokyo, Japan
Study rationale: Finesteride is often regarded as first-line treatment for male patients with androgenic
alopecia (AGA). However, after several years of treatment, patients often reach a plateau.
CG210 is a GMP-grade topical botanical blend that has clinically demonstrated its efficacy to
reestablish regular A/T ratio (and hence normal hair cycle) in AGA sufferers within 44 days. Its
unique clinically validated mechanisms of action are: preventing premature apoptosis of cells in
hair follicles; reducing micro-inflammation in the scalp, and increasing collagen content. We
would expect to get a beneficial effect when combining oral Finasteride 1 mg (acting on
androgens) with topical CG210 (acting on apoptosis and micro-inflammation, two key factors
causing hair loss).
Hair diameter is an accurate clinical parameter for hair miniaturization (larger diameter¼ longer
anagen phase¼ improved proportion of anagen vs telogen hair (A/T ratio)). An increase in hair
diameter should also affect the cosmetic appearance and hair volume.
Objective: To evaluate the clinical effect of the topical anti-hair loss CG210 vs placebo on hair
diameter in Japanese AGA patients already using Finasteride 1 mg for 43 years.
Study design: Randomized, double-blind, placebo-controlled, single-center, prospective, with
two parallel groups.
Group A: Topical placebo provided to nine male alopecia subjects already taking Finasteride
1 mg treatment for 43 years.
Group B: Topical CG210 provided to seven male alopecia subjects already taking Finasteride
1 mg treatment for 43 years.
Results: Mean diameter of hair in the Finesterideþ topical CG210 group versus Finester-
ideþplacebo group increased by 36.9%. No adverse events were observed.
Conclusion: Application of topical CG210 in combination with Finasteride 1mg demonstrated a
statistically and clinically significant improvement in hair diameter and overall cosmetic appearance.
Therefore, CG210 offers AGA sufferers an effective option to be used either alone to prevent and stop
excessive hair loss or in combination with Finasteride to enhance patient outcome.
P059
Lifestyle evaluation of Korean androgenetic alopecia patients
GS Choi, CY Bang, M Kang, JH Moon and JW Byun Department of Dermatology, Inha University,
College of Medicine, Incheon, Republic of Korea
Background: Androgenetic alopecia (AGA) is the most common type of hair loss, and androgens
and genetic predisposition are believed to be the major factors that influence the development of
AGA. Although there have been previous reports about the relationship of family history,
smoking, and insulin resistance with AGA, no previous study has investigated the lifestyle, such as
eating habits, in AGA patients.
Objectives: The aim of this study is to investigate the family history, lifestyle, including smoking
and eating habits, in AGA patients and to compare with the data from Korea Health Statistics
2009: Korea National Health and Nutrition Examination Survey (KNHANESIV-3).
Methods: We retrospectively evaluated a total of 347 male patients with AGA who visited the
Department of Dermatology, Inha University School of Medicine, from September 2010 to August
2012.
Results: AGA with paternal family history was the most common (49.9%) and both (paternal and
maternal) family history was the least (10.1%). BMI and smoking did not show significant
differences, but eating habits showed statistically significant difference according to duration of
AGA. Patients with longer disease duration (45years) showed more intake of meat but less intake
of fish than patients with shorter disease duration. Also, AGA patients showed less intake of beef,
bean, and squid in comparison to the average Korean population.
Conclusions: This is the first study to investigate lifestyle, such as eating habits, in AGA
patients and to compare the result with data from Korea Health Statistics. However, further
study is needed to define the casual relationship between eating habits and the development
of AGA.
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Patients’ satisfaction with the phototrichogram in androgenetic alopecia patients
S-Y Park, H Hong and W-S Lee Department of Dermatology and Institute of Hair and Cosmetic
Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
Objectives: Phototrichogram has been employed widely as a standard method for the
determination of hair count, length, and thickness. The objective of this study was to evaluate
patients’ satisfaction with phototrichogram.
Methods: Patients with androgenetic alopecia (AGA) who were measured with a phototrichogram
(Folliscope (LeedM) 2.8, Republic of Korea) participated in this study. The patients answered to
questionnaires composed of three domains: patients’ satisfaction, the convenience, and
comparison to other treatments not using a phototrichogram. A 5-point scale was used.
Results: One hundred nineteen patients with AGA (male 77, female 42) were enrolled. In the
patients’ satisfaction domain, about 55% of the patients answered that they could realize
accuracy in diagnosis and receive objective information about their conditions. Overall 63% of
patients were satisfied with the phototrichogram. In the domain of convenience, most patients
had no complaints about the process. 4.2% of patients replied that the process was time
consuming and 13.4% of them felt discomfort in the method of measurement. 55.6% of the
patients experienced an increase in satisfaction compared to the treatments not using
phototrichogram.
Conclusion: Clinicians have considered phototrichogram as a standard tool for evaluation of
AGA. But overall, only 63% of the patients were satisfied with the phototrichogram in this study.
This percentage was certainly as per our expectation. These results may be related to the fact that
the patients were not fully informed about its uses and importance in the process of diagnosis and
treatment of AGA. We expect an increase in patient satisfaction on providing sufficient
information about the phototrichogram.
P061
The frequency of antinuclear antibody in patients with patterned hair loss and
alopecia areata
H Kang, WJ Choi and JE Kim Department of Dermatology, St. Paul’s Hospital, College of
Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Alopecia areata (AA) is an inflammatory disorder of the scalp that shows acute and
sometimes chronic hair loss. Although the cause of AA is unknown, it is suspected to be an
autoimmune disease. Although the significance of antithyroid antibodies in AA patients has
been reported, few studies have examined the significance of antinuclear antibodies (ANA)
in AA patients. Most studies reported no significant difference in terms of ANA titers
between AA patients and normal controls. Meanwhile, pattern hair loss, also called
androgenic alopecia, appears to result from androgen hyperactivity and genetic predisposition.
However, the whole mechanism of pattern hair loss has not been proved. Even in
pattern hair loss, there has not been any report about its relation with ANA. We retro-
spectively reviewed our patients who visited our hospital and checked the ANA in serum
during 2009–2011. A total of 107 patients (51 females and 56 males) with patterned hair
loss and 17 patients with AA (12 females and 5 males) were included. Their median ages were
38.3 and 38.9 years, respectively. Hematologic tests, thyroid function tests, and autoantibody
tests were performed. In AA patients, 35.3% of 17 AA patients showed a positive ANA test.
Among them, 23.5% were female and 11.8% male. In pattern hair loss patients, 30.4% of 105
patients (female: 19.1%, male: 11.3%) showed positive ANA. Our study suggests that ANA might
be related to alopecia areata and pattern hair loss, which means that the anti-nuclear antibody’s
immunologic effect may act through the hair loss mechanism. Futhermore, we analyzed the
relation between the severity of patterned hair loss and ANA using data from the patients’ hair
phototrichogram.
P062
Towards a cell-based treatment for androgenetic alopecia in men and women:
12-month interim safety results of a phase 1/2a clinical trial using autologous
dermal sheath cup cell injections
K McElwee, D Panich, D Hall and R Hoffmann RepliCel Life Sciences Inc., Vancouver, BC,
Canada
Cultured dermal sheath cup cells (DSC) from mouse vibrissae induced hair follicles de novo equal
or superior to dermal papilla cells and also integrated with resident hair follicles in mouse
ears producing larger follicles with longer, thicker hair. These observations have been
developed into a GMP-manufacturing protocol for the treatment of androgenetic alopecia in
humans (clinicaltrials.gov identifier: NCT01286649). Ten men and nine women with
mild to moderate androgenetic alopecia were recruited to a phase 1/2a clinical safety trial with
informed consent. For each subject, a biopsy from the scalp occiput was processed to isolate
DSC cells from terminal hair follicles. Using a randomized, double-blind, placebo-
controlled design, subjects subsequently received, via a validated semi-automatic injector,
autologous, cultured DSC or vehicle alone in two separate predefined, tattoo-marked,
contralateral scalp areas with thinning hair. Subjects are to return to the clinic for
safety/tolerability and histopathological assessments, as well as global, macro, and TrichoScan
images of the scalp and injection sites at regular intervals over 24 months. Injection site
macro images are to be assessed by independent reviewers for local reactions and tolerability.
Efficacy is to be assessed by determining cumulative hair thickness per area (mm cm2), mean
hair thickness (mm), and terminal, vellus, and total hair density (n cm2) in the injected regions.
Here we report the clinical development of this program and present the safety data at 12 months
post injection.
CICATRICAL ALOPECIA
P063
Direct immunofluorescence of plucked hair in cicatricial alopecia: a preliminary
case report
O Dicle1, C Celik Ozenci2, S Ozden2 and S Uzun1 1Department of Dermatology, Akdeniz
University School of Medicine, Antalya, Turkey and 2Histology and Embryology, Akdeniz
University School of Medicine, Antalya, Turkey
Background: Direct immunofluorescence (DIF) is conventionally an important diagnostic tool in
certain types of cicatricial alopecia. Recently, it has been shown that plucked hair can be used as
substrate for DIF in the diagnosis of pemphigus. It is also crucial to perform this research in
primary scarring alopecia, an immunological disease that target hair follicles.
Objective: Our aim was to assess the DIF of plucked hairs in a patient with scalp discoid lupus
erythematosus (DLE), which is one of the common causes of scarring alopecia.
Materials and methods: We performed DIF on plucked hair in a case of DLE with typical clinical
and histological findings and positive lupus band test of skin biopsy. Fifteen hairs were obtained
in the same way as for the trichogram. Selected intact anagen plucked hair were processed for
DIF. Five microns of cryosections obtained from plucked hairs were fixed in methanol-acetone
and were then processed for DIF. The sections were incubated for 1 hour with the following
fluorescein isothiocyanate (FITC)–conjugated antibodies: IgG, C3, IgM, IgA, and fibrinogen.
Propidium iodide (PI) was used as a nuclear stain.
Results: IgG and C3 were immunopositive in diffuse granular pattern in the basal membrane of
the epidermis, and IgG expression was also present in the outer sheath cells of the hair follicle. On
the other hand, IgA, IgM, and fibrinogen expressions were not present in the hair follicle.
Conclusion: It seems that in DLE, a prototype of scarring alopecia, DIF of plucked hair has
diagnostic value by utilizing horizontal cryosectioning. This is the first report about DIF of
plucked hair in a DLE patient that demonstrates the possible usage of hair plucking as an
alternative and less invasive technique for obtaining specimens for DIF, as well as contributing to
its the rapid diagnosis.
P064
Frontal fibrosing alopecia: a genetic disease?
GL Becher1, S Holmes1 and I McLean2 1Southern General Hospital, Allen Lyell Centre for
Dermatology, Glasgow, UK and 2University of Dundee, Professor of Human Genetics, Dundee,
UK
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia characterized by
progressive hair loss from the frontal hairline, often involving the eyebrows. The disease is
reported almost exclusively in post-menopausal women. The incidence of FFA appears to be
increasing, but the etiology is uncertain. Seven reports of familial FFA have been reported in the
literature. We report a further family in which three females in two generations are affected by
FFA. The results of whole-exome analysis of affected and unaffected members will be presented.
A 43-year-old woman presented with a 1-year history of recession of the frontal hairline,
associated with eyebrow thinning. On examination, there was scarring alopecia and hair
recession at the frontal and left temporal areas with perifollicular erythema at the affected
hairline. Biopsy of the affected scalp showed a perifollicular lymphohistiocytic infiltrate with
follicle destruction and scarring. The clinical and histological appearances were in keeping with
FFA. On closer questioning, a similar pattern of hair loss was reported in both her mother and
maternal aunt. Subsequent examination of these individuals also revealed frontal fibrosing
alopecia. Male family members were unaffected. Blood samples were drawn from all three
female affected members, as well as from the patient’s unaffected brother and father, and sent for
whole-exome gene sequencing. Exome sequencing is an efficient technique to selectively
sequence the coding regions of the genome. It is a cheaper but effective alternative to whole-
genome sequencing in identifying the causal variants associated with a particular disease.
The results of this testing are currently pending and will be available at the time of presentation.
To our knowledge, this is the first report of genetic testing in a familial case of FFA and adds to the
small number of familial FFA cases.
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Is hair transplantation indicated in frontal fibrosing alopecia?
F Jimenez1 and E Poblet2 1Clı´nica Dr. Jimenez-Acosta, Las Palmas, Gran Canaria, Spain and
2Anatomı´a Patolo´gica, Universidad de Murcia, Murcia, Spain
Frontal fibrosing alopecia (FFA) is an acquired scarring alopecia of unknown etiology. Medical
treatment is usually non-effective and many patients with FFA become highly distressed by the
typical band-like alopecia involving the frontal and temporal hairlines, and as the disease
progresses they find it difficult to camouflage. This is the reason why more and more patients look
into the possibility of a hair transplant as a permanent solution. However, there is little experience
about the outcome of hair transplantation in patients with FFA.
In this study we describe the long-term follow-up of three patients with biopsy-proven FFA in
whom test hair grafting was performed. The results of the hair transplant tests showed that the
transplanted hair follicles initially grow well, but after 3–5 years most of them had been slowly but
progressively destroyed.
A punch biopsy of one of the remaining transplanted FUs was carried out, showing the typical
histopathological findings of FFA. The histological confirmation of FFA in the transplanted
follicles suggests that FFA displays ‘‘recipient dominance’’, since the recipient area appears to
have an effect on the survival rates of the transplanted hairs. It is conceivable that a local factor
present in the frontotemporal skin region might be a determinant factor of the follicular
destruction.
In conclusion, our experience shows that the long-term outcome of hair transplantation in FFA
patients can be disappointing, and all potential patients should be advised of the possibility of hair
graft loss over time. It is important to note that the initial growth of the hair grafts should not be
interpreted as a successful outcome.
P066
Scarring alopecia of the sideburns: a unique presentation of frontal fibrosing
alopecia in men
YM Lenzy1 and LJ Goldberg2 1Department of Dermatology, RiverBend Medical Group, Springfield,
USA and 2Department of Dermatology, Boston University Medical Center, Boston, USA
Objective: To describe the clinical and histopathological features of four men with scarring
alopecia of the sideburns.
Case 1: A 51-year-old black man presented with symmetric thinning of the bilateral sideburns.
Examination revealed alopecia with loss of follicular ostia, but no perifollicular eythema or scale.
A punch biopsy of the right sideburn revealed features consistent with lichen planopilaris (LPP).
Case 2: A 58-year-old white man presented with thinning hair on the frontal scalp and loss of
sideburns and body hair. Examination revealed loss of lateral eyebrow hair and sideburns,
alopecia with loss of follicular ostia on the crown, and patchy non-inflammatory alopecia of the
face, trunk, and extremities. A punch biopsy of the left sideburn revealed LPP.
Case 3: A 40-year-old black man presented with symmetric thinning of the lateral eyebrow hair
and sideburns bilaterally. Examination revealed no perifollicular eythema or scale. A punch
biopsy of the left sideburn revealed LPP.
Case 4: A 53-year-old white man presented with scalp pruritus and hair loss from the sideburns
and temporal scalp. Clinically, patchy alopecia and mild perifollicular erythema was present at
the sideburns, and perifollicular scale on the scalp. A punch biopsy of the sideburn skin revealed
late-stage LPP.
Discussion: Frontal fibrosing alopecia (FFA) is a variant of LPP that predominantly affects post-
menopausal women. It causes scarring alopecia of the frontal and preauricular hairline, and often
causes loss of eyebrows as well as body hair. Hair loss in non-scalp sites tends to have less
perifollicular erythema and scale. We report four men with scarring alopecia of the sideburns,
whose biopsies revealed LPP. This brings the total of histologically confirmed men with FFA to 7.
Only one of the seven patients had perifollicular erythema. LPP should be considered in the
differential diagnosis of sideburn alopecia, even in the absence of inflammation.
P067
Cicatricial alopecia—a retrospective review of 52 cases
A Khalid1, KS Chen2 and PD Yesudian2 1Southport and Ormskirk Hospital NHS Trust, Ormskirk,
UK and 2Glan Clwyd Hospital, Bodelwyddan, UK
Aims: To review the clinicopathological correlation of clinical and histological findings, and
therapeutic options in cicatricial alopecia (CA).
Methods: We retrospectively analyzed 52 patients with CA (M:F¼10:42, mean age 58.8 years,
range 28–92 years) from three district general hospitals.
Results: The clinical diagnoses included lichen planopilaris (LPP) (n¼ 21, 40.4%), chronic
cutaneous lupus erythematosus (CCLE) (n¼ 11, 21.2%), frontal fibrosing alopecia (FFA) (n¼ 6,
11.5%), folliculitis declavans (FD) (n¼10, 19.2%), and pseudopelade of Brocq (PB) (n¼ 3, 5.8%).
One case remained undiagnosed. Thirty-seven patients (71.2%) underwent scalp biopsies.
Correlation between clinical and histological findings was present in 70.3% (26/37) of cases (LPP,
14/18 (77.8%); CCLE, 5/6 (83.3%); FD, 6/7 (85.7%); FFA, 0/2 (0%); PB, 1/3 (33.3%);
undiagnosed, 0/1 (0%)). In LPP, topical corticosteroids (TC) were used in 81.0% (17/21) of
patients, with control of disease in 35.3% (6/17) and regrowth in 23.5% (4/17). Topical
calcineurin inhibitors were used in 23.8% (5/21), and stabilizing disease in 60% (3/5). Oral/
intralesional corticosteroids were used in 19.0% (4/21), and stopping progression in one case.
Antimalarials were prescribed in 9.5% (2/21), with regrowth in one. All patients with CCLE were
treated with TC, halting disease progression in 45.5% (5/11). Among those treated with
antimalarials, 62.5% (5/8) were stabilized. Ciclosporin stopped progression in one case. FD was
managed with systemic antibiotics (tetracyclines, macrolides, and rifampicinþ clindamycin),
with success in 70% (7/10). Treatment for FFA included TC in 83.3% (5/6), which halted disease
progression in three patients. PB was effectively treated with antimalarials in one case.
Conclusions: In our limited review, we have noted that TC is beneficial in LPP, FFA, and CCLE,
with an overall response rate of 54.5% (18/33). The addition of antimalarials is helpful in CCLE.
Systemic/topical antibiotics are the mainstay of treatment for FD. Multi-centre, prospective
studies are required to elucidate the gold standard treatments for each type of CA.
P068
Afro-American alopecia: specific treatments and transplantation
P Bouhanna Hospital Saint-Louis, Paris, France
Introduction: Afro-American hair and scalp present typical aspects in ethnic hairdressing and
grooming, morphology, and physiology (coiled and helical hair shaft, elliptic or flattened cross
section, curved hair root, low hair density, and slow hair growth), leading to specific pathological
problems and to adapted treatments.
Materials and methods: Specific Afro-American hair pathologies include traction alopecia, hot-
comb alopecia, folliculitis and pseudofolliculitis, acne keloidalis, dissecting cellulitis, and
cicatricial alopecia. Medical and cosmetological treatments should be adapted to dry and brittle
hair shafts and to the specific inflammatory sensitivity of black patients’ scalp.
Discussion: Surgical treatments, procedure, instruments, and techniques should be adapted
according to alopecia area and the scalp and hair ethnic specificity. Before doing any treatment,
all the traction of the hair roots and hair shafts is completely stopped.
For Afro-American patients it is easier to achieve a good and dense esthetic result with the FUL
(follicular unit long) hair rather than the FUE (follicular unit extraction) procedure. This is almost
due to the curved hair roots and the lowest donor hair density.
Afro-American patients are notably susceptible to postinflammatory hyperpigmentation or
hypopigmentation, and hypertrophic or even keloidal scarring process.
Conclusion: For quiescent alopecia and non-aggressive hair styling in Afro-Americans, it is
possible to get a definitive and aesthetic reconstruction with follicular unit transplant.
P069
Frontal fibrosing alopecia: a case-note review over a 12-year period in a tertiary
center
A Russell1, MP Wallace2, SS Haque Hussain2, J Sterling2 and E Rytina3 1Department of
Dermatology, University of Cambridge, Cambridge, UK; 2Department of Dermatology, Cam-
bridge University Hospitals Foundation Trust, Cambridge, UK and 3Department of Dermato-
pathology, Cambridge University Hospitals Foundation Trust, Cambridge, UK
Frontal fibrosing alopecia (FFA) is a distinctive cicatricial alopecia with a rising incidence. It
mainly affects postmenopausal women, with a typical clinical picture of frontotemporal scarring
hair loss, follicular hyperkeratosis, and variable peri-follicular erythema. Eyebrow involvement is
common with occasional involvement of body hair loss (particularly the forearms) and, rarely,
eyelash loss. The condition is extremely challenging to manage with an often limited treatment
response. A wide variety of topical and systemic pharmacological modalities have been reported
in the literature.
We sought to explore the approach to management of this condition in our tertiary center for a
12-year period between 2000 and 2012. Patients coded with a diagnosis of ‘‘frontal fibrosing
alopecia’ on the electronic medical record system were identified. Fifteen patients had clinical
and histological confirmation of FFA, and a case-note review was undertaken to determine the
treatments used and their documented efficacy.
The commonest modality employed was super-potent topical steroids in 9/15 (60%) of patients.
This resulted in stabilization or improvement in 4/9 (44%) of cases used. Lymecycline 408 mg
once daily was used in 4/15 (26%) of patients and led to improvement in two cases. Dutasteride
was used in three patients, with one patient not tolerating the medication, one deriving some
benefit, and one experiencing progression on treatment. 2/15 patients were subsequently
escalated to immunosuppressive treatment with either azathioprine or ciclosporin and an
improvement was seen in both cases.
FFA is a condition with significant morbidity and impact on quality of life. It has an as yet
uncharacterized aetiology and is likely to be underdiagnosed in the general population.
Treatment remains a challenge, but in our small, retrospective case series super-potent topical
steroids were most helpful.
P070
First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a
pilot comparative study in folliculitis decalvans
B Matard1, T Meylheuc2,3, R Briandet2,3, I Casin4, P Assouly1, B Cavelier-Balloy5 and
P Reygagne1 1Hair Disease Center, Sabouraud Center Saint Louis Hospital, Paris, France; 2INRA,
UMR 1319 Micalis, Jouy-en-Josas, France; 3AgroParis Tech, UMR Micalis, Jouy-en-Josas, France;
4Department of Microbiology, Saint-Louis Hospital, Paris, France and 5Department of Pathology,
Saint Louis Hospital, Paris, France
Background: The cause of folliculitis decalvans (FD) remains unknown. We hypothesized that a
bacterial biofilm could be involved in its pathogenesis.
Objective: To assess the presence or not of a bacterial biofilm in the hair roots of the scalp in FD.
Patients and methods: Hairs plucked from four patients and three controls were examined by field
emission scanning electron microscopy (FESEM) and confocal laser scanning microscopy (CLSM).
Results: Bacterial communities organized as biofilms were observed both by FESEM and by CLSM
in the infra-infundibular part of hair follicles in all patients and in two of the three controls. In
patients and controls, these biofilms were formed exclusively of bacilli of comparable shapes
compatible with P. acnes.
Discussion: As the growing knowledge about biofilms shows, it seems possible that the normal
and pathological scalp hair follicle microbiota are organized in biofilms as suggested by our
observations and recent literature data. In line with our hypothesis, this study has shown the
presence of biofilms in the hair follicles of patients with FD and raises the question of its causal
role in FD pathogenesis. The hypothesis of a follicular biofilm in FD could explain the recurrences
despite appropriate antibiotic therapy for S. aureus obtained from the lesions (which are also
active against P. acnes), histology (influx of polymorphonuclear neutrophils that secrete cytokines
that destroy the hair follicles without destroying the biofilm), and the usual normal immune and
genetic background of patients. Thus, S. aureus observed frequently on the skin in these patients
would only be opportunistic.
Conclusion: This pilot study provides the first evidence of the presence of bacterial biofilms in the
infra-infundibular part of human scalp hair follicles. These biofilms were detected both in FD
patients and controls, suggesting their ubiquity as a commensal biofilm with a possible
pathogenic shift in FD.
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Vulval and oral lichen planus in frontal fibrosing alopecia
A-L Chew, CM Stefanato, I Savarese, SM Neill, D Fenton and FM Lewis St John’s Institute of
Dermatology, Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, UK
Lichen planus (LP) is an inflammatory dermatosis affecting many cutaneous and mucosal sites.
This study describes the patterns of alopecia observed in patients with vulval lichen planus.
In the 4-year period from January 2009 to December 2012, 83 new patients referred to the
specialist Vulval Clinic were diagnosed with vulval lichen planus. All patients were routinely
asked and examined for any hair loss. There were 16 patients (19.2%) with scarring alopecia of
the scalp, and these were grouped into those with diffuse alopecia, one or more localized patches
of alopecia, or with the patterned variant of frontal fibrosing alopecia (FFA).
The commonest pattern encountered was that of FFA, which was present in 8 women (50%), with
6 of them also exhibiting loss of eyebrow hair. All of these patients also had oral LP, and in 7 of
the 8 cases the patients had the erosive scarring variant of vulval LP. Four patients had a single
patch of alopecia localized at the crown, two patients had multiple patches, and two patients had
diffuse scarring alopecia. In all those patients who had a scalp biopsy, the characteristic
histopathological features of lichen planopilaris were identified.
Our study documents that a significant percentage of patients with vulval LP have associated
alopecia, with FFA being the commonest clinical pattern. This suggests a further expansion of the
FFA clinical spectrum, identifying a specific subgroup with concomitant vulval involvement.
P072
Reassessing the histopathology of primary cicatricial alopecias: an evaluation of
256 biopsies
AB Bormate Jr.1, VH Price2 and TH McCalmont3 1Section of Dermatology, Department of
Medicine, University of the Philippines - Philippine General Hospital, Manila, Philippines;
2Department of Dermatology, University of California San Francisco, San Francisco, California,
USA and 3Department of Pathology, University of California San Francisco, San Francisco,
California, USA
Despite years of study, many dermatopathologists find it difficult to render specific diagnoses
based solely on histopathological features. A small study demonstrated that histopathological
findings in biopsies from 20 cicatricial alopecia patients were separable into lymphocyte-
mediated and neutrophil-mediated cicatricial alopecia.
With a significantly larger sample, this study aimed to test whether certain histopathological
features are characteristic of specific clinical variants. It also aimed to compare the histopathology
of cicatricial and non-cicatricial alopecias.
Cases were retrieved and reviewed from records of the UCSF Dermatopathology Service and the
UCSF Hair Clinic. Clinical and histopathologic diagnoses were tabulated and matched to the
NAHRS working classification. Consecutive cases were included up to a maximum of 30 per
entity. Histopathologic assessment was blinded. Cases of chronic cutaneous lupus erythematosus
(CCLE) were included. Non-cicatricial alopecia cases served as controls. Over 25 histopathologic
attributes were scored, tabulated, and compared.
A total of 256 biopsies were scored, including 198 from 109 cases of cicatricial alopecia, 27 from
CCLE, and 31 from non-cicatricial alopecia cases. Irrespective of the clinical diagnosis, cicatricial
alopecia was typified by concentric perifollicular fibrosis, loss of sebaceous glands, inflammation
involving the upper segment, compound follicle formation, and scarring of fibrous tracts. A
plasmacyte-rich infiltrate (49% vs. 1%), extra-adventitial inflammation (80% vs. 22%), and
fibrosis (78% vs. 5%), and extensive compound follicle formation (60% vs 10%) favored a
diagnosis of neutrophil-mediated rather than lymphocyte-mediated cicatricial alopecia. Features
that have been suggested to be specific to certain clinical variants, like squamotization and
premature desquamation of the inner sheath, were not limited to lichen planopilaris or central
centrifugal alopecia and were identified in other cicatricial alopecias.
We contend that many attributes held to be characteristic of certain clinical variants of cicatricial
alopecia are not specific. However, a distinction between lymphocyte-mediated and neutrophil-
mediated cicatricial alopecia is generally possible.
P073
Impaired ubiquitin–proteasome system in cicatricial alopecia: implications for
inflammatory response
RS Subbaiah, MC Consolo, P Mirmirani, VH Price and P Karnik Department of Dermatology,
Case Western Reserve University, Cleveland, Ohio, USA
Primary cicatricial alopecia (PCA) is a group of inflammatory disorders that cause scarring and
permanent hair loss. Mechanisms that trigger the inflammatory response in PCA are poorly
characterized. Here, the goal was to determine whether the ubiquitin–proteasome system (UPS), a
major ATP-dependent protein degradation pathway, is defective in PCA. The UPS consists of
concerted actions of enzymes that tag ubiquitin onto proteins to mark them for degradation. This
leads to their recognition by the 26S proteasome complex that degrades ubiquitinated proteins. TEM
studies of PCA subtypes showed the accumulation of protein aggregates in hair follicle cells. Studies
aimed to identify protein aggregates tagged or untagged with ubiquitin from diseased cells are
currently in progress. Evidence of protein aggregation suggests for the first time that the proteasome
system may be impaired in PCA. We used an integrated proteomics and transcriptomics approach to
characterize the UPS in centrifugal cicatricial alopecia (CCCA), frontal fibrosing alopecia (FFA), and
lichen planopilaris (LPP). Our analysis revealed that the gene and protein expression associated with
the proteasome complex is deregulated in unaffected scalp tissue in all subtypes. In addition,
enzymes required for protein ubiquitination are de-regulated, suggesting the impairment of the UPS
in PCA. To determine if oxidative stress causes UPS inactivation, we carried out western blotting
with four hydroxynonenal antibodies. Mass spectrometric analysis of the bands obtained showed
that enzymes of the ubiquitin–proteasome complex are subject to oxidative modification, suggesting
that this post-translational modification causes impairment of UPS. Intriguingly, proteome analysis
identified the major histocompatibility complex (MHC) and inflammasome proteins to be de-
regulated in PCA. Our data suggest that accumulation of damaged proteins due to UPS impairment
may serve as the primary trigger for inflammatory responses in PCA. Thus, UPS activation may be a
promising new treatment strategy for PCA.
P074
Small fiber neuropathy in symptomatic lichen planopilaris (LPP) and frontal
fibrosing alopecia (FFA)
M Hordinsky1, S Kavand1, W Kennedy2, G Crabb2, M Pierre-Louise1, I Doche3 and M Ericson1
1Department of Dermatology, University of Minnesota, Minneapolis, USA; 2Department of
Neurology, University of Minnesota, Minneapolis, USA and 3Department of Dermatology,
University of Sao Paulo, Sa˜o Paulo, Brazil
LPP is a cicatricial alopecia that is commonly associated with scalp symptoms such as pain,
burning, paresthesias, and pruritus. FFA is a clinically distinct cicatricial alopecia but is
histologically very similar to LPP. There has been little research on the role of neurogenic
inflammation in these diseases. While peroxisome proliferator-activated receptor gamma (PPARg)
expression has been found to be decreased in lichen planopilaris (LPP), neuropeptide-induced
inflammation may also be a major contributor to disease pathogenesis and symptomatology.
Calcitonin gene-related peptide (CGRP) is elevated in chronic inflammatory conditions, while
PPARg is usually decreased. Substance P (SP) induces production and release of cytokines such as
IL-1, IL-6, and TNF-a in addition to PPARg through the neurokinin 1 (NK1) receptor. To evaluate
the role of neurogenic inflammation in LPP and FFA, 4-mm skin biopsy specimens were obtained
from the affected scalp skin of four LPP patients, three FFA patients, and six control subjects. The
biopsy samples were stained for Protein Gene Product (PGP) 9.5, CGRP, and SP using an
immunofluorescence technique. The distribution and quantification of CGRP and SP expression
in the subepidermal nerve plexus and PGP 9.5 in epidermal nerve fibers were evaluated using
confocal microscopy. We found a statistically significantly lower epidermal nerve fiber density
(Po0.05), a trend toward lower CGRP expression, and similar SP expression in patients with both
LPP and FFA as compared to normal control samples. These findings suggest the pain-affected
patients’ experience could be related to the loss of epidermal nerve fibers, characteristic of a small
fiber neuropathy. Treatment with medications such as topical gabapentin or clonidine could
potentially be beneficial in symptomatic patients.
P075
Epidemiology of patients with central centrifugal cicatricial alopecia
A McMichael1, C Hector2 and G Binsaif3 1Department of Dermatology, Wake Forest School of
Medicine, Winston-Salem, North Carolina, USA; 2Wake Forest School of Medicine, Winston-
Salem, North Carolina, USA and 3Department of Dermatology, King Saud University Riyadh,
Riyadh, Saudi Arabia
Central centrifugal cicatricial alopecia (CCCA) is a form of scarring hair loss primarily seen among
African American women. Symptoms and the severe disfigurement caused by this form of hair
loss lead to large numbers of patients seeking treatment. This study examines common hair care
practices, family history, health history, and stage of disease in CCCA patients.
A survey was administered including: severity of CCCA, age of onset, familial prevalence,
concurrent medical conditions, efficacy of treatments used, and history of all hair care practices
employed. Stage of hair loss was recorded and photographs of each subject’s scalp were taken.
Thirty-eight subjects were recruited. Subjects presenting with stage 5 hair loss according to the Central
Scalp Scale report an average duration of hair loss that is longer than those with stage 1. Subjects with
more severe CCCA tend to shampoo more frequently. Steroids, topically applied or given as injections
to the scalp, are both the most commonly used treatment for CCCA and are reported to have helped
more than topical minoxidil (Po0.001). Of the many listed concurrent medical conditions, over 50%
of subjects reported experiencing facial hair growth, vaginal yeast infections, and seborrheic
dermatitis. Of the 38 subjects, 37 reported a history of using a chemical relaxer on their hair and 21
subjects continue to use a relaxer. Using a hot comb, and other styling techniques, also has a high
prevalence in the subjects’ history but is not used in their current routine.
The study was conducted with subjects seen in one medical center, but these data will be
combined with that from other sites, totalling 250 subjects as part of the NAHRS Cicatricial
Alopecia Work Group. A larger sample size from regions across the United States will further
provide valuable information and add strength to the trends we have found.
P076
Facial papules in women with frontal fibrosing alopecia
JC Donovan Department of Dermatology, University of Toronto, Toronto, Ontario, Canada
Introduction: A connection between facial papules and frontal fibrosing alopecia was recently
introduced to the literature. Papule histology resembles that of lichen planopilaris.
Objective: To review the frequency of facial papules in patients seen in the University of Toronto
Hair Clinic over the years 2010–2012 and to identify risk factors and response to treatment.
Materials and methods: A retrospective review of clinical and photographic records of patients
with FFA was performed.
Results: Thirty-four patients with frontal fibrosing alopecia were identified. Thirty patients were
post-menopausal and four were pre-menopausal. Facial papules were present in 10 (32%). In
eight women the facial papules developed slowly and in two women they developed rapidly
associated with intense erythema. Compared to women without the facial papules, women with
facial papules were more likely to have indicated loss of body hair (80% vs. 17%, Po0.005).
Facial papules were also more likely in women with more than 1.5 cm of frontal loss (62% vs.
10%, P¼0.002). Topical treatment of the facial papules was uniformly poor, including those
involving topical steroids, retinoids, metronidazole, and tacrolimus. One woman developed
facial papules while concurrently receiving oral hydroxychloroquine and experienced resolution
without further treatment.
Conclusion: Facial papules are associated with frontal fibrosing alopecia in a proportion of
women, and, like the scalp condition itself, present particular treatment challenges.
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Review of the use of diphencyprone in the treatment of alopecia areata: the last
20 years in Glasgow
RC Lamb and S Holmes The Alan Lyell Centre for Dermatology, Southern General Hospital,
Glasgow, UK
Immunotherapy with diphencyprone (DCP) can be used to treat alopecia areata (AA); however, its
efficacy is variable within the literature and response to treatment cannot currently be predicted.
We reviewed the patient data from our DCP service from 1991 to 2010, including outcome and
patient variables that may affect treatment response.
During this time we carried out 205 treatments with available data. A total of 162 courses of
treatment (on 133 patients) were completed and overall 19.1% (31/162) had a response of
90–100% cosmetic satisfaction or complete re-growth (490% cosmetic satisfaction).
Overall 62.4% (101/162) of patients had some response to DCP treatment (including vellus hair)
detectable at the end of the treatment course, but 23.5% (38/162) did not respond. An additional
13% (21/162) responded to DCP but relapsed during treatment. Our data suggested that patients
with mild AA, a shorter history of AA, and no history of atopy are more likely to achieve 490%
cosmetic satisfaction. Additionally, on average, patients achieving 490% cosmetic satisfaction
had been exposed to a higher median concentration of DCP compared to non-responders.
In all, 5.9% (12/205) of patients commencing DCP treatment terminated treatment early due to
side effects. Notable side effects included a type-I urticarial reaction to DCP, severe facial
swelling, and an acneiform eruption.
Overall our data, which appear to be one of the largest consecutive series of patients treated with
DCP, suggest that in our unit approximately 1 in 5 patients achieve 490% cosmetic satisfaction
with DCP treatment; however, 1 in 5 patients does not respond. In addition, it may support
previous reports of the associations of atopy, longer history of AA, and more extensive AA with a
less favorable outcome to DCP and appeared to be well tolerated by most.
P078
Analysis of quantitative changes in hair growth during treatment with
chemotherapy or tamoxifen in breast cancer patients: a cohort study
N Garcia Bartels, K Hillmann, J Lindner, R Nuwayhid, A Stroux, J Lademann and U Blume-
Peytavi Klinik fu¨r Dermatologie, Venerologie und Allergologie, Charite´-Universita¨tsmedizin
Berlin, Berlin, Germany
Aims: Chemotherapy-induced alopecia (CIA) is widely dreaded by breast cancer patients. The
onset, pattern, and amount of hair loss differ depending on the treatment regime and have not yet
been quantified using standardized techniques. This study aimed at quantifying and comparing
the effect on hair loss in women receiving either chemotherapy or tamoxifen, by evaluating hair
growth parameters.
Methods: In a monocentric, prospective observational cohort study, 34 breast cancer patients,
after surgery treated with either chemotherapy or tamoxifen, were included. Patients were
evaluated once before, twice during, and twice after therapy. At each visit, telogen–anagen hair
ratio and hair density per cm2 were quantified by phototrichogram in two defined areas of the
scalp, one frontal and one occipital. The course of hair loss and regrowth was visualized with
global photography.
Results: Telogen hair ratio increased on both investigation sites after 3 and 6 weeks of
chemotherapy. Two weeks after cessation of chemotherapy, telogen hair ratio decreased and hair
density was lower compared to baseline. Twelve weeks after cessation of chemotherapy baseline
levels of hair density were reached. Patients treated with tamoxifen showed no significant
differences in telogen–anagen hair ratio. Hair density decreased in the frontal areas 18 weeks after
therapy onset, but not in the occipital area.
Conclusions: This study reveals that the type, course, and quantity of hair loss differ comparing
chemotherapy and tamoxifen. Evaluation of CIA using objective methods is mandatory to
evaluate preventive or therapeutic outcomes in the future.
P079
Adalimumab to treat recalcitrant dissecting cellulitis of the scalp
Y Mansouri and MR Kaur Department of Dermatology, Heart of England NHS Trust, Solihull
Hospital, Solihull, UK
Dissecting cellulitis of the scalp (DCS) is an uncommon condition, mostly seen in young men.
Treatment is often disappointing and includes antibiotics, oral isotretinoin, topical, intralesional
and systemic steroids, radical surgical excision with skin grafting, carbon dioxide laser, and, more
recently, tumor necrosis factor (TNF) antagonists. To date there have been six reports of DCS
treated with TNF antagonists (adalimumab and infliximab). We report our recent experience using
adalimumab to treat recalcitrant DCS, and review the literature in this area.
A 48-year-old Afro-Caribbean man presented with a 20-year history of tender plaques, sinuses,
and pustules with foul-smelling discharge on the scalp leading to scarring alopecia. He was under
a hepatologist for fatty liver disease, with GGT levels up to 37 times the upper limit of normal, and
ALT twice the upper limit. Skin biopsy was in keeping with DSC.
Various treatment modalities had been unsuccessful, including topical and intralesional steroids,
long-term prednisolone up to 20 mg daily, systemic antibiotics (doxycycline, flucloxacillin,
ciprofloxacin, amoxicillin, erythromycin, and clarithromycin), dapsone, isotretinoin, and surgical
drainage. The involved area was too extensive for surgical resection alone and therefore anti-TNF-
a agents were considered with or without surgery for any residual disease. Most cases of liver
toxicity associated with TNF antagonists have been linked to infliximab and to a lesser extent to
etanercept; therefore we chose adalimumab. This was initiated 7 weeks ago with a partial
response so far and we plan to update you on his further progress. Reassuringly, his liver function
has improved since initiation. There have been four previous reports of treatment of DCS with
adalimumab, however, none in a patient with liver disease.
The treatment of DCS remains challenging, but anti-TNF-a agents promise at least palliative
treatment of this disfiguring disease, thus potentially reducing the extent of scarring alopecia and
reducing the need for extensive surgical excision.
P080
Clinical characteristics and prevalence of chemotherapy-induced alopecia in
childhood
M Choi1, SY Park1, DL Jin1, MS Kim2, KH Cho1, HJ Kang2 and OS Kwon1,3 1Department of
Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Division
of Hematology/Oncology, Department of Pediatrics, Seoul National University College of
Medicine, Seoul, Republic of Korea and 3Institute of Human-Environment Interface Biology,
Seoul National University College of Medicine, Seoul, Republic of Korea
Chemotherapy-induced alopecia (CIA) is a frequently observed complication with high psycholo-
gical morbidity in patients who underwent chemotherapy. In addition, there is an increasing number
of reports of permanent CIA, which usually occurs under high-dose conditioning chemotherapy and
subsequent hematopoietic stem cell transplantation (HSCT). We investigated the clinical
characteristics of CIA, including permanent CIA, in pediatric patients and analyzed factors that
might be associated with development of CIA. We conducted a questionnaire survey in pediatric
patients who had been treated with high-dose conditioning chemotherapy followed by HSCT due to
various underlying diseases. In addition, we obtained clinical details from reviews of medical
records and evaluated the status of hair regrowth by global photography and phototrichogram.
A total of 159 patients were included. The mean age of participants was 12.1±5.3 years
(mean±SD) and age at diagnosis and HSCT were 6.2±4.7 and 7.4±4.9 years, respectively.
Mean hair density was 198.3±47.4 cm2. CIA began at 1.5±1.4 months and sustained till
2.2±1.6 months after the initiation of chemotherapy.
Hair regrowth started 2.6±1.6 months after chemotherapy ceased and lasted for 7.3±4.9
months. When hair regrew following chemotherapy, 67.1%, 58.3%, and 78.8% of patients
experienced density, color, and texture change compared with hair status before chemotherapy,
respectively. Regrown hair was thinner (80.4%) and lighter (79.8%) than the original in texture
and color. Out of 159 patients, 19 (12%) had extensive hair loss (Olsen criteria 4 or more) at 6
months post chemotherapy, namely permanent CIA. Increasing age at HSCT is a significant risk
factor for permanent CIA by multivariable logistic regression analysis (Po0.05).
Although CIA in the pediatric patients has been not investigated compared to adult patients, it
surely is a very distressing side effect in children at an impressionable age. Therefore we must
provide appropriate information before and after chemotherapy and support the patients
psychologically.
P081
Loose anagen hair syndrome: a survey of 171 patients
R Lurie1 and D Ben-Amitai2 1Pediatric Dermatology Hair Research Clinic, Schneider Children’s
Medical Center of Israel, Petah Tiqva, Tel Aviv, Israel and 2Pediatric Dermatology Hair Research
Clinic, Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel
Background: The loose anagen hair (LAH), which is also known as loose anagen syndrome (LAS),
is a disorder of abnormal anagen hair anchorage. The LAH is a sporadic or autosomal dominant
disorder with variable expressivity that primarily affects children. The typical complaint of the
parent is that the child’s hair is lusterless and does not grow. Gentle traction results in hair that is
painlessly removed. Diagnosis of LAH syndrome relies on the number and percentage of LAH at
the hair-pull test and on trichogram. Olsen et al and Tosti et al proposed diagnostic criteria for
LAS on the basis of the hair pull test and trichogram. Pull-test results with a painless extraction of
at least 10 LAHs and the presence of more than 80% LAH on trichogram were regarded as
positive.
Patients and methods: Between 2000 and 2012, 450 consecutive children who applied to a
specialist hair clinic were assessed for loose anagen hair syndrome (LAS). The diagnosis included
a complete medical case history, clinical examination, hair pull test, and trichogram administered
to each patient. Scanning electron microscopy (SEM) was performed on selected cases. A total of
171 children with LAS having the minimum percentage of 80% LAH were chosen from 450
children who had a percentage of LAH 450%.
Results: Children with LAH included 131 girls (76.6%) and 40 boys (23.4%). More statistical
analysis will be presented in the poster. We will show association with hereditary or
developmental disorders that we found.
Conclusion: LAH syndrome occurs in children and could be on the one hand underdiagnosed; on
the other hand, unaffected individuals may present with the same mutation as observed in the
affected. The condition is not rare. LAS should be diagnosed only when the pull test shows 85% or
more LAH and trichogram shows 80% or more LAH.
P082
A pilot clinical study of hair grafting in chronic leg ulcers
F Jimenez1, C Garde2, E Poblet3, B Jimeno2, J Ortiz2, M Martı´nez4, A Gutierrez-Rivera5, V Perez-
Lopez5, U Etxaniz5, C Naveda2, JL Higuera6, N Egu¨es7, E Escario4 and A Izeta5 1Clı´nica Dr.
Jimenez-Acosta, Las Palmas, Gran Canaria, Spain; 2Outpatient Care Unit, Hospital Donostia, San
Sebastian, Spain; 3Anatomı´a Patolo´gica, Universidad de Murcia, Murcia, Spain; 4Department of
Dermatology, Hospital General Universitario de Albacete, Albacete, Spain; 5Department of
Bioengineering, Instituto Biodonostia, San Sebastian, Spain; 6Department of Vascular Surgery,
Hospital Donostia, San Sebastian, Spain and 7Research Unit, Instituto Biodonostia, San Sebastian,
Spain
Epidermal sheets spread centrifugally post injury from the hair follicle infundibulum to
reepithelialize the wound bed. Healing progresses faster in skin areas rich in terminal hair
follicles. These observations are consistent with the role of the hair follicle as a major reservoir for
progenitor cells. To evaluate the feasibility and potential healing capacity of autologous scalp
follicular grafts transplanted into the wound bed of chronic leg ulcers, 10 patients with ulcers of
an average size of 36.8 cm2 and a 10.5-year duration were included in this pilot study. Within
each ulcer we randomly assigned a 2 cm 2 cm ‘‘experimental’’ square to receive 20 hair grafts
and a nongrafted ‘‘control’’ square of equal size. The procedure seemed to be safe. At the 18th-
week end point, we observed a 27.1% ulcer area reduction in the experimental square as
compared with 6.5% in the control square (P¼ 0.007). Histological analyses showed enhanced
epithelialization, neovascularization, and dermal reorganization. We conclude that terminal hair
follicle grafting into wound beds is feasible in an outpatient setting and represents a promising
therapeutic alternative for nonhealing chronic leg ulcers. We conclude that terminal hair follicle
grafting into wound beds is feasible in an outpatient setting and represents a promising
therapeutic alternative for nonhealing chronic leg ulcers.
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Frontal fibrosing alopecia and lupus overlap in a man
S Khan1, DA Fenton2 and CM Stefanato1 1Department of Dermatopathology, St John’s Institute of
Dermatology, London, UK and 2St John’s Institute of Dermatology, London, UK
A 46-year-old Caucasian man, with an otherwise unremarkable past medical history, presented
with a 3-months history of eyebrow thinning. On examination he was found to have erythematous
and pruritic eyebrows, associated with preauricular and supraauricular hair loss. One year later
he reported the development of photosensitivity and photo-aggravation at the sites of hair loss. An
initial biopsy of the left temple showed decreased density of terminal hair follicles and focal
perifollicular fibrosis, consistent with scarring alopecia. Direct immunofluorescence study was
negative. Two years later, he represented with worsening hair loss. On examination, almost
complete loss of the eyebrows, beard, and hair thinning bilaterally at the temples, as well as hair
loss of the forearms were noted. Biopsies from the scalp, eyebrow, and arm all showed the
features of lichen planopilaris. This pathology, combined with the clinical picture, was consistent
with frontal fibrosing alopecia (FFA). However, basement membrane zone thickening was
highlighted by PAS on both the scalp and eyebrow biopsies. Direct immunofluorescence study
demonstrated a bright granular basement band staining with IgG and, to a lesser extent, IgM, IgA,
and fibrin, consistent with lupus. The patient’s serology subsequently revealed positivity for
antinuclear antibodies, anticardiolipin antibodies, and lupus anticoagulant. There were no
systemic symptoms of lupus. This case is noteworthy, as it illustrates the rare occurrence of frontal
fibrosing alopecia in a man. Also, this is only the seventh case of biopsy-proven FFA in a male
reported in the literature and, moreover, the first male case with coexisting lupus. Our case
highlights the importance of multiple biopsies and follow-up in the diagnosis of FFA-lupus
overlap syndrome.
P085
Sebaceous gland atrophy: a potential pitfall in the histopathologic evaluation of
non-scarring alopecia associated with psoriasiform dermatitis of the scalp
NL Clayton, DA Fenton and CM Stefanato St John’s Institute of Dermatology, St Thomas’ Hospital,
London, UK
Sebaceous gland atrophy of the scalp was originally reported by Headington et al. in 1989 in
association with psoriasis. This finding is seldom taken into consideration when evaluating scalp
biopsies in the context of nonscarring alopecia. Sebaceous glands undergoing atrophy show loss
of mature sebocytes, leaving basaloid epithelial aggregates that can morphologically resemble
telogen hair follicles. Furthermore, advanced sebaceous gland atrophy resulting in complete loss
may mimic scarring alopecia. We searched our alopecia histopathological database between
2006–2012, looking for scalp biopsy reports containing the terms ‘‘psoriasiform epidermis’’,
‘‘psoriasis’’, and ‘‘seborrhoeic dermatitis’’. Ten cases were identified, eight of which were
retrieved and studied. All biopsies had been sectioned horizontally and vertically. Clinically, all
patients had a history of hair loss but only one case provided a history of psoriasis and one of
severe eczematous dermatitis involving the scalp. Histologically, all cases showed nonscarring
alopecia with overlying psoriasiform epidermis and variable degrees of sebaceous gland atrophy
simulating telogen hair follicles and scarring alopecia. Our study highlights the importance of
being aware of sebaceous gland atrophy when evaluating scalp biopsies for nonscarring alopecia.
We also draw attention to potential diagnostic pitfalls that may occur in the absence of adequate
clinical–pathological correlation.
P086
Trichorrhexis nodosa after hair transplantation: dermoscopic, pathologic, and
electron microscopy analyses
BC Park1, JY Kim1 and ST Hwang2 1Department of Dermatology, Dankook University College of
Medicine, Cheonan, Republic of Korea and 2Doctor Hwang’s Hair-Hair Clinic, Seoul, Republic of
Korea
Trichorrhexis nodosa may have a genetic etiology but appears to result from repeated physical
and chemical trauma, such as hair permanent liquid and blow drying. Although repeated hair
shaft trauma is the major cause of acquired trichorrhexis nodosa, the other factors that cause
acquired trichorrhexis nodosa remain inconclusive. Hair transplantation is a relative safe
procedure compared to other surgical corrections for alopecia, but mild or severe complications
can occasionally result from malpractice or poor quality control. Herein, we report a previously
unpublished case of trichorrhexis nodosa induced by hair transplantation and describe the
evaluation of this condition with blood test, dermatoscopy, scanning electron microscopy, skin
biopsy, and hair mineral analyses. A 38-year-old man visited our dermatology clinic with
breakage and lack of growth in hair that had been transplanted 3 years previously. The
transplanted hairs failed to grow and broke off easily, although 1 year had passed since the hair
transplantation. The overall survival rate of the transplanted hairs was very low. Transplanted
hairs were distributed sparsely, and were short and lusterless on the recipient frontal area of the
scalp. On dermoscopic examination, intermittent whitish discolored nodes of hair shaft were
apparent, and the ends of the hair appeared weathered on close observation. There were many
transplanted hairs with pits on the recipient area. The tips of hairs were severely split and the
nodular swelling of the hair shaft exhibited the so-called ‘crushed paint brush’ appearance upon
scanning electron microscopy. Histopathologic examination of the scalp biopsy showed a fibrous
tract around the previous transplanted follicles. We also assessed if the transplanted hairs were
located more deeply than the surrounding existing normal hairs. The blood and hair mineral
analyses, which included a thyroid function test and copper and sulfur determinations, were
normal.
P087
Invisible bleeding from clean-shave haircuts
NP Khumalo1,2, K Mkentane3,4, C Muthukarapan5, D Hardy6, S Korsman6, P Berman7, T
Mthebe8, LM Davids4 and J Rousseau5 1Division of Dermatology, University of Cape Town, Cape
Town, South Africa; 2Division of Dermatology, Groote Schuur Hospital, Cape Town, South
Africa; 3Department of Dermatology, University of Cape Town, Cape Town, South Africa;
4Department of Human Biology, University of Cape Town, Cape Town, South Africa;
5Department of Genetics, University of Cape Town, Cape Town, South Africa; 6Divisions of
Medical Virology, University of Cape Town, Cape Town, South Africa; 7Department of Chemical
Pathology, University of Cape Town, Cape Town, South Africa and 8Department of Clinical
Laboratory Sciences, Groote Schuur Hospital, Cape Town, South Africa
Blood-borne viruses such as the human immunodeficiency virus (HIV) are a major public health
concern affecting millions of people worldwide. The risk of virus transmission through non-sexual
routes such as contaminated barbering equipment could easily be eliminated with adequate
sterilization. A history of at least one episode of visible bleeding after a clean-shave haircut has
been reported in 32% and 24% of men from a population and an HIV study respectively.
Although hairdressers have recommended practice, there is little to no evidence of equipment
sterilization. Specific RNA markers are used in forensic medicine to detect invisible blood; this
study aimed to investigate whether these markers could be used to detect microscopic bleeding
resulting from clean-shave haircuts. An initial pilot study including five men of unknown HIV
status was conducted in 2011. Two swab samples were collected from the scalp of each
participant immediately after a clean-shave haircut performed by a professional barber with no
visible surface exudate; one sample was tested for RNA markers hemoglobin beta (HBB), spectrin
beta (SPTB), and porphobilinogen deaminase (PBGD), and the second for albumin. A follow-up
study included eight HIV-positive males; two scalp swab samples were taken from each person
and tested for HBB and HIV PCR using a commercial test. In the first pilot study 4/5 samples were
positive for both HBB and albumin. Thus, HBB was considered the more reliable marker and used
for the second study, in which 1/8 participants tested positive for HBB. HIV was not detected in
any of the eight HIV-positive participants. No visible bleeding was observed by the volunteers,
barbers, and doctor collecting the samples. However, evidence of bleeding was found in 46% of
subjects, a concerning finding that requires further scrutiny in our country with its high HIV
prevalence.
P088
Appearance of mycosis fungoides (MF) localized on the scalp with clinical signs of
alopecia areata
A Miesel, M Fleischer, C Rose, TW Fischer and D Zillikens Department of Dermatology,
Allergology and Venerology, University Hospital of Luebeck, Luebeck, Germany
A 67-year-old woman presented in our weekly hair disease clinic with massive, patchy hair loss
and strongly positive pull test. She had a history of 30 years of parapsoriasis on the trunk and
extremities. On the scalp, several slightly reddish, up to 8-cm-large, scaly patches of nearly
complete, diffuse hair loss without signs of scarring were visible. One of the differential diagnoses
was an initial alopecia areata (AA), but the slight erythema and the whitish dandruff did not
support this diagnosis. On the extremities and the trunk there were multiple oval, livid-red
macules. A biopsy from the scalp showed histologically a folliculotropic mycosis fungoides (F-
MF) with a peri- and intrafollicular infiltrate of mostly CD4-positive, atypical T-lymphocytes. Prior
biopsies of the trunk showed the histological picture of a parapsoriasis. Not only histologically
there are parallels between F-MF and AA, but also clinically, an AA-like appearance of hair loss in
patients with MF has been described. In patients with AA we could recently demonstrate that an
oral prednisolone pulse therapy descending from 50 to 10 mg per day over 8 weeks showed good
results with hair regrowth in 81% of the cases. In the case presented here, we therefore applied
this treatment scheme and observed a stop of hair loss with negativation of pull test after 8 weeks
of therapy. Dense hair regrowth occurred another 8 weeks later. In conclusion, F-MF should be
considered and a biopsy should be taken if the diagnosis of AA is clinically doubtful. Therapeutic
options are glucocorticoids or bexarotene, both topical and oral.
P089
Dermatomyositis and scalp pruritus is associated with small fiber neuropathy
M Hordinsky1, S Kavand1, G Crabb2, E Hurliman2, K Bohjanen1, K Kane1 and W Kennedy2
1Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA and
2Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA
Scalp involvement in dermatomyositis (DM) is common and manifests as an erythematous
to violaceous psoriasiform dermatitis. Pruritus is common. We report a 40-year-old
Caucasian woman with a diagnosis of DM who was referred for evaluation and treatment
of severe scalp pruritus of 4 years duration. Examination of the scalp revealed diffuse erythema
and fine scale; examination of the rest of the integument revealed the presence of
Gottron’s papules and a diffuse poikiloderma of her neck, face, and upper back. Despite
multiple topical and systemic treatment modalities including topical and systemic steroids,
mycophenolate mofetil, dapsone, methotrexate, IVIG, and hydroxychloroquine the patient’s
scalp pruritus persisted. At the time of presentation, she was taking hydroxychloroquine 200 mg
twice per day. Examination of herscalp biopsy revealed hyperkeratosis, epidermal effacement,
and a thickened basement membrane. No significant dermal inflammatory component was
seen. A 4-mm scalp biopsy was also obtained from affected scalp skin and from a normal
healthy control for nerve studies. The samples were stained for Protein Gene Product 9.5 (PGP
9.5) using an immunofluorescence technique. The distribution and structure of PGP-
immunoreactive nerve fibers were evaluated in the upper dermis and epidermis using confocal
laser microscopy. Visual microscopic examination and quantitative analysis of the microscopy
images suggested morphological abnormalities characterized as ‘‘sprouting’’ or ‘‘tufting’’
abnormalities of epidermal nerve fibers along with a significant decrease of epidermal nerve
fiber density similar to that observed in some cases of small fiber peripheral neuropathies. Further
studies are needed to confirm these changes in a larger number of patients with DM and scalp
pruritus. These results provide an opportunity to consider novel treatment approaches with agents
such as topical gabapentin or oral medications that target neuropathic changes such as
pregabalin, the selective serotonin reuptake inhibitors (SSRIs), or mixed serotonin noradrenaline
reuptake inhibitors.
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Inverse Koebner reaction observed in alopecia areata: the Renboek phenomenon
J Ovcharenko1, O Litus2, K Khobzey3, I Serbina1 and A Zlotogorski4 1Department of
Dermatovenereology, Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine;
2Department of Dermatovenereology, National Medical Academy of Postgraduate Education,
Kyiv, Ukraine; 3Medical Centre EuroDerm, Kyiv, Ukraine and 4Department of Dermatology and
the Center for Genetic Diseases of the Skin and Hair, Jerusalem, Israel
Psoriasis and alopecia areata (AA) may be present in one patient. In some patients the
development of psoriasis in AA lesions may be followed by the Renboek phenomenon (hair
regrowth starting from the psoriatic plaques within the AA area). In Koebner phenomenon
psoriasis appears in traumatic or inflammatory regions. In Renboek phenomenon the
inflammatory process is inhibited by psoriasis. We describe a 23-year-old woman who developed
psoriasis of the trunk and elbows at age 13, and scalp AA at age 15, both of which resolved
following topical treatment with steroid creams. In April 2012 psoriasis recurred, involving the
trunk, extremities, and the scalp. In June 2012 the psoriasis on the central scalp completely
resolved following the appearance of a focus of AA in this region. Later, in August 2012, the
relapse of psoriasis in the scalp was followed by partial hair regrowth in the AA region. The
transition from psoriasis to other immune-mediated inflammatory disease may be induced by
cytokine balance changes. Consequently, in some cases psoriasis may be the cure for AA
(Renboek phenomenon). Nevertheless, other potential mechanisms should be further investi-
gated, as it might be the clue to new specific pathogenic treatment of AA.
P091
Drug-induced hair loss—rational diagnostics and therapeutic options
GA Lutz Hair & Nail, Bonn, Germany
Hair loss induced by drugs is often discussed controversially despite it being caused
by antineoplastic agents. But, besides the neoplastic agents, there are many other different
drugs that can cause diffuse hair loss and consequential alopecias. Usually, only scalp hair is
involved, and patients note hair loss 3–4 months after beginning a medication. The hair loss is of
the diffuse type and is dominated by a telogen effluvium if the drug has only a moderately
inhibiting potency. In cases of strong inhibition, such as with antineoplastic agents,
severe alopecias can occur within the first 3 weeks of medication, characterized by telogen/
dystrophic hair root patterns. In most cases hair regrowth starts after discontinuation of the
medication. But in certain cases alopecia can remain. To confirm drug-induced hair loss, all
medicines taken in the past 4 months must be analyzed as possible agents of disturbing hair
growth. When there is a temporal association between the onset of hair loss and the
commencement of a medication, the medication can be taken into account as a possible cause
of the hair loss, especially when other triggers of telogen effluvium or diffuse hair loss are
excluded. Possible causes and diseases that induce and imitate diffuse hair loss can be very
different, e.g., dermatological, internal, and endocrinological diseases, childbirth, fever, iron,
zinc, or biotin deficiency, or hair damage through cosmetic procedures. A thorough exclusion of
these potential confounders is necessary before hair loss can be attributed to the medication.
What evidence-based diagnostic and relevant therapies should be taken into consideration to
solve this problem? This presentation summarizes 20 years of experience in the management of
drug-induced hair loss, and discusses the relevance of specific diagnostic procedures, as well as
possible therapeutic options and their results.
P092
Weft hair extensions causing a distinctive horseshoe pattern of traction alopecia
J Ahdout1 and P Mirmirani2 1Department of Dermatology, University of California, Irvine,
California, USA and 2Department of Dermatology, University of California, San Francisco,
San Francisco, California, USA
Traction alopecia (TA) represents a pattern of traumatic hair loss caused by a pulling force applied
to the hair shaft over time. This excessive tensile force results from hair styling practices such as
tight ponytails, braids, cornrows, chingons, or religious head coverings. Hair loss of the marginal
hair line with a ‘‘fringe sign’’ is the most commonly recognized pattern of TA. Weft hair
extensions, which have gained in popularity because of their ease and rapidity of application,
may also cause TA, but in a distinct ‘‘U’’ or horseshoe pattern. Wefted hair extensions consist of
multiple strands of hair held together by a band of fine threads. These extended-wear hairpieces
are attached directly to the hairline by being sewn, bonded, glued, or clipped. Hair loss in a
horseshoe pattern may mimic scarring alopecia; however, a detailed history will often reveal the
cause of hair loss.
P093
Scalp eccrine porocarcinoma arising in nevus sebaceous of Jadassohn
FA Mardones1 and I Harz2 1Department of Dermatology, University of Chile, Santiago, Chile and
2University of Andes, Santiago, Chile
Nevus sebaceous of Jadassohn (NSJ) is a cutaneous hamartoma usually located in the scalp and
may contain epidermal, follicular, sebaceous, apocrine, and eccrine elements. Up to 15 percent
of them may develop benign or malignant tumors, most commonly syringocystoadenoma
papilliferum, trichoblastoma, and basal cell carcinoma. Although surgical removal is indicated,
the timing of excision is controversial, since malignant degeneration is rare before puberty.
Localized enlargement and ulceration suggest malignant transformation in a preexisting NSJ. In
this case report, an unusual porocarcinoma (PC) developed within a longstanding scalp NSJ. A
35-year-old healthy man consulted for a rapidly growing tumor in his scalp. He had this lesion
since childhood, but in the last 4 months a nodule had grown in one of its margins. Physical
examination showed a 1.5 1.1 cm2 yellowish-orange irregular alopecic plaque in the left
parietal area. Complete surgical excision was performed and histopathology informed marked
epithelial hyperplasia, and prominent sebaceous glands together with small and rudimentary hair
follicles, suggestive of the NSJ. In the same sample, multiple intraepidermal nests of poroid cells
were observed, with atypia, pleomorphism, and necrosis that also extended into the dermal
stroma. These findings indicated a PC. Eccrine PC is uncommon and develops from intraepithelial
or upper dermal acrosyringium of eccrine sweat glands. It may develop as a primary tumor or
from malignant transformation of eccrine poroma. Less than 5% of them are reported in the scalp
and it has the potential to disseminate locally and systemically. The treatment of choice is surgical
excision with broad margins. This case emphasizes the importance of prophylactic removal or
close clinical follow-up of NSJ in an adult.
P094
Hair trichotomy in a female patient with depression
A Carvalho Leite Ju´nior and F Padovez Trichology, CAECI and Universidade Anhembi Morumbi,
Sa˜o Paulo, Brazil
A 21-year-old female patient comes for consultation with what was described as a hair loss on the
scalp top that had started about a year ago. On her first appointment, she reported her scalp hair
was spontaneously falling out and that she was extremely upset about the problem. Concerning
recent major events, she just mentioned the birth of her daughter about 2 years ago and that her
husband abandoned the house approximately 18 months ago. She neither mentioned nor
presented any kind of scalp alteration, such as pain, excessive oilness, itching, ulceration, or
scaling. The patient showed good hair density on the area of complaint. There were no signs of
hair miniaturization under the trichoscope. The most important clinical sign was the presence of
scalp hair on the area of complaint that seemed to have been cut with some sort of instrument,
such as scissors, trichotomy machine, or even a blade. On her first consultation, the patient
reinforced the claim that her scalp hair loss was spontaneous and that she did not manipulate her
hair.
During the second consultation, the patient’s mental state was more compromised and her
scalp hair seemed to have been cut even shorter. The patient confirmed that she trichotomized
her hair every 3 to 4 days, and she also confirmed a still untreated depressive state, previously
diagnosed by a psychiatrist. According to the new scenario we suggested the patient to visit the
psychiatrist again to initiate the treatment for depression and evaluate the necessity of a
psychotherapy.
P095
Tinea capitis—a case series
SD Ghate1,2 1Department of Dermatology, Nulife Hospital, Mumbai, India and 2Department of
Dermatology, Swastik Hospital, Mumbai, India
Introduction: Tinea capitis is the commonest disease of the hair in childhood. It spreads by close
contact in children and by sharing of combs. This condition can be properly managed only if it is
diagnosed correctly. I shall be presenting 20 such cases seen in my private practice in Mumbai,
India. This clinical case series classifies the patients on their clinical presentation.
Methods: Twenty cases (12 males and 8 females) were included. Only those cases where baseline
clinical photographs were available were considered for the analysis. The clinical diagnosis was
confirmed by microscopy and woods lamp examination, although all cases were given treatment
based on clinical diagnosis alone. Fungal culture was not done due to cost factor. All were treated
with oral terbinafine.
Observations: The inflammatory variant of tinea capitis was the commonest seen in 10 cases
(50% of the total). This was followed by a gray patch seen in 8 cases. Black dot tinea capitis
was seen in 2 cases. Scarring was seen in 5/10 cases (50%). Woods lamp examination
showed fluorescence in 5 cases. The KOH mount was positive for fungal hyphae in 10 cases.
The response to treatment was excellent in all the cases. Post-treatment photographs were
available in 6 cases.
Conclusions: This study highlights that prevalence of inflammatory tinea capitis is common. Fifty
percent of inflammatory tinea capitis had scarring alopecia. The response to treatment was
excellent, implying that there was no terbinafine resistance in the cases studied.
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Low-level laser therapy for alopecia areata—case relate
A Carvalho Leite Ju´nior1 and F Padovez2 1Department of Trichology, CAECI and Universidade
Anhembi Morumbi, Sa˜o Paulo, Brazil and 2Hair Therapy, Universidade Anhmebi Morumbi,
Sa˜o Paulo, Brazil
Alopecias are diseases that cause more hair loss than what is considered to be normal.
In regular bases alopecias do not induce systemic disorders. But sometimes the intensity
and the clinical appearance have a social and psychological negative impact on patients’
lives.
Alopecia areata is a non-cicatricial form of alopecia that promotes round hair-loss areas in any
region of the hairy body, with higher incidence in the scalp and beard. So far the etiology of this
problem has not been fully elucidated, but studies point toward autoimmune issues. Given these
gaps in the explanation of its etiology, treatments also have variable effectiveness, and so far
corticosteroids have been the leading choice in clinical therapy as a way to decrease the activity
of the immune system.
The low-level laser therapy (LLLT), one proposal in the field of non-invasive and non-drug form of
treatment, has shown a promising option in the regrowth of the affected areas.
This study case shows very positive results in the replacement of the hair in areas of alopecia in a
male patient with alopecia areata after ten sessions of LLLT with red light.
FACTORS INFLUENCING HAIR GROWTH
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Primary cilia-mediated cellular signaling in dermal papilla cells
K Matsushima1, M Suematsu1, C Mifude1, S Aramaki2, M Tanaka2, T Yasunaga2 and K Kaseda1
1Saravio Central Inst., Saravio Cosmetics Ltd., Beppu, Japan and 2Department of Bioscience and
Bioinformatics, Kyushu Institute of Technology, Iizuka, Japan
Dermal papilla cells (DPC) produce various intercellular signaling molecules and thereby play
essential roles in hair growth and development. Great amount of attention has been paid to an
antenna-like organelle (primary cilium) as a signaling center in mammalian cells. However, little
is known about the roles of primary cilia in DPC. Here we show that the DPC cilium is involved in
producing cell growth signals. Immunochemistry, together with electron microscopic observa-
tions, showed that primary cilia protruded from cultured human follicle DPC. The ciliary length
was distributed around 2 mm and the diameter was approximately 0.2mm, which is in good
agreement with previous observations in other mammalian cells. In order to investigate a role of
the organelle in intercellular signaling, mesenchymal stromal cells were grown in DPC-pretreated
media under different conditions and the cellular viability was quantified. In the presence of
lithium chloride, the cilia length of DPC became longer and the mesenchymal stromal cells
became more viable. In contrast, shortening of DPC cilia by KIF3A knockdown reduced the
viability of the mesenchymal cells. These results suggest that cilium-based signaling in DPC plays
a key role in maintaining other cells. We are currently trying to identify candidates that regulate
cilia structure and its signaling function. Understanding the primary cilia of DPC could provide
fundamental insight into hair regulation and a clue towards the future clinical application.
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Prospective case series to evaluate hair shaft abnormalities after chemotherapy
and during tamoxifen therapy in breast cancer patients evaluated by optical
coherence tomography
K Hillmann1, J Lindner2, U Blume-Peytavi1, J Lademann3, A Lux4, A Stroux5, A Schneider6 and N
Garcia Bartels1 1Charite´-Universita¨tsmedizin Berlin, Clinical Research Center for Hair and Skin
Science, Department of Dermatology and Allergy, Berlin, Germany; 2University Otto-von-
Guericke, Department of Gynecology and Obstetrics, Magdeburg, Germany; 3Charite´-
Universita¨tsmedizin Berlin, Center of Experimental and Applied Cutaneous Physiology,
Department of Dermatology and Allergy, Berlin, Germany; 4University Otto-von-Guericke,
Institute for Biometry and Medical Informatics, Magdeburg, Germany; 5Charite´-Universita¨tsme-
dizin Berlin, Institute for Biometry and Clinical Epidemiology, Berlin, Germany and 6Charite´-
Universita¨tsmedizin Berlin, Interdisciplinary Breast Center, Berlin, Germany
Background: Antineoplastic cancer treatment is frequently associated with alopecia. In literature
and private practice, changes in texture and shape of regrowing hair after chemotherapy have
been reported, but an evaluation on a scientific base is lacking. Optical coherence tomography
(OCT) provides highly reproducible measurements of hair shaft parameters, similar to those
produced in horizontal sectioning of embedded hair shafts.
Objectives: The aim of this study was to evaluate hair shaft alterations and differences in diameter
before breast cancer chemotherapy and after regrowth, as well as before and during anti-
hormonal tamoxifen treatment using OCT.
Methods: 34 women, aged 29–68 years, were included via consultations in an inter-
disciplinary breast center; they were receiving either tamoxifen or chemotherapy. Before
treatment and a minimum of 12 weeks after end of chemotherapy or 28 weeks after start of
tamoxifen intake, 20 hairs were cut from two different sites of the scalp (frontal, occipital) and
examined by OCT technique. The cross section (CS) and the form factor (FF) were evaluated
as hair shaft parameters. The ratio of the maximal and minimal hair shaft diameters was used
to determine the FF.
Results: 12 weeks after the end of chemotherapy, the cross section of hairs was significantly lower
compared to hairs taken at baseline (Po0.001). The FF varies between these two time points for
the occipital area but not for the frontal. For tamoxifen-treated patients, neither change in CS nor
change in FF was observed. Comparing both groups, there were significant differences in CS and
in FF after 28 weeks of tamoxifen intake, but not for baseline.
Conclusions: The reported changes in hair structure after chemotherapy may be due to reduction
of hair shaft caliber and increase of FF in regrowing hairs. The OCT technique is a promising
method to gain more insight into chemotherapy-induced changes of hair morphology.
P099
Apoptosis causes inactivation of vitamin D receptor in human hair derma papilla
cells and human keratinocyte through VDR ablation
SY Kim1, MY Kim2, BC Park3, MN Kim2 and BJ Kim2 1Department of Convergence Medicine and
Pharmaceutical Biosciences, Graduate School, Chung-Ang University, Seoul, Republic of Korea;
2Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of
Korea and 3Dankook University College of Medicine, Dankook University, Cheonan, Republic of
Korea
Aims: Vitamin D receptor (VDR) is a ligand-dependent transcription factor that mediates
regulation of epidermal homeostasis and hair growth. In contrast, VDR ablation hinders the
maintenance of normal hair follicle. In recent studies, we found that VDR was decreased in
alopecia areata (AA) and alopecia universalis (AU) lesions compared with the non-lesion areas. In
this study we investigated the mechanism of VDR in cultured human hair dermal papilla cells
(DPCs) and human keratinocytes.
Methods: Cell viability was assessed by MTT assay. We analyzed the expression levels of VDR,
b-catenin, Wnt3a, Wnt5a, and Wnt10b by western blot analysis. Also, VDR silencing was
conducted using small interfering RNA (siRNA) for VDR in human hair (DPCs) and human
keratinocytes. Also, VDR and cleaved caspase-3 expressions were determined using immune-
fluorescence assay. (This research was supported by the Basic Science Research Program through
the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science
and Technology (2010–0021960).)
Results: We showed that VDR was expressed in human hair dermal papilla cells (DPCs) and
human keratinocytes. Lithocholic acid (LCA) is a ligand of the vitamin D receptor (VDR); LCA
treatment induced upregulated expression of VDR and enhanced cell proliferation in a dose-
dependent manner. We also showed that VDR silencing downregulated protein VDR and b-
catenin and attenuated expression levels of the VDR in both cells. Moreover, we found that VDR
silencing dramatically decreased the viability, whereas co-administration with LCA significantly
restored the viability, which is associated with VDR repression by LCA. Correspondingly,
immune-fluorescence analysis showed that VDR silencing activated cleaved caspase-3 in human
keratinocytes.
Conclusion: These results indicate that VDR plays a critical role in human hair DPCs and human
keratinocyte cell survival.
P0100
Localization of mucins in human skin and hair follicles
T Nomiyama, R Tamagawa-Mineoka, J Asai, K Masuda, H Takenaka and N Katoh Department of
Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science,
Kyoto, Japan
Background and aim: Mucins are high-molecular-weight glycoproteins. There are at least 18
human mucins in skin and hair follicles, but their localization and functions are unclear. Secreted
mucins colocalize in the immune system and several recent studies have indicated that
membrane-bound mucins have evolved from the secreted type and have important roles in
cellular signal transduction. Secretion of mucins is controlled by cytokines and cell adhesion
factors related to the hair cycle. The purpose of this study was to investigate the localization of
mucins in human skin and hair follicles.
Subjects and methods: Scalp skin specimens were obtained from six subjects. The epidermis,
dermis, bulb, and proximal hair follicles were isolated and RT–PCR for mucin (MUC) genes was
performed. Alcian blue and immunohistochemical staining were also performed.
Results: In the anagen VI stage, mucins were strongly deposited in the dermal papilla
and connective tissue sheath in proximal hair follicles. Mucins were present in the thickened
vitreous membrane in the catagen stage, but were not observed in the telogen phase. Various
MUC mRNAs were detected in the skin and hair follicles, and the expression patterns of MUC1,
3, 4, 8, 13, 15, and 17 were analyzed immunohistochemically. Several kinds of MUC were
observed in the epidermis. MUC was present in the dermal papilla in the anagen III stage, and
MUC1, 3, 4, 8, 13, and 15 were observed in the dermal papilla and hair bulb in the anagen VI
stage. The outer sheath cells of proximal hair follicles strongly expressed MUC1, 8, and 15, while
MUC3, 4, 13, and 17 were detected in the cell membrane of a few of the outermost strata. In the
catagen phase, most MUC had disappeared, but MUC3 was deposited in the thickened vitreous
membrane.
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Placental growth factor-induced hair growth promotion
S-Y Yoon1,2, SJ Jo1,2, CY Shin1,2, J-Y Shin3, J-I Kim3, OS Kwon1,2 and KH Kim1,2 1Department of
Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Institute
of Human-Environment Interface Biology, Seoul National University Medical Research Center,
Seoul, Republic of Korea and 3Department of Biochemistry and Molecular Biology, Seoul
National University College of Medicine, Seoul, Republic of Korea
The dermal papilla (DP) comprises the specialized mesenchymal cells at the bottom of the hair
follicle and plays a pivotal role in hair formation, hair induction, and cell cycle. Abnormality of
the DP function is the main cause of the imbalance of hair growth cycle and hair loss. Dermal
papilla cells gradually lose their distinct characteristics following subculture of the cells. In this
study, dermal papillae were isolated from human hair follicles and were serially subcultured. In
each subculture passage of #1, #3 and #5 (n¼ 4), we compared the gene expression profiles using
transcriptome analysis. We could obtain a list of 2,249 downregulated genes following the
subsequent passages. Among the downregulated genes, placental growth factor (PlGF) was
selected. Our purpose was to elucidate the function of PlGF in hair follicle cells and to evaluate
the biological role of PlGF. First, we could confirm that mRNA and protein expression levels of
PlGF were significantly decreased following subsequent passages. PlGF induced proliferation of
hDPCs in BrdU-ELISA assay and in western blot analysis; it was revealed that PlGF would prevent
cell death by increased phosphorylated Erk and cyclinD1 and promote the survival by
upregulation of phosphorylated Akt and bcl2. SiRNA of PlGF downregulated the mRNA
expression of some representative genes related to the stimulation of hair growth, such as IGF1,
HGF, and FGF2. We also found that PlGF could enhance hair shaft elongation in ex vivo hair
organ culture. In summary, these in vitro results indicate that PlGF would have a certain role in
hair growth promotion and therefore may serve as an additional therapeutic mechanism for the
treatment of alopecia.
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Influence of ceramide on the human hair follicle and its role in hair cycle
X-H Jin1, H Hong1, L-Q Pi1, ST Hwang2 and W-S Lee1 1Department of Dermatology and Institute
of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic
of Korea and 2Dr. Hwang’s Hair-Hair Clinic, Seoul, Republic of Korea
Objective: Ceramide, a major class of hair lipid, may help determine the physicochemical
properties of human hairs. It also triggers apoptogenic signals in many cell lines. Transformation
of anagen to catagen is considered to be caused by apoptosis and terminal differentiation of hair
follicles (HFs). However, the influence and role of ceramide in HFs and hair cycle has not yet
been studied.
Methods: The purpose of the current study was to investigate the role of ceramide in human HFs,
especially its association with the hair cycle. We observed that HFs express ceramidase, an
enzyme that catalyzes the hydrolysis of ceramide, at mRNA and protein levels. Furthermore, we
examined whether ceramide accumulation induced by N-oleoylethanolamine (NOE), a
competitive inhibitor of ceramidase, influences human hair growth, a change in hair cycle,
and proliferation/apoptosis-related molecular expression.
Results: During the transformation from anagen to catagen, ceramidase expression appeared to be
downregulated. NOE inhibited the human hair growth and promoted transformation from anagen
to catagen in organ-cultured human HFs.
Conclusion: Altogether, these results indicate ceramide might be an important regulatory factor
for the human hair cycle. The effect of apoptosis induced by ceramide accumulation in the
catagen stage is affected by modulating the ceramide hydrolytic pathway.
P103
Functional presence of the endocannabinoid system in human hair follicle-derived
outer root sheath keratinocytes
E Herczeg-Lisztes1, IL Szabo´1, A Ola´h1, AG Szo¨llo˜si1, N Vasas1, K Sugawara2, R Paus2 and T Bı´ro´1
1Department of Physiology, University of Debrecen, Debrecen, Hungary and 2Department of
Dermatology, University of Luebeck, Luebeck, Germany
Aims: We have previously shown that the endocannabinoid anandamide (AEA) inhibits hair shaft
elongation and induces apoptosis-driven catagen regression of human hair follicles (HFs) via the
activation of cannabinoid receptor-1 expressed by epithelial cells of the HF. Since HFs were also
shown to produce endocannabinoids, in the current study, we aimed at investigating the
functional presence of the endocannabinoid system (ECS) in cultured human HF-derived outer
root sheath keratinocytes (ORSKs).
Methods: To investigate the proliferation, viability, and cell death, a series of colorimetric (MTT-
assay) and fluorescent assays (CyQUANT, DilC1(5)-SYTOX Green staining) were employed.
Furthermore, expression of elements of the ECS was identified by immunocytochemistry and
quantitative ‘‘real-time’’ PCR (RT-qPCR), whereas alterations in the gene expression levels
following various treatments were assessed by RT-qPCR.
Results: Expressions of enzymes involved in the synthesis (N-acyl-phosphatidylethanolamine-
specific phospholipase D, diacylglycerol lipase-a and -b) and degradation (fatty acid amide
hydrolase and monoacylglycerol lipase) of the endocannabinoids were identified in the ORSKs.
Moreover, AEA was shown to inhibit cellular proliferation and induce apoptosis-dominated cell
death in a concentration-dependent manner. Of further importance, AEA exerted a remarkable
anti-inflammatory effect (significant suppression of the basal and/or poly-(I:C)-induced expression
of HLA-DRA and various pro-inflammatory cytokines, e.g. interleukin (IL)-1b, IL6, IL8, and tumor
necrosis factor-a) and induced differentiation. Finally, according to our preliminary results,
elevation of the endogenous AEA ‘‘tone’’ of the ORSKs by selective inhibitors of the cellular
uptake (AM404) or degradation (URB597) of AEA appeared to mimic the above effects of the
exogenously applied AEA.
Conclusions: Collectively, our data strongly suggest that a functional ECS is expressed
in the ORSKs and that AEA may be a key endogenous regulator of their biological processes.
Therefore, pharmacological modulation of the endocannabinoid ‘‘tone’’ could be a promising,
novel tool for the management of relevant hair growth disorders and HF-related inflammatory
conditions.
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Deletion of the Sox21 gene drastically affects hair lipids
S Kawaminami1, S Breakspear2, Y Saga3, B Noecker4, Y Masukawa1, M Tsuchiya2, M Oguri1, Y
Inoue1, K Ishikawa5 and M Okamoto5 1Analytical Science Research Laboratories, Kao
Corporation, Tochigi, Japan; 2Global R & D - Beauty Cosmetics, Kao Corporation, Tokyo, Japan;
3Division of Mammalian Development, National Institute of Genetics, Shizuoka, Japan; 4Kao
European Research Laboratory, Kao Germany GmbH, Darmstadt, Germany and 5Analytical
Science Research Laboratories, Kao Corporation, Wakayama, Japan
Objective: The effects of Sox21 gene deletion on the hair lipid, 18-methyleicosanoic acid (18-
MEA), which is bound to the surface of each cuticle cell, and cholesterol (CH), cholesterol sulfate
(CS), and ceramides (CERs), which play crucial roles in the chemical diffusion barrier, water
holding, and cell cohesion, have been studied. Sox genes encode a family of transcription factors
and are defined as containing the high-mobility group box of a gene involved in sex
determination called SRY, which resides on the Y-chromosome. In Sox21/ mouse hair,
generated by knockout of the Sox21 gene, some structural proteins like keratins and keratin-
associated proteins are downregulated, but seemingly only in the hair shaft cuticle. This leads to
improper cuticle formation and a loss of interdigitation with the inner root sheath, with the result
that cyclic alopecia occurs.
Methods: Lipids extracted from Sox21þ /þ and Sox21/ hairs of mice were measured by liquid
chromatography-mass spectrometry. The distribution of 18-MEA was observed by time of flight
secondary ion mass spectrometry.
Results: For the cuticle-specific bound lipid 18-MEA, which was found to predominantly exist as
the free form in Sox21/ hair, total levels and distribution were unexpectedly unchanged. This
indicates that while the biosynthesis of 18-MEA is unaffected its covalent attachment to the
cuticle surface is disrupted by loss of keratin-associated protein binding partners. Although
the class compositions differed, the total CER levels were found to be comparable between
Sox21þ /þ and Sox21/ hairs. Deletion of the gene was also found to increase cholesterol
sulfate (CS) levels.
Conclusions: The biosynthesis process might be associated with cuticle keratinocyte maturation,
since both CS and CERs are known bioactives in keratinocyte differentiation.
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Nrf2 in the hair follicle: activation and protection against oxidative insult
IS Haslam1, G Jenkins2, R Bhogal2, F-L Lim2, N Farjo3, B Farjo3 and R Paus1,4 1Institute of
Inflammation and Repair, University of Manchester, Manchester, UK; 2Unilever R&D, Bedford,
UK; 3Farjo Medical Centre, Manchester, UK and 4University of Luebeck, Luebeck, Germany
Nrf2 (nuclear factor (erythroid-derived 2)-like 2) is a transcription factor that has received
widespread attention in recent years. This ‘‘master regulator’’ is responsible for controlling the
expression of hundreds of downstream genes, yet its predominant role is in defense against redox
imbalance. Activators of Nrf2 are currently under investigation as potential therapeutic agents in a
number of inflammatory conditions and pathologies in which redox imbalance is implicated. The
role of Nrf2 in hair follicle (HF) biology is currently unknown, yet the scalp and hair are frequently
exposed to oxidative stress in the form of UV radiation. We therefore sought to examine the
impact of Nrf2 activators in the regulation of downstream target genes in the human HF, with a
view to understanding its role in HF biology. Full-length human HFs were obtained following hair
transplant surgery. HFs were cultured for 24 hours in the presence of known Nrf2 activators,
Sulforaphane and tBHQ (tert-butylhydroquinone). The expression of downstream targets (heme-
oxygenase 1, HMOX-1; NADPH quinone reductase 1, NQO1; and catalase) were investigated on
the gene (qPCR) and protein (IHC) levels. The impact of sulforaphane and tBHQ treatment on
proliferation and apoptosis was assessed by Ki67-TUNEL staining. Activation of Nrf2 resulted in
significant increases in HMOX-1 and NQO1 gene and protein expression, with no change in
catalase levels. In the absence of oxidative insult, activation of Nrf2 did not alter levels of
proliferation or apoptosis in the hair follicle matrix keratinocytes. These results indicate that the
Nrf2 pathway is active in the HF and may play a role in protecting the HF against redox insult. As
such, targeting Nrf2 may be a promising mechanism for protecting HFs against oxidative damage.
Future work aims to further elucidate the biological impact of Nrf2 activation on HF growth
during oxidative stress.
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Hepcidin, the iron-regulating peptide—what you need to know about its role in
hair loss and, in particular, chronic telogen effluvium (CTE)
DH Rushton School of Pharmacy & Biomedical Sciences, University of Portsmouth, London, UK
Relatively low serum ferritin concentrations are associated with increased hair shedding in some
(34%) but not all healthy individuals. Why do some iron-deficient/anemic females experience
increased hair shedding while others do not? Could the answer lay with hair follicle iron
metabolism and the iron-regulating peptide hormone, hepcidin? The homozygous ‘Mask’ mouse
(a hepcidin knockout mutant that inhibits iron absorption) fed on a normal mouse diet develops a
gradual loss of body but not facial hair, leading to almost complete trunk nudity within 4 weeks.
In addition, they become iron deficient, anemic, and the female is infertile. However, following
iron supplementation all symptoms completely resolve. In humans hepcidin regulates iron
absorption and in hereditary hemochromatosis hepcidin expression is suppressed, resulting in
unregulated iron uptake. Furthermore, hemochromatosis affects only certain populations
(northern Europeans) with variable penetrance. Serum ferritin concentrations in menstruating
females expressing hemochromatosis are significantly lower than age-matched affected males,
but are significantly higher than unaffected females. This highlights the role of menstrual blood
loss in measured serum ferritin concentrations when determining the so-called ‘normal’ reference
ranges for iron-related variables in women of reproductive age currently employed by hospitals
and reference laboratories. In 35 years of studying unexplained CTE in premenopausal women,
we have never found a fasting serum ferritin concentration above 130mg l1 (with an erythrocyte
sedimentary rate (ESR)o10 mm per hour), indicating women with hemochromatosis do not
experience iron-related CTE. In iron-deficient individuals, an increase in follicular hepcidin
expression would decrease iron uptake, releasing iron for the essential tissues. Conversely, no
change in hepcidin expression leaves follicular iron uptake unaffected, even in individuals with a
low serum ferritin concentration. It is hypothesized that hepcidin regulation of hair follicle iron
metabolism might operate in CTE, with variable penetrance, explaining why only some iron-
deficient individuals are affected.
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Dickkopf-1, an inhibitor of Wnt, regulates hair follicle growth degeneration in
human hair dermal papilla cells and is associated with downregulation of VDR
through DKK1-released inflammatory cytokines
SY Kim1, HM Kim2, TR Kwon1, YS Song1 and BJ Kim2 1Department of Convergence Medicine and
Pharmaceutical Biosciences, Graduate School, Chung-Ang University, Seoul, Republic of Korea and
2Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea
Aims: Dickkopf-1 (DKK-1) inhibits canonical Wnt/b-catenin signaling and maintains follicle
anagen. In previous study, we found that DKK-1 suppressed the expressions of VDR and b-catenin
in dermal papilla cells. This study examined the role of DKK1 in hair growth degeneration in
human dermal papilla cells (DPCs).
Methods: Cell proliferation in human DPCs was assessed by MTT assay. We determined the levels
of VDR, GSK-3b, and b-catenin by western blot analysis. Also, VDR expression was determined
using immune-fluorescence assay in DKK1-treated cells. The role of DKK1 in human DPCs was
examined by determining the levels of IL-1b, IL-6, and TNF-a using enzyme-linked
immunosorbent assays (ELISA) and the expression levels of VDR, GSK-3b, and b-catenin using
reconstruction of living skin equivalents (LSEs). (This research was supported by the Basic Science
Research Program through the National Research Foundation of Korea (NRF) funded by the
Ministry of Education, Science and Technology (2010–0021960).)
Results: We found that DKK1 did not alter DP cell proliferation in a dose-dependent manner.
However, we found that DKK1 treatment reduced the expression of VDR and b-catenin in human
DPCs in a time- and dose-dependent manner. As shown by immune-fluorescence analysis, DKK1
attenuated levels of VDR expression at a concentration of 50ng ml1. In addition, the LSE system
containing human keratinocytes and DPCs showed that DKK1 downregulates VDR and b-catenin,
whereas it upregulates GSK-3b. We observed that DKK1-treated cells showed upregulation of TNFR2
expression and enhanced cytokine levels of IL-1b, IL-6, and TNF-a compared with non-treated cells.
Conclusion: In summary, the results of the present study demonstrate that DKK1 reduced expression
levels of VDR and b-catenin in DPCs through the cooperative effect of inflammatory cytokines. There-
fore, we suggest that DKK1 promotes hair loss through the inflammation factor in human hair DPCs.
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Tissue damage after ionizing radiation in skin and hair follicles: short- and long-
term effects after a single high dose and multiple low doses in mice
K Kinoshita1, H Kato1, H Ishimine2, K Doi1, N Aoi1, K Inoue1, K Shiraishi3, K Nakagawa3, A
Kurisaki2, S Itami4 and K Yoshimura1 1Department of Plastic Surgery, University of Tokyo, Tokyo,
Japan; 2Research Center for Stem Cell Engineering, National Institute for Advanced Industrial
Science and Technology, Ibaraki, Japan; 3Department of Radiology, University of Tokyo, Tokyo,
Japan and 4Department of Regenerative Dermatology, Osaka University, Osaka, Japan
Introduction: It remains unclear how ionizing radiation damages healthy skin and hair follicles in
the short and long term.
Methods: C57BL/J6 mice (8 weeks old) were divided into three groups (control: CTR, 10 Gy once
irradiation: 10Gy1, 5 Gy twice irradiations: 5Gy2). After hair epilation, the groin area was
radiated. At 0, 1, 2, and 4 weeks, 3 and 6 months after irradiation, the skin samples were
evaluated histologically and macroscopically.
Results: At 1, 2, and 4 weeks, the epidermis was thicker in 10 Gy 1 than in CTR and 5 Gy 2,
without increasing the layer number of epidermal keratinocytes. The number of capillaries in the
dermis was fewer in 5Gy 2 and 10Gy 1 than in CTR at 1 and 2 weeks. At 4 weeks, the dermis
was thicker in CTR than in 5Gy 2 and 10Gy 1. At 6 months, the subcutaneous fat tissue was
thinner in 5Gy 2 than in 10 Gy and CTR. At 3 and 6 months, capillaries in the groin fat of
5Gy 2 and 10Gy 1 appeared to be fewer than those of CTR and the size of adipocytes became
smaller in 5Gy 2. Many of the hair shafts disappeared at 1 week, followed by gradual regrowth
of hairs by 3 months. The number and size of hair remained decreased in 5Gy 2 and 10Gy 1
than in CTR at 6 months when hairs were restored and the gray hairs were macroscopically
observed.
Discussions/conclusions: In the short term (1–4 weeks), the number of hair follicles and capillaries
decreased and the dermis became thinner because of acute radiation injury. In the long term (3–6
months), tissue damage was generally more severe in 5Gy2 than 10Gy 1. These data provide
clinical insights for minimizing short- and long-term radiation injury and revitalizing the radiated
ischemic and fibrous tissue.
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TRPV1 antagonist, PAC-14028, can accelerate hair growth in vivo
JA Seo, I-H Bae, MY Park, K-W Lee, Y-H Park and K-M Lim Medical Beauty Research Institute,
AmorePacific Corporation R&D Center, Yongin, Republic of Korea
Transient receptor potential vanilloid type 1 (TRPV1) is a cation channel activated by diverse
noxious stimuli like capsaicin, low pH, or heat. TRPV1 is expressed not only in peripheral sensory
nerve fibers (C and Ad) but also in the skin epidermal cells, including hair follicle. Recently, it was
revealed that TRPV1 might be associated with hair growth control. Here we aimed to investigate if
the blockade of TRPV1 might affect hair growth, by employing a new TRPV1 antagonist, PAC-
14028. The effect of PAC-14028 on hair growth was evaluated in vivo using an anagen induction
and a catagen induction model in C57BL/6 mice. In macroscopic evaluation, PAC-14028
accelerated the onset of anagen hair cycle (14 days after treatment) compared to vehicle (27–28
days after treatment). Mice treated with 1% PAC-14028 showed significantly increased hair
weight in a dose-dependent manner (101.25±16.51 and 56.81±10.58 mg for PAC-14028 1%
and vehicle control, respectively). In the catagen induction model, the 1% PAC-14028-treated
group showed darker skin as determined by a skin chromameter, which was comparable to 2%
minoxidil. In addition, 1% PAC-14028 increased the skin thickness, confirming the delay of
catagen induction. These results demonstrate that TRPV1 antagonist could be useful for hair
growth based on anagen elongation and induction in vivo.
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Effect of recombinant growth factors mixture on hair growth promotion in vitro
and in vivo
IP Son1, K Li1, BJ Kim1, TH Kang2, TY Han3, JY Ahn4, YS Choi5, SY Kim1,6, TR Kwon1,6, HM Kim1, YH
Lee1 and YS Song1,6 1Department of Dermatology, Chung-Ang University College of Medicine, Seoul,
Republic of Korea; 2Phytomecca Co., Ltd., Incheon, Republic of Korea; 3Department of Dermatology,
Eulji General Hospital, College of Medicine, Eulji University, Seoul, Republic of Korea; 4Department of
Dermatology, National Medical Center, Seoul, Republic of Korea; 5Department of Dermatology, Ulsan
University Hospital, Ulsan, Republic of Korea and 6Convergence Medicine and Pharmaceutical
Biosciences, Graduate School, Chung-Ang University, Seoul, Republic of Korea
Background: Although hair loss may not be a life-threatening disorder, it has a great impact on a
person’s self-respect, mental health, and quality of life. Thus, it is important to develop new
therapeutic materials that prevent hair loss and enhance hair growth.
Objective: This study was aimed to investigate the effects of recombinant growth factors mixture
(RGFM) on hair growth promotion in vitro and in vivo.
Methods: We evaluated cell proliferation in cultured human DPCs by MTT assay and determined cell
migration in DPCs using Phage contrast microscopy and measured the expression levels of
extracellular signal-regulated kinase (ERK), Akt, GSK-3b, and b-catenin by western blot analysis. We
also performed topical application onto the back skins of 7-week-old C57BL/6 mice after depilation.
(This research was financially supported by the Ministry of Knowledge Economy (MKE), Korea
Institute for Advancement of Technology (KIAT) through the Inter-ER Cooperation Projects.)
Results: RGFM treatment increased the proliferation of cultured human DPCs in a dose-
dependent manner. Also, RGFM treatment enhanced the migration of cultured DPCs at a
concentration of 1,000 ng ml1. The expression levels of phosphorylated ERK and phosphorylated
Akt significantly increased at 1,000 ng ml1 of RGFM. RGFM also decreased GSK-3b expression
and increased b-catenin expression. In addition, RGFM treatment on the back skins of C57BL/6
mice significantly promoted hair growth compared with control treatment.
Conclusion: RGFM promotes the proliferation, migration, and survival of human DPCs by
activating both ERK and Akt. Moreover, RGFM induced the proliferation of human DPCs by the
upregulation of b-catenin accompanied by inhibition of GSK-3b. Thus, we suggest that RGFM
promotes human hair growth through these proliferative effects on human DPCs.
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Enhancement effect on the transfollicular delivery of sodium fluorescein using
iontophoresis
I Han, MY Kang, M Kim and JC Kim Department of Immunology, Kyungpook University, Daegu,
Republic of Korea
In order to enhance the effect of hair growth drugs, the transfollicular delivery of drugs has been
intensively investigated with various chemical and physical enhancing methods. To find a better
way for transfollicular delivery, we studied the penetration route of sodium fluorescein (SF) using
iontophoresis on hairy C57BL/6 and hairless SKH1 murine skin. SF is highly hydrophilic
substance that has two oxyanions within one molecule. SF did not penetrate much by passive
diffusion at 8 hours after 20-minute topical application. However, when applying the cathodic
conduct for SF iontophoresis at 0.4 mV cm2 for 20 minutes, strong green fluorescence of SF
was observed along the transfollicular pathway in hairy skin regardless of hair cycle stage (anagen
vs. telogen). Also, significant amounts of SF were found under the hairless skin by iontophoresis,
but less and lower delivery than shown in hairy skin. In hairy skin, electric intensity (0.1 to
0.4 mV cm2) and application time (5–30 minutes) correlated well with the amounts and the
depth of SF in transfollicular delivery. In the combination of various types of liposome (neutral,
cationic, anionic type) and iontophoresis, only cathodic conduct significantly enhanced the
transfollicular delivery of SF regardless of liposome types, while anodic conduct did not increase
it even in cationic liposome formulation. The ionic polarity of the liposome in this study did not
influence the amount or direction of SF delivery in the transfollicular pathway by iontophoresis.
This result might be due to lack of sufficient electric charge of liposomes that could entrap the
whole charge of SF molecule, or the low entrapment efficiency of SF within the liposomes due to
the high hydrophilicity of SF. Finally, in the combination of hydrogel and iontophoresis, high
viscosity rather reduced the iontophoretic transfollicular delivery of SF without hydrogel.
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Genomewide expression analysis for the impact of a hair-growth-promoting
formulation in an in vitro model for situations of diminished hair growth
T Hengl, M Lange, K Schlinzig and HF Abts Merz Pharmaceuticals GmbH, Frankfurt a.M., Germany
Diminished hair growth is believed to be associated with reduced activity of follicular keratinocytes. We
previously described an in vitro model using normal, human, epidermal keratinocytes (NHEKs)
mimicking the situation of diminished hair growth for screening the effect of hair-growth-promoting
agents and formulations on cellular proliferation and metabolic activity. An in vitro correlate of the hair-
growth-promoting formulation Panto(vi)gar was shown to have a positive impact on the metabolic
activity and cell proliferation of NHEKs in this test system. In a systematic approach to identifying the
underlying molecular mechanisms of Panto(vi)gar-mediated improvement of keratinocyte physiology,
we performed a genomewide DNA-chip-based expression profiling (covering 27.958 Entrez gene
RNAs) for the identification of potential Panto(vi)gar-regulated genes.Differentially expressed genes were
identified by comparing the expression profiles of NHEKs under minimal growth conditions and after
cultivation with a Pantogar in vitro-correlate (P-IC). The treatment with P-IC resulted in a significant
modulation of gene expression leading to expression differences ranging from 2- to 207-fold. Inter-
experimental correlation analysis revealed good reproducibility of the in vitro test system. Stringent
parameters for the identification of differentially expressed genes reduce significantly the identification
of false-positive genes. In summary, we identified 866 genes which were upregulated, while 411 genes
were downregulated by P-IC treatment and showedX4-fold expression difference. A functional group
analysis identified a statistically significant induction of genes associated with cell cycle and cell
proliferation. Thus, the identified P-IC differentially regulated genes fit well to the observed phenotype of
the cells. In addition, P-IC appears to regulate also genes associated with cell death, extracellular matrix,
response to oxidative stress/DNA damage, and genes associated in general with regulation of hair
growth. The established pool of Panto(vi)gar-regulated genes provides the foundation for further analysis
of the molecular basis of the beneficial effect of this hair-growth-promoting formula on hair growth.
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IL-6 inhibition in vitro using protease inhibitors of exogen
RK Bhogal1, S Goff1 and G Turner2 1Colworth Discover, Unilever R&D, Bedfordshire, UK and
2Port Sunlight Discover, Unilever R&D, Bebbington, UK
The hair growth cycle consists of a number of phases, including anagen (the active growing
phase), catagen (regression phase), and telogen (the resting phase). Exogen is the term used to
describe the process of hair fiber shedding, and has been proposed to be an independent, yet
active event of the hair cycle. There exists limited understanding of the biochemical events
involved in exogen. It has been proposed to start after the hair follicle has been in telogen, and to
continue until the ultimate release of the club fiber from the follicle. It has also been suggested
that exogen involves proteolytic processes. We have previously reported localization of
proteolytic activity around human club root tips of exogen fibers and ex vivo inhibition of this
activity using Trichogen and climbazole. Here we present data showing the anti-inflammatory
potential of the above materials in vitro. Primary human keratinocytes were treated with
Trichogen or climbazole for 24 hours in the presence of TNFa. Following treatment, conditioned
medium was collected and analyzed for IL-6. Our investigations showed that both Trichogen and
climbazole reduced TNFa-induced IL-6 secretion in the above in vitro model. IL-6 has recently
been observed to be upregulated in balding dermal papilla (DP) cells compared to non-balding,
and IL-6 inhibited hair shaft elongation in vitro. These data suggest that Trichogen and climbazole
may impart the additional benefit of attenuating the inflammatory cytokines apart from their
potential to inhibit proteolytic activity. Further work is required to determine whether these
benefits can be observed in vivo in subjects with scalp or hair follicles under inflammatory states.
P114
Mycophenolic acid has concentration-controlled effect on the hair growth-related
genes
K Jeong1, YJ Lee1, JE Kim1, BJ Kim2, YM Park1 and H Kang1 1Department of Dermatology, College
of Medicine, The Catholic University of Korea, Seoul, Republic of Korea and 2Department of
Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea
Mycophenolic acid (MPA) has several biological effects as an immunosuppressant, but little is
known about its biological activity as a hair growth effector. Recently, it was reported that MPA
has been shown to be effective in the treatment of inflammatory disorders such as lichen
planopilaris (LPP) and psoriasis by selectively inhibiting T lymphocyte activity. The Microneedle
Therapy System (MTS) needle roller is a procedure that stimulates the skin to produce new
collagen formation and to help cell revitalization. In a previous study, we found the effects of MTS
roller on hair growth.
We hypothesized that MPA has either direct or indirect effects on the proliferation and apoptosis
of dermal papilla cells (DPCs) of the human hair follicle. To determine the effects of topical MPA
in stimulating hair growth, we designed an experiment applying topical MPA plus MTS roller in
mice, and then the measurement of hair growth was compared with 5% Minoxidil, used as
positive control. We also performed the cell proliferation in cultured DPCs by diphenyl
tetrazolium bromide (MTT) assay and measured the elongation of hair follicles in organ culture.
Hair growth after microneedle stimulation was evaluated with a photograph and hand-held digital
microscope.
MPA significantly increased the proliferation of DPCs and elongation of hair follicle in organ
culture. Hair elongation was significantly increased (by 115%) at 0.75mM of MPA. However,
high concentrations of MPA significantly decreased the hair growth effects. MPA plus MTS
roller-applied groups showed strongly increased gene expression compared with the
positive control in RT–PCR. We suggest that the MPA plus MTS roller stimulates hair growth
in vivo and high concentration of MPA affects the toxicity on DPCs. If we adjust and select
the proper concentrations of MPA, it might be one of the therapeutic options for the treatment
of hair loss.
P115
Hair growth inhibition by topical application of a type II ribosome inactivating
protein (RIP)
MB Kondhalkar and PB Parab APT Research Foundation, Pune, India
Introduction: The very few topical treatment options available for Hirsutism patients led us to
look for an effective solution to this unmet need. Cytotoxic lectins like Ricin are widely
considered to be dermally inactive, as the amount being absorbed is minimal. However, our
studies are the first report showing the role of the topically applied type II ribosome inactivating
protein Ricin in inhibiting the growth of mammalian hair. This study is expected to lead to a new
tool in dermatology.
Aims: To assess the role of topically applied Ricin on growth of hair.
Methods: Ricin was purified using crosslinked guar gum matrix and galactose gradient. Purity of
ricin was confirmed using SDS–PAGE. Ricin of varying concentrations was applied on skin
patches prepared by removing hair by waxing of albino mice. Skin biopsies and histopathology
(hematoxylin-eosin staining) were done after 10 days of treatment for the first group and after 30
days for the second group.
Results: Hair growth on all the test patches was delayed and sparse when compared to the control
patches. No adverse reaction to the skin was observed. Histopathology sections studied from all
the biopsies showed no adverse reaction to other skin structures. All the sections marked as test
samples showed reduced number of hair follicles as compared to the control. Some of the hair
follicles from the test samples appeared empty, whereas some of them showed hair follicle
dystrophy wherein the normal ladder-like structure of the hair follicle was disturbed.
Conclusions: Ricin, which represents Type II RIPS, is a promising lead candidate for hair growth
inhibition. Our lab is pursuing further qualitative and quantitative studies for inhibition hair
growth by ricin and related proteins.
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Mechanisms of caffeine antiandrogenic on human dermal papilla cells in vitro
W Fan1,2 and X Zhuang1,2 1Department of Dermatology, First Affiliated Hospital of Nanjing
Medical University, Nanjing, China and 2Department of Dermatology, Jiangsu Province Hospital,
Nanjing, China
Objective: To investigate the possible antiandrogenic effects of caffeine on human dermal papilla
cells in vitro.
Methods: Human dermal papilla cells, taken from the vertex, occiput, and pubis, were cultivated
for 48 hours in vitro with 0.0005% caffeine and 10 nM testosterone separately or in combination.
We measured the relative growth and apoptotic rate by MTT assay and flow cytometry. Real-time
PCR was applied to analysis of the mRNA of 10 candidate genes connected to the possible
signaling pathway of AGA.
Results: 0.0005% caffeine stimulated the proliferation and inhibited the apoptosis of human DPCs
in vitro. AR, SRD5A2, P53, FasR, GSK-3b, and TGF-b2 showed significant regulation in vertex
DPC culture treated with concentrations of 10 nM testosterone; significant gene expressions were
analyzed for Bcl-2 and b-catenin in the combined treatment group. In pubic cell culture P53 and
FasR were downregulated with testosterone; further apoptosis suppression can be achieved by
caffeine treatment.
Conclusion: Caffeine probably plays a role in the antiandrogenic effect on human dermal papilla
cells in vitro by acting on different signaling pathways.
P117
From bacterial quorum sensing a possible treatment for hair
B Marzani, D Pinto, A Benedusi and G Giuliani R&D, Giuliani S.p.A., Milan, Italy
Quorum sensing is one of the most important mechanisms for bacterial cell-to-cell communi-
cation, which is perhaps the most important tool in the battle for survival. Plantaricin A
(PlnA) is a quorum sensing signal molecule produced by Lactobacillus plantarum with
antimicrobial and pheromone activities. In our previous study we demonstrated the acceleration
of wound healing by PlnA used as pure peptide or biologically synthesized during co-cultivation
of two strains of Lactobacillus. Considering the deleterious role of oxidative stress and
the importance of the vascular network in hair loss and growth, we studied the possible
modulations induced by chemically or biologically (by L. plantarum in association with
L. rossiae) synthesized PlnA in these aspects. The effect on transcriptional regulation of
vascular endothelial growth factor (VEGF) gene was assayed through RT-PCR and ELISA, while
the cellular antioxidant protection was tested by MTT and dichlorofluorescein assays after H2O2
oxidative stress induction.The results obtained showed that VEGF expression is remarkably
induced both by synthetic PlnA treatment and by treatment with a co-culture supernatant
containing PlnA.For all treatment times treatment with co-culture PlnA at 10 mg/ml resulted in the
highest VEGF increment. Particularly, at 10 mg/ml the induction by co-culture supernatant PlnA
was higher than that by synthetic PlnA at the same concentration. As regards oxidative stress
protection, compared with H2O2-stressed control cells, cells treated for 2, 4, 16, and 24 hours
with PlnA preparations showed increased survival. These results were confirmed by determining
the concentration of intracellular reactive oxygen species. Compared with H2O2-stressed control
cells, cells treated with chemically or biologically synthesized PlnA showed decrease in ROS
concentrations. These findings suggested that antimicrobial peptide pheromone PlnA was
positively sensed by human cells promoting certain important activities useful in the treatment of
hair loss.
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Effects of ectoine on follicular aging processes
M Giesen, G Fuhrmann, M Briese, S Rasche, T Goerlach, D Petersohn and T Foerster Henkel AG
& Co KGaA, Duesseldorf, Germany
Oxidative stress followed by DNA damage and changes in mitochondrial functionality has been
considered to be etiological for several aging processes in human beings. Additionally, it has been
shown that also hair follicles, similar to other human tissues, exhibit age-related changes at the
molecular level, such as an altered gene expression of structural proteins. As further studies
suggested a link between cellular aging parameters in the hair follicle and oxidative stress, we
evaluate the different bioactivities regarding their potential to counteract typical aging
characteristics in follicular cells. Ectoine is a natural compound that is produced in high
concentrations, e.g., by halophilic microorganisms and confers resistance towards salt,
temperature, and UV stress by stabilizing cellular biopolymers such as proteins. Our studies
showed that Ectoine furthermore reveals a high potential to protect cellular functions against
oxidative stress, the resulting DNA damage, and impaired mitochondrial function. We treated
follicular outer root sheath keratinocytes with sublethal doses of hydrogen peroxide and checked
the expression of structural proteins and mitochondria-relevant genes with and without pre-
treatment with Ectoine. Additionally, we measured the amount of produced reactive oxygen
species and determined the degree of DNA damage using the COMET assay. In these assays
Ectoine exhibited not only a significant restoration of essential cellular parameters under oxidative
stress but also a reduction of DNA damage up to 80%. These data suggest that Ecotine shows a
high potential to antagonize follicular aging processes.
1410 Journal of Investigative Dermatology (2013), Volume 133
ABSTRACTS
P119
Klotho expression pattern in human scalp skin and hair follicles
X-H Jin1, L-Q Pi1, ST Hwang2 and W-S Lee1 1Department of Dermatology and Institute of Hair
and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of
Korea and 2Dr. Hwang’s Hair-Hair Clinic, Seoul, Republic of Korea
Background: Klotho is a newly identified anti-aging protein that plays a pivotal role in regulating
aging. However, whether klotho is expressed in human hair follicles (HFs) and whether klotho
expression correlates with hair growth have not yet been clearly shown.
Objectives and methods: In this study, we examined the expression of klotho in human scalp
skin, human HFs, and its expression change in organ-cultured human HFs using reverse
transcriptase-polymerase chain reaction and immunofluorescence.
Results: Klotho was expressed in human scalp skin and HF at both gene and protein levels. In
human scalp skin, prominent klotho expression was observed in the epidermis. Klotho expression
in the epidermis was increased with keratinization from the basal layer to stratrum corneum. In
human anagen HFs, prominent klotho expression was observed in the epithelium. Klotho
expression in the epithelium was increased with keratinization in henle layer and hair cuticle. In
human catagen HFs, klotho expression was observed in the epithelial strand.
Conclusion: Altogether, these results indicate that klotho might be an important regulatory factor
for human hair growth and hair cycle change.
P120
Microcirculation disorders of scalp skin in patients with diffuse alopecia
YA Gallyamova Department of Dermatovenerology, Russian Academy for Postgraduate Medical
Educational, Moscow, Russian Federation
Normal functioning of scalp skin vascular system provides full-blown nutrition and development
of dermal papilla in the bulge zone of hair follicle, thereby playing an important role in hair cycle
regulation.
Purpose: To estimate scalp skin microcirculation disorders in patients with diffuse alopecia.
Materials and methods: We examined the scalp skin in 120 patients with complaints on loss of
hair by the ‘‘Lazer Doppler flowmeter’’ method. Active factors of microcirculation control were
investigated (the factors directly influencing the microcirculation system)—endothelial, myo-
genic, and neurogenic mechanisms of vessels’ lumen and tonus regulation. These factors of
regulation control and modulate the blood flow on the part of the vascular wall and are realized
through its muscular component. Active mechanisms influence the blood flow transverse
oscillations as a result of vessel muscles’ alternating contraction and relaxation (taking turns one
after the other in episodes of vasoconstriction and vasodilation). Microhemodynamics testing of
scalp skin in patients with diffuse alopecia has made it possible to reveal the different disorders of
vascular tone regulation and to prescribe the differentiated treatment that has raised the efficiency
and reduced the time of treatment in such patients. Topical preparations (Mynoxidil or Aminexil),
which are peripheral vasodilators, were prescribed for disorders of myogenic and neurogenic
oscillations, which are connected with the sympathetic adrenergic (mainly, thermoregulating)
influences on the smooth muscle of arterioles and arteriole areas’ arteriole–venule anastomoses.
Topical irritants (the preparations, containing alcohols, tincture of red pepper, diethyl ether, etc.)
and massage of scalp were used at signs of increase in vessels’ endothelial tone. Regular
physiotherapeutic procedures were recommended for these patients. This treatment promoted the
release of vasoactive substances (the nitrogen oxide and histamine)influencing the microvascular
endothelium.
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Evaluation of diffuse hair loss in premenopausal women in the Indian scenario
S Mutalik1 and S Pandit1,2 1Planet Skin, Pune, India and 2Pandit Clinic, Pune, India
Methodical evaluation of 50 women in the premenopausal age group from the Indian scenario
suffering from diffuse hair loss was done considering the following hematological criteria: (1)
hemoglobin concentration; (2) RBC indices; (3) transferrin saturation; (4) serum vitaminB12 level;
and (5) serum vitaminD3 level. The diagnosis of alopecia was confirmed by clinical tests. In a few
patients, where indicated, thyroid function tests and pelvic ultrasonography were done. The
results were tabulated and analyzed. Most patients were in the age group 26–40. We found that
there was a significant percentage of patients having deficiency of Vitamin D3 and Vitamin B12.
Hemoglobin levels were low in a significant number of patients. The patients were treated for the
underlying deficiencies and the patients were then followed up from 3 to 6 months. The
treatments included hematinics, B12 injectables, or Vit D3 supplements, as per the need. We
could follow up with 40 patients, and subjective and clinical evaluation of improvement in hair
fall was noted. There were a significant number of patients showing moderate to dramatic
improvement in the hair fall.
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Usage of platelet-rich plasma in alopecia treatment
O Liashenko and I Popova Centr Zdorovia Volossya (Hair Health Center), Kyiv, Ukraine
Human hair has an important role in visual appearance and social communication. An alopecia
is a common disorder affecting both men and women. Minoxidil and finasteride are
effective treatment methods, but those who have poor response to them have limited
treatment capabilities. One kind of cell therapy that is in use nowadays is autologous
platelet-rich plasma (also known as PRP). PRP is a component of whole blood that
contains concentrated platelets that play a key role in a human life preservation-
bleeding blockage. As a source of platelets, PRP contains several growth factors and other
cytokines that stimulate healing of bone and soft tissue. There are a lot of technologies for
obtaining PRP, which are in use in different countries around the world. We have been using PRP
in combined treatment of more than 150 patients with good effect. The obtained results are
inspiring, but there is a necessity of uniting our colleagues’ efforts to investigate this issue deeper
and in a more profound way. PRP might be a safe, effective, and well-tolerated treatment
for alopecia.
P123
Increased rates of alopecia and hirsutism in obese compared with non-obese
children/adolescents: a population-based study
P Mirmirani1 and D Carpenter2 1The Permanente Medical Group, Vallejo, California, USA and
2Kaiser Permanente Division of Research, Oakland, California, USA
Study design: We conducted a retrospective population-based study by analyzing the
electronic medical records of the Kaiser Permanente Northern California (KPNC)
Managed Healthcare System. All members aged 5–17 years with at least one recorded body
mass index (BMI) value in 2009 were eligible. Diagnoses of inflammatory alopecias were
excluded. Patients were classified as normal BMI, overweight, or obese according to age- and
sex-specific criteria established by the Centers for Disease Control (CDC). Obesity was defined as
a BMI 495th percentile, overweight as 85th–95th percentile, and normal BMI as o85th
percentile.
Results: Data from a total of 248,775 subjects were analyzed. The prevalence of alopecia
and hirsutism in this cohort was low: alopecia (normal BMI 0.34%, overweight 0.42%,
and obese 0.42%); hirsutism (normal BMI 0.06%, overweight 0.15%, and obese 0.17%).
Alopecia was not associated with being overweight or obese. However, rates of hirsutism were
significantly higher in those subjects who were overweight or obese as compared to those who
had a normal BMI (Po0.0001). Among girls who had a diagnosis of hirsutism, the rates of PCOS
were high (31.0%), whereas the frequency of PCOS in girls with a diagnosis of alopecia were
lower (2.8%).
Conclusions: Obesity results in an increased mass of adipose tissue with a corresponding
increase in secretion of peptide hormones, cytokines, and paracrine transmitters, among others.
Thus, it is possible that in obese patients, androgen as well as non-androgen or inflammatory
signals may induce facial hirsutism in children and adolescents. Further study of the effects of
adipose tissue as an endocrine organ capable of influencing the pathophysiology of the hair is
warranted.
P124
Effect of several anthraquinone derivatives on hair growth
H-S Cho, J Bak and S Lee Skinomics Research Center, LG Household & Healthcare Ltd., Daejeon,
Republic of Korea
Hirsutism affects 5–15% of women. It is defined as the excessive growth of coarse hairs in women,
which may appear in a male-like pattern, i.e. face, chest, stomach, and thighs. It is therefore
primarily of cosmetic and psychological concern. Thus, it is important to develop new therapeutic
materials to stop hair growth or to delay hair growth. Anthraquinone has gained lots of interest
because of its various biological activities, including anti-tumor, anti-bacterial, and anti-
inflammatory effects. In this study, we tested the effects of several anthraquinone derivatives,
including emodin, aloe-emodin, and physcion, on hair growth using in vivo and in vitro test
models. After topical application of emodin onto the back of C57BL/6 mice, earlier conversion of
anagen to telogen was induced. To investigate the action mechanism, we treated cultured dermal
papilla cells with anthraquinone derivatives. The growth of dermal papilla cells, however, was
not affected by anthraquinone derivatives. Among them, RT-PCR analysis showed that emodin
induced mRNA levels for transformation growth factor-b (TGF-b), suggesting that the effects of
emodin on hair growth may be mediated through the regulation of growth factors in dermal
papilla cells. We further investigate the effect of emodin on the TGF-b signaling pathway.
Interestingly, emodin induced Smad 2 and 3 expresion in a dose-dependent manner. Taken
together, our results showed that emodin delayed hair growth via the Smad-mediated TGF-b
signaling pathway and can be used for helping in hair growth control.
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Corticotropin-releasing hormone downregulates hair growth-related cytokines in
cultured human dermal papilla cells
EY Lee1, JH Jeon1, E-J Choi1, M-H Lee2, S Lee3, YH Kim4 and S Kang1 1Department of Applied
Bioscience, CHA University, Seoul, Republic of Korea; 2OBM Lab., Daejon, Republic of Korea;
3Department of Biomedical Technology, Sangmyung University, Cheonan, Republic of Korea and
4College of Pharmacy, Chungnam National University, Daejon, Republic of Korea
Corticotropin-releasing hormone (CRH) is involved in the stress response and there is increasing
evidence that stress influences skin diseases such as hair loss. In cultured human hair follicles,
CRH inhibits hair shaft elongation, induces premature regression, and promotes the apoptosis of
hair matrix keratinocytes. We investigated whether CRH influences the dermal papilla cells that
play pivotal roles in hair growth and cycling. Human dermal papilla cells were treated with CRH,
ACTH, and cortisol, key stress hormones along the hypothalamic–pituitary–adrenal (HPA) axis, for
1–24 hours. Interestingly, CRH modulated expression of cytokines related to hair growth (KGF,
Wnt5a, TGFb-2, Nexin) in cultured dermal papilla cells. CRH receptors are downregulated by
negative feedback systems. Pretreatment of antalarmin and astressin2B, CRH receptor
antagonists, prevented the CRH-induced modulation of cytokines. Furthermore, CRH increased
cAMP production and the influence of CRH is also abolished by PKA inhibitor. Since the CRH
induces POMC expression through the cAMP/PKA pathway, we analyzed POMC mRNA, ACTH,
and cortisol levels. Interestingly, while CRH induced POMC expression in cultured human
dermal papilla cells, alteration of protein levels of ACTH and cortisol was not observed. These
results indicate that CRH operates within dermal papilla cells through CRH receptors along the
classical CRH signaling pathway and provide a novel insight into the mechanism triggered by
CRH stimulation in human dermal papilla cells.
P126
A novel PPARc modulator (GMG-43AC) inhibits human hair growth and
inflammatory response in keratinocytes, and upregulates expression of epithelial
stem-cell-associated keratins, K15 and K19
Y Ramot1,2, A Mastrofrancesco3, E Herczeg-Lisztes4, T Biro4, M Picardo3, JE Kloepper2 and R Paus2,5
1Department of Dermatology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel;
2Department of Dermatology, University of Luebeck, Luebeck, Germany; 3Laboratory of Cutaneous
Physiopathology and Integrated Center of Metabolomics Research, S. Gallicano Dermatologic
Institute (IRCCS), Rome, Italy; 4Department of Physiology, University of Debrecen, Debrecen,
Hungary and 5Institute of Inflammation and Repair, University of Manchester, Manchester, UK
In the skin, signaling through peroxisome proliferator-activated receptors-gamma (PPARg) exerts anti-
inflammatory effects, and modulates keratinocyte and sebocyte differentiation. PPARg signalling may
also be needed for the maintenance of hair follicle (HF) epithelial stem cells. We have investigated
whether a newly designed PPARg modulator, GMG-43AC, alters human hair growth in vitro, and/or
the expression of stem cell-associated keratins. In addition, we have assessed the capability of this
compound to inhibit induction of IL-6 in primary culture of normal human keratinocytes (NHKs). Scalp
HFs from 6 healthy females were cultured with 0.01–1mM GMG-43AC or vehicle for 6 days, and
NHKs were treated with 10ng/ml TNF-a and 30ng/ml IFN-g with or without the addition of 0.5mM
GMG-43AC for 6 and 24hours. The expression of IL-6 at mRNA and protein levels was evaluated by
real-time PCR and ELISA, respectively. Despite substantial interindividual variations in the HF response
to GMG-43AC, overall, 1mM of GMG-43AC inhibited hair shaft elongation, enhanced catagen
development, and increased hair matrix keratinocyte apoptosis. Yet, GMG-43AC also upregulated
expression of keratins K15 and K19. Microarray analysis revealed several candidate GMG-43AC target
genes that invite subsequent mechanistic studies. In the NHKs model, GMG-43AC inhibited
inflammation. The observed hair growth-inhibitory effects of GMG-43AC associated with the anti-
inflammatory activity on keratinocytes, together with its favorable toxicological profile, make this
compound an interesting candidate for development as a future anti-hirsutism agent. Interestingly,
GMG-43AC appears to rather stimulate the HF’s vital epithelial stem cell pool and thus may help to
preserve the HF’s regeneration potential. Together with its anti-inflammatory effects, this effect may also
be interesting for the management of lichen planopilaris, where PPARg signaling is deficient.
P127
Influence of oxygen tension on hair growth and cycle and the therapeutic
potential of systemic normobaric oxygenation
H Kato1, K Kinoshita1, N Aoi1, K Inoue1, S Itami2 and K Yoshimura1 1Department of Plastic
Surgery, University of Tokyo Hospital, Tokyo, Japan and 2Department of Regenerative
Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
Introduction: The influence of magnitude of oxygen tension on the hair follicle remains unclear, though
ischemia clearly induces apoptosis and hair loss. We investigated the relationship between tissue
oxygen tension and hair growth and cycle, and evaluated the potent value of oxygenation therapy.
Methods: Organ culture of human hair and rat whisker follicles was performed under three
different oxygen concentrations (1%, 6%, and 20%). The back skin of 8-weeks-old C56BL/6 mice
was epilated (anagen induction), and then they were divided into two groups and were housed
under normobaric 20% or 60% oxygen. Hyperoxygenation was performed during early anagen,
mid-anagen, and catagen phase, and the hair was evaluated macroscopically and histologically.
Results: Hair growth was significantly faster under higher oxygen concentration in organ culture
of both rat and human hair follicles. This indicates the sensitivity of hair follicles to oxygen and
the importance of skin vascularity and tissue oxygen tension. In animal experiment, ki67þ cells
in hair follicles appeared to be more increased under 60% oxygen than under 20% oxygen
between 2 to 4 days after epilation. At 1 week and 2 weeks after epilation, the length of hair was
significantly extended under 60% oxygen. It was suggested that hyperoxygenation therapy
accelerated anagen induction and promoted hair growth. On days 15 to 18 after epilation, the
number of TUNELþ cells in hair follicles appeared to be reduced under 60% oxygen, suggesting
that oxygen therapy may delay catagen transition and extend anagen term.
Conclusion: These data indicated the strong influence of surrounding tissue oxygen tension on
hair growth and cycle, which may partly explain scalp hair loss with aging and ischemia. Unlike
hyperbaric oxygenation, normobaric oxygenation is safe and can be applied for a long period.
The therapy may be beneficial to a variety of hair loss associated with scalp ischemia.
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Eplerenone stimulates human hair growth ex vivo
JE Kloepper1, S Klominek1, T Biro´2, N Farman3 and R Paus1,4 1Department of Dermatology,
University of Luebeck, Luebeck, Germany; 2DE-MTA ‘Lendulet’ Cellular Physiology Group,
Department of Physiology, University of Debrecen, Debrecen, Hungary; 3INSERM U 872,
University Pierre et Marie Curie, Paris, France and 4Institute of Inflammation and Repair,
University of Manchester, Manchester, UK
Aldosterone and glucocorticoids bind to the mineralocorticoid receptor (MR). Although human
skin also expresses MR and can generate glucocorticoids, the important role of the MR in
regulating the water and ion homeostasis in the kidney is well described but remains unknown
in human skin. However, overexpression of MR causes abnormal hair follicle (HF) development
in mice, and the MR antagonist, spironolactone, can modulate human hair growth in vivo. We
have explored the hypothesis that MR-mediated signaling impacts on this non-classical organ, the
human HF, and modulates human hair growth in vitro. MR mRNA and protein expression and
transforming growth factor beta 2 (TGFb2) transcription of human scalp HFs were analyzed.
Microdissected human scalp HFs were exposed in our serum-free human HF organ culture system
to aldosterone (classical MR agonist), spironolactone (non-selective MR antagonist), and
eplerenone (selective MR antagonist), and hair shaft elongation, HF cycling, proliferation, and
apoptosis were assessed morphometrically. Human scalp HFs constitutively expressed MR mRNA
and protein in situ. MR expression appeared to be downregulated during catagen development
and by spironolactone. Eplerenone enhanced human hair shaft production and hair matrix
keratinocyte proliferation, and retarded spontaneous HF regression (catagen). Since spironolac-
tone reduced TGFb2 transcription, downregulation of this potent hair growth inhibitor may
underlie these effects, at least in part. These preliminary data provide the first indication that
MR-mediated signaling functions as an important modulator of human scalp hair growth and
that inhibitors of MR signaling need to undergo systematic exploration as novel candidates for
anti-hair loss treatment.
P129
Age-related expression changes of wnt signaling-associated genes in human hair
follicle
SN Kim1, AR Kim1, SY Lee2 and WS Park1 1Advanced Hair Research Laboratory, AMOREPACIFIC
Corp. R&D Center, Gyeonggi-do, Republic of Korea and 2Skin Research Center, Dermapro,
Seoul, Republic of Korea
The effect of age on various features of scalp and hair shaft, for example, hair loss, hair graying,
and hair luster reduction, has been investigated previously. However, the mechanism and key
regulators of the hair aging process were largely unknown. This study aimed to determine the
major aging factors of hair aging in human hair bulb area using microarray analysis. We collected
ten scalp hairs plucked from the vertex area of each of 26 young (22–29 years) and 29 old (61–69
years) Korean women. Total RNA isolated from the hair bulb region were pooled in two age
groups as young (20 s) and old (60 s). The gene expression profile of the hair bulb area of each
group was analyzed using microarray (Affymetrix GeneChip Scanner 3000 7G) and real-time
PCR. From 54,675 human genome probes, 1,179 genes showed 42-fold differential expression
with aging, including 649 upregulated and 530 downregulated genes. Among the changed genes,
the expression of five genes associated with the wnt signaling pathway, WIF1, DKK3, FRZB, SHH,
and GSK3B, was confirmed with real-time PCR. As a result, three genes known as wnt inhibitors,
WIF1, DKK3 and FRZB, showed consistently increasing expression pattern in the aged hair bulb
area. In conclusion, the wnt pathway in normal hair might be inactivated with aging following
aging-related hair loss or senescent alopecia. This study suggested that the wnt signaling pathway
plays an important role in hair aging as well as hair development. Further studies are required to
understand the specific role of wnt-related genes in hair follicle aging.
P130
Human scalp hair follicles possess the enzymes to synthesize prostaglandins and
prostamides from phospholipids and contain PGF2a in vivo
KG Khidhir1,2, M Shalbuf1, NP Farjo3, BK Farjo3, JW Wang4, DF Woodward4, SM Picksley1 and
VA Randall1 1Centre for Skin Sciences, University of Bradford, Bradford, UK; 2Department of
Biology, University of Sulaimani, Al-Sulaimanyiah, Iraq; 3Farjo Medical Centre, Manchester, UK
and 4Department of Biological Sciences, Allergan Inc., Irvine, California, USA
Prostamides are recently discovered biological lipids closely related to the paracrine regulators,
prostaglandins (PG). We demonstrated that a prostamide F2a analogue, bimatoprost, developed as a
glaucoma treatment, stimulates the growth of rodent back follicles in vivo and human scalp follicles
in organ culture and that scalp follicles contain receptors for PGF2a (FP) and prostamide F2a. Since
this suggests that these molecules have biological roles in hair follicles, we investigated whether
follicles contain the enzymes to synthesize prostaglandins and prostamides de novo from
phospholipids. We also examined whether normal scalp follicles contain PGF2a. Scalp hair
follicles were individually microdissected from non-balding scalp skin by elective cosmetic surgery
with appropriate approvals and extracted for enzyme gene expression identification by RT-PCR,
qPCR, and sequencing, or for PGF2a measurement by electrospray tandem mass spectrometry
coupled to liquid chromatography (LC/ESI-MS/MS). Enzyme protein expression was analyzed on
frozen scalp skin sections using dual color immunofluorescence with FITC and DAPI nuclear
fluorescence to confirm follicular structures. Isolated scalp hair follicles (n¼ 5) expressed the genes
for all enzymes to synthesize the key central PGH2 and prostamide H2 (from which other PGs and
prostamides are made) de novo from phospholipids: PLA2, NAPE-PLD, COX-1, COX-2, FAAH1, and
FAAH2. Immunofluorescence confirmed their protein expression in the hair bulb. Follicles also
contained measurable amounts of PGF2a (13.39±1.8 pg per mg of follicle protein; mean±SEM,
n¼ 3). The enzyme that synthesizes prostamide F2a, prostamide/PGF synthase, was also present.
Thus, scalp hair follicles possess the necessary enzymes for the local synthesis of both prostaglandin
and prostamide mediators from phospholipids and contain PGF2a. This suggests that these paracrine
mediators may have natural roles in hair follicles; further analysis of these should increase our
understanding of hair follicle biology and may lead to further treatments for hair disorders.
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Closing KATP channels in human hair follicles inhibits hair growth, promotes
catagen-like changes, and alters paracrine signalling; could this be a new
therapeutic approach for excessive hair disorders?
H Rahman1, N Farjo2, B Farjo2 and V Randall1 1Centre for Skin Sciences, University of Bradford,
Bradford, UK and 2Farjo Medical Centre, Manchester, UK
Excessive hair growth disorders, hirsutism and hypertrichosis, are currently poorly controlled.
Since drugs that open KATP channels in plasma membranes often stimulate hair growth, e.g.
minoxidil and diazoxid, we investigated the effect of closing such channels in human hair
follicles. Human hair follicles contain two types of KATP channels, SUR1 and SUR2B, with
differing sensitivity to KATP channel regulators. Therefore, we assessed the effect of tolbutamide,
which closes both SUR1 and SUR2B channels, on hair growth in organ culture and paracrine
signalling in human hair follicles and dermal papilla cells. Human hair follicles were
microdissected, and observed, measured, and photographed daily for 9 days while being
cultured with, or without, tolbutamide (10 nM–1 mM). After incubation with 1 mM tolbutamide,
total RNA was extracted from hair follicles after 4 days (three pooled samples, each from five
individuals) and dermal papilla cells after 48 hours. Differences in gene expression determined
using DNA microarray analysis were confirmed using quantitative real-time PCR. Tolbutamide
had no effect at 10 nM but at 100 nM–1 mM it significantly inhibited human follicle growth in organ
culture and stimulated catagen-like changes, which were confirmed by histology. Tolbutamide at
1 mM altered follicular paracrine signalling, increasing gene expression of inhibitory TNF
(Po0.05) and its receptor, TNFRSF1A (Po0.01), and decreasing stimulatory FGF-10 (Po0.01)
and FGFR2 receptor (Po0.05). In cultured dermal papilla cells tolbutamide also reduced
expression of FGF10 (Po0.01) and FGFR2 (Po0.05), while increasing TNF (Po0.05) and
TNFRSF1A (Po0.05). Therefore, closing both SUR1 and SUR2B KATP channels decreased hair
growth, induced catagen-like changes, and altered paracrine signalling in both follicles and
dermal papilla cells. This strongly suggests that follicular KATP channels have an important
biological role in hair growth. Further understanding should enable novel therapies for excessive
hair disorders.
P132
Effect of the hair follicle environment on nanocarriers’ stability and drug release
properties
F Rancan1, S Hadam1, Z Afraz1, B Bellier2, R Wagner3, C Graf4, J Lademann5, E Ruehl4, B
Verrier6, U Blume-Peytavi1 and A Vogt1 1Clinical Research Center for Hair and Skin Science,
Department of Dermatology and Allergy, Charite´-Universita¨tsmedizin Berlin, Berlin, Germany;
2Laboratory of Immunity and Infection, Universite´ Pierre et Marie Curie, Paris, France; 3Institute
of Medical Microbiology, University of Regensburg, Regensburg, Germany; 4Physikalische
Chemie, Institut fu¨r Chemie und Biochemie, Freie Universita¨t Berlin, Berlin, Germany; 5Center of
Experimental and Applied Cutaneous Physiology, Department of Dermatology and Allergy,
Charite´-Universita¨tsmedizin Berlin, Berlin, Germany and 6Institut de Biologie et Chimie des
Prote´ines, UMR 5086 CNRS/UCBL, Lyon, France
Several types of particulate carrier systems are under investigation for transcutaneous drug delivery as
well as hair follicle targeting. Previous work by our own group and others characterized the important
role of hair follicles as reservoir, where particles can be stored for days as well as a shunt penetration
pathway. Over the past years, it has become clear that particles can be used to target active
compounds to different regions of the pilosebaceous unit. For a translation of such approaches into
clinical and cosmetic applications, however, more detailed investigations on the way in which
different particle types interact with the hair follicle environment are very important. Using human skin
explants, we combined high-resolution imaging techniques and cell biology methods (magnetic cell
separation, flow cytometry) to investigate particle distribution on the skin surface and possible
translocation of different carrier classes ranging from rigid inorganic particles, like gold or silica
particles, to fluorescent lipid and polymer particles and virus-like particles. We found a bright spectrum
of penetration and release properties depending on the particle type. Rigid particles accumulated in
skin furrows and hair follicle canals and were taken up by skin dendritic cells, when activated by
mechanical skin barrier disruption. Biological particles, like virus-like particles, were detected by
means of electron microscopy in the first epidermal layers in the proximity of hair follicles, pointing to
very specific interactions of these particles with skin and the follicular epithelia. On the contrary,
flexible lipid and polymer particles aggregated in the hair follicle canal, where they released their load
to the different skin layers in a time-dependent manner. We conclude that a variety of drug release
features and targeting functions can be achieved by choosing the appropriate type of particle in
accordance to its physicochemical property and its interaction with the hair follicle environment.
P133
Thyrotropin-releasing hormone (TRH) modulates keratin expression in human skin
Y Ramot1,2, G Zhang2, J Hardman3, IS Haslam3, T Biro4, L Langbein5 and R Paus2,3 1Department
of Dermatology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel; 2Department
of Dermatology, University of Luebeck, Luebeck, Germany; 3Institute of Inflammation and
Repair, University of Manchester, Manchester, UK; 4Department of Physiology, University of
Debrecen, Debrecen, Hungary and 5Division of Skin Carcinogenesis, German Cancer Research
Center, Heidelberg, Germany
Keratins are major structural components of the skin and hair, and their importance has been
emphasized by recent evidence showing that keratins have a much wider spectrum of functions (e.g.
wound healing, hair follicle (HF) cycling). Therefore, it is of utmost importance to understand their
regulatory mechanisms. Although some evidence exists regarding steroid hormone regulation, little is
known on neuroendocrine control of human keratin expression. Preliminary microarray-based
evidence had suggested that thyrotropin-releasing hormone may modulate keratin expression in
human HFs. Therefore, our aim was to elucidate whether TRH has modulating effects on keratin
expression in human skin, under physiologically relevant conditions in situ. Serum-free organ cultures
of male or female human scalp HFs and scalp skin were treated for 12hours–6 days with 100 ng ml1
TRH or vehicle, and the expression of selected keratins was assessed by quantitative
immunohistomorphometry and RT-qPCR. Staining intensity of hair keratins K31 and K32 was
increased, while that of K85 and K86 was reduced after 6 days in culture. Staining intensity of
epithelial keratins K14 and K17 was also reduced. TRH also modulated expression of the epithelial
stem cell-associated K15 and K19. In the interfollicular epidermis, TRH stimulated expression of K6,
K14, and K17, both at the mRNA and protein levels. Stimulation of the same keratins was also evident
in the eccrine sweat and sebaceous glands. These findings introduce the neuropeptide hormone TRH
as a novel modulator of selected human hair keratins in situ. The keratin-modulating effect of TRH
revealed here invites novel neuroendocrine strategy that utilizes neurohormones to therapeutically
modulate keratin expression in human skin and its appendages.
P134
Systemic angiotensinergic stimulation modulates epithelial–mesenchymal
transition and collagen deposition in skin and hair follicle
ZP Jara1, M Consolo2, SP Panicker2, K Honda2, P Karnik2 and S Karnik1 1Cleveland Clinic,
Cleveland, Ohio, USA and2Department of Dermatology, CWRU, Cleveland, Ohiio, USA
The mechanisms of hair follicle scaring in inflammatory disorders such as primary cicatricial alopecia
(PCA) are unclear. Expression profiling studies on scalp biopsies from PCA patients revealed that the
upregulation of TGFb and the fibrosis pathway is associated with either reduced PPARg or increased
AhR. Mechanistic studies in mice and in cultured hair follicle outer root sheath cells with specific
agonists and antagonists of PPARg and AhR indicated coordinated regulation of expression of TGFb
and COL1A1 genes as well as the vascular angiotensin receptor, AGTR1. Thus, scarring may involve
AGTR1 signaling. In the present study we tested the hypothesis that system-wide angiotensinergic
stimulation induces destruction of pilosebaceous units in the skin, which can be prevented by AGTR1
blockade. We infused C57BL6 mice (n¼10, each group) with either the AGTR1 agonist ([Sar1]AngII,
1,400 ngkg1 per minute) or the AGTR1 inverse agonist (Candesartan, 1,000ng kg1 per minute) or
saline for 28 days by surgically implanting subcutaneous osmotic minipumps. Blood pressure was
160±8 in the [Sar1]AngII infusion mice, whereas it was 122±10 in the saline infusion group and
118±6 in the Candesartan infusion group. As expected, hypertrophy combined with increased
collagen deposition and elastin lamina disruption was observed in the cardiac and vascular tissues in
mice after [Sar1]AngII infusion, but these effects were not observed in the Candesartan-infused mice.
Histopathology of the skin samples analyzed showed that the pilosebaceous units are significantly
deformed and perhaps rendered dysfunctional, specifically in the [Sar1]AngII infusion mice. The skin
histopathology of the Candesartan-treated group was normal. Further molecular analysis for PPARg,
AhR, TGFb, collagen synthesis, and scarring pathways in these samples is in progress. We will show
evidence for the expression of epithelial to mesenchymal transition (EMT) markers, to demonstrate
EMT in skin upon [Sar1]AngII infusion. Thus, systemic angiotensinergic stimulation may produce skin
lesions involving EMT and collagen deposition in hair follicle that resembles scarring in PCA.
GENETIC HAIR DISORDERS AND HAIR FIBER
SCIENCE
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Novel KRT86 mutation in a Turkish family with monilethrix: first-time
identification of a mutational mosaicism
S Redler, S Wolf, D Stienen and R Betz Institute of Human Genetics, University of Bonn, Bonn,
Germany
Monilethrix is a rare genetic disorder with a high intrafamiliar and interfamilial variability of hair loss.
The clinical hallmarks consist of diffuse or localized occipital and temporal alopecia, hair fragility,
and follicular keratosis of the occipital region. Patients show distinctive hair shaft anomalies with
periodic constrictions, resulting in elliptical nodes and internodes, variation of hair shaft thickness,
and a tendency to fracture at the constriction sites. The inheritance pattern is mostly autosomal
dominant with pathogenic mutations in the keratin genes KRT81, KRT83, or KRT86, but an autosomal
recessive form has also been described with mutations in DSG4 (desmoglein 4). We investigated a
consanguineous Turkish family with three affected children and clinically apparently unaffected
parents. The siblings developed progressive hair loss within the first weeks of life. The mother had
noticeably no hair loss but a self-reported history of mild hair fragility. The father showed no
abnormalities in hair growth or structure. Sequencing of DSG4 revealed no pathogenic mutation.
Therefore, we sequenced the coding exons of KRT86 and revealed the novel mutation c.1231
G4T;p.Glu411X in exon 7 in the three affected children as well as in the mother. The mutational
signal observed in the mother was much weaker than the signal observed in the children, pointing to
a mutational mosaicism. SNaPshot analysis revealed a substantial mutation-level variation between
the three children and the mother. To our knowledge, this is the first time that a mutational mosaicism
was demonstrated for monilethrix or any other monogenic hair loss disorder. The mother who carried
the KRT86 mutation as a mosaic showed a less severe picture than her children, suggesting that a
KRT86 mosaicism leads to a milder form.
P136
An international repository for mouse models of human hair diseases
JP Sundberg1, SF Rockwood2, H Pratt2 and C Lutz2 1Research and Development, The Jackson
Laboratory, Bar Harbor, Maine, USA and 2Genetic Resource Science, The Jackson Laboratory,
Bar Harbor, Maine, USA
The laboratory mouse is the premier mammalian biomedical model for most human diseases. The
Jackson Laboratory is a private, nonprofit, research institution that developed a centralized,
international repository for inbred and mutant mice in the 1940s and serves as the template for other
repositories around the world. The Jackson Laboratory Rare and Orphan Disease Center was recently
launched to focus on partnering with scientists, foundations, and other experts around the world to
enable the development, standardization, optimization, and rapid distribution of preclinical mouse
models for basic research and drug discovery. Being able to offer the resources and expertise to
enable the design, construction, and management of preclinical mouse models of disease, in
combination with a global delivery system, expertise in technical transfer issues, and genetic quality
control, uniquely positions the Center to put new tools into the hands of scientists and thereby
accelerate drug discovery. Complementing the Center’s model development pipeline is one of the
most comprehensive mouse repositories in the world, consisting of a growing collection of over 7000
spontaneous and engineered mouse lines, including several hundred dealing with skin and hair
diseases. The wide array of easily accessible, well-characterized biomedical tools, and mutant allele
strains serves as an unmatched companion resource for the building of novel disease models with
applications in translational research. Contributing your disease model to the Rare and Orphan
Disease Center enables researchers across the globe to have greater access to tools for drug efficacy
testing and discovery. If you would like to donate your mouse strain to the Jackson Laboratory Mouse
Repository, please see: www.jax.org/donate-a-mouse. To learn more about The Jackson Laboratory
Rare and Orphan Disease Center, please visit our website at www.jax.org/rare.
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Mutation detection of type II hair cortex keratin gene hHB6 in a Chinese han
family with congenital monilethrix
Q Song1, Z Ye1, X Nan2, H Zhao2 and X Chen1 1Peking University Third Hospital, Beijing, China
and 2Department of Medical Genetics, School of Basic Medical Sciences, Peking University,
Beijing, China
Monilethrix (MIM 158000) is an autosomal dominant hair disorder characterized clinically by
alopecia and follicular papules. In this study, we identified a Chinese family with monilethrix by
light microscopic and scanning electron microscopic (SEM) examination. A heterozygous
transversion mutation c.1204G4A(p.E402K) in the seventh exon of hHB6 was identified in both
of two patients. Study of the relationship between the phenotype and the mutation of the Type II
hair keratin gene hHB6 provided the molecular basis to further explore the pathogenesis of
monilethrix.
P138
A novel deletion mutation in the TRPS1 gene underlies trichorhinophalangeal
syndrome type I
S Dai1, X Nan2, C-T Li1, X-R Chen1, H-S Zhao2, F-S Zhang1 and Q-H Song1 1Peking University
Third Hospital, Beijing, China and 2Peking University, Beijing, China
Tricho-rhino-phalangeal syndrome (TRPS) is a rare autosomal dominant disorder. Deletion or
mutation of the TRPS1 gene leads to the tricho-rhino-phalangeal syndromes type I or type III. In
this article, we describe a Chinese patient affected with type I TRPS and showing prominent pilar,
rhinal, and phalangeal abnormalities. Mutational screening and sequence analysis of TRPS1 gene
revealed a previously unidentified 4-base-pair deletion of nucleotides 1783–1786
(c.1783_1786delACTT). The mutation causes a frame shift after codon 593, introducing a
premature stop codon after 637 residues in the gene sequence. This deletion is an unquestionable
loss-of-function mutation, deleting all the functionally important parts of the protein. Our novel
discovery indicates that sparse hair and metacarpal defects of tricho-rhino-phalangeal syndromes
in this patient are due to this TRPS1 mutation. In addition, these data further support the critical
role of TRPS1 gene in hair and partial skeleton morphogenesis.
P139
Combination of atrophoderma vermiculatum, KPA, hypotrichosis with palmar pits
in a family—an interesting case report from South India
P Nirmaladevi1,2 and K Dhanalakshmi1 1Dermatology, Tirunelveli Medical College, Tirunelveli,
India and 2Department of Dermatology, The TamilNadu Dr MGR Medical University, Madras,
India
Atrophoderma vermiculatum (AV) is a variant of kertosis pilaris atrophicans (KPA)
otherwise called folliculitis ulerythmatosa reticulata or honeycomb atrophy. It occurs
usually as a distinct entity, rarely with keratosis pilaris or as part of syndromes like Rombo.
We report here a combination of AV with extensive keratosis pilaris (KP), KPA, hypotrichosis of
the eyebrows, scalp, and beard region in a father and his two daughters, the latter also showing
milia, palmar pits, and enamel defects. The mother was unaffected. Marriage was non-
consanguineous. Two female children of 10 and 5 years, respectively, presented with
asymptomatic skin lesions over the face since 5 months of age. Both had multiple follicular
papules over the face admixed with milia, especially around the eyes and malar areas.
Multiple atrophic scars were present over both the cheeks almost in a symmetric pattern.
Loss of eyebrows was prominent in both the siblings. Also, the younger sibling had papules
and scars over the frontal scalp with patchy loss of hair. Father (35 years old) had
prominent atrophic scars characteristic of AV associated with total loss of eye brows, and sparse
hairs on the mustache, beard, and chest with baldness in the frontal scalp. He also had prominent
keratosis pilaris papules all over the body. Biopsy of the eyebrow and follicular lesion showed
prominent follicular hyperkeratosis with dilated orifices associated with perifollicular chronic
inflammation and fibrosis. Milia lesion showed the characteristic picture. AV lesion showed
follicular atrophy as well as mid to deep dermal fragmentation of collagen (woolly appearance),
which was more prominent underlying the follicular areas. Enamel defects and palmar pits were
present in both siblings. AV with hypotrichosis and palmar pits have not been reported so far to
the best of our knowledge. Hence, this could be a new combination and may point to an
association with ectodermal dysplasia, possibly with autosomal dominant mode of inheritance, in
these cases.
P140
Nonphotosensitive trichothiodystrophy: a report of two male sibs
BG Nur1, H Akbas2, E My`hcy`1 and O Dicle3 1Department of Pediatric Genetics, Akdeniz
University School of Medicine, Antalya, Turkey; 2Department of Medical Biochemistry, Akdeniz
University School of Medicine, Antalya, Turkey and 3Department of Dermatology, Akdeniz
University School of Medicine, Antalya, Turkey
Trichothiodystrophy (TTD; MIM #601675) describes a group of autosomal recessive disorders
characterized by brittle, sulfur-deficient hair. TTD can be associated with variable neuroecto-
dermal manifestations including mental and developmental delay, ichthyotic skin, nail dystrophy,
and cutaneous photosensitivity with a wide variety of phenotypes. The diagnosis of TTD is based
on bright and dark areas known as ‘‘tiger tail’’ pattern observed by polarizing microscopy of the
hair and low sulfur content. We report an 18-year and a 13-year-old male sibs with short and
brittle hair who presented with mental retardation and ataxia. Clinical examination revealed
widespread follicular keratosis mostly prominent on the trunk and extremities, short, dry, brittle
hair, and sparse eyebrow and nail dystrophy. Apart from dermatological findings the patients had
ataxia, dental caries, and malocclusion. Moderately decreased intelligence quotients (IQ) were
noted in both of them. Growth development and osseous radiographies were normal. Polarizing
light microscopic examination showed pathognomonic alternating light and dark bands in
addition to the structural hair abnormalities including trichoschisis and trichorrhexis nodosa seen
on light microscopy. Hair amino-acid analysis determined by using liquid chromatography
coupled with tandem mass spectrometry (LC-MS/MS) showed marked decrease in cystine content
of hair compared with those of control hair. thus confirming the diagnosis of TTD. The name
‘trichothiodystrophy’ comprises several phenotypes with many cutaneous and neurological
features on the basis of hair abnormalities with low sulfur content. These cases will contribute to
the literature with additional features that have rarely been reported in trichothiodystrophy.
P141
Visual attention to and perception of undamaged and damaged versions of natural
and colored female hair
B Fink1, F Neuser2, G Deloux2, S Ro¨der1 and PJ Matts2 1University of Goettingen, Goettingen,
Germany and 2London Innovation Centre, The Procter & Gamble Company, Egham, UK
Female hair color is thought to influence physical attractiveness and, although there is some
evidence for this assertion, research has yet not addressed the question how structural integrity of
the hair shaft affects the optics and, thus, perception of female hair color. Here we investigate
whether people are visually sensitive to subtle differences in hair images of natural and colored
hair before and after a controlled cuticle damage process. We used eye-tracking technology to
measure the visual attention of men and women to randomized pairs of standardized images of
natural and colored hair tresses, each pair combining the same tress before and after controlled
cuticle damage. The same hair images were then rated for perceived health, age, and
attractiveness. Undamaged versions of natural and colored hair were perceived as significantly
younger, healthier, and more attractive than the corresponding damaged versions. Visual
attention to images of undamaged colored hair was significantly higher than to their damaged
counterparts, while in natural hair the opposite pattern was found. We argue that the divergence
in visual attention to undamaged colored female hair and damaged natural female hair and
associated ratings is due to differences in social perception and discuss the source of apparent
visual difference between undamaged and damaged hair.
P142
Follicular neogenesis in marie-unna hereditary hypotrichosis
A Jamil1, R Dover1, N Tiffin2, M Wehner3, RC Betz3 and AG Messenger1 1Dermatology, Royal
Hallamshire Hospital, Sheffield, UK; 2Histopathology, Royal Hallamshire Hospital, Sheffield, UK
and 3University of Bonn, Institute of Human Genetics, Bonn, Germany
Marie-Unna Hereditary Hypotrichosis (MUHH) is an autosomal dominant genotrichosis
due to a mutation in the 5-prime UTR (termed U2HR) of the HR gene. Affected
individuals have coarse, wiry hair in childhood and then develop progressive hair
loss in early adulthood. U2HR mutations are thought to cause increased translation of the
main physiological HR ORF, but the consequent effect on hair follicle pathobiology has
not been determined. We have studied biopsies from four patients with MUHH. The U2HR
mutation was confirmed in two of these patients, whereas the other two patients were from
families in which the U2HR mutation had been identified in other family members. All four
biopsies showed similar features. The most striking finding was of numerous follicular buds
arising from epidermis and from the outer root sheath of preserved terminal follicles. Most of these
buds were at an early stage of anagen development, with few beyond Anagen 2. Dermal papilla
morphology was often abnormal with a broad upper pole. Some preserved terminal follicles
showed grossly excessive hyperpigmentation in hair bulb epithelium and in the dermal papilla.
These histologic features of MUHH are highly distinctive and, to our knowledge, unique in
human hair follicle pathology. They appear to show follicular neogenesis and resemble the
changes seen in mice overexpressing beta-catenin. A study on a mouse model of MUHH
indicated that the HR mutation causes the upregulation of the wnt signaling pathway (Kim et al
Hum Mol Genet 2010;19;445–53) and our findings would support this concept in the human
equivalent. The initial development of terminal follicles in MUHH and their subsequent loss
remains to be explained.
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A position effect on FGF13 underlies X-linked congenital-generalized
hypertrichosis
GM De Stefano1, KA Fantauzzo1,2, L Petukhova2,3, M Kurban2, M Tadin-Strapps1, B Levy4, D
Warburton1,4, ET Cirulli5, Y Han5, R Cepeda-Valdes6, J Cesar Salas-Alanis7 and AM Christiano1,2
1Department of Genetics and Development, Columbia University, New York, USA; 2Department
of Dermatology, Columbia University, New York, USA; 3Department of Epidemiology, Columbia
University, New York, USA; 4Department of Pathology and Cell Biology, Columbia University,
New York, USA; 5Center for Human Genome Variation, Duke University School of Medicine,
Raleigh, North Carolina, USA; 6Dystrophic Epidermolysis Bullosa Research Association, Mexico
City, Mexico and 7Dermatology Service Hospital Universitario, Uanl, Mexico
Hypertrichosis describes all forms of excessive hair growth for a given body location of an
individual that does not depend on androgen stimulation. We and others have defined position
effects involving the TRPS1 and SOX9 genes underlying autosomal forms of hypertrichosis;
however, the genes that control increased hair follicle (HF) growth in X-linked hypertrichosis
(XLH) remain unknown. Here we analyzed the DNA from a Mexican family with X-linked
congenital-generalized hypertrichosis (MIM307150), as well as deafness and dental anomalies.
Using whole-genome sequencing and SNP oligonucleotide microarray analysis, we identified a
389 kb intrachromosomal insertion at an extragenic palindrome site on chromosome Xq27.1 that
completely cosegregates with the disease, and confirmed it by using FISH. Quantitative RT-PCR
revealed that among the six genes surrounding the insertion, FGF13 levels are significantly
(Po0.001) decreased in the patients by fourfold, whereas mRNA levels of the neighboring genes
remain unchanged. Importantly, RNA sequencing confirmed the selective decrease on FGF13
expression in XLH. We localized FGF13 to the outer root sheath (ORS) of the human HF using in
situ hybridization and immunofluorescence staining, and revealed a striking decrease in FGF13
localization throughout the ORS of patient HFs. As FGF13 liesB1 Mb away from the insertion in
XLH, we postulate that a position effect occurs as a result of the insertion, and suggest that altered
FGF13 levels influence important downstream signaling pathways, which ultimately lead to the
terminal hair overgrowth phenotype of XLH.
P144
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause
autosomal dominant hypotrichosis simplex
SM Pasternack1, M Refke1, E Paknia2, HC Hennies3, T Franz4, N Scha¨fer1, A Fryer5, M van
Steensel6, E Sweeney5, M Just7, C Grimm2, R Kruse8, C Ferra´ndiz7, MM No¨then1, U Fischer2 and
RC Betz1
1Institute of Human Genetics, University of Bonn, Bonn, Germany; 2Department of Biochemistry,
University of Wu¨rzburg, Wu¨rzburg, Germany; 3Center for Dermatogenetics, Innsbruck Medical
University, Innsbruck, Austria; 4Department of Anatomy, University of Bonn, Bonn, Germany;
5Cheshire and Merseyside Genetics Service, Alder Hey Hospital, Liverpool, UK; 6Department of
Dermatology, Maastricht University Medical Centre, Maastricht, Netherlands; 7Service of
Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain and 8Dermatological
Practice, Paderborn, Germany
Hypotrichosis simplex (HS) comprises a group of hereditary isolated alopecias that are
characterized by a diffuse and progressive loss of hair starting in childhood with a wide
phenotypic variability. We mapped an autosomal dominant form of HS to chromosome
1q31.3–1q41 in a Spanish family. By direct sequencing, we identified the heterozygous mutation
c.1A4G (p.Met1?) in SNRPE, which results in the loss of the start codon of the transcript. We
identified the same mutation in a simplex HS case from the United Kingdom, and an additional
mutation (c.133G4A, p.Gly45Ser) in a simplex HS case originating from Tunisia. SNRPE encodes
a core protein of U snRNPs, the key factors of the pre-mRNA-processing spliceosome. The
missense mutation c.133G4A leads to a glycine to serine substitution and is predicted to disrupt
the structure of SNRPE. Western blot analyses of HEK293T cells expressing SNRPE c.1A4G
revealed an N-terminally truncated protein, and thus the mutation might result in the use of an
alternative in frame downstream start codon. Subcellular localization of mutant SNRPE by
immunofluorescence analyses, as well as incorporation of mutant SNRPE proteins into U snRNPs,
was found to be normal, suggesting the function of U snRNPs in splicing, rather than their
biogenesis that is affected. In this report, we link a core component of the spliceosome to hair
loss, thus adding another specific factor in the complexity of hair growth. Furthermore, our
findings extend the range of human phenotypes that are linked to the splicing machinery.
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Trichomegaly, or Hollywood ‘‘movie lashes’’, resulting from mutations in FGF5
and an elongated hair cycle anagen phase
CA Higgins1, L Petukhova1,2, YY Ho1, E Drill1, L Shapiro3, M Wajid4 and AM Christiano1,5
1Department of Dermatology, Columbia University, New York, USA; 2Department of
Epidemiology, Columbia University, New York, USA; 3Department of Biochemistry, Columbia
University, New York, USA; 4Department of Zoology, University of Education Lahore, Okara,
Pakistan and 5Department of Genetics and Development, Columbia University, New York, USA
Trichomegaly, or Hollywood ‘‘movie lashes’’ (OMIM 190330), refers to an autosomal recessive
disorder characterized by the growth of excessively long eyelashes; however, the genetic basis of
this disease remains unknown. To identify molecular regulators of eyelash growth, we ascertained
two consanguineous families from Pakistan who presented with familial trichomegaly. First, using
whole-genome SNP genotyping and autozygosity mapping, we identified an extended region of
high autozygosity on chromosome 4q21.21 within family 1. We then used whole-exome
sequencing and identified distinct pathogenic mutations in both the families within the fibroblast
growth factor 5 (FGF5) gene (c.158_159delTA and c.459þ 1delG), which lies directly within the
region of autozygosity. Subsequent direct sequencing of FGF5 in several additional trichomegaly
families identified a third mutation (c.T520C). To ascertain the effects of FGF5 mutations on
human hair growth and anagen duration, we obtained and measured plucked hair fibers from
patients’ forearms and found them to be significantly longer than control hair fibers, indicative of
a prolonged hair growth phase and a shifted anagen:telogen ratio. Moreover, we found that FGF5
protein was absent in plucked patient hair samples compared with controls using whole-mount
immunofluorescence. Mutations in FGF5 underlie the angora phenotype in several mammalian
species including mouse, dog, and rabbit among others, all of which exhibit an elongated anagen
phase and excessive hair growth; however, until now, a human counterpart had not been
described. We have identified FGF5 as a crucial regulator of hair growth in humans for the first
time, and demonstrated a profound effect on the elongation of hair usually residing in telogen.
Moreover, as this phenotype is strikingly visible in the eyelashes, this discovery raises the
possibility of therapeutic targeting of FGF5 to selectively enhance the eyelash growth.
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Detection of chronobiological features on the surface of human hair through the
multi-stage analysis of Wilhelmy-force profiles
FJ Wortmann1, G Wortmann1 and E Schulze zur Wiesche2 1Materials, University of Manchester,
Manchester, UK and 2Henkel AG & Co. KGaA, Hamburg, Germany
The natural surface of human hair is hydrophobic, consisting of a bilayer of heavily cross-linked
proteins toward the cell inside, combined with a layer of fatty acids to the outside. The surface
properties can be characterized through the wetting- or Wilhelmy-force in water. Wetting-force
curves along segments of hair from female test individuals with lengths equivalent to about 1
month of growth (approx. 10 mm) are presented. In a multi-step analysis, applying curve
smoothing, Fourier, and Principal Component Analysis for hair lengths comprising daily and
weekly growth (2 mm), a compound circadian rhythm is observed, which through its typical
bimodality can be linked to wake and sleep phases. The data set furthermore indicates systematic
monthly changes with apparent relations to the menstrual cycle. This view is supported by
observations of marked changes of this monthly pattern with the onset of pregnancy. Furthermore,
consistent systematic changes on the same time scale are absent for male head hair. These results
confirm that the wettability curves are nonstochastic in nature and that hair has a systematically
nonhomogeneous, hydrophobic surface, which can be viewed in the context of the fluid mosaic
model for cell membranes. This leads to the hypothesis that the hair surface preserves a rather
detailed and long-term, individual chronobiological record. This record is ‘‘written’’ by the
composition of the cell membrane of the cuticle cell before cell death. A practical application of
this analytical approach is the determination of the pattern of distribution for cosmetically
relevant material on the surface of human hair.
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Fractions of cortical cell types correlate with macroscopic bending modulus in
human hair
T Itou1, Y Ezawa1, S Nagase1, A Mamada1, S Inoue2 and K Koike1 1Kao Corporation, Tokyo, Japan
and 2Kao Corporation, Wakayama, Japan
It has been shown that para-like and ortho-like cortical cells exist in human hair and the
intermediate filaments (IFs) are arranged in parallel and helically in these cells, respectively. In
this presentation, factors that correlate with macroscopic bending modulus of hair will be
discussed from the viewpoints of cortical cells and macrofibrils. Bending stress and the diameters
of the major and minor axes were evaluated for hair samples from 156 Japanese female donors.
Although the bending elasticity was apparently well explained by the moment of inertia, which is
a function of the major and minor axes, the calculated bending modulus was not constant and the
difference between the maximum and the minimum values was more than double. Transverse
sections of hair having various bending moduli were dual-stained with fluorescent dyes and
observed under a fluorescence light microscope to evaluate the ratio of para- and ortho-like
cortical cells. As the result, it was found that the hair of high bending modulus were rich in para-
like cortical cells and those of low bending modulus were rich in ortho-like cells, and this trend
was confirmed to be statistically significant. The moduli at the micro-scale, inside macrofibrils, in
para- and ortho-like cortical cells were estimated by atomic force microscopy nanoindentation
measurements. The difference in the modulus between the two types of cortical cells was only
6.4%, which was too small to explain the larger difference in the macroscopic bending modulus.
This leads to a possibility that the difference in the morphology of macrofibrils is more plausible. It
is suggested that the intermacrofibrillar material, of which the amounts are quite different in the
para- and ortho-like cortical cells, is contributing to the difference in the modulus of cortical cell
types, and this leads to the large difference in the macroscopic bending modulus of human hair.
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In vitro assembly of human hair keratin intermediate filaments: combination of
keratin proteins and their properties
Y Honda1, K Koike2, S Masuko1 and S Ando3 1Anatomy & Physiology, Saga University, Saga,
Japan; 2Beaty Research Center, Kao Corporation, Tokyo, Japan and 3Applied Microbial
Technology, Sojo University, Kumamoto, Japan
Objectives: Keratins are intermediate filament proteins in epithelial cells and are classified into
cytokeratins and hard keratins forming hair, nails and so on. There are 17 kinds of keratin proteins
in human hair. The reasons for the existence of many species in hair and their molecular functions
in the course of forming hair were not clear. To investigate these proteins’ functions and
properties, in vitro assembly of human hair keratin intermediate filaments was examined.
Methods: Five kinds of recombinant proteins of human hair keratin (hK35, hK36, hK38, hK81,
and hK85) were prepared by using E. coli. Recombinant cytokeratins (hK14 and hK5) were also
prepared as control. The recombinant proteins were purified by column chromatography and
analyzed by two-dimensional electrophoresis. In vitro assembly was observed to form
intermediate filaments under various conditions, such as when salt and urea concentrations
varied.
Results: Under the optimized assembly treatment conditions, regular intermediate filaments with
a 10-nm diameter and hundreds nano-meter length were formed, as confirmed by TEM. The
optimum concentrations of salt and urea for the assembly were different between cytokeratins and
hair keratins. Furthermore, as the complex of hK36 and hK81 was most stable among those tested,
it was considered that the stabilities of the intermediate filaments formed may depend on the
combination of particular hair keratins.
Conclusions: The assembly conditions of particular hair keratin intermediate filaments were
optimized and the properties examined.
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ALOX12 inhibitors promote cuticle maturation that affects hair texture
K Kizawa1, T Takahashi2, T Fujimori3, R Suzuki2 and T Kawai3 1Innovative Beauty Research
Laboratory, Kanebo Cosmetics Inc, Odawara, Japan; 2Global R&D-Beauty-Cosmetics, Kao
Corporation, Tokyo, Japan and 3Skin-Care Research Laboratory, Kanebo Cosmetics Inc,
Odawara, Japan
Aims: Hair cuticles are multiple scale-like layers that originate from a specific population
of trichocytes in hair follicles. This specialized protective tissue has marked effects on
the texture and resilience of hair fibers. During cuticle differentiation, specific citrulli-
nation of dimeric Ca2þ -binding S100A3 causes assembly of a S100A3 homotetramer.
This study aimed to identify compounds that modulate the post-translational modifications of
S100A3 associated with cuticle maturation in the SW480 cell line and in immature trichocytes of
organ cultures.
Methods: Proteins were extracted from individual hair with characteristic types of cuticle
damage, and from an SW480 cell line (EC87092801) and isolated human hair follicles, following
culture in the presence of various compounds. The isoelectric variants of S100A3 that migrated on
2D-PAGE gels (pI range 3.9–5.1) were detected by western blot analysis.
Results: Acidic shifts of S100A3 (indicating post-translational modifications such as citrullination)
in individual hair correlated with the mechanical strength of hair cuticles. S100A3 is expressed in
the SW480 cell line, according to a public database. The 2D-PAGE pattern of S100A3 displayed
an acidic form and an unmodified form. The level of post-translationally modified S100A3 in
SW480 cells was significantly increased, following the supplementation of culture medium with
arachidonate lipoxygenase (ALOX) inhibitors for 48 hours. The effects of ALOX12 inhibitors
(Hinokitiol, Esculetin, and others) and an ALOX15 inhibitor (PD146176) on modification of
S100A3 were compared in SW480 cells and cultured hair follicles. The effective concentration for
S100A3 modification correlated with the previously reported IC50 value of the ALOX12 inhibitor
in vitro.
Conclusions: Post-translational modification of S100A3 confers mechanical resistance to hair
cuticles. Using an SW480 cell line and cultured hair follicles, several ALOX12 inhibitors that
promote S100A3 modification were selected. Topical application of these ALOX12 inhibitors
may improve the texture and resilience of hair.
HAIR FOLLICLE DEVELOPMENT, CONTROL
OF THE HAIR CYCLE AND PIGMENTATION
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Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing
of anagen entry in mouse hair follicles
AJ Kellenberger1,2 and M Tauchi1,2,3 1Division of Molecular Neurology, University Hospital
Erlangen, Erlangen, Germany; 2Institute of Anatomy II, University of Erlangen-Nuremberg,
Erlangen, Germany and 3Department of Neurology, University Hospital Erlangen, Erlangen,
Germany
Mammalian target of rapamycin (mTOR) has a critical role in the regulation of cell growth and
survival by integrating major signal inputs, such as nutrients, growth factors, energy, and stress.
There is limited evidence that mTOR influences hair follicles (HFs), which undergo cycles of
quiescence (telogen), growth (anagen), and regression (catagen). Activated mTOR was detected in
telogen HFs and it is known that diverse molecules taking part in the mTOR signaling pathway,
including Wnt, FGF-1 and Akt-related molecules, control HF proliferation. Thus, we sought to
investigate whether mTOR, in particular mTOR complex 1 (mTORC1), regulates the hair growth
cycle by using immunohistochemical, biochemical, and in vivo functional approaches. mTOR
activity was quantitatively evaluated by measuring mTORC1-specific kinase activity throughout
the hair cycle. The analysis of mTORC1 kinase activity showed phase-dependent changes: low in
telogen, high in anagen, and late morphogenesis. The localization of activated mTOR in HFs was
assessed by immunohistochemical staining using antibodies against phosphorylated mTOR at
S2448 (p-mTOR) and phosphorylated p70S6K at T389 (p-p70S6K), a downstream target of mTOR.
In telogen, only scattered p-mTOR/p-p70S6K-positive cells were detected in the bulge region;
however, when anagen initiation approached, the number of stained cells was increased. These
results were indicative for mTOR’s role in hair growth initiation at the onset of anagen. In vivo
pharmacological analysis using the specific mTORC1 inhibitor, rapamycin, showed a delay in the
hair cycle initiation, reflecting mTOR’s role in temporal regulation of anagen initiation. This study
adds functional evidence that mTOR signaling is involved in the hair cycle regulation. We suggest
that mTORC1 may modulate the timing of anagen initiation in HFs.
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Regulatory T cells increased in the area around and above the bulge of mouse
vibrissa follicles in catagen
M Oishi, I Niibe and T Matsuzaki Department of Biological Science, Shimane University, Matsue,
Japan
Regulatory T cells (Tregs), a subpopulation of T cells expressing a transcription factor Foxp3,
suppress immune responses of other immune cells and maintain tolerance to self-antigens.
Inducible Tregs are generated in the periphery and exert their suppressor activity mainly by
producing IL-10 and TGF-b. They also express LIF, which is known to have a pivotal role on
maintaining stemness of ES cells. Therefore, we examined the changes of distribution and number
of Tregs during hair cycle by immunohistochemistry for Foxp3 in the back skin of C57BL/6 mice.
Tregs were mainly detected in shallow dermis less than 100 mm in depth from the skin surface.
Their number was the maximum in early anagen, suddenly decreased until late anagen, and
gradually increased again during catagen and telogen. Tregs also localized in upper hair follicles
around and above the bulge. They markedly increased in number in catagen more than a 10-fold
and diminished in telogen. To understand the function of Tregs on hair cycle progression, the
back skin samples were collected at various time points of the hair cycle and mRNAs were
isolated. Q-PCR revealed that the expressions of tgf-b1 and il-10 mRNAs were high in early
anagen and low in late anagen. Their expression patterns coincided with the number of Tregs in
the dermis. Interestingly, transcription of lif gene was markedly elevated in catagen. It was similar
to the change of Treg number in the follicular epithelium around the bulge. Treg differentiation is
thought to be dependent on TGF-b, which is known to have crucial roles both in inducing catagen
and stimulating stem cell renewal. As Tregs secrete TGF-b and LIF, our data suggest that they
could regulate the stem cell status in the vicinity of the bulge area by changing their number and
localization during the hair cycle.
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A meeting of two chronobiological systems: Period1 and BMAL1 modulate the
human hair cycle
Y Al-Nuaimi1, JA Hardman2, IS Haslam2, T Biro3, BI Toth3, N Farjo4, B Farjo4, M Philpott5, R
Watson2, B Grimaldi6, JE Kloepper7 and R Paus2,7 1Salford Royal Foundation Trust, Salford Royal
Hospital, Salford, UK; 2Inflammation and Repair, University of Manchester, Manchester, UK;
3Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary; 4Farjo Medical
Centre, Manchester, UK; 5Centre for Cutaneous Research, Queen Mary’s University of London,
London, UK; 6Italian Institute of Technology, Genova, Italy and 7Department of Dermatology,
University of Luebeck, Luebeck, Germany
The hair follicle (HF) is a continuously remodeled mini organ that cyclically switches between
growth (anagen), regression (catagen), and relative quiescence (telogen). As the anagen–catagen
transformation of microdissected human scalp hair follicles (HFs) can be observed in organ
culture, this permits one to study the as yet unknown oscillator system that drives this
autonomous, rhythmic tissue remodeling activity at the intersection of developmental,
chronobiological, and growth-regulatory mechanisms. Here we have tested the hypothesis that
the clock system is involved in the anagen-to-catagen transition. We show that in the absence of
central clock influences isolated, organ-cultured human HFs show circadian changes in the gene
and protein expression of core clock genes (CLOCK, BMAL1, Period1) and clock-controlled genes
(c-Myc, NR1D1, CDKN1A), and that Period1 expression is also hair cycle-dependent. Knock-
down of BMAL1 or Period1 in human anagen HFs significantly prolonged anagen and stimulated
hair matrix keratinocyte proliferation. Moreover, individual silencing of these two core clock
genes also stimulated HF melanogenesis in a hair cycle-independent manner. This provides the
first evidence that peripheral core clock genes modulate human HF cycling and pigmentation
under clinically relevant in vitro conditions, and are an integral component of the elusive ‘‘hair
cycle clock’’. Specifically, our study identifies BMAL1 and Period1 as promising novel targets for
the therapeutic modulation of human hair growth and pigmentation.
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Reprogramming regular skin fibroblasts into hair-inducing dermal papilla cells
C Clavel1,2, A Rezza1,2 and M Rendl1,2,3 1Department of Developmental & Regeneration Biology,
Mount Sinai School of Medicine, New York, USA; 2Black Family Stem Cell Institute, Mount Sinai
School of Medicine, New York, USA and 3Department of Dermatology, Mount Sinai School of
Medicine, New York, USA
Cell-based regenerative therapies are still unavailable to restore hair follicles in hair loss patients
and to generate new hair follicles in burn victims or patients with other debilitating skin disorders.
Currently, there is a lack of know-how to expand fully functional DP cells in the culture dish for
hair-inductive cell transplantations. To generate sufficient cell quantities for hair regenerative
therapies, we sought to reprogram regular fibroblasts into DP cells. The overexpression of
previously identified DP signature transcription factors (TFs) in freshly isolated fibroblasts, in
combination with inhibitors of histone modifiers, significantly upregulated several DP signature
genes. Furthermore, 3D aggregation clustering of TF-overexpressing fibroblast lines isolated from
double-transgenic Sox2-GFP/Lef1-RFP reporter mice activated reporter activity and induced the
DP molecular identity. Our preliminary data suggest that the right combination of DP TFs can
reprogram DP niche fate in regular fibroblasts that can potentially be utilized in future hair
restoration efforts.
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Development of the mouse dermal fat layer is linked to hair follicle development,
occurs independently of subcutaneous fat, and is marked by restricted early
expression of FABP4
K Wojciechowicz1,2, K Gledhill1, CA Ambler1, C Manning1 and CA Jahoda1 1School of Biological
and Biomedical Sciences, Durham University, Durham, UK and 2Division of Molecular Biology,
Netherlands Cancer Institute, Amsterdam, Netherlands
The laboratory mouse is a key animal model for studies of fat biology, metabolism, and disease;
yet the developmental changes that occur in tissues and cells that become the fat layer in mouse
skin have received little attention. Moreover, the terminology around this body of fat is often
confusing, as no distinction is made between fat within the skin and subcutaneous fat. Here the
development of fat in mouse dorsal skin was investigated from before birth to the end of the first
hair follicle growth cycle. Using Oil Red O staining, immunohistochemical, qRT-PCR, and
TUNEL staining, we confirmed previous observations of a close spatio-temporal link between hair
follicle development, vasculogenesis, and the start of adipogenesis. However, unlike previous
studies, we observed that the skin fat layer was created from cells within the lower dermis. By day
16 of the embryonic development (e16), the lower dermis was demarcated from the upper dermal
layer, and its commitment to adipogenesis was signaled by the expression of FABP4, a marker of
adipocyte differentiation. Fabp4 expression was overwhelming in the lower dermis of the fetal
skin. In mature mice, the skin fat layer is separated from underlying subcutaneous fat by the
panniculus carnosus. We observed that the skin fat did not combine or intermix with
subcutaneous fat at any developmental time point. By transplanting skin isolated from e14.5
mice (before the start of adipogenesis), under the kidney capsule of adult mice, we showed that
skin fat develops independently and without influence from subcutaneous depots. This study has
reinforced the developmental link between hair follicles and fat. We argue that because skin fat
develops from cells of the dermis and independently from subcutaneous fat, it is accurately
termed dermal fat, and that in laboratory mice at least that dermal fat could represent a separate
fat depot.
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ATM expression in hair bulb melanocytes is a marker of oxidative stress in
canities-prone scalp
SK Sikkink1, O Freis2, L Danoux2 and DJ Tobin1 1Centre for Skin Sciences, University of Bradford,
Bradford, UK and 2Beauty Care Solutions France, BASF, Pulnoy, France
The ATM (ataxia-telangiectasia-mutated) gene encodes a kinase that acts as a cellular sensor and
provides a checkpoint for DNA damage repair. Evidence suggests a role for ATM in protecting
cells from damage caused by oxidative stress, and may also protect melanocyte stem cells from
premature differentiation in mouse hair follicles. We have earlier shown that ATM is expressed
exclusively in melanocytes within the hair follicle and that loss of ATM expression is associated
with canities (hair graying) within the human scalp tissue. Here we examined the expression of
ATM in hair follicle melanocytes (HFM) cultivated from human anagen scalp follicles (20-year-
old male and 56-year-old female). Basal levels of ATM were expressed in the nuclei of
melanocytes grown under routine culture conditions. The incubation of cells with 40mM
hydrogen peroxide (H2O2) to induce oxidative stress produced a twofold increase in ATM
expression (over basal levels) as detected by western blotting and densitometry in HFM isolated
from the young donor, compared with a fourfold increase in cells from the older donor. Increased
ATM expression was returned to basal levels by coincubation in an antioxidant mixture of
Vitamin E (105 M) and Quercetin (106 M). Selective siRNA knockdown of ATM gene expression
in HFM before H2O2 incubation sensitized cells to treatment and produced visible areas of cell
detachment and death compared with controls. The latter was more prevalent in hair melanocytes
established from the older versus the younger donor. In conclusion, we show that ATM (a
canities-associated hair bulb biomarker) is also a marker of oxidative stress in hair follicle
melanocytes. ATM appears to have an important role in protecting human hair follicle
melanocytes from oxidative stress/damage, and maintenance of its expression may be important
for hair bulb melanocyte survival in canities-prone scalp hair follicles.
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Stem cell factor/c-kit signaling in the hair bulb is essential to maintain hair
pigmentation in adult human hair follicles in vivo and in organ culture
T Vafaee1,2, TJ Jenner1, SM Picksley1 and VA Randall1 1University of Bradford, Bradford, UK and
2University of Leeds, Leeds, UK
Changes in hair pigmentation are associated with hormonal changes and increased age. As stem
cell factor (SCF)/c-kit signaling is implicated in hair melanocyte development and androgen-
stimulated changes in hair pigmentation, molecular biological and organ culture methods were
used to investigate whether this is also involved in normal human hair graying. Individual anagen
follicles were microdissected from human scalp samples from 10 people aged 45–68 years. Gene
expression of SCF (soluble and membrane-bound) and c-kit was compared in pigmented and
unpigmented lower hair follicles from the same individuals. To clarify which cell types expressed
these genes, further follicles were microdissected to isolate bulb matrix components. To establish
whether local SCF is necessary for adult hair pigmentation in a dynamic situation, the effect of
anti-c-kit antibodies on human anagen follicles in organ culture was examined. Cryosections of
cultured follicles and scalp skin were examined immunohistologically to localize melanocytes.
Pigmented anagen human hair follicles expressed the genes for soluble and membrane-bound
SCF and c-kit with soluble SCF having the highest levels. Unpigmented hair follicles expressed
significantly less SCF and c-kit than pigmented follicles. Pigmented hair matrix cells always
expressed c-kit unlike those from unpigmented follicles (only two out of six). There were also
differences in follicular behavior in organ culture. Unpigmented hair follicles maintained anagen
longer and grew faster than matched pigmented follicles (n¼ 6). Anti-c-kit antibody reduced hair
pigmentation and increased growth; melanocytes became undetectable by immunohistochem-
istry. In scalp sections, unpigmented follicles showed significantly reduced expression of
melanocyte antigens and c-kit in the hair bulb. These results indicate that loss of hair melanocytes
and/or melanin facilitates increased cell division/differentiation. They also confirm that SCF/c-kit
signaling within anagen hair bulbs is necessary to maintain bulb melanocytes and hair
pigmentation in normal adult scalp follicles in organ culture and in vivo.
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Effect of the catagen transition induced by epidermal growth factor on a mouse
model of chemotherapy-induced alopecia
J-S Yoon1,2,3, SH Paik1, JY Lee2,3, HH Ryu1, CY Shin2,3, KH Min4, SJ Jo1,2,3, KH Kim1,2,3 and O-S
Kwon1,2,3 1Department of Dermatology, Seoul National University College of Medicine, Seoul,
Republic of Korea; 2Laboratory of Cutaneous Aging and Hair Research, Clinical Research
Institute, Seoul National University Hospital, Seoul, Republic of Korea; 3Institute of Human-
Environment Interface Biology, Seoul National University College of Medicine, Seoul, Republic
of Korea and 4Bio Research Laboratory, Life Science Research Institute, Daewoong Pharmaceu-
tical Co., Ltd., Yongin, Republic of Korea
Chemotherapeutic agents primarily damage highly proliferative anagen hair follicles, and thus it
would be worthwhile to investigate whether the transition of hair follicle to less proliferative stage
(i.e. catagen) may have beneficial effects on the prevention of chemotherapy-induced alopecia
(CIA). The aim of the present study was to investigate the effect of the catagen transition induced
by epidermal growth factor (EGF) on C57BL/6 mouse model of CIA. We pretreated hair follicles
with a vehicle or EGF encapsulated with nano-liposome system (50 mg/ml or 100 mg/ml), which
has been reported to enhance the localization of EGF in skin, before treatment with a
chemotherapeutic agent. To validate the catagen-inducing property of EGF and damage response
after chemotherapy, we evaluated the hair cycle score in histological sections and the number of
TdT-mediated dUTP nick-end labeling (TUNEL)-positive cells in the hair bulbs of control and
EGF-treated mice. It was noted that topical EGF application induced early catagen-like stage,
representing with a narrower dermal papilla compared with anagen VI hair and increased
apoptotic cells as observed by TUNEL staining. In addition, after the injection of a
chemotherapeutic agent (cyclophosphamide 120 mg/kg), hair follicles treated with EGF entered
the less severe chemotherapeutic insult of the dystrophic anagen pathway, followed by primary
recovery, whereas hair follicle treated with vehicle entered the more severe chemotherapeutic
insult of the dystrophic catagen pathway, followed by secondary recovery. Thus, the results of this
study suggest that catagen inducers could be useful as a new alopecia protection strategy,
especially in the context of CIA.
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IL-1b-mediated protection from chemotherapy-induced alopecia in the wound-
healing milieu
NC Yin, TC Wikramanayake, O Stojadinovic, LM Mauro, M Tomic-Canic, G Elgart, LA Schachner
and JJ Jimenez Department of Dermatology and Cutaneous Surgery, University of Miami Miller
School of Medicine, Miami, Florida, USA
Wound healing is an intricately orchestrated cascade of events relying heavily on cellular
crosstalk. Among the chief effectors of these interactions are cytokines, chemokines, growth
factors, and degradation proteases. In addition to these molecules, hair follicles aid in the process
of epithelialization by way of providing stem cells. Although much is known about the role of the
hair follicle in wound healing, the effect of the wound healing milieu itself on the hair follicle
remains obscure. In this regard, we observed that excisional wounding results in phenotypic
changes in the neighboring hair follicles that render them resistant to chemotherapy. This effect is
observed when 3-day-old rat pups are wounded and chemotherapy is administered on day 11.
The driving hypothesis behind this study was that selective players of the wound healing milieu
confer protection against chemotherapy-induced alopecia. Therefore, we screened the levels of
cytokine expression post wounding by DNA array analysis. As it has been well documented that
IL1-b, TNF-a, IFN-g, EGF, FGF, and TGF-b are released early in the wound healing process, we
proceeded to systematically inject all the aforementioned cytokines intracutaneously into the left
flank of 3-day-old rats to mimic the wound healing milieu and injected etoposide, cyclopho-
sphamide, or doxorubicin/cyclophosphamide on day 11. Of all the cytokines tested, IL1-b was
the only one that induced protection from alopecia against all the chemotherapies. Indeed, it was
observed that there was a 27-fold increase in IL-1b over other cytokines at this stage. Taken
together, these results strongly indicate that IL-1b is a key regulator of the hair follicle cycle alone
or in the wound healing milieu itself.
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Topical botanical extract for the management of chemotherapy-induced alopecia
(CIA)
J Liu, L Zhang and S Harti Legacy Healthcare, Lausanne, Switzerland
Chemotherapy-induced alopecia (CIA) is considered the most visible and emotionally distressing
side effect of cancer therapy. However, there are no approved satisfactory pharmacological
treatments available. The chemotoxic agents damage the rapidly dividing anagen cells that
undergo premature apoptosis inducing the early onset of catagen. The intrinsic pathway of
apoptosis is essentially mitochondria-dependent and executed by members of anti-apoptotic Bcl-
2. Pharmacological inhibition of apoptosis pathways has been proposed to prevent CIA.
Considering the sensitivity of cancer patients, AGA subjects could potentially be recruited for
proof of concept study. We present our study of a GMP-grade botanical extract (hereafter ‘‘the
Product’’) on AGA subjects, using Bcl-2 as a biomarker. Out of safety concerns, Bcl-2 levels in
non-alopecia and AGA subjects were checked and compared.
Study design: Use a phototrichogram to calculate A/T ratio of 19 AGA male subjects before and
after topical application of the product. Use immunohistochemistry to examine scalp biopsies
from 25 male non-alopecia subjects and 15 AGA sufferers (before and after application of the
Product).
Results: The product raised the A/T ratio from 2.96 (day 1) to 4.30 within 44 days, resulting in an
increase of 8200 new anagen hair in 86 days. The product prevents premature apoptosis (by
reestablishing intracellular Bcl-2 from its markedly low level) and dampens the microinflamma-
tory status in the scalp (by acting through Langerhans cells), two key aspects causing AGA. After
the product application, the raised Bcl-2 level (from 1.72 to 3.24; P¼ 0.001, paired t-test)
remained below the normal Bcl-2 level of non-alopecia subjects (4.73). No adverse events were
observed.
Conclusion: The anti-hair loss product is a safe agent that stops premature apoptosis (early
onset of catagen) in AGA subjects. It may provide with a promising strategy to manage CIA in
cancer patients receiving chemotherapy or radiotherapy, in a dosage and formulation to be
investigated.
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Inhibition of proteases involved in the exogen process by Zinc gluconate
GA Turner1, RK Bhogal2 and I Chandler2 1Unilever R&D, Bebington, UK and 2Unilever R&D,
Sharnbrook, UK
Hair loss is a common problem and is suffered by much of the world population in both women
and men. The hair follicle (HF) renews itself in a cyclic manner, undergoing periods of growth
(anagen), regression (catagen), and rest (telogen) before restarting the cycle. More recently, a
fourth phase termed ‘exogen’ in the hair cycle was proposed by Stenn et al. Our studies have
identified proteases localized in the human hair follicle. Proteases have been implicated in the
exogen process of hair shedding, and we have searched for a cosmetically acceptable active
system that would be capable of inhibiting the proteases found in the hair follicle with the
potential to reduce hair shedding. We have demonstrated earlier that a combination of Trichogen
and climbazole is capable of inhibiting protease activity in hair fiber club root extracts. Trichogen
is a complex mixture of ingredients, including natural plant extracts. We have carried out an
investigation to identify the protease inhibitory component(s) of Trichogen and investigated the
mode of enzyme inhibition. Acetyl tyrosine and zinc gluconate were found to be the major
protease inhibitory components of Trichogen. The mode of inhibition was identified to be
noncompetitive. The combination of zinc gluconate and climbazole was found to have a
synergistic inhibitory effect on a serine protease, trypsin. We also conducted studies to measure
the force required to remove hair using a pig skin model. Results indicate that zinc gluconate
produced an increase in the force required to remove the fibers. These findings indicate that zinc
gluconate þ /- climbazole may be useful in delaying hair fall in consumers by inhibiting the
enzymatic processes contributing to exogen.
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A method to accurately evaluate hair growth in organ-cultured hair follicles
X-H Jin1, L-Q Pi1, ST Hwang2 and W-S Lee1 1Department of Dermatology and Institute of Hair
and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of
Korea and 2Dr. Hwang’s Hair-Hair Clinic, Seoul, Republic of Korea
Background: Hair follicle (HF) organ culture techniques are widely used in hair biology
research. In HF organ culture, hair growth is commonly used as a measurement of follicular
activity. For the measurement of hair growth, the microscope fitted with an eyepiece graticule is
routinely used. However, using this method, it is difficult to measure the crooked hair growth,
which is always showing in the cultured HFs. Furthermore, even in the same anagen phase,
individual HFs are not consistent and show different hair growth ability, dependent on the hair
bulb size.
Objectives and methods: In this study, we propose an improved method that is designed to
accurately measure the HF length in organ-cultured HFs. The improvement focused on the
measurement of crooked hair growth and the detection of effective hair growth relative
parameters to minimize the difference in hair length of individual HFs in same phase.
Results: We showed that there is a significant difference in HF length between linear length,
which is measured by routine method, and crooked length, which is measured by improved
method used in this study. Auber’s line was the most effective hair growth-relative parameters to
minimize the difference in hair length of individual HFs in the same phase. With this
improvement, the discrete trend of individual HFs was significantly reduced.
Conclusion: Altogether, these results indicate that the current novel method should be a more
accurate measurement of hair growth.
P162
A comparison of methods of anagen synchronization in the chemotherapy-
induced alopecia adult rat model
NC Yin, TC Wikramanayake, LM Mauro, S Choudhary, G Elgart, CI Perez, LA Schachner and JJ
Jimenez Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine,
Miami, Florida, USA
Chemotherapy-induced alopecia (CIA) is a psychologically devastating side effect experienced by
65% of cancer patients receiving anti-neoplastic therapy. To date, there is no effective treatment
curbing this unwanted hair loss. However, several reliable animal models have been developed
for the purpose of screening various prophylactic agents. The adult mouse and rat models are
often utilized for their extrapolative properties to the human condition. To induce CIA in the adult
murine models, hair follicles (HFs) must be synchronized into the anagen before the
administration of chemotherapeutic agents. Clipping and waxing have previously been described
as effective modes of HF synchronization. However, waxing was shown to result in the
regeneration of thinner hair fibers. Furthermore, traumatic removal of the hair shaft by waxing
induces wounding. Consequently, we sought to compare the histological profiles of adult rat skin
treated with one of four methods of depilation: shaving, clipping, waxing, or plucking to
determine whether they induce similar HF changes. Biopsies were taken at the time of
chemotherapy administration, 15 days after depilation. There were significant differences in the
histological profiles of shaving and clipping versus waxing and plucking. Both waxing and
plucking resulted in severe HF distortion and noticeable trauma. Moreover, the superficial
portions of the HF appeared to be cystic in nature. In contrast, skin biopsies from the shaving or
clipping methods demonstrated atraumatic, unaffected-looking follicles. Taken together, forcibly
removing the hair shafts by either waxing or plucking traumatizes the hair follicle and
surrounding structures, consequently affecting hair regrowth and possibly subsequent experi-
mental results.
P163
Biomarker analysis of hair follicles in canities-affected human scalp
SK Sikkink1, O Freis2, L Danoux2 and DJ Tobin1 1Centre for Skin Sciences, University of Bradford,
Bradford, UK and 2Beauty Care Solutions France, BASF, Pulnoy, France
Canities (or graying) is an age-linked loss of pigment from hair. Although the specific cause(s) of
the associated deletion of melanogenically active melanocytes from affected human scalp anagen
hair bulbs is unclear, oxidative stress appears to be involved. We have examined, by
immunohistochemistry, the follicular melanin unit in variously pigmented follicles from the
aging human scalp of 22 healthy individuals (22–70 years). Over 20 markers were selected within
the following categories: melanocyte-specific, apoptosis, cell cycle, DNA repair/damage,
senescence, and oxidative stress. Immunohistochemistry revealed a reduction in melanocyte-
specific markers in proportion to the extent of canities. A major finding of this study was the strong
and exclusive expression of ATM (a protein that phosphorylates several key proteins to activate
the DNA damage checkpoint, leading to cell cycle arrest, DNA repair, or apoptosis) within
surviving melanocytes in canities-affected hair bulbs, the frequency of which correlated with
pigmentation status. Increased levels of 8-OhDG (a major product of DNA oxidation with links to
oxidative stress), GADD45 (a multi-protein interactive stress sensor modulates the cellular
response to genotoxic/ physiological stress), and GP-1 (an enzyme that protects cells from
oxidative damage) were detected within some bulbar melanocytes, although they lacked a clear
association with the age of the donor or the extent of canities. Surprisingly, we found no specific
evidence of increased expression of other studied markers of oxidative stress, senescence, or DNA
damage/repair in the canities-affected melanocytes compared with surrounding bulbar
keratinocytes, although some markers did show basal expression in other parts of the hair
follicle. In conclusion, we identify here ATM, GADD45, and GP-1 immunoreactivity as important
biomarkers of melanocyte status in canities-affected human scalp hair follicles. These markers
may provide protection against canities through the DNA/Damage repair pathway.
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Evaluation of hair follicle regeneration ability using hair patch assay
H Choi, K Nam, CH Huh, J Na and K Park Seoul National University College of Medicine,
Seongnam, Republic of Korea
With the introduction of hair regeneration techniques, hair follicle regeneration became much
easier. However, current success in de novo hair regeneration has been dependent on the use of
cells from newborn or embryonic mice. The aim of this study was to find key genes that determine
hair follicle inductivity in newborn. ‘‘DPC (dermal papilla cell)-rich dermal cells’’ from newborn
(p0), postnatal day 7(p7) and postnatal day 14 (p14) C57BL6 mice were transplanted with
epidermal cells from adult C57BL6 mice. Dermal cells from p0 mice successfully induced new
hair follicles with adult epidermal cells. However, hair-inducing ability decreased rapidly
thereafter; dermal cells from p7 mice induced less hair follicles and dermal cells from p14 mice
failed to induce hair follicles. Gene expression of dermal cells from p0 and p7 mice was
compared with cDNA microarray, and a marked decrease of histidine decarboxylase (HDC)
expression was observed. RT-PCR analysis also showed that mRNA level of HDC is much lower
in p7 mice compared with p0 mice. To assess the role of HDC in folliculogenesis, HDC
expression in p0 dermal cells was suppressed with small interfering RNA. Hair patch assay
showed that the HDC siRNA-treated p0 dermal cells induced less hair follicle and shorter and
thinner hair shafts than mock-treated cells. We also found that the expression of adiponectin was
suppressed. It is reported that adiponectin showed hair growth-promoting effects. However, in
our study, hair patch assay demonstrated that the number of hair is increased after small
interfering RNA (siRNA to adiponectin) treatment. These findings suggested that the same factors
can have diverse effects according to the different developmental stages. Finally, hair patch assay
can be a useful tool to investigate the role of each gene in neofolliculogenesis.
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The role of Sox2 in mouse hair-type specification and pigmentation
B Ho, C Cheng and K Cheah Department of Biochemistry, The University of Hong Kong,
Hong Kong, Hong Kong
Signals from the dermal papilla (DP) are essential in regulating hair morphogenesis. Sox2 is
specifically expressed in the DP of primary and secondary hair, and a recent study has shown that
the loss of Sox2 in the DP affects hair growth and the migration of progenitor cells. However, the
functions of Sox2 in hair-type specification and pigmentation remain to be understood. To
analyze the function of Sox2 in hair-type specification, we utilized Sox2Ysb/Ysb and Sox2Lcc/Lcc
allelic mutants, which the cis-acting regulatory elements of Sox2 were disrupted because of
chromosomal rearrangements. Sox2 was downregulated in the DP during embryonic develop-
ment. They displayed lighter hair coat color because of a change in hair-type specification, with
increased number of tertiary hair and reduced secondary hair without a change in total density.
The band of pheomelanin was extended in the mutants as well. These data suggest an additional
role of Sox2 in specifying hair types and pigmentation, apart from regulating hair growth during
morphogenesis.
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Leontopodium alpinum (Edelweiss) extract activates wnt/b-catenin signaling,
induces anagen, and increases hair follicle formation in skin reconstitution assays
SN Kim1, AR Kim1, PJ Park2, Y Zheng3, G Cotsarelis3 and WS Park1 1Advanced Hair Research
Laboratory, AMOREPACIFIC Corp. R&D Center, Gyeonggi-do, Republic of Korea; 2Bioscience
Research Institute, AMOREPACIFIC Corp. R&D Center, Gyeonggi-do, Republic of Korea and
3Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Wnt/b-catenin signaling has an important role in many developmental processes, including hair
follicle morphogenesis and stem cell differentiation. Recently, wnt/b-catenin signaling has also
been revealed as a crucial factor of hair follicle regeneration in adult skin. In search of novel hair
growth-stimulating agents, hundreds of plant extracts were screened for wnt/b-catenin signaling
activation using a TOP Flash reporter assay. The generated candidates were also examined on the
expression and translocation of b-catenin and phosphorylation of GSK3b using immunocyto-
chemical and immunoblot analyses. We finally observed the anagen induction at the dorsal skins
of 7-week-old C57BL/6 mice with topical application, and hair follicle formation in skin
reconstitution assays with silicone chamber. We found that the extract of Leontopodium alpinum
(Edelweiss) with cold-water extraction method significantly stimulated the transcriptional activity
of TOP Flash. Edelweiss also induced the expression and nuclear translocation of b-catenin in
cultured human dermal papilla cells, and enhanced the phosphorylation of GSK3b. We further
observed earlier conversion of telogen-to-anagen phase on the dorsal skins of C57BL/6 mice
applied with Edelweiss extract compared with nontreated controls (n¼ 9). Furthermore, in
preliminary studies (n¼ 4) using reconstitution assays, we demonstrated that the Edelweiss extract
added to isolated neonatal mouse dermal and epidermal cell mixtures, which were then injected
into the back skin of nude mouse in a silicone chamber, resulting in skin with significantly greater
numbers of hair follicles compared with control nontreated mixtures. Our results suggest that the
Edelweiss extract activates the wnt/b-catenin signaling pathway and induces hair growth and new
hair follicle generation in reconstitution assays. These preliminary findings suggest that additional
experiments are warranted to test the effects of the Edelweiss extract on hair growth.
P167
P63 and TGF-b1 and -b2 can be important markers in the differentiation degree
and malignancy potential of sebaceous and follicular tumors
K-H Kim, S-Y Jeon, D-Y Ko, J-W Hong and K-H Song Department of Dermatology, Dong-A
University College of Medicine, Busan, Republic of Korea
Among the epidermal appendage tumors, certain tumors may show any stages of differentiation
such as hyperplasia (hamartoma), adenoma, benign epithelioma, primordial epithelioma, and
malignant tumor. The p63 gene is expressed in normal human epidermal appendages, and its
correlation with tumor grading and/or aggressive behavior in epithelial tumors was well studied.
During catagen development in ORS and epithelial strands of the hair, TGF-b1 is increased.
However, during the carcinogenesis process, TGF-b1 and -b2 as tumor suppressors may also have
pro-oncogenic activities in a complex manner. We planned to elucidate the expressions of TGF-
b1 and -b2 and p63 in benign and malignant tumors toward hair and sebaceous gland directions
and their importance in differentiation degrees of the corresponding tumors. Therefore, we
conducted immunohistochemical studies with some antibodies such as Gli1 (a marker for
sebaceous tumors), PHLDA-1 (a marker for hair follicle ORS cells), p63, TGF-b1, and TGF-b2 in
trichofolliculoma (n¼ 1), desmoplastic trichoepithelioma (n¼ 3), trichilemmal carcinoma (n¼3),
morpheaform BCC (n¼ 3), nevus sebaceous (n¼ 4), sebaceous hyperplasia (n¼ 3), sebaceous
adenoma (n¼ 3), sebaceous epithelioma (n¼ 3), and sebaceous carcinoma (n¼4). Gli1 proteins
were expressed in the basaloid cells, sebocytes, sebaceous carcinoma cells, and were decreased
with the higher differentiation. PHLDA-1 was expressed in the ORS cells and some cells of
follicular tumors. The p63 was expressed in the nuclei of the outermost basaloid cells (seboblasts)
and poorly differentiated sebaceous carcinoma cells, and was also seen in tumor cells toward hair
direction. Remarkably, TGF-b1 was expressed exclusively in the nuclei of benign and malignant
(hair) follicular tumors in correlation with the differentiation degree, but not so in sebaceous
tumors. Moreover, TGF-b2 was seen focally in the structures of dermal papilla. In conclusion, we
propose the usefulness of p63 and/or TGF-b1 in the differentiation degree and malignancy
potential of sebaceous and follicular tumors and in discerning between trichilemmal carcinoma
and sebaceous carcinoma, for example.
P168
Size of the human hair follicles
M Ahmad and MH Mohmand Hair Transplant Institute, Islamabad, Pakistan
Objectives: To know the size of different hair follicles in Pakistani population
Materials and methods: The study was conducted on 15 patients undergoing first session of the
hair transplantation selected randomly. The donor area was marked in the sitting position. About
40 ml of tumescent solution (xylocaine, epinephrine, and normal saline) were used in the donor
area. The strip was harvested in prone position. The donor site was closed using 3–0
nonabsorbable monofilament suture. The strip removed was kept in the normal saline at room
temperature. The strip was thoroughly washed and any trace of blood was removed. The strip was
divided into three equal parts. The slivering and cutting of the follicles was done using the
microscope at 10X magnification. From the patient, 10 follicles each of one-hair, two-hair, three-
hair, and four-hair were selected randomly. The size of each follicle was measure and noted.
Results: The size of one-hair FU ranged from 0.mm to 0.9 mm (average 0.44 mm). Majority of the
follicles had 0.3 mm (40%) and 0.4 mm (24%). The two-hair FU had an average size of 0.72 mm
(ranging from 0.4 mm to 1.3 mm), majority having 0.4 mm to 0.6 mm (52%). The average size of
three-hair FU was 1.30 mm (ranging 0.9 mm to 1.7 mm) and four-hair FU was 1.50 mm (ranging
from 0.9 mm to 2.4 mm).
Conclusion: The one-hair FUs are the smallest-sized FUs, being 0.44 mm in diameter.
The instruments for making the recipient sites should be equal or larger than the average
follicle size.
HAIR RESTORATION
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New antioxidants, the vitamin E derivatives, improve anti-cancer drug-induced
alopecia and inhibit various kinds of cancer growth
K Nakajima1, M Inomata1, Y Kohno1, H Shiroshita1, T Etoh1, N Shiraishi1, S Hagiwara2, T
Noguchi2 and S Kitano3 1Faculty of Medicine, Department of Surgery I, Oita University, Yufu,
Japan; 2Faculty of Medicine, Department of Aneshesiology and Intensive Care Medicine, Oita
University, Yufu, Japan and 3Faculty of Medicine, Oita University, Yufu, Japan
Objectives: The oxidative stress and active oxygen are strongly associated with the development
of inflammation and malignant tumor. The vitamin E derivatives, which are known as
antioxidants, have anti-inflammatory and/or anti-cancer actions. We coupled amino acids to
vitamin E and developed various kinds of vitamin E derivatives that strengthened the stability and
antioxidant effects. We investigated the effects of new antioxidants on anti-cancer drug-induced
alopecia and cancer cell growth.
Methods: Wistar rats (8 days old) were cotreated with cytosine arabinoside (AraC; 20 mg/kg by
daily intraperitoneal injection; day 0–day 6) and ESeroS-GS (0, 0.5, 01, 2, or 4% topically applied
in a white petrolatum base; day 0–day 12). A control group received daily saline injections (day
0–day 6) and topical application of white petrolatum (day 0–day 12). At day 12, we evaluated hair
loss and histologic changes to scalp tissue for each group (n¼ 10). We measured caspase 3/7
activities and performed malondialdehyde assay in the skin tissue. The proliferation rates of
various cancer cell lines were determined by trypan blue exclusion assay.
Results: Rats treated with AraC and 0% ESeroS-GS cream exhibited complete hair loss; however,
cotreatment with 1%, 2% ESeroS-GS significantly reduced chemotherapy-induced hair loss. A
histopathological study showed an accumulation of inflammatory cells around the root of hair in
the control group, whereas these histological findings were reduced in ESeroS-GS groups. In the
ESeroS-GS group, caspase 3/7 activities and MDA levels were significantly reduced than those in
the control group. Vitamin E derivatives inhibited the growth of various kinds of cancer cell lines,
but did not inhibit growth to skin fibroblasts.
Conclusions: Our findings demonstrate that ESeroS-GS reduces chemotherapy-induced alopecia,
indicating the potential use of ESeroS-GS as a therapeutic tool against this common side effect of
chemotherapy.
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The alpha-lipoic acid derivative, sodium zinc dihydrolipoylhistidinate (DHLHZn),
reduces chemotherapy-induced alopecia in a rat model and inhibits various kinds
of cancer growth
M Inomata1, K Nakajima1, Y Kohno1, H Shiroshita1, T Etoh1, N Shiraishi1, S Hagiwara2, T
Noguchi2 and S Kitano3 1Faculty of Medicine, Department of Surgery I, Oita University, Yufu,
Japan; 2Faculty of Medicine, Department of Aneshesiology and Intensive Care Medicine, Oita
University, Yufu, Japan and 3Faculty of Medicine, Oita University, Yufu, Japan
Objectives: Alopecia is one of the most common side effects of chemotherapy, for which
treatments have not been developed. In the present study, we evaluated the effects of sodium zinc
dihydrolipoylhistidinate (DHLHZn), a new derivative of the multifunctional antioxidant alpha-
lipoic acid, to treat chemotherapy-induced alopecia.
Methods: Wistar rats (8 days old) were cotreated with cytosine arabinoside (AraC; 20 mg/kg by
daily intraperitoneal injection; day 0–day 6) and DHLHZn (0, 0.5, or 5% topically applied in a
white petrolatum base; day 0–day 12). A control group received daily saline injections (day 0–day
6) and topical application of white petrolatum (day 0–day 12). At day 12, we evaluated hair loss
and histologic changes to scalp tissue for each group (n¼ 10). Caspase 3/7 activity and
Malondialdehyde (MDA) level were measured using ELISA. Furthermore, effects of new
antioxidants on cancer cell growth, and the expression of cell cycle-related proteins and their
phosphorylation were investigated using bio-plex method.
Results: Rats treated with AraC and 0% DHLHZn cream exhibited complete hair loss; however,
cotreatment with 0.5% or 5% DHLHZn significantly reduced chemotherapy-induced hair loss.
Histologic analysis revealed that AraC treatment promoted inflammatory cell infiltration of hair
follicles, but this inflammatory response was attenuated by DHLHZn. DHLHZn inhibited the
growth of various kinds of cancer cell lines, but did not inhibit the growth to skin fibroblasts.
DHLHZn arrested the cell cycle of colorectal cancer cells, and the apoptosis did not induce it.
Conclusions: New antioxidants, a-lipoic acid derivative, improved anticancer drug-induced
alopecia with reduced inflammation, and inhibited the cancer cell growth with arrested cell
cycle. This study indicates the potential use of this alpha-lipoic acid derivative as a therapeutic
tool against this common side effect of chemotherapy.
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LED irradiation stimulates hair growth through activated ERK and Akt from human
dermal papilla
HM Kim1, SY Kim1,2, TH Kang3, TR Kwon1,2, YH Lee1, YS Song1,2, K Li1, MN Kim1 and BJ Kim1,2
1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of
Korea; 2Department of Convergence Medicine and Pharmaceutical Biosciences, Graduate
School, Chung-Ang University, Seoul, Republic of Korea and 3Phytomecca Co., Ltd., Incheon,
Republic of Korea
Aims: This study was aimed to investigate the effects of light-emitting diode (LED) irradiation on
hair growth promotion in vitro.
Methods: We assessed cell proliferation in cultured human DPCs by MTT assay and determined
the level of KGF by RT-PCR and measured the expression levels of extracellular signal-regulated
kinase (ERK), Akt, GSK-3b, and b-catenin by Western blot analysis. (This research was supported
by Basic Science Research Program through the National Research Foundation of Korea (NRF)
funded by the Ministry of Education, Science, and Technology (2011–0008687)).
Results: LED irradiation did not influence the proliferation of cultured human DPCs in various
wavelengths (415, 530, 630, 660, 850, 940), but increased the proliferation of cultured DPCs at
830 nm irradiation. Similarly, RT-PCR analysis revealed the increase in the amount of mRNA for
KGF after LED irradiation at 830 and 940 nm in human DPCs. In addition, LED irradiation (830,
850, and 940 nm) enhanced the expression levels of phosphorylated ERK and phosphorylated Akt,
and increased b-catenin expression.
Conclusion: LED irradiation enhances the survival of human DPCs by stimulating together ERK,
Akt, and b-catenin at 830, 850, and 940 nm. In addition, LED irradiation at 830 nm induced the
proliferation of human DPCs by the activation of b-catenin and release of KGF. Thus, we suggest
that LED irradiation promotes human hair growth.
P172
Low-level light enhances hair follicle epithelial–mesenchymal interaction and
anagen entry
SM-Y Fan1, Y-S Sheen2, C-C Chan1, H-W Lee1 and S-J Lin1 1Institute of Biomedical Engineering,
National Taiwan University, Taipei, Taiwan, Republic of China and 2Department of
Dermatology, National Taiwan University Hospital and National Taiwan University College of
Medicine, Taipei, Taiwan, Republic of China
The low-level light irradiation has gained popularity in the treatment of various types of alopecia
in recent years, but the underlying mechanism is unknown. In this research, we aim to investigate
the mechanisms. Primary dermal papilla cells and epithelial cells were irradiated with low-level
light of wavelength 630 nm. We found a higher proliferation rate of either dermal papilla cells or
keratinocytes that was associated with a higher proportion of cells in S/G2M phase in the
irradiated group. We also found that the stimulative effect was mediated through the ERK and Akt/
PI3K pathways. Keratinocytes showed a higher cell proliferation rates when cocultured with low-
level light-irradiated dermal papilla cells than irradiated keratinocytes that were not cocultured
with dermal papilla cells. In the in vivo condition, we found low-level light-shortened telogen in
the irradiated mice. Hence, low-level light not only promoted cell growth in each cell
compartment but also enhanced the epithelial–mesenchymal interaction, thereby leading to
earlier anagen entry and reduced alopecia.
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Hairline preference among various layers of Korean population
GS Choi1, I Park2 and M Kang1 1Department of Dermatology, Inha University, College of
Medicine, Incheon, Republic of Korea and 2Ilove Hair Center, Seoul, Republic of Korea
When planning hair transplantation, degree of alopecia and esthetic preference should be
considered for hairline design. There are various methods and criteria for hairline design.
However, the techniques introduced in previous reports are subjective and ethnic, and racial
differences result in different hairline preference, making it difficult to apply to various races. The
aim of this study was to determine hairline preference among four different hairline shapes in
Korean population. We investigated the preference of height of hairline because hair
transplantation to a round-type hairline is commonly carried out in female patients in Korea,
and determination of height of hairline is very important. In addition, we investigated whether
hairline preference is affected by sex, age, education, social status, location, marital status, and
history of hair transplantation. A total of 609 raters were asked to evaluate and rate the hairline
profile through online questionnaire using eight photographs showing different hairlines. M-type
hairline was selected as the most preferred hairline, whereas round-type hairline was selected the
least. In contrast, round-type hairline was selected as the most preferred hairline in the group with
a history of hair transplantation. Apart from the history of hair transplantation, several factors such
as sex, age, education, social status, location, and marital status also affected the hairline
preference.
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Symptoms of scalp burning and pain help identify patients with a potential
contraindication to hair transplant surgery
JC Donovan Department of Dermatology, University of Toronto, Toronto, Canada
Introduction: Many scalp diseases present a contraindication to hair transplant surgery, including
active scarring alopecias, alopecia areata, and hair-shedding disorders. Symptoms of scalp
itching, burning, or tenderness should raise the hair transplant surgeon’s suspicion for another
diagnosis, in addition to androgenetic alopecia. In my practice, patients with significant
symptoms of scalp burning or tenderness typically receive a scalp biopsy to exclude hair loss
conditions that cannot be transplanted.
Objective: To review the sensitivity of the symptoms of scalp burning and pain in identifying
patients with a possible contraindication to hair transplant surgery.
Materials and methods: A retrospective review of the records of 523 consecutive patients (348
men and 175 women) seeking advice on hair restoration was conducted. Information regarding
current symptoms of itching, burning, and tenderness was evaluated and compared with the final
diagnosis rendered.
Discussion: Occasional itching was documented in 109 of 523 (21 %) of patients and was more
likely in those currently using minoxidil and those with pityriasis capitis and seborrheic dermatitis
(Po0.05). A total of 47 patients (9 %) reported having burning and/or tenderness in the scalp, and
29 of these patients (62 %) were ultimately diagnosed with a condition that presented a
contraindication to hair transplant surgery. These included diagnoses of either active cicatricial
alopecia (lichen planopilaris, folliculitis decalvans, and central centrifugal cicatricial alopecia) or
alopecia areata diffusa. In 12 of the 47 (26 %) patients with burning and/or tenderness, the
diagnosis was not clinically obvious and the clinical tool served as a helpful method to exclude
patients with contraindications to surgery.
Conclusion: Burning and tenderness are important scalp symptoms that should not be ignored by
the hair transplant surgeon. A quick screening of scalp symptoms should always be sought.
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Hair transplantation in androgenetic and scarring alopecia: differences in
techniques
AM Finner Trichomed Clinic for Hair Medicine and Hair Transplantation, Berlin, Germany
Modern hair transplantation involves microsurgical follicular unit transplantation (FUT),
performed in multiple delicate steps using local tumescent anesthesia. The main indication is
mid-stage androgenetic alopecia in men and women. Hair is harvested from the donor area in an
elliptic strip using trichophytic closure to minimize the linear scar, followed by microscopic
dissection of natural follicular units of one-hair to four-hair (FUT). This technique can be
repeated, leading to high graft numbers. The other option is follicular unit extraction (FUE) using
very small punches leaving only pinpoint scars. The overall graft yield is lower, and
overharvesting may result in visible occipital thinning. To create recipient sites, small slits are
made in high densities, also in thinned areas to increase hair density. The esthetic outcome is
determined by a long-term plan, an authentic hairline design, as well as distribution, angle, and
direction of the slits and careful graft handling. Medical treatments should be combined with hair
transplantation, but not alter the surgical plan. In secondary scarring alopecias, such as after
surgery or trauma, the technique is adjusted depending on scar quality. An initial scar reduction
or conditioning is possible. Larger grafts with more perifollicular tissue may have higher survival
rates. In hypertrophic scars, the use of small punches to create the recipient size may improve the
blood supply and decrease pressure on the grafts. In atrophic scars, preoperative injections of
saline may improve tissue quality. Usually, multiple sessions are required, gradually increasing
graft density and skin quality. In primary scarring alopecias, hair transplantation should be limited
to burnt-out stages to decrease the risk of graft failure and reactivation. Biopsies or test areas may
be helpful, and the interfollicular tissue is usually normal. Current areas of research in hair
restoration include graft-holding solutions, wound healing, tissue engineering, and robotic
automation.
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Micrograft indications for eyebrows, eyelashes, beard, and mustache alopecia
P Bouhanna Hospital Saint-Louis, Paris, France
Introduction: Definitive female eyebrows thinning and eyelashes alopecia can be esthetically
reconstructed with hair implants ‘‘one by one’’. Men with facial hair have various connotations
such as wisdom and knowledge, sexual virility, masculinity, or high social status. The beard and
mustache transplantation has roles mostly in the correction of cicatricial or traumatic alopecia,
cleft lip scar, or small area of missing hair. A minority of cases is for the enhancement of virility in
men. A schematic pattern for drawing the outline and understanding of the hair direction has been
purposed.
Objective: To purpose the easy schematic pattern of drawing the beard, the mustache, the
eyebrows, and the eyelashes; to describe the use of two procedures of follicular units: follicular
unit extraction (FUE) and follicular unit long hair (FUL).
Methods: (1) Design of the area to be transplanted according to a schematic pattern and the
patient’s esthetic desire; (2) nerve blocks and local cream anesthesia; (3) 500 to 1500 one-hair
follicular unit; (4) follicular unit long hair (FUL)—no previous shaving of donor area; (5) follicular
unit extraction (FUE)—previous shaving of donor area; (6) hair harvested from the scalp will grow
at the same rate as scalp hair.
Results: (1) Choose the hair color, thickness, and orientation; (2) implantation parallel to the skin;
(3) no bandage; (4) crusts for 7 days; (5) sometimes swelling for 3–4 days.
Conclusion: The reconstruction of eyebrows and eyelashes allows an esthetic and definitive
result. The beard and mustache pattern varies among the ethnic group. The Arabians and
Caucasians have a more extensive area and higher density, whereas the Asians have the least
presentation of facial hair. High patient satisfaction is achievable if patients are well selected and,
particularly, among the psychological profile.
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Estimation of pre-operative scalp mobility for strip harvesting
M Ahmad and MH Mohmand Hair Transplant Institute, Islamabad, Pakistan
Objectives: A very simple method has been developed to assess the scalp mobility.
Materials and methods: The study was conducted on 50 patients who underwent surgery by strip
method. Only the patients undergoing the first session were included. Patients undergoing the
second or third session or those undergoing FUE (follicular unit extraction) were excluded. A scale
was devised (grade 05).
TECHNIQUE: First of all, the upper line was marked in the donor area, and the movement of the
skin was noted above and below the reference line, then the lower line was marked according to
the surgical plan, and the movement above and below the line was marked. The degree of the
overlap was noted.
Results: The mean age of the patients was 35.12 years and majority of them (52%) belonged to
the younger age group (o35 years). Majority of the patients (36%) belonged to group III and 24%
belonged to group IV of the vertical elasticity scale. Only 6% of the patients belonged to group I
(Table 1). A 10-mm overlap was noted in 20% of the patients, followed by a 9-mm overlap in
10%.
Conclusion: It is an inexpensive method to measure pre-operative scalp mobility for strip
harvesting.
PSYCHOLOGY AND HAIR DISORDERS
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Familial trichotillomania in three generations
Y Ramot1, A Maly2, L Horev1, V Molho-Pessach1 and A Zlotogorski1 1Department of
Dermatology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel and 2Department
of Pathology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel
Trichotillomania (TTM) is a type of impulsive control disorder, characterized by recurrent pulling
of hair, which leads to pleasure and relief of tension. It is estimated that 1–3% of the general
population suffers from this condition. The disease leads to hair loss, which may sometimes be
severe and lead to significant social and functional impairment. The etiology of this disorder is
still unknown, although some have suggested a genetic component, based on several reports of
familial hair pulling. Here we report a case of familial TTM in three generations. A 13-year-old
male presented with a 1-year history of focal hair loss in the mid-frontal scalp. He was earlier
treated with local steroids for presumed alopecia areata, with no improvement. Examination
revealed a patchy area of hair loss, with several short broken hair of varying lengths. Dermoscopy
and pathology examinations were consistent with TTM. Upon further questioning, the father
admitted repeated pulling of his beard hair since puberty. The paternal grandfather also suffers
from severe recurrent hair pulling of his beard since puberty, which sometimes precludes him
from leaving home. Several reports, including a recent twin concordance study, have suggested a
higher incidence of TTM and other obsessive-compulsive disorders in family members of TTM
patients. However, to our knowledge, this is the first report of TTM in a three-generation family.
This report strengthens the possibility that TTM is a genetic disease, probably with a complex
inheritance pattern. It also underlines the importance of proper taking of family history when
examining a TTM patient.
P179
Ex vivo hair follicle model to evaluate damage induced by photoepilation
MAA van Vlimmeren1, TAM Nuijs1, GE Westgate2, MG Zeitouny1 and NE Uzunbajakava1 1Care
and Health Applications, Philips Research, Eindhoven, Netherlands and 2University of Bradford,
Bradford, UK
Photoepilation, based on absorption of light by melanin pigment, is a commonly used
method to remove unwanted body hair using short pulses of laser or intense pulsed light (IPL).
To improve the efficacy of photoepilation treatment, physiological understanding of the
effects of photoepilation is crucial. We developed an ex vivo hair follicle model to
evaluate the damage induced by various photoepilation treatment parameters. We evaluated
the effects of multiple flashes with a consumer IPL device, as an alternative to pulse trains and
stacking used in professional systems. Human skin samples obtained few hours post surgery
were treated with a single flash or three consecutive flashes of a consumer device for
photoepilation. Both control and treated follicles (n¼10) were extracted and placed in culture
for the evaluation of their growth rate during 10 days. At day 2, follicles were killed for
histological cell viability analysis using H&E staining and TUNEL method. Control follicles
retained normal morphology and a linear growth rate of B250mm/day during culture. Treated
follicles generally showed an anagen-to-catagen transition, observed as a retraction of the hair
fiber from the dermal papilla (DP). No macroscopic differences were observed between single
and triple flashes. Histology demonstrated three types of damage: (1) detachment of DP from a
damaged hair fiber (occasionally with damaged DP); (2) damaged DP moving upward with
damaged hair fiber; and (3) matrix disruption. Follicles treated with one flash generally
demonstrated damage type 1, whereas three consecutive flashes resulted in type 2 damage,
occasionally along with type 3 damage. Overall, we developed a physiological ex vivo hair
follicle model to monitor follicular damage induced by different treatment parameters. The model
is used for pre-clinical tests and validation of an opto-thermal hair follicle model. This
fundamental knowledge will provide further understanding, and thereby possible improvement of
photoepilation treatment efficacy.
P180
Female hair loss dysmorphic disorder vs female pattern hair loss: how do the
quality of life deficits compare?
DH Kingsley1,2 1World Trichology Society, Staten Island, New York, USA and 2British Science
Corporation, New York, USA
Hair is a significant component of the importance of physical attractiveness and body image, and
therefore losing hair often affects an individual’s physical appearance, self-image, self-esteem,
and overall quality of life. Previous studies on the psychological and quality of life effects of
female pattern hair loss have shown that women with genetic hair loss are more ashamed,
distressed, anxious, and concerned about their hair loss, have lower self-evaluation and self-
esteem scores, and have more psychosocial problems than men with genetic alopecia or women
with normal amounts of hair. A woman’s genetic alopecia is likely to lead to greater social
problems, as well as having a negative effect on her general daily life and causing her to feel more
uncomfortable in the presence of others. However, not every woman who complains of hair loss
actually has a hair loss problem. A small percentage of women with no obvious hair thinning are
extremely concerned about losing their hair. Few studies have been conducted on these women
who present with complaints of hair loss yet exhibit normal amounts of hair loss. The studies that
have mentioned this condition have described it as symbolic for obtaining help for other
underlying psychological or personal problems, marital or work problems, or from anxiety,
depression, and obsessive-compulsive disorder. This phenomenon has been called Hair Loss
Dysmorphic Disorder (HLDD). This presentation will compare the quality of life effects of hair
loss on women with HLDD (that is, women without a hair loss problem) with the quality of life
effects of hair loss on women with female pattern hair loss. It will also discuss specific case
histories of women with HLDD, as well as potential subsets of HLDD.
P181
Alopecic models down the ages
PD Yesudian Department of Dermatology, Betsi Cadwaladr University Health Board,
Bodelwyddan, UK
From time immemorial, artists have endeavored to depict beauty in their masterpieces. Since the
Renaissance, the more astute observers noted that even pathological changes in the human body
(including hair disorders) have been exhibited in priceless works of Art. This review analyses a
few examples of male and female alopecia in paintings between the 16th and 19th centuries.
Male alopecia is probably less often represented in Art compared to its frequency in real life. ‘‘On
the threshold of Eternity’’ is a Van Gough masterpiece painted in 1890. It depicts a bald man
about to commit suicide. The artist seems to have instinctively felt the emotional pain
experienced by man with androgenetic alopecia. ‘‘Aigueperse St. Sebastian’’, drawn nearly five
centuries ago by Andrea Mantegna (1431–1506), hangs in the Louvre. The central figure of the
martyred St. Sebastian is flanked by two villainous archers who have assassinated him. One of the
assassins is clearly shown to have round patches of alopecia in the beard area, possibly indicating
alopecia areata. It may be an expression of the artist’s moral condemnation of the killer.
Illustrations of female alopecia are less frequent as women generally want to look beautiful in
their paintings. Jan Vermeer (1632–75), a Dutch artist, is well known for his series of paintings of a
young woman. A closer examination shows frontal recession in almost every picture. It is variably
attributed to postpartum hair loss, traction, circumferential pressure by tight head dresses, or
plucking of hairs by the woman in the paintings. La Mujer Barbuda, painted by Ribera in 1631, is
a further example of female alopecia, possibly androgenetic. The subject also shows signs of
virilization, suggesting that an androblastoma (androgen producing tumour) may have been
responsible.
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Hair loss as an expression of stress—psychosomatic concepts applied to trichology
F Padovez1, A Carvalho Leite Ju´nior1, MA Cisterna2, ML Bovcon2, RDCAA Santos3, SB de
Carvalho3, M Terra3 1Department of Trichology, CAECI and Universidade Anhembi Morumbi,
Sa˜o Paulo, Brazil; 2Department of Trichology, Asociacio´n Argentina de Tricologı´a - AATRI,
Buenos Aires, Argentina and 3Psicossoma´tica, CAECI - Faculdades de Cieˆncias da Sau´de,
Sa˜o Paulo, Brazil
Studies of Hans Seyle, in the 1950s, stated that many clinical problems have their origin in
stressful events. On the basis of these concepts and knowing that, within the principles of
embryology, nervous and skin systems are derived from the same embryonic tissue (ectoderm),
we decided to investigate how the relationship between the two tissues proceeds from the psychic
aspects and results in clinical signs of hair loss. The evaluation of patients who suffer from hair
loss shows very strongly how this clinical sign may be the result of stressors. Furthermore, the
stress resulting from the perception of hair loss feeds back the clinical sign making it even more
severe as it modifies the chemistry involved in the hair cycle and causes hair loss. A frequent
example of such cases is alopecia areata, an autoimmune disease that affects around 0.5 to 2% of
the population in various age groups. This condition is usually triggered by stressful or traumatic
events. Studies using laboratory animals conducted by the team of researcher Ralf Paus proved
that events that generate stress induce anagen follicle to enter into catagen phase, causing an
effluvium that tends to decrease when the stressors cease. Our group based this study on
analytical psychology especially with the concepts of archetype, complex and symbol, as well as
the structure and dynamics of personality relates to the phenomenon of stress-triggering diseases
whose clinical sign is hair loss.
STEM CELLS AND EPIGENETICS
P183
microRNAs are important players controlling hair follicle development and
regeneration
M Ahmed1, M Alam1, V Emelianov2, A Sharov2, A Mardariev1 and N Botchkareva1 1University of
Bradford, Bradford, UK and 2Boston University Medical Center, Boston, Massachusetts, USA
Hair follicle development is governed by complex programs of gene activation and silencing,
including microRNA-dependent modulation of gene expression. We show that miR-214 is
expressed in the hair follicle (HF) during skin morphogenesis and its cycling. To explore its role in
the control of skin development, we generated doxycycline-inducible miR-214 (K14-rtTA/TRE-
miR-214) transgenic mice (TG). Activation of transgene expression during skin embryogenesis
resulted in the development of thinner epidermis, reduced keratinocyte proliferation, and
appearance of a ‘‘rough’’ coat postnatally as a result of the development of about 40% fewer HFs
in back skin. The hair bulbs in TG mice were markedly reduced in size, which was associated
with decreased cell proliferation in the hair matrix and significantly thinner hair shaft production.
However, the ratio between different HF types (guard, awl, auchene, or zig-zag) in TG and WT
mice was not changed. The inhibitory effects of miR-214 on skin and HF development were
associated with decreased expression of the key components of the Wnt signaling pathway (beta-
catenin, Lef-1), as well as with activation of BMP signaling in the epidermis and HFs as was
documented by increased pSmad1/5 expression. A luciferase reporter assay confirmed
bioinformatic prediction that miR-214 directly targets beta-catenin in keratinocytes. In primary
keratinocytes, miR-214 mimic prevented nuclear translocation of beta-catenin in response to Wnt
activator, lithium chloride, abrogated lithium chloride-induced expression of Axin2, and
significantly diminished TOPflash activity induced by the Wnt activator BIO. Taken together,
these data reveal an essential role of miR-214 in the control of skin and HF development and
suggest miR-214 as a key regulator of the activity of the Wnt/beta-catenin signaling pathway in
the keratinocytes.
P184
Roles of MED1 in quiescence of hair follicle stem cells and maintenance of normal
hair cycling
T Nakajima1, S Inui1, T Fushimi1, F Noguchi1, Y Kitagawa1, JK Reddy2 and S Itami1 1Osaka
University, Suita, Japan and 2Northwestern University, Chicago, Illinois, USA
MED1 (Mediator complex subunit 1) is expressed by human epidermal keratinocytes and
functions as a coactivator of several transcription factors, including nuclear receptors. To
elucidate the role of MED1 in keratinocytes, we established keratinocyte-specific Med1-null
(Med1epi/) mice using the K5Cre-LoxP system. Development of the epidermis and appendages
of Med1epi/ mice was macroscopically and microscopically normal until the second catagen
stage of the hair cycle. However, the hair cycle of Med1epi/ mice was spontaneously repeated
after the second telogen stage and the characteristic hair cycle–domain pattern was observed on
Med1epi/ back skin. These features do not occur in wild-type mice. Although the hair cycle of
Med1epi/ mice was frequently repeated until 6 month of age, hair follicles of Med1epi/ mice
could not enter the anagen thereafter, resulting in sparse pelage hair in older Med1epi/ mice.
Interfollicular epidermis of Med1epi/ mice was acanthotic and more proliferative than that of
wild-type mice, whereas these findings were less evident in older Med1epi/ mice. Flow
cytometric analysis revealed that the numbers of hair follicle bulge stem cells were reduced in
Med1epi/ mice from a few months after birth. The SOX9 expression in Med1epi/-derived
cultured keratinocytes was downregulated, and the SOX9 expression was reduced in some 6-
month-old Med1epi/ hair follicles by immunohistochemical studies. These results suggested that
MED1 has roles in maintaining quiescence of keratinocytes and preventing depletion of the
follicular stem cells.
P185
The role of nestin-expressing stem cells in formation of the hair follicle sensory
nerve
S Mii1, J Duong1, Y Tome1, A Uchugonova2, F Liu3, Y Amoh4, N Saito4, K Katsuoka4 and RM
Hoffman1,5 1AntiCancer Inc., San Diego, California, USA; 2Department of Biophotonics and Laser
Technology, Saarland University, Saarbruecken, Germany; 3Department of Anatomy, Second
Military Medical University, Shanghai, China; 4Department of Dermatology, Kitasato University
School of Medicine, Kanagawa, Japan and 5Department of Surgery, University of California San
Diego, San Diego, California, USA
Vibrissa hair follicles including their sensory nerve stump were excised from transgenic
mice in which the nestin promoter drives green fluorescent protein (ND-GFP) and were placed in
3D culture supported by Gelfoam. Confocal microscopy showed trafficking of the nestin-
expressing cells from the bulge to the whisker sensory nerve stump over a 21-day period of
Gelfoam culture. ND-GFP expressing cord-like structures extended from the nerve stump by day
10. The cord-like structures consisted of ND-GFP–expressing spindle-shaped cells, which
coexpressed the neuron markers b-III tubulin, the immature Schwann-cell marker p75NTR, and
TrkB which is associated with neurons. b-III tubulin-positive fibers, consisting of ND-
GFP–expressing cells were observed to extend 500mm from the whisker nerve stump. The fibers
had growth cones on their tips expressing F-actin, demonstrating that they were growing axons.
The extending whisker sensory nerve was highly enriched in ND-GFP cells, which appeared to
have a major role in its elongation, as well as joining with other nerves in the 3D culture,
including the sciatic nerve, the trigeminal nerve, and the trigeminal nerve ganglion. A major role
of the nestin-expressing cells in the hair follicle is to extend the follicle sensory nerve and join
with other nerves.
P186
Topology–dependent plucking leads to more regenerating hairs than plucked via
extrafollicular macroenvironment modulation
C-C Chen1,2,3, L Wang4, TX Jiang1, S Shi4 and CM Chuong1 1Department of Pathology, University
of Southern California, Los Angeles, California, USA; 2Department of Dermatology, Taipei
Veterans General Hospital, Taipei, Taiwan, Republic of China; 3Department of Dermatology,
Yang ming University, Taipei, Taiwan, Republic of China and 4Center for Craniofacial Molecular
Biology, University of Southern California, Los Angeles, California, USA
Recent work showed that hair stem cell activity is controlled by both intrafollicular and
extrafollicular dermal factors. On the basis of this, regeneration following intrafollicular hair
plucking can elicit signaling changes in the adjacent dermal environment and activate
neighboring unplucked follicles in the region. To test this, 200 hairs were plucked with different
spacing. Interestingly, high-density hair plucking can initiate the regeneration of up to 1000 hairs
by activating adjacent unplucked telogen follicles. A gene profiling–based molecular comparison
of plucked / unplucked / induced follicles and their surroundings combined with bead-mediated
molecular misexpression and genetic mutant analyses demonstrated that this novel extrafollicular
hair induction process involves apoptosis and Tnf-a signaling. A new tissue interaction
mechanism was discovered in which an injured organ can not only activate its own stem cells
but also spread activation signals to other organs through extrafollicular signaling cascade. This
work provides a new possibility for enhancing hair regeneration and lays down the basis for future
translational application.
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Competitive balance of intrabulge BMP/WNT signaling reveals a robust gene
network governing stem cell homeostasis and cyclic activation
E Kandyba1, Y Leung1, Y-B Chen2, R Widelitz3, C-M Chuong3 and K Kobielak1 1Eli and Edythe
Broad Center for Regenerative Medicine & Stem Cell Research, Department of Pathology,
University of Southern California, Los Angeles, California, USA; 2Norris Medical Library,
University of Southern California, Los Angeles, California, USA and 3Department of Pathology,
University of Southern California, Los Angeles, California, USA
Hair follicles facilitate the study of stem cell behavior because stem cells in progressive activation
stages are ordered within the follicle architecture, and they are capable of cyclic regeneration. To
study the gene network governing the homeostasis of hair bulge stem cells, we developed a
Keratin 15–driven genetic model to directly perturb molecular signaling in the stem cells. We
visualize the behavior of these modified stem cells, evaluating their hair-regenerating ability and
profiling their molecular expression. Bone morphogenetic protein (BMP)–inactivated stem cells
exhibit molecular profiles resembling those of hair germs, yet still possess multipotentiality
in vivo. These cells also exhibit upregulation of Wnt7a, Wnt7b, and Wnt16 ligands and Frizzled
(Fzd) 10 receptor. We demonstrate direct transcriptional modulation of the Wnt7a promoter.
These results highlight a previously unknown intra-stem cell antagonistic competition, between
the BMP and Wnt signaling pathways, to balance stem cell activity. Reduced BMP signaling and
increased Wnt signaling tilt each stem cell toward a hair germ fate and, vice versa, on the basis of
a continuous scale dependent on the ratio of BMP/Wnt activity. This work reveals one more
hierarchical layer regulating stem cell homeostasis beneath the stem cell dermal papilla–based
epithelial–mesenchymal interaction layer and the hair follicle intradermal adipocyte–based tissue
interaction layer. Although hierarchical layers are all based on BMP/Wnt signaling, the
multilayered control ensures that all information is taken into consideration and allows hair
stem cells to sum up the total activators/inhibitors involved in making the decision of activation.
P188
Global genome analysis of Lhx2 target genes in hair follicle stem cells and their
progenies reveals the nonrandom distribution and topological associations with
functionally related gene loci
K Poterlowicz1, A Mardaryev1, M Fessing1, A Sharov2, Y Peng3 and V Botchkarev1 1Centre for
Skin Sciences, University of Bradford, Bradford, UK; 2Department of Dermatology, Boston
University Medical Center, Boston, Massachusetts, USA and 3School of Computing, Informatics
and Media, University of Bradford, Bradford, UK
Lhx2 transcription factor operates as a central link in the genetic networks that coordinate
multiple signaling pathways controlling organ development and stem cell maintenance and
differentiation. Lhx2 also controls hair follicle development, cycling, and differentially regulates
Sox9, Tcf4, and Lgr5 in hair follicle stem cells during skin regeneration after injury. Integration of
global microarray data obtained from Lhx2-null mice and genome-wide ChIP data revealed that
majority of the Lhx2 target genes were upregulated in the Lhx2 null mice versus WT controls, thus
suggesting that Lhx2 operates predominantly as transcriptional repressor. Allocation of Lhx2
target genes to distinct chromosomes showed their nonrandom distribution, and topological
analysis revealed that 123 Lhx2 targets belong to keratinocyte-specific gene loci, such as
Epidermal Differentiation Complex or keratin-associated protein locus, as well as to smaller
genomic loci containing functionally related genes (e.g., encoding Wnt ligands, serpin protease
inhibitors, distinct adhesion molecules, and so on.). Expression changes of the functionally related
non-Lhx2 targets in such loci in Lhx2-null versus WT mice were similar compared with the
expression dynamics of the direct Lhx2 target genes. Analyses of the regulatory regions of these
non-Lhx2 target genes showed significant (Po0.01) enrichment of the binding sites for Sox9 and
Tcf4 transcription factors, serving as direct Lhx2 targets in hair follicle stem cells. These data
suggest existence of positive regulatory loops between Lhx2 and Sox9/Tcf4 that might provide
coordinated control of expression of functionally related genes in distinct genomic loci. Thus,
Lhx2 regulates gene expression in hair follicle stem cells through targeting not only single genes
but also functionally related gene groups in distinct loci, it and might also form regulatory
networks with other transcription factors.
P189
Direct differentiation of hair follicle stem cells into dopaminergic neurons without
reprogramming
M Tauchi1,2, A Kellenberger1, MM Tejada Bonilla1,2, D Amato3, E Meyer-Blazejewska4, S
Havlicek5, U Schlo¨tzer-Schrehardt4, B Winner5, CP Mu¨ller3 and J Winkler1 1Division of
Molecular Neurology, University Hospital Erlangen, Erlangen, Germany; 2Department of
Neurology, University Hospital Erlangen, Erlangen, Germany; 3Department of Psychiatry and
Psychotherapy, University Hospital Erlangen, Erlangen, Germany; 4Department of Ophthalmol-
ogy, University Hospital Erlangen, Erlangen, Germany and 5Junior Research Group III of
Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Erlangen, Germany
Cell-based therapy is considered a promising mean for restoration in neurodegenerative disorders.
Transplantation of dopaminergic neurons generated from embryonic neural precursor cells
(NPCs) or induced pluripotent stem cells shows functional recovery in animal models of patients
with Parkinson’s disease. One of the major challenges remains to define a cellular source for
neurons, which is ideally safe, effective, and easily accessible. Hair follicle stem cells (HFSCs) are
pluripotent and may spontaneously differentiate into various cells including neurons. HFSCs are
of ectodermal origin. In addition, a population of HFSC readily expresses the NPC marker Nestin.
Therefore, we hypothesized that HFSCs may differentiate into dopaminergic neurons without viral
vector–induced reprogramming, ectoderm induction, and neural induction, which are usually
necessary for non-neural cells to differentiate into neurons in vitro. Whisker hair follicles from
male C57BL/6 mice were dissected and single-cell suspension from the bulge region was
obtained by enzymatic digestion. After 2–3 weeks of culturing under proneurogenic conditions,
we obtained slow-growing, sphere-forming, NPC-like cells. RT-PCR analyses revealed that the
HFSCs express many marker genes for NPCs and embryonic stem cells. Important genes for the
differentiation of NPCs into dopaminergic neurons (e.g. Nurr1) were already expressed in HFSCs.
Immunostaining confirmed that HFSCs expressed Nestin, Sox2, and GFAP. Subsequently,
directed differentiation was attempted to generate dopaminergic neurons from the HFSCs. After
the differentiation, HFSCs expressed markers of mature neurons (e.g. MAP2) and enzymes for
dopamine synthesis/degradation (e.g. TH) both in mRNA and protein level. Finally, dopamine
production and release was confirmed in the medium by means of HPLC. Taken together, our
study demonstrated that HFSCs have the potential to differentiate into dopaminergic neurons
without reprograming. HFSCs may be able to serve as a safe, effective, and easily accessible
source for dopaminergic neurons for research and/or therapeutic purposes.
P190
Human hair follicle dermal cells provide enhanced support for both epithelial and
embryonic stem cell culture proliferation and maintenance
A Gardner1, RP Hill1,2, CA Higgins3, CJ Whitehouse1, S Yung4, X Zhang4, HC Crawford1, R
Richer2, A Dodds2, WA Owens4, C Lawrence5, S Rao6, B Kara2, SE James7, M Lako4 and CA
Jahoda1 1School of Biological and Biomedical Sciences, Durham University, Durham, UK;
2FUJIFILM Diosynth Biotechnologies UK, Billingham, UK; 3Department of Dermatology,
Columbia University, New York, USA; 4Institute of Genetic Medicine, Newcastle University,
Newcastle-Upon-Tyne, UK; 5Department of Dermatology, Royal Victoria Infirmary, Newcastle-
Upon-Tyne, UK; 6University Hospital Durham, Durham, UK and 7School of Pharmacy and
Biomolecular Sciences, University of Brighton, Brighton, UK
Both human hair follicle dermal papilla (DP) and dermal sheath (DS) cells support epithelial cells
responsible for hair fiber production and maintenance, indicating that they could be effective
supports for epithelial cell populations in vitro. Furthermore, we hypothesized that both human
DP and DS cells could maintain pluripotent stem cells in an undifferentiated state. Cultures of
adult human DP, DS, and outer root sheath (ORS) were isolated through microdissection from
donor hair follicles, with dermal fibroblasts (DF)-isolated and keratinocytes-isolated cultures from
donor adult glabrous tissue. For epithelial support, DP, DS, and DF, cultured in dermal favoring
MEM, were compared with the gold standard of 3T3 mouse fibroblasts and epithelia favoring the
Rheinwald and Green medium. DP, DS, and DF were compared with mouse embryonic
fibroblasts (MEFs) for their ability to maintain the pluripotency of the human H9 ES line, and
human induced pluripotent stem cells (iPSCs). Keratinocytes formed significantly more colonies
when cocultured with DP (30.9±4.2) and DS cells (35.7±5.1) when compared with
keratinocytes cocultured with DF cells (15.1±6.2, all n¼ 3). Levels of rhodamine-B eluted from
keratinocytes cocultured with DS and DP cells in MEM were comparable and similar to those
obtained from keratinocytes cultured using 3T3 cells and R&G medium. Both groups displayed
significantly (n¼ 4, Pp0.001) increased proliferation compared with DF and 3T3 cocultures in
MEM. ES cells cocultured with MEF, DP, or DS cells showed comparable levels of expression of
SSEA-4, TRA-1-60, Oct4, and Nanog. Similarly, human iPSCs cocultured with MEF, DP, or DS
cells maintained normal ES morphology, similar levels of alkaline phosphatase activity, and TRA-
1-60 and TRA-1-81 expression levels. ES and iPS colonies cocultured with DF lost expression of
the aforementioned markers. These data suggest that follicular dermal cells could provide a xeno-
free alternative to current support cells for stem and epithelial cell culture.
P191
Upper part of hair follicle can produce large numbers of cultured nestin-
expressing stem cells for nerve repair demonstrating clinical potential
Y Amoh1, S Mii1,2, R Aki1, Y Hamada1, K Kawahara3, RM Hoffman2,4 and K Katsuoka1
1Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan;
2AntiCancer Inc., San Diego, California, USA; 3Department of Physiology, Kitasato University
School of Medicine, Sagamihara, Japan and 4Department of Surgery, University of California San
Diego, San Diego, California, USA
We have previously demonstrated that the stem-cell marker nestin is expressed in hair follicle
stem cells. Nestin-expressing cells were initially identified in the hair follicle bulge area (BA)
using a transgenic mouse model in which the nestin promoter drives the green fluorescent protein
(ND-GFP). The hair follicle ND-GFP–expressing cells are keratin 15 negative and CD34 positive
and could differentiate into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes
in vitro. Subsequently, we showed that the nestin-expressing stem cells could affect nerve and
spinal cord regeneration after injection into mouse models. We previously separated the mouse
vibrissa hair follicle into three parts (upper, middle, and lower) and cultured each part and
showed that the upper part produced large numbers of multipotent stem cells. In the present
study, the upper part of the follicle produced sufficient cultured nestin-expressing stem cells for
transplantation between severed sciatic nerve fragments of the mouse. The transplanted cell
differentiated into GFAP-positive Schwann cells and promoted the recovery of pre-existing axons.
The method described here is appropriate for future use with human hair follicles producing
nestin-expressing hair follicle stem cells in sufficient quantities for nerve and spinal cord
regeneration in the clinic.
P192
Acceleration of skin wound healing in keratinocyte-specific mediator complex
subunit 1 null mice
F Noguchi, T Nakajima, S Inui and S Itami Osaka University, Suita-shi, Japan
MED1 (Mediator complex subunit 1) is a coactivator of several nuclear receptors and functions in
multiple transcription signaling pathways. We have already established keratinocyte-specific
MED1 null mice (Med1epi/) using K5-Cre-LoxP system and found epidermal hyperplasia in
Med1epi/ mice. In this study, to investigate the function of MED1 in skin wound healing, full-
thickness wounds were generated on the backs of Med1epi/mice and the healing process was
analyzed. Macroscopic wound closure and microscopic rate of re-epithelialization were
accelerated in 8-week-old Med1epi/ mice compared with age-matched wild-type mice.
The number of Ki67-positive cells at leading edges of the wounds was higher in 8-week-old
Med1epi/ mice compared with age-matched wild-type mice, whereas the migration of
keratinocytes, dermal contraction, and the area of a-SMA-positive myofibroblasts in the
granulation tissue were unaffected. Immunoblotting revealed that the expression of follistatin
was decreased and JNK was phosphorylated in Med1epi/ keratinocytes in vitro. Furthermore,
we demonstrated that skin wound healing in 6-month-old Med1epi/ mice was significantly
delayed compared with age-matched wild-type mice, corresponding to our previous observation
that the numbers of hair follicle bulge stem cells were reduced in older Med1epi/ mice. These
results provide a novel insight into MED1 function, as well as a possible new therapeutic
approach for skin wound healing and aging.
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Targeting of antigen presenting cells by HIV-1 virus-like particles for
transcutaneous vaccination
Z Afraz1,2, F Rancan2, S Hadam2, R Wagner3, M Scha¨fer-Korting1, U Blume-Peytavi2 and A Vogt2
1FU-Berlin, Facbereich Biologie, Chemie, Pharmazie, Berlin, Germany; 2Clinical Research
Center for Hair and Skin Science, Department of Dermatology and Allergy, Charite´-
Universita¨tsmedizin Berlin, Berlin, Germany and 3Institut of Medical Microbiology, University
of Regensburg, Regensburg, Germany
The idea of easy accessibility of cutaneous antigen presenting cells (APC) fostered the
development of various transcutaneous vaccination strategies. In intact skin, the hair follicles
are key structures, because deposition of vaccine in hair follicle openings and delivery to the skin
APC across such barrier discontinuities have been shown to be highly promising approaches. In
human explants, we investigated the effect of three different administration routes for
transcutaneous vaccine delivery on skin penetration and cellular uptake of fluorescently labeled
virus-like particles (VLPs) carrying HIV-1 antigen. The effect of Cyanoacrylate Skin Surface
Stripping (CSSS), which induces mild barrier disruption and opens hair follicles, was compared
with the effects of pricking of epidermis and dermal injection. Skin penetration was assessed
microscopically on cryosections. CD1c-positive APCs were isolated from human skin by
magnetic cell separation, as well as HLA-DR-positive migratory cells, and were analyzed by flow
cytometry and fluorescence microscopy. We observed VLP uptake after CSSS and pricking by
Langerhans cells (relative mean fluorescence intensity (rMFI): 1.36; 1.05) and also by dermal
CD1a-positive dendritic cells (DCs) (rMFI: 1.12; 1.11). CD1ahigh DCs showed particle uptake after
CSSS, pricking, and ID (rMFI: 1.16; 1.11; 1.17). Uptake was also detected in migrated HLA-DR-
positive DCs after CSSS, as well as after pricking (rMFI: 1.11; 2.56). Absolute numbers of particle-
positive cells varied among the probes. However, in each individual sample, reduction of
particle-positive epidermal cells was accompanied by an increase in particle-positive dermal and
migratory cells, suggesting that particle uptake by APC occurred in all samples and induced APC
migration. In conclusion, different administration modes resulted in particle uptake by different
APC populations and different migration patterns. These results open perspectives for specific
targeting of skin APC subsets. In fact, recent studies suggest that targeting of different skin APC
subsets may affect the quality of immune response.
P194
Optimization of intercellular communication inside the human hair follicle
A Perrin, C Meyrignac, S Ratz, C Gondran, JM Botto and N Domloge ASI Vincience, Global Skin
Research Center, Ashland Specialty Ingredients, Sophia Antipolis, France
The hair follicle (HF) is a highly organized and regulated organ that undergoes a cyclic activity.
Successive phases of regeneration and regression give rhythm to the hair follicle life. Because of
its unique organization and functioning, the HF is the seat of numerous interactions that take
place inside the HF itself and between the HF and its cutaneous environment. In the present
study, we were interested in studying the interactions implicating laminin-511 (LN-511), its
integrin receptor, and b-catenin. Indeed, the LN-511 pathway was previously associated with hair
follicle maintenance in the active phase of the hair cycle (anagen). For this purpose, we
developed a specific compound that targets LN-511. The first part of the study involved
characterizing the expression levels of LN-511 and a3- and b1-integrins in cultured normal
human keratinocytes (NHKs) and dermal papilla cells (DPCs). Thereafter, in order to study
communication between these two cell types, we applied conditioned medium of NHKs treated
with the selected compound on DPCs. We observed an increase in b-catenin staining in DPCs
treated with NHK-conditioned medium, suggesting an effect on intercellular communication. The
outcomes of the treatment were then studied at the level of the hair follicle by using two models:
ex vivo scalp biopsies and isolated hair follicles. A 24 h application of the compound led to an
increase in the staining intensities of LN-511 and a3- and b1-integrins in the hair follicles of both
models. Moreover, in the hair follicles maintained in culture for a longer time, the compound
helped in preserving LN-511 expression and HF structure. Maintaining intercellular commu-
nication inside the hair follicle, by targeting LN-511, could be considered as a potential way to
preserve optimal hair-growth environment.
P195
Structural analysis of a hair cuticle using TOF-SIMS and AFM
K Ishikawa1, M Okamoto1, N Tanji1 and S Aoyagi2 1Analytical Science Research Laboratories,
Kao Corporation, Wakayama, Japan and 2Faculty of Life and Environmental Science, Shimane
University, Shimane, Japan
A hair cuticle, which consists of flat overlapping cells that surround the hair fiber, protects inner
tissues against external stimuli. In this study, the composition and the physical properties of the
hair cuticle were directly analyzed by two different methods. First, depth profiling of the amino
acid composition was conducted by using time-of-flight secondary ion mass spectrometry (TOF-
SIMS) combined with the C60 sputtering technique. Second, the elastic modulus was measured by
atomic force microscopy (AFM). By applying these two methods, the correlations between the
composition of each tissue layer in a single cuticle cell and the physical properties were
investigated. For healthy hair fibers, it was revealed that the elastic modulus of each tissue
increases as the cysteine/cystine content increases. In addition, the existence of a thin layer that
has a characteristic amino acid composition on the outermost hair surface is considered to be the
epicuticle. It was concluded that significant information about the nature of the hair cuticle can
be obtained by the methods presented in this paper.
P196
Imaging the penetration and distribution of small molecules in hair fibers
DJ Moore, S Gourion-Arsiquaud and J Coret TRI/Princeton, Princeton, New Jersey, USA
Biophysical applications of Fourier transform infrared (FTIR) imaging microspectroscopy
and confocal Raman spectroscopy techniques have been developed, which permit the
collection of hundreds of spatially resolved spectra from biological samples and substrates.
These arrays of spectra can then be interrogated to produce two-dimensional and three-
dimensional images describing any feature of the biological sample’s composition, conformation,
and organization inherent within the infrared and Raman spectra. A significant advantage in
interpreting the results of these ‘‘molecular histology’’ images is that they are generated
without the addition of exogenous fluorescent probes or chemical stains being added to the
sample. Thus, they directly describe the distribution and organization of the hair’s endogenous
molecules. We have recently shown that these biophysical FTIR imaging and confocal Raman
techniques can be applied to cross sections of human hair and intact hair fibers, respectively, to
image the changes associated with environmental and chemical stress. In the current work, we
have sectioned human hair and collected large arrays of spatially resolved FTIR spectra across
many hair sections exposed for increasing time periods to solutions containing small molecules
such as resorcinol believed to penetrate the fiber. Hair fibers from the same experiments were
analyzed with confocal Raman spectroscopy. Spectra were collected from the hair surface to a
depth of approximately 20 microns into the fiber. Both experimental methods successfully
demonstrated that they can directly image the penetration of small molecules into hair and visual
both the concentration and distribution of the penetrating molecule as a function of exposure
time. This presentation will present the specific results from FTIR and Raman imaging of
resorcinol penetration into hair while also discussing this as a general approach to measure small
molecule penetration into hair fibers including imaging subsequent changes in hair protein
chemistry.
P197
How does lifestyle stress affect the hair follicle? Development of ex vivo and
in vitro approaches
C Gondran1, A Perrin1, C Meyrignac1, S Ratz1, G Menon2, JM Botto1 and N Domloge1 1ASI
Vincience, Global Skin Research Center, Ashland Specialty Ingredients, Sophia Antipolis, France
and 2ASI Corporate Research Center, Wayne, Indiana, USA
The hair follicle (HF) is constantly exposed to multiple stressors, resulting in modifications of hair
final appearance. The cumulative effects of these daily aggressions were reported to contribute to
hair graying and reduction of hair diameter, leading to thinner hair. In the present study, different
approaches were developed to evaluate the effect of lifestyle stress on HF, from the most
complete full-thickness scalp biopsies to isolated HF and cultured HF cells. The first model
developed consisted in full-thickness biopsies of scalp skin, maintained in an air–liquid interface
culture system. This model preserved the interactions between the HF and its cutaneous
environment and allowed topical application of potential stressors or formulated products. By
performing serial sections at the level of the HF, followed by hematoxylin-eosin staining, we
observed the damaging effects in the hair bulb, resulting from the topical application of a
detergent solution. Moreover, this ex vivo model was also appropriate for the evaluation of
damage induced by UVA/UVB irradiation and oxidative stress. The second model used was the
HF isolated from scalp skin by microdissection. When exposed to H2O2 stress, a reduction of
melanin content was observed in the hair bulb, as revealed by performing the Fontana-Masson
staining. Finally, using fibroblasts from dermal papilla cells, we developed a model of in vitro-
aged human dermal papilla cells (HDPC) by applying methylglyoxal (MGO). The aged phenotype
of MGO-stressed HDPC was confirmed by altered cell morphology, increased beta-galactosidase
staining, reduced alkaline phosphatase activity, and disorganized fibronectin network.
Furthermore, electron microscopy revealed vacuolization and decrease in intracellular organelles
in stress-induced senescent cells. Combinations of these different methods could help understand
HF response to different stressors affecting its functioning, and propose solutions for HF
protection.
P198
Mild hydration effect on bound-water dynamics in human hair monitored by
1H-NMR
D Zalitacz, H Haran˜czyk, P Nowak and P Delong Institute of Physics, Jagiellonian University,
Cracow, Poland
Gaseous-phase hydration significantly modifies the biological and physical properties of many
biological systems and biopolymers, including the hair fibre. By using hydration kinetics, sorption
isotherm,1H-NMR spectroscopy, and relaxometry, we analyzed a number of water-binding sites
on human hair, the sequence and kinetics of their saturation, and formation of tightly and loosely
bound water fractions. Terminal Dark Hair came from 21-year-old Caucasian female. Hair color
was defined as W (brown black) according to the Fisher-Saller scale, terminal Red Hair came from
25-year-old Caucasian female (IV according to the Fisher-Saller scale), and terminal Gray Hair
came from 57-year-old Caucasian male. Proton free induction decays (FIDs) were recorded using
a high-power relaxometer. The resonance frequency was 30 MHz. All measurements were
performed at room temperature (t ¼ 220C). The hydration kinetics shows (i) a very tightly bound
water fraction, (ii) a tightly bound water, and (iii) a loosely bound water pool. The sorption
isotherm is sigmoidal in form reasonably well-fitted using Dent model. The relative mass of water
saturating primary binding sites is average equal to DM/m0 ¼ 0.07. 1H-NMR signals show a
Gaussian component (T2*E18ms), coming from solid matrix of hair, and two exponential
components (T2L1*E60–250 ms and T2L2*E300–580ms, respectively) from water tightly and
loosely bound. The liquid to solid signal ratio L/S increases linearly with the increased hydration
level.
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Correlating confocal Raman and FTIR spectroscopic imaging of hair with changes
in fiber mechanical properties as a function of chemical stress
S Gourion-Arsiquaud, J Coret, DJ Moore TRI/Princeton, Princeton, New Jersey, USA
Confocal Raman and Fourier transform infrared (FTIR) imaging spectroscopy methods are used to
characterize biological substrates including bone, teeth, and skin by producing spatially resolved
images describing any feature of the sample composition and structure inherently characterized
in the spectra, thereby generating images without the use of probes or stains. Recently, we have
extended IR imaging microspectroscopy and confocal Raman microscopy to the study of human
hair fibers, generating images that characterize the spatial distribution of protein secondary
structures (alpha-helix, beta sheet), lipid chain conformational order, and the distribution of
disulfide cross-links in hair fibers. In the current work, changes in the organization and chemistry
of hair fiber components as a function of chemical and physical stress, including pH and UV
radiation, have been imaged with confocal Raman and FTIR spectroscopy. These new data will
be presented to illustrate the general utility of IR and Raman for characterizing the molecular
impact of external stresses upon hair structure. Results from corresponding mechanical studies of
the bulk and surface mechanical properties of fibers, and fiber assemblies, will be presented to
provide a direct link between the changes in the molecular biophysics and chemistry of the hair
fiber to changes in the fiber material properties.
P200
Straight hair as a phenomenon of reality distortion in South America
A Carvalho Leite Ju´nior1, MA Cisterna2 and ML Bovcon3 1Department of Trichology, CAECI and
Universidade Anhembi Morumbi, Sa˜o Paulo, Brazil; 2Asociacio´n Argentina de Tricologı´a -
AATRI, Buenos Aires, Argentina and 3Department of Trichology, Asociacio´n Argentina de
Tricologı´a - AATRI, Buenos Aires, Argentina
Brazilian and Argentine clinical centers studied over 200 patients with digital tricoschopy, micro
and macro photography, hygroscopicity, sebumetry, and electron microscopy. The results obtained
quantify the hair fiber damage in patients relating to some degree of chronic alopecia. After a
detailed anamnesis and physical/trichological exams, the diagnosis is diffuse alopecia caused by
repetition of chemical and physical aggressors, which is difficult to treat because of the severity of
the damage and psychological impact. We found that this type of alopecia caused by hair-
straightening products is an increasing South American issue that finally results in hair damage:
(1) Women face tremendous sociocultural pressure and succumb to commercials and fashion
trends, causing them to undergo hair-straightening procedures.
(2) After the fourth straightening session, the increase in fiber weakness is a common
manifestation, trichorexis nodosa can be a clinical feature, and the intended results of the
procedures are not as good as expected.
(3) Patients even change their hairstylist/hairdresser to hide the fact that they have undergone
previous straightening procedures, because ethical professionals refuse to perform the procedure
if there is some evidence of risk to hair health.
(4) Patients continue to undergo the straightening procedure hoping, at each new procedure, for
better results than those obtained after the previous straightening sessions.
(5) The hair fiber is overexposed to the straightening methods, increasing the risk of trichorexis
nodosa and the patient complains of no hair growth.
(6) The need for good results from the straightening method increases after the first few sessions
and raises the anxiety of the patient, thereby worsening the clinical features.
Although regulations in Brazil and Argentina prohibit the use of formaldehyde-containing
straightening products, their widespread use is a striking phenomenon. Such is the degree of
perceived need and sociocultural requirements for straight hair, which leads women to be
exposed to health- and hair health–related risks.
P201
Quantitative risk assessment for contact allergens: a simplified approach for hair
dye ingredients
C Goebel1, TL Diepgen2, M Krasteva3, H Schlatter1, J-F Nicolas4, B Blo¨meke5, PJ Coenraads6, A
Schnuch7, JS Taylor8, R Fautz9, W Schuh10, GF Gerberick11 and I Kimber12 1The Procter &
Gamble Company, Darmstadt, Germany; 2University Hospital Heidelberg, Heidelberg,
Germany; 3L’Ore´al, Asnie`res, France; 4Universite´ Lyon1, INSERM U 851, Lyon, France; 5Trier
University, Trier, Germany; 6University Medical Center Groningen, Groningen, Netherlands;
7IVDK at the University of Go¨ttingen, Go¨ttingen, Germany; 8Cleveland Clinic, Cleveland, Ohio,
USA; 9Kao Germany GmbH, Darmstadt, Germany; 10Henkel AG & Co. KGaA, Du¨sseldorf,
Germany; 11The Procter & Gamble Company, Cincinnati, Ohio, USA and 12University of
Manchester, Manchester, UK
The majority of consumers can use hair colorants without any worry. However, hair dyes can cause
allergic skin reactions in a small number of individuals, like other ingredients in common use
products, such as certain foods or drugs. Here, we discuss the Quantitative Risk Assessment (QRA) for
contact allergens, which is a risk-assessment approach allowing to assess the actual allergy (induction)
risk of products containing ingredients with a given allergy potential. The QRA comprises a number of
key steps, mainly determination of a no-expected-sensitisation-induction-level (NESIL), followed by
the application of sensitization assessment factors (SAFs), reflecting uncertainties regarding variations
between the subjects, different product use patterns, and matrix effects. Both allow the determination
of an acceptable exposure level (AEL) to be then compared with the consumer exposure level (CEL)
resulting from product use. This approach has been successfully applied to a variety of product types
and ingredients, like perfume ingredients or preservatives. Here, we propose an alternative approach
within the QRA, to be used for hair dye ingredients featuring precise product exposure data generated
in support of the EU commission hair dye safety strategy. This data set provides firmly established
dose/unit area concentrations under relevant consumer use conditions, referred to as the Measured
Exposure Level (MEL). The MEL includes product exposure scenarios usually addressed by SAFs. In
this instance, it is therefore possible to make a direct comparison between the NESIL with the MEL, as
a proof-of-concept quantification of the risk of skin sensitization under product-in-use conditions. This
is illustrated by two specific hair dye ingredients, PPD, and resorcinol. Comparison of the robust and
toxicologically relevant NESIL and MEL data is therefore considered an improvement versus a hazard-
based classification of hair dye ingredients.
P202
Quantitative analysis of hair surface properties using ATR-FTIR spectroscopy and
high-throughput microfluorometry
S Gourion-Arsiquaud, J Coret and DJ Moore TRI/Princeton, Princeton, New Jersey, USA
Hair fiber surface properties are influenced by several factors including chemical treatments and
external environment factors such as ultraviolet (UV) radiation exposure. In this study, control and
chemically bleached hair samples were analyzed by attenuated total reflectance Fourier
transform infrared (ATR-FTIR) spectroscopy and microfluorometry. The information inherent in
the ATR-FTIR spectra of hair provides chemical information on the outer few microns of the hair
surface and semiquantitatively can track the formation of cysteic acid following oxidative
treatment of the hair. By using cationic fluorescent labels, the micro-fluorometry measurement
quantitatively detects electrical charge modifications at the hair surface after chemical oxidation.
The two measurement methods are complimentary in providing direct characterization of surface
chemistry changes, as well as changes in surface energy and charge properties. The extent of
change in both hair fiber surface parameters is shown to increase with longer peroxide treatment
times and longer UV exposure times. These measurement techniques, and the results of the
specific chemical and UV stresses used in the current work, will be discussed with a focus on their
general application to provide quantitative surface information related to hair fiber damage,
protection, and repair.
P203
The influence of keratin actives on the internal structure and thermal stability of
hair
F Bell Unilever R&D, Bebington, UK
Consumers regularly subject their hair to intensive treatment, care, and styling routines to help
themselves achieve desired look. The actions performed by the consumer introduce changes to
the chemistry and physics of hair fibers and the consequence of these changes are generally
perceived by the consumer as damage. Combing and brushing of hair mechanically abrades the
surface of hair and making them rougher and increasing their frictional characteristics. Hair
lightening or coloring treatments generally involve an oxidative step to break down melanin and
to develop the new hair color, but the hair fiber protein can also be oxidized that results in
changes in the number and types of covalent and noncovalent bonds and interactions in the fiber
influencing structural integrity, thermal stability, and mechanical properties. It has been shown
that certain organic acids, carbohydrates, and salts can penetrate into hair and influence the
secondary structural characteristics, which in turn change the hair’s thermal stability.
Transmission Fourier Transform Infra-Red (FTIR) has been used to demonstrate the chemical
and structural changes arising from damage treatments and has subsequently shown the location
and impact of a number of active materials on the fiber structure. Differential scanning
calorimetry (DSC) has been used to show a decrease in the thermal stability resulting from
damage and has subsequently shown how the stability reduction can be ameliorated through
application of the aforementioned active materials. DSC results have shown that the magnitude of
the thermal stability change can be increased by the repeated application of the active materials
from a hair care product system and have been shown to increase the thermal stability of
damaged hair to a level equal to or greater than that of undamaged hair.
P204
Long-term effect of anti-dandruff shampoo on scalp condition
S Bennett, KA Darling and JR Matheson Clinical CFC, Unilever R&D, Bebington, UK
Background & Objective: This study was designed to build the understanding of how scalp
condition changes with antidandruff shampoo treatment, as well as to give insights into the
natural variability in scalp condition, over a 12-month period.
Methods: This is an UK-based study of a double-blind, parallel, randomized design. Subjects
were recruited on the basis of both self-perception of dandruff (Y/N) and visual technical
assessment of scalp (TWHS) to provide a range of scalp conditions. Subjects underwent a run-in
phase (2–4 weeks) on beauty shampoo and were then randomized to one of the three shampoos
(1% zinc pyrithione shampoo, prototype antidandruff shampoo, and placebo shampoo). The
allocated shampoo was used at home as a part of their normal hair care routine for 12 months.
Dandruff was assessed at baseline (Feb) and after 4, 12, 26, 39, and 52 weeks. Data were
analyzed using analysis of covariance with product, week and TWHS as main fixed effect.
Results: For the whole population, both antidandruff shampoos gave significantly lower scores
compared with the placebo shampoo at all time points (Po0.05). Both active shampoos were also
superior to the beauty shampoo in the lower flake population (TWHSo28, n¼ 229). In the
populations with higher flakes (TWHS428, n¼ 78), the zinc pyrithione shampoo was superior to
placebo at all time points, whereas the prototype shampoo was not significantly different from the
placebo at 12 and 39 weeks. Further analysis of the data suggested that there are seasonal changes
in scalp flake levels.
Conclusions: The data demonstrate a sustained anti-dandruff benefit for dandruff sufferers with
continued zinc pyrithione shampoo use. In addition, those subjects with low levels of scalp flakes
also showed benefit from the use of the anti-dandruff shampoos.
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Electrophoretical comparison of individual and commercial hair strands and the
effects of internal and external influences
G Wortmann1, A Zalfen2, A Schwan3 and FJ Wortmann1 1Materials, University of Manchester,
Manchester, UK; 2European Patent Office, The Hague, Netherlands and 3Procter & Gamble
Service GmbH, Darmstadt, Germany
The knowledge about changes of human hair proteins introduced by aging, environmental
influences, and cosmetic treatments is an important requirement for the development of
innovative cosmetic products. The electrophoretical fractionation of hair cortex proteins is a well-
established tool for analyzing such changes. The analysis of electrophoretical protein patterns
(SDS-PAGE) gives detailed information about chemical changes of the intermediate filament
proteins, as well as of the various groups of intermediate filament–associated proteins. For the
electrophoretical analysis, cortex proteins have to be reductively extracted from hair. The amount
of extractable cortex proteins varies from person to person, as well as along hair length. A
progressive decrease in the amount of extracted proteins can be observed along hair fibers due to
weathering-induced cross-linking and protein loss. A large variation in protein extractability can
be observed between the individuals, which is assumed to be caused by different diffusion rates
for reagents into the fiber. These variations can clearly be distinguished from genetic changes in
protein band formation in the pattern. Commercially available hair strands generally show a
reduced extractability of cortex proteins. Changes in the extractability are not influenced by hair
color and age of donors. Statistical evaluation of electrophoretical protein patterns is able to give
detailed information about weathering along hair, as well as individual extractability, separately
for intermediate filament proteins and intermediate filament–associated proteins. This approach
shows specific promise for the detailed analysis of chemical processes of cosmetic relevance
based, namely, on reduction and oxidation.
P206
Hair and scalp surface properties, and formulation design, influence the selective
delivery and deposition of actives
J Coret, S Gourion-Arsiquaud and DJ Moore TRI/Princeton, Princeton, New Jersey, USA
Inducing the targeted delivery of actives to scalp compared with hair would greatly enhance the
efficacy of actives that treat scalp disorders. In addition, the selective deposition of actives onto
the surface of hair fibers, but not on to scalp, would reduce unwanted staining and/or irritation
risks associated with certain types of hair products. The deposition of model actives onto
biological substrates such as hair and skin was studied using a variety of Fourier transform infrared
(FTIR) spectroscopy and confocal Raman spectroscopy methods in combination with analytical
methods such as tape stripping. The influence of pH, a critical formulation solution parameter,
was studied for two water-soluble actives with very different pKa values such that the actives have
opposite ionic charges at a specific pH. These initial studies will describe the deposition of each
active as measured in separate ex vivo hair and skin experimental models. The results are
discussed in the context of inducing and controlling selective deposition of specific actives or
drugs on hair versus scalp skin, or vice-versa. The influence of chemical treatment of hair on
active delivery and deposition was also studied by comparing deposition results on undamaged
hair to that of bleached hair. Our spectroscopic results indicate that active deposition is heavily
influenced by long-range electrostatic factors and is dependent on the nature of the ionic groups
that are to be found on each biological surface.
P207
The design of superior emulsions in hair care: a model of deposition and thin-film
lubricant performance
S Wire, N Shaw and P Warren Unilever R&D, Bebington, UK
The use of silicones and oils in personal products is well known. In the case of hair care products,
such as shampoos and conditioners, silicones and oils are commonly used to reduce the
damaging friction encountered during daily hair care routines, and they impart a smooth and
superior feel to the substrate. Silicones in particular are remarkable in being able to deliver highly
significant lubricant effects from very thin films. Detailed studies of molecular dynamics in these
films have therefore been an area of significant industrial and academic interest in recent years.
These studies have highlighted the importance of molecular considerations in the design of
superior lubricant systems. In aqueous products, such as hair shampoos, however, these materials
are often incorporated as emulsions. In this case, the emulsion characteristics such can heavily
influence the performance of the final film. In this paper, we present a physical model of emulsion
deposition and final film performance. This model correlates extremely well with experimental
data and demonstrates the significant influence of properties such as emulsion particle size and
spreading behavior. In this manner, the lubricant film may be designed to deliver superior
lubrication while minimizing the amount of material required. In applications such as the design
of superior hair products, therefore, this may be used to deliver benefits such as hair smoothness
without incurring consumer-perceived negatives such as heaviness and greasiness.
P208
Scalp and hair health—interrelationships and molecular insights
MK Hordinsky1, JR Schwartz2, MG Davis3 and RC Rust4 1Department of Dermatology, University
of Minnesota, Minneapolis, Minnesota, USA;2Sharon Woods Innovation Center, The Procter &
Gamble Company, Cincinnati, Ohio, USA; 3Mason Innovation Center, The Procter & Gamble
Company, Cincinnati, Ohio, USA and 4German Innovation Centre, Procter & Gamble Service
GmbH, Schwalbach, Germany
Scalp and hair problems have high global prevalence spanning across genders and ethnicities.
We will review the current scientific knowledge in this area and then present new hair and scalp
research, both at the micro and molecular levels, which has led to a new, detailed understanding
of these problems that will help in the advancement of their effective treatment and prevention.
The scalp surface features a unique microenvironment comprising of the superficial surface and a
substantial portion of the follicular infundibulum. The surfaces in all areas of this microenviron-
ment are sebaceous, lipid-rich, relatively dry, and physically protected by hair. For the most
common scalp condition, dandruff, the presence of hair is a prerequisite. Conversely, the hair
fiber is negatively affected by the physiological changes associated with this very scalp condition.
We have complemented molecular methods for assessing the scalp condition with new
approaches toward assessing the microenvironment of the follicular infundibulum. These
methods have enabled a detailed understanding of the scalp conditions and have led to the
development of superior technologies for treating and preventing these conditions, as well as
providing a favorable environment for healthy hair to grow. Beyond the scalp, the hair fiber can
degrade as a function of external stress, one type being oxidative stress. Reliable measures to
understand what is happening to the hair fiber undergoing oxidative stress can provide invaluable
data to understand new mechanisms and treatment approaches. The field of proteomics has
enabled us to examine how oxidative stress impacts on the integrity of a hair fiber’s protein
structure. To that end, we have previously shared biomarkers linked to oxidative coloring.
Recently, we have identified peptide biomarkers that differentiate the oxidative damage done to
hair’s protein composition via UV-light from that of oxidative coloring. These fundamental
protein changes have been linked to the perception of hair quality.
P209
Effects of basic amino acids on hair
C Taylor, P Carpenter and S Chandra Unilever R&D, Bebington, UK
The hair fiber is particularly rich in cysteine, serine, and glutamic acid, and the properties of the
constituent amino acids confer functionality on the hair fiber due to the prospective interactions
that take place. The hydroxyl, amide, and basic functional groups can interact via hydrogen
bonding and ionic interactions. Hair proteins are composed of a greater proportion of negatively
charged amino acids, which can encourage the uptake of positively charged species. Dibasic
amino acids such as arginine and lysine have been examined to assess their effect on hair fiber
properties using a number of techniques. Uptake and penetration into the fiber has been
confirmed using radio labeling and fluorescent detection. The impact of these actives has also
been studied using a number of physicochemical techniques and the increase in the protein
denaturation temperature has been measured by differential scanning calorimetry. This work has
shown that these amino acids are taken up by the hair fiber and the impact on damage has been
demonstrated.
P210
Comparison Study between the tribological and nanomechanical properties of
two ethnic groups of hair fibers
AE Eltom, NF De Oliveira and SADS Camargo Engenharia Metalu´rgica e de Materiais, Federal
University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
In the past, the chemical and physical properties of the hair fibers, like chemical composition,
microstructure, and hair growth, were extensively studied. It was found that human hair is a
biological nanocomposite fiber with well-characterized microstructures. In this work, the
tribological and nanomechanical properties, such as coefficient of friction, hardness, and Young’s
modulus, of different hair fibers were measured using the nanoscratch and nanoindentation
techniques. The nanoindentations tests were performed on both the transverse and the
longitudinal surfaces of each hair fiber. These properties, as a function of hair structure (hair of
different ethnicity), were discussed.
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Evaluation of postoperative edema in patients having hair transplant surgery
M Ahmad Hair Transplant Institute, Islamabad, Pakistan
Swelling or edema of forehead or eyelids is a common consequence of hair transplant surgery.
The study was conducted to evaluate the status of postoperative edema after hair transplant. All
the patients who underwent hair transplantation surgery from January 2007 to December 2009
were included. All the procedures were performed under local anesthesia. About 100 ml of
tumescent anesthesia was used for the recipient areas using 1% xylocaine with 1:100,000
epinephrine and 40 mg of Triamcinolone acetate. After the surgery, an elastic bandage was used,
which was removed after 16 to 20 hours. Patients were advised to apply ice packs and were
instructed to lie in the supine position for 48 hours. No oral / intramuscular / intravenous steroids
were advised. Any swelling/edema was assessed and classified according to different grades
(grade ‘0’ to ‘IV’). A total of 300 male patients were included in the study. The average age of the
patients was 36.1 years. Majority of the patients belonged to middle age group (31 to 40 years).
Majority of the patients (95.7%) developed ‘no edema’ or ‘swelling’ postoperatively. Few patients
(4%) developed edema in the forehead but none of them developed a black eye. Only one patient
developed periorbital edema. Thus, we see that local use of steroid prevents edema formation.
P212
Clinical and biochemical evaluation of the effectiveness of shampoo RV3438D in
chronic recurrent squamous states -Interest of a maintenance treatment
V Turlier1, C Viode2, A Bacquey3, E Durbise4, R Oliveira Soares5, O Lejeune2, C Villeneuve6,
A Rouquier7, V Mengeaud7 and A-M Schmitt8 1Exploration clinique, Pierre Fabre Dermo
Cosmetique, Toulouse, France, 2Biologie Clinique, Pierre Fabre Dermo Cosmetique, Toulouse,
France, 3Syste`me et Me´thodes, Pierre Fabre Dermo Cosme´tique, Toulouse, France, 4Private,
Cahors, France, 5Hospital Cuf Descobertas, Lisbon, Portugal, 6Altran Sud Ouest, Blagnac, France,
7Exploration Clinique, Pierre Fabre Dermo Cosmetique, Toulouse, France, 8Pierre Fabre Dermo
Cosmetique, Toulouse, France
Background: Relapses are always observed after stopping scalp anti-dandruff treatment.
Shampoo RV3438D (cyclopiroxolamine, zinc, acid Pirythione beta-glycyrrhetinic acid) was
developed to treat chronic recurrent squamous states (CRSS).
We wanted to evaluate the effect of a short attack phase on the improvement of CRSS, its
persistence and interest in a maintenance phase in the prevention of recurrences.
Materials and methods: A total of 67 subjects with CRSS of moderate-to-severe scalp erythema
and itching have been included in this study conducted in 2 phases: phase 1 (attack 2 weeks),
noncomparative and phase 2 (8 weeks), comparative, divided in 2 parallel groups, namely,
maintenance or discontinuation (‘stop’) group. RV3438D shampoo was used 3 times /week
during phase1 and then 1 time /week during phase2 only in the maintenance group, alternating
with a neutral shampoo. In the ‘stop’ group, only the neutral shampoo was used. The efficacy of
the shampoo was assessed as follows: clinically, on the basis of the Overall Clinical Dandruff
Score, erythema, global efficacy, self-assessment (efficacy, dandruff, discomfort, and itching), and
time to first recurrence; biochemically (scale samples), on the basis of Malassezia species (qPCR)
and inflammation markers (ELISA analysis). Tolerance was observed.
Results: During phase 1, clinical scores, the quantity of malassezia species, and the levels of
inflammation markers significantly decreased (Po0.0001). During phase 2, in the ‘maintenance’
group, the improvement was maintained with a decrease from baseline remaining significant
(Po0.05). In the group ‘stop’, improvement regressed significantly for all the parameters studied.
Intergroup difference was significant, and the time to relapse was found to be significantly higher
in the ‘maintenance’ group (P¼ 0.0001). Transient reactions to shampoo have been observed in
8.6% of the cases, mainly after the first use.
Conclusion: The effectiveness of shampoo RV3438D on clinical and biochemical signs of CRSS
was demonstrated after a short attack phase. In a period of 8 weeks after discontinuing the
treatment, this improvement regressed significantly. This decline could be avoided by introducing
a maintenance treatment (1/sem), allowing the maintenance of treatment effect, and spacing
significant recurrences.
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Microstructural re-engineering of conditioners for better performance
G Roberts, C Richards, G Mcleod and C Giles Unilever R&D, Bebington, UK
Hair conditioners are currently a major source of growth within the hair products category. A
growth, which is partly driven by an insatiable consumer demand for improvements in the look
and feel of hair, and a demand, which is further exacerbated by the rise in hair chemical
treatments, which while improving and changing the look of hair do cause significant
deterioration to the health and tactile properties. Hair conditioners help to ameliorate dryness
and/or damage arising from environmental exposure (sun, UV), use of devices (hair dryers and
hair straighteners), or through chemical treatments (bleach and perming). In particular,
conditioners lubricate the hair and aid in detangling to prevent the various types of damages,
such as breakage and split ends, which is most commonly caused when the hair is wet.
Performance of products during the wet/rinsing stage is also critical in driving an enhancement in
the look and shape of the hair at the end. Hair that is more easily detangled and aligned during the
wet condition will be more manageable and styled once dried. Hair conditioners contain a
number of different components; however, it is the lamellar gel phase in the hair conditioner,
which is critical for developing the wet-conditioning benefits of detangling and alignment.
Presented in this poster will be new insights on how the microstructure of a lamellar gel phase can
be engineered in order to deliver the optimum hair conditioner gel phase. Moreover, presented in
this poster will be the technical and consumer benefits of engineered gel phases, including
friction/lubrication, breakage, detangling, and manageability benefits.
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Trials and tribulations of aging hair—It is not only how it grows but also what we
do to it!
S Chandra, S Maguire and T Paoli Unilever R&D, Bebington, UK
As you age, one of the first signs is the loss of pigmentation, resulting in grey hair. However, there
are other important changes leading to issues with manageability. These can be attributed to two
main areas: (a) diameter changes and (b) sebum level reduction. Diameter reduction together with
changes in the shape of the fiber, results in lack of volume and thin appearance. It has been
shown that the strength of the hair fiber is relative to its thickness, thinner fibers require less
energy to break. Sebum levels rise up to the age of 30 and then fall, reduction in sebum results in
hair and scalp being drier leading to misalignment and reduction in shine. These changes in hair
cause women to alter their routine: wash frequency decreases and styling product use, perming,
and coloring increase. These habitual changes could result in hair being damaged. For example,
chemical treatment may result in wearing away or lifting of the cuticles leaving hair rough, with
coarser feel and less shine. Bleached and damaged hair is weaker and therefore would break
easily. These will be discussed in this poster.
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Hair care benefits arising from the application of hair oils
F Bell Unilever R&D, Bebington, UK
The application of oils to hair is a cultural norm in India and provides a number of care,
appearance, and style benefits. Traditionally, naturally derived oils such as those from coconut,
sesame, and mustard have been a commonplace but a number of alternative oils are
now available to the consumers. This work describes the observations from a number of
experiments in which the delivery and benefits of a natural oil and an oil blend are compared.
It has been shown that the oil blend can penetrate the hair more readily than the natural oil,
while providing similar or larger magnitude physical property benefits but with improved feel
characteristics.
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Involvement of the immune response in regeneration of experimentally
amputated whisker follicles in vivo and in a novel culture model of regeneration
using newborn follicles
S-W Li1,2, C Higgins3, K Sorensen2, AM Christiano3 and CA Jahoda2 1College of Life Science,
Tarim University, Alar, China; 2School of Biological and Biomedical Sciences, Durham
University, Durham, UK and 3Department of Dermatology, Columbia University, New York, USA
Follicles have a unique capacity to regenerate a functional end bulb after experimental
amputation. Previous work suggests that regeneration entails an initial phase resembling skin
wound healing, followed by specific remodeling of the bulb involving epithelialmesenchymal
interactions. A key feature of the phenomenon is that the mesenchymal (dermal) components of
the follicle (the dermal papilla and dermal sheath) reconstitute without scarring (fibrosis).
Macrophages, as well as TGFb family members, have been strongly linked with fibrosis; therefore
one hypothesis is that lower follicle regeneration involves a reduced or modified immune
response. This study aimed to investigate this question and to develop a novel culture model of
follicle regeneration. For in vivo studies mouse and rat whisker follicles were experimentally
amputated and follicles recovered between 24 hours and 3 weeks postoperatively. For in vitro
work, follicles were isolated from newborn mice, bases amputated, and the follicles cultured on
filters for up to 4 days. All specimens were cryofrozen or wax processed for immunohistochem-
istry/immunofluorescence. Early changes to the epithelium mirrored that of skin wound healing
with migration of the follicle epithelium to fill the inner follicle silo, upregulation of cytokeratin15
near the follicle base, and strong expression of fibronectin. The in vitro model was able to
undergo this first phase of regeneration. Labeling of in vivo specimens with a CD68 antibody (rat)
and CD11b, F4/80 antibodies (mouse) identified highest concentrations of macrophages around
the site of amputation at 48 hours, these cells being lost by 7 days. Interestingly, macrophages
were also detected in the culture model. TGFb1 was strongly expressed in follicle dermis,
although, interestingly, not at the immediate site of dermal papilla regeneration. We suggest that
lack of scarring in regenerated follicles cannot be attributed to lack of an immune response,
although subtleties involving macrophage subpopulations are currently being investigated.
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Full-thickness skin with mature and cycling hair follicles using tissue culture
expanded human cells
X Wu, L Scott and K Stenn Aderans Research Institute, Inc., Marietta, Georgia, USA
Regeneration of hair follicles using tissue cultureexpanded human dermal and epidermal cells has
been a long-term challenge. Although a recent report described human hair follicle formation
within a skin equivalent containing TSCII mutant skin fibroblast cells, the hair shafts formed were
abnormal. Here, we report the formation of skin with robust hair follicle growth using dissociated
and cultured human scalp dermal cells combined with cultured neonatal foreskin keratinocytes.
Our results show a full-thickness skin containing mature epidermis, dermis, and subcutis. The
regenerated hair follicles show normally layered sheaths with sebaceous glands, arrector pili
muscles, dermal papilla, and mature hair shafts. The follicles show anagen, catagen, and telogen
forms. We demonstrated that the regenerated skin and the hair follicles therein (including
interfolliclular and follicular epidermis, dermal fibroblasts, papilla, and dermal sheath) are of
human origin. Staining with differentiation markers documented good follicular and inter-
follicular epidermal maturation and regenerated interfollicular and follicular epidermis with
distinct differentiated layers. Interestingly, human antigen-positive sweat glands, vessels, and
neurons were present in the skin grafts, a novel finding. Time-course analysis shows that
neogenesis of human hair follicles recapitulates embryonic morphogenesis. Finally, we show that
the reconstituted skin can maintain human features for at least 1 year after grafting and that it is
able to heal with human cells after injury. In summary, our findings have four implications:
1. Tissue culture expanded human cells can indeed produce mature skin with subcutis and fully
developed cycling, shaft-forming hair follicles, and eccrine glands.
2. Closer study of this system will allow mechanistic insights into human skin and appendage
physiology and morphogenesis.
3. This system will allow for new laboratory models of skin disorders using patient or mutated
cells.
4. The method will accelerate the generation of a complete skin for clinical applications.
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Enhancing hair follicle neogenesis in bioengineered human skin substitutes
R Thangapazham1, P Klover1, S Li1, J-A Wang1, Y Zheng2, L Sperling1, G Cotsarelis2 and T
Darling1 1Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA and
2University of Pennsylvania, Philadelphia, Pennsylvania, USA
Bioengineered dermalepidermal composites (DECs) restore barrier function but not hair follicles
(HFs) to the skin. Our initial objective was to demonstrate de novo human HF neogenesis in
grafted DECs. Human Dermal Papilla (DP) cells isolated from lateral scalp dermis from three
female donors (HDP43, HDP47, and HDP52, named according to donor age in years) were
propagated in vitro. Reconstitution assays using HDP47 and HDP52 grown as spheroids were
positive for HF induction only when coinjected with mouse epidermal aggregates but not with
human neonatal foreskin keratinocytes. Moreover, HFs that were formed were chimeric with
mouse-derived cells comprising the epithelial component and human-derived cells dominating
the region adjacent to the epithelium. Remarkably, we achieved human HF neogenesis in grafted
DECs made using HDP47 and foreskin keratinocytes. Interestingly, the percentage of cells
staining positive for alkaline phosphatase activity, a DP marker, which correlates with
trichogenicity, was significantly different among the samples (Po0.001), with the majority of
HDP47cells showing activity. Our next step was to determine the effect of keratinocyte passage
on HF neogenesis. DECs were created with HDP47 and either primary or passaged keratinocytes;
these were then grafted onto immunodeficient mice and were harvested after 8 weeks. All of the
grafts using primary keratinocytes (n¼6) had HFs, 83% of grafts using passage 1 keratinocytes
(n¼ 6) had HFs, and only 71% of grafts using passage 3 keratinocytes (n¼ 7) had HFs. Enhanced
HF neogenesis using early keratinocyte cultures may be the result of greater abundance and/or
responsiveness of progenitor cells with a capacity for HF formation. These studies demonstrate the
feasibility of using normal human cells to create superior skin substitutes that develop skin
appendages. Furthermore, the studies provide a model system to optimize autologous tissue
engineered skin substitutes for clinical applications.
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Interleukin 6 promotes adult de novo hair follicle organogenesis through STAT3
phosphorylation
AM Nelson, AS Katseff, SR Resnik and LA Garza Department of Dermatology, Johns Hopkins
Medical School, Baltimore, Maryland, USA
Adult de novo organogenesis holds great promise in regenerative medicine. As a potential therapy
for many types of alopecias, we study Wound-Induced Hair follicle Neogenesis (WIHN), where
embryogenesis is recapitulated after full-thickness excisional wounding and de novo hair follicles
are counted within the healed wound. To identify causes of natural variation, we screened gene
expression differences between mice with high and low WIHN levels. Interleukin 6 (IL-6) was
identified as prominently upregulated in mice with increased WIHN. We hypothesized that IL-6
and subsequent STAT3 phosphorylation promotes WIHN. Both IL-6 and STAT3 phosphorylation
are increased immediately after wounding and in the re-epithelialized keratinocytes. Levels of IL-
6 mRNA (n¼ 4; Po0.05) and protein (n¼3; Po0.05) positively correlated with regeneration
ability among mouse strains. Exogenous addition of recombinant IL-6 during wound healing
significantly increased WIHN in C57BL/6J mice (n¼ 20; Po0.01). Paradoxically, WIHN is also
significantly increased in IL-6 null mice, compared with strain-matched (C57BL/6J) controls
(n¼ 45; Po0.01), highlighting the complexity associated with tissue regeneration. However,
phosphorylation of STAT3, a downstream mediator of IL-6 signaling, is also significantly
increased in IL-6 null mice compared with controls (n¼ 4; p¼ 0.02), suggesting that other IL-6
superfamily members that also activate STAT3 compensate for IL-6. Indeed, the IL-6 family
member oncostatin M (OsM) is significantly increased (n¼4, Po0.01) in IL-6 null mice
compared with strain-matched controls. Underscoring its importance, pharmacological inhibition
of STAT3 phosphorylation inhibits WIHN in both wild-type (n¼6–9; p¼ 0.01) and IL-6 null mice
(n¼ 7–9; p¼0.03). Overall, these findings demonstrate that IL-6 and STAT3 phosphorylation
trigger hair follicle regeneration. These results suggest targets to promote de novo hair
morphogenesis in human clinical trials for alopecias and also argue against generalizations
about inflammatory mediators negatively impacting regeneration.
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Human hair follicle neogenesis using microenvironmentally reprogrammed
dermal papilla cells
CA Higgins1, CA Jahoda2 and AM Christiano1,3 1Department of Dermatology, Columbia
University, New York, USA; 2Biological and Biomedical Sciences, Durham University, Durham,
UK and 3Genetics and Development, Columbia University, New York, USA
Hair follicle (HF) neogenesis refers to the generation of an entirely new HF in recipient skin using
HF dermal papilla (DP) cells. This has been extensively demonstrated in rodent skin, either using
intact DP or using cultured DP cells. In contrast, HF neogenesis in human skin has not previously
been achieved using human cells. We performed global transcriptional profiling of both intact
and cultured DP cells using the Affymetrix U133Plus2.0 array, which revealed several pathways
expressed in intact DP, which are capable of neogenesis, but absent in cultured cells, that lack the
potential to induce de novo HF growth. We postulated that one approach to restoring the
microenvironmental and anatomical context of intact DP is to grow the cells in hanging drops,
which results in the formation of DP spheroids. We then profiled DP spheroids for changes in
gene expression and determined that the average correlation coefficient between the
transcriptomes of intact DP and the cultured cells is 0.42, whereas that between the intact DP
and the spheroids it is 0.56, which equates to a significant restoration of an intact DP signature by
3D culture. To evaluate whether recapitulation of the DP signature equated to a restored
inductive potential, we established a contextual human-to-human HF neogenesis assay that could
be used to assess the inductive capacity of human DP cells in human skin. When we
microimplanted DP spheroids into recombined foreskins placed onto the back of SCID mice, we
observed marked HF neogenesis by 6 weeks, showing for the first time that intact human DP can
induce de novo human HFs. We conclude that the partial restoration of the transcriptional profile
in human DP cells, achieved simply by growing the cells in a 3D spherical microenvironment, is
sufficient in some instances to restore the inductive capacity of DP cell cultures and elicit human
HF neogenesis.
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Calcium microcapsule: a possible scaffold for building artificial dermal papillae
C-M Lin1, K Huang2 and Y Li3 1Shantou University Medical College, Shantou, China; 2S.
Gallicano Dermatologic Institute (IRCCS) Second Affiliated Hospital, Shantou University Medical
College, Shantou, China and 3First Affiliated Hospital, Shantou University Medical College,
Shantou, China
Although dermal papilla (DP) transplantation is one of the most promising treatments for baldness,
lack of DP with hair follicle inductive properties still remains a major obstacle. Previously, we
developed artificial DP by enclosing DP cells (DPCs) within microcapsules. In this study, we used
barium (Ba) and calcium (Ca) microcapsules as candidates for a scaffold for artificial DP. We
compared both microcapsules in terms of biocompatibility, structural stability, and permeability,
as well as cell viability and hair follicle inductive properties in the short term. Both Ba and Ca
microcapsules maintained xenogenic DPCs in an immunoisolate environment and induced the
formation of hair follicle structures. Biocompatibility, permeability and cell viability were better
with Ca than Ba microcapsule scaffolds. Especially, biocompatibility was better with Ca than Ba
microcapsules when transplanted into the peritoneal cavity of mice. Ca microcapsules were
assessed for long-term inductive properties with xenotransplantion into SpragueDawley rat ears.
Before 20 weeks, Ca microcapsules gathered together, with no substantial immune response.
After 32 weeks, some microcapsules were near inflammation cells and were wrapped with fiber.
A few large hair follicles were found. Control samples showed no marked changes in the
implantation site. Ba microcapsules are advantageous for structural stability. Even after
microcapsules are broken, the inside cell can be isolated from immune cells. Ba microcapsules
may be of use in short-term transplantation study. Ca microcapsules may provide an effective
scaffold for building artificial DP.
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Human Scalp-derived fibroblasts are multipotent and trichogenic
B Marshall, K Watkins and K Stenn Aderans Research Institute, Marietta, Georgia, USA
Along with the hematopoietic and intestinal systems, the hair follicle has become one of the three
current laboratory models for studying stem cells. Because of its cyclic reformation, the hair
follicle also serves as a powerful tool for studying tissue regeneration. By using a mouse system,
many laboratories have isolated hair folliclederived cells that can regenerate into skin and its
appendages. In this study, we report the isolation and tissue culture expansion of human adult
scalp fibroblasts, which have mesenchymal stem cell (MSC) and trichogenic properties.
Fibroblasts were isolated from fragments of human adult occipital full-thickness scalp skin (IRB
approved protocol) and used at passage 2. Adipose derived MSCs were purchased (Thermo
Scientific). Trichogenicity was measured using the Aderans HPA (Hair Patch Assay) (Zheng et al.
2005). Expression of progenitor and dermal papilla cell genes were probed using real time
RT-PCR. The properties (differentiation potential, trichogenicity, and gene profile) of stem cells
derived from the scalp were compared with stem cells derived from adipose. By using the
bioassay, we found human scalp-derived fibroblasts induce and are incorporated into hair
follicles. When placed into differentiation medium the same population of cells has the ability to
differentiate into adipocyte, osteocyte, smooth muscle, glial, and neural cell lineages. These cells
displayed high levels of progenitor cell and papilla genes. In comparison, although adipose
derived MSCs form somatic lineages (adipocyte and osteocyte), they are not trichogenic in the
bioassay and express lower levels of progenitor and hair follicle associated genes. Our studies
suggest that MSCs isolated from human scalp skin make up the trichogenic population in the
dermis. These cells are unique, when compared with adipose derived MSC, having differentiated
into additional lineages and in their trichogenic properties.
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Hair follicle restoration by intradermal microinjection of trichogenous dermal
cells in a humanized-scalp model mouse
M Inamatsu1, M Yamao1, T Okada1 and K Yoshizato1,2 1Phoenixbio Co., Ltd., Higashihirroshima,
Japan and 2Osaka City University, Osaka, Japan
Hair follicles (HFs) are generated in the embryonic skin development and, once established, are
retained through life by a unique self-renewal activity termed recycling. Hitherto, accumulated
studies have revealed basic mechanisms underlying these processes, and the development of
modern technologies has enabled us to manipulate the cells that have major roles in these
processes. However, therapeutic technology has not been established by which clinicians can
restore weakened or miniaturized hairs by autotransplanting healthy trichogenous dermal cells.
The absence of a suitable rodent model for evaluating the therapeutic activities of the respective
hair follicle cells in regeneration and restoration of damaged human HFs (h-HFs) has been one of
the said obstacles. In the present study, we first generated a rodent model that has the humanized
skin composed of h-HFs, which we call ‘‘a humanized scalpmodel mouse’’. Second, we damaged
the model’s h-HFs in their lower half parts by inserting an ophthalmologist’s scalpel. Third, we
microinjected into the amputated area the NEO-STEMlabeled human trichogenous dermal cells,
which had been propagated in serial cultivation, and we followed the development and growth of
the damaged HFs up to 8 weeks posttransplantation. These transplanted cells were incorporated
into the damaged regions of the HFs by 2 weeks after transplantation and participated in restoring
hair bulbs. These HFs composed of host cells and transplanted cells, which we call chimeric HFs,
continued to develop into normal hairs by 8 weeks posttransplantation. In conclusion, HFs whose
lower half parts had been injured were restorable to normal HFs by receiving exogenous
trichogeneous dermal cells into the damaged regions. The presently developed humanized
scalpmodel mice are expected to be an appropriate and useful in vivo model to explore a
clinically effective technology for hair restoration therapy by autologous cell transplantation to
patients with weakened or miniaturized hairs such as androgenic alopecia.
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Long-term organ culture of intact hair follicle units in a chip-based perfusion
system
G Lindner, B Atac, A Thomas, I Wagner, R Horland, R Lauster and U Marx Technische Universita¨t
Berlin, Berlin, Germany
Since decades, the hair follicle organ culture model developed by Philpott and colleagues has
been the gold standard when it comes to compound testing on human hair growth in vitro. Here,
truncated human hair follicles were cultured with a potential hair growth promoting or inhibiting
agent by measuring the length of the emerging hair shaft with the adjacent inner and outer root
sheath. One limiting factor of this system is the reduced time of culture before showing massive
cellular and matrix protein destruction. Although signs of catagen progression can been observed,
other stages of the hair follicle cycle cannot be investigated. This includes miniaturized or
dormant follicles. Here, we report on a chip-based perfusion system capable of culturing
complete philosebaceous units freshly taken during a hair transplantation procedure using
Follicular Unit Extraction (FUE). In comparison with truncated hair follicles and follicles cultured
with conventional static conditions, perfused follicular units showed remarkable consistency of
the follicular structure and vitality revealed by matrix protein expression and TUNEL/ Ki67 double
labeling after 14 days of culture. After clipping, hair shaft growth beyond the epidermis could
easily be measured online. Keeping the follicular unit structure intact, also sebocyte and
melanocyte functions could be studied. These results render the used chip-based perfusion system
to be a useful tool for long-term culture of hair follicles, keeping most of their structure
undamaged. Additional hair follicle stages like telogen, early Anagen, and late catagen or even
miniaturized hair follicles seen in androgenetic alopecia can easily be placed and observed
within the chip-System.
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Effect of stretching force on human hair dermal papilla cells: possibility of
manipulating mechanobiology to induce hair regeneration
T Koyama1,2, R Ogawa3, K Kobayashi1,2, T Hama4 and H Hyakusoku3 1Josai Clinic, Tokyo, Japan;
2NPO Future Medical Laboratory, Tokyo, Japan; 3Department of Plastic, Reconstructive and
Aesthetic Surgery, Nippon Medical School, Tokyo, Japan and 4ANGFA Co., Ltd., Tokyo, Japan
Introduction: Mechanical forces have an important role in regeneration of tissues, such as bone,
cartilage, blood vessels, and myocardium. For hair regeneration, interaction of hair dermal papilla
cells (HDPCs) with hair matrix cells is essential. Our hypothesis is that appropriate mechanical
stimulation on the HDPCs may enhance its interaction with hair matrix cells to accelerate hair
regrowth. As our first step, we evaluated the effect of a stretching force on HDPCs by analyzing
the gene expression of stretch-stimulated HDPCs.
Methods: A commercialized cell line of HDPCs was cultured with 10% fetal bovine
serumcontaining Dulbecco’s Eagle medium. Thereafter, 1x105 of three-passaged cells were
seeded on a silicone chamber that can be stretched cyclically by computer modulation. The
stretching stimulation was set as 20% stretch, 10 cycles/min for 24 and 72 hours. Thereafter, the
cells were harvested and their gene expression was analyzed using cDNA microarray methods.
Results: The HDPCs aligned themselves perpendicularly to the stretching direction 72 hours after
stretching, whereas the non-stretched cells showed a random distribution. After 24 hours of
stretching, 373 and 407 genes were upregulated and downregulated, respectively (n¼ 5). After 72
hours of stretching, 2655 and 2823 genes were upregulated and downregulated, respectively
(n¼ 5). The upregulated genes included hair growth genes such as VEGF, WNT, BMP, and PDGF,
and the downregulated genes included hair-removing genes such as IL-6 and TNF.
Conclusion: An optimal stretching force applied for a suitably long period can upregulate hair
growth genes and downregulate hair removal genes in HDPCs. Thus, mechanical force may be
useful in hair tissue engineering. In addition, mechanical stimulation of the scalp may be a
natural, easy, and economical way to stimulate hair growth. Further studies will be required to
understand the effect of mechanical force in hair regeneration.
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Transplantation of hair follicle dermal cells as a therapeutic approach for
recessive dystrophic epidermolysis bullosa
K Gledhill1, L Bruckner-Tuderman2, A Christiano3, AP South4 and CA Jahoda1 1School of
Biological and Biomedical Sciences, Durham University, Durham, UK; 2Department of
Dermatology, Freiburg University, Freiburg, Germany; 3Department of Dermatology, Columbia
University, New York, USA and 4Division of Cancer Research, Dundee University, Dundee, UK
Intravenous (IV) injection of bone marrow stem cells and direct injection of dermal fibroblasts to
skin wounds are being investigated as cell therapies for the treatment of recessive dystrophic
epidermolysis bullosa (RDEB). Both approaches have resulted in the improvements in skin
integrity; however, our hypothesis is that other cell types may be capable of doing the same thing
more efficiently. Dermal cells from the hair follicle, which are derived from skin, may also be
good candidates for a cell therapy for RDEB as they produce type VII collagen, have natural
wound healing and stem celllike properties, and are capable of supporting normal epidermal
keratinocytes in a three-dimensional skin culture model. We are currently investigating in normal
mice the wound homing response and durability of murine dermal sheath cells after IV
administration, and a novel method of direct transplantation of these cells into skin using three-
dimensional cell aggregate. At present, our data demonstrate that murine dermal sheath cells can
indeed home to skin wounds. Moreover, these cells persist in skin for a number of weeks while
eliciting only a minimal immune response. We are currently also testing the capacity of murine
dermal sheath cells to restore basement membrane function in collagen VII hypomorphic mice
and human dermal sheath cells to support human keratinocytes from RDEB patients in three-
dimensional skin culture models.
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New development in unlimited hair follicle transplant
C-M Lin1, K Huang2 and Y Li3 1Shantou University Medical College, Shantou, China; 2Second
Affiliated Hospital, Shantou University Medical College, Shantou, China and 3First Affiliated
Hospital, Shantou University Medical College, Shantou, China
Hair transplantation has had an important role in the treatment of hair loss. However, hair
transplantation in fact represents hair redistribution. Thus, traditional hair transplantation is
greatly restricted by insufficient transplants. Some studies have demonstrated that HF (hair
follicle) upper fragments can regrow HFs. Despite the low success rate, hair graft number can be
increased by hair follicle dissection. Here, we established a method to increase the regrowth rate
of ‘‘single HF upper fragments.’’ HF upper fragments were obtained from the vibrissa of
SpragueDawley rats at the level of hair bulb. Segments were transplanted underneath the skin of
nude mice (6 segments per mouse, 1.5-cm distance between segments). Then culture medium of
vibrissa HF was injected into the transplanted sites every 2 days, and grafts were excised at days 3,
7, and 9 and weeks 2 and 4. The control group received DMEMþ 10% fetal calf serum instead of
HF culture medium. In all, 91.7% of the fragments (66/72) were able to regrow into intact HF
from 7 days to 4 weeks. Only 2/38 of control mice fragments showed intact HF regrowth after 4
weeks of transplantation. We traced the expression of Wnt5a during the regrowth of HF: at 3 days
after transplantation, the experimental group showed Wnt5a expression at the newly formed
connective sheets. At 9 days, Wnt5a was expressed strongly at the typical newly formed DPs. We
also designed a novel HF transplantation device that includes scissors at the bottom to dissect the
HF bulb when obtaining HF from the donor. The remaining HF bulbs were able to regrow intact
HFs in the donor sites. As well, the upper site of HFs can be used as hair graft transplants by the
method above. Thus, our HF fragment transplantation method is a new development in unlimited
hair follicle transplant.
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Scalable production of controllable dermal papilla spheroids on polyvinyl alcohol
surface: effect of spheroid size on efficiency and efficacy of hair follicle
regeneration
Y-C Huang1, C-C Chan1,2, W-T Lin1, H-Y Chiu2,3 and S-J Lin1,2 1Institute of Biomedical
Engineering, National Taiwan University, Taipei, Taiwan, Republic of China; 2Department of
Dermatology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan,
Republic of China and 3Department of Dermatology, Hsin-Chu Branch of National Taiwan
University Hospital, Hsinchu City, Taiwan, Republic of China
Organ size and numbers are vital issues in bioengineering for hair follicle (HF) regeneration.
Murine HF dermal papilla (DP) cells are able to induce HF neogenesis when transplanted as
aggregates. However, how the preparation of murine and human DP aggregates affects HF
inductivity and the size of regenerated HF is yet to be determined. Here, we report a scalable
method for the production of controllable human and rat DP spheroids in general labs for
reproducible experiments. Compared with more hydrophobic polyethylene and poly(ethylene-
co-vinyl alcohol), DP cells are poorly adhesive to hydrophilic polyvinyl alcohol (PVA). Seeded in
the PVA-coated 96-welled commercial PCR tube arrays, DP cells quickly aggregate into single
spheroids with progressive compaction. Varying seeded cell numbers and culture periods enable
us to control the size and cell number of the spheroids. The spheroids obtained have high viability
and preserve DP characters. A proof of principle experiment was conducted to examine the size
effect on the efficiency and efficacy of HF regeneration. We found that both human and rat DP
spheroids are able to induce HF neogenesis and larger DP spheroids exhibit higher HF inductivity.
However, the average diameter of regenerated hair fiber did not significantly change with the
increasing size of transplanted DP spheroids. The result suggests that an appropriate size of DP
spheroid is essential for HF inductivity, but its size cannot be directly translated to a thicker
regenerated hair. Our results also have implications on the efficiency and efficacy in the
regeneration of other epithelial organs.
P229
Follicular epithelium prone nature distinguishes a human induced pluripotent
stem cell line with hair forming capacity from others lines
OK Veraitch1, T Kobayashi1, Y Imaizumi2, W Akamatsu2, M Amagai1, H Okano2 and M
Ohyama1 1Department of Dermatology, Keio University, Tokyo, Japan and 2Department of
Physiology, Keio University, Tokyo, Japan
We previously generated human induced pluripotent stem cellderived ectodermal precursors
(hiPSC-EPCs) using three hiPSC lines. 201B7 hiPSC-EPCs better communicated with human
dermal papilla (DP) cells than WD39 and WDT2 lines in coculture and contributed to hair
morphogenesis in vivo. The aim of the current study is to investigate what properties endowed
201B7 hiPSC-EPCs such functional privileges. To probe their natural fate, each hiPSC line was
converted into embryo bodies and allowed to differentiate without induction. 201B7 line more
readily expressed ectoderm and epithelial markers, whereas WD39 and WDT2 lines were prone
to express endoderm and mesoderm markers. To further assess the epithelial/ ectodermal prone
nature intrinsic to 201B7, additional hiPSC lines (414C2, 253G2 and 409B2) were tested.
Interestingly, 414C2 line demonstrated lineage marker expression similar to that of 201B7.
However, when converted to EPCs and cocultured with human DP cells, 201B7, but not 414C2
line, upregulated all follicular keratinocyte genes (KRT75, MSX2, LEF1, and TRPS1) and DP
biomarkers (ALPL, BMP4, and LEF1) examined, suggesting that ectodermal / epithelial prone
nature alone was not a mechanism enabling 201B7 hiPSC-EPCs to interact well with trichogenic
mesenchyme. WNT and SHH signaling are essential in hair follicle development. In particular,
WNT activation predisposes keratinocytes to a follicular fate. All hiPSC-EPCs expressed higher
levels of WNT signaling genes than normal human keratinocytes (NHKCs). Interestingly, 201B7
hiPSC-EPCs expressed lower level of WNT-negative regulator AXIN2 but higher levels of LEF1
and WNT downstream target CCND1 compared with other hiPSC-EPC lines, implying that 201B7
hiPSC-EPCs might be in higher WNT-activated state than other lines. SHH gene expression levels
were higher in all hiPSC-EPCs than in NHKCs; however, line-specific upregulation was not
observed. Accordingly, 201B7 hiPSC-EPCs were distinguished by follicular epithelium prone
nature via a possible WNT-activated state, which may be essential to achieve efficient HF
regeneration using hiPSC-EPCs.
P230
Optimized preparation of dermal papilla cell (DPC) construct for hair
regeneration therapy
H Kato, K Kinoshita, N Aoi, K Inoue and K Yoshimura Department of Plastic Surgery, University of
Tokyo, Tokyo, Japan
Introduction: To develop an efficient and practical hair regeneration therapy, we have sought to
optimize DPC culture method (Aoi N, et al. Stem Cells Transl Med, 2012) and DPC
transplantation method, which we call ‘‘hemi-vascularized sandwich (HVS) method’’ (Aoi N,
et al. J Tissue Eng Regen Med, 2012). In this study, we sought to optimize preparation of
transplantation construct of cultured DPCs.
Methods: We prepared three different DPC transplants (cell suspension, cell sheet and cell
aggregation) using cultivated rat DPCs (rDPCs), rDSCs (dermal sheeth cells), rDFs (dermal
fibroblasts), h (human) DSCs, hDPCs, and hASCs (adipose-derived stem cells). Expression of hair
inductivity-associated genes was examined with real time RT-PCR. Each cell construct was
transplanted into the sole skin of rat with HVS method. In addition, some constructs were
combined with aggregation, sheet, or collagen scaffold. Eight weeks after transplantation,
harvested samples were histologically evaluated.
Results: Electron microscope showed that a large aggregate made of 15 small DPC aggregations had
a proper space to allow plasmatic diffusion and avoid central necrosis. In both rat and human
samples, TGFb2 mRNA expression was the highest in cell sheet than other constructs in both DPCs
and DSCs. Wnt10b was higher in aggregation than in suspension and sheet in rDSCs and hDSCs.
ALP was higher in aggregation than in suspension and sheet in human DSCs and DPCs. In animal
experiments, visible hairs were regenerated only in DPC sheet transplantation, while immature hair
follicles were histologically observed in aggregation and combinations with aggregation.
Discussions/Conclusions: The construct form substantially changed DPC function such as hair
inductivity. TGFb2 expression appeared to be a reliable index predicting hair inducing capacity of
DPCs. A sheet was the most efficient form with functioning DPCs, but a combination with
undifferentiated aggregates may work better for hair regeneration with cycling.
P231
Laser-assisted rapid patterning of epithelial-mesenchymal interaction for skin and
hair follicle regeneration
W-H Wang1, C-C Chan1,2, M-W Lin1, M-Y Fan1, H-W Lee1 and S-J Lin1,2 1Institute of Biomedical
Engineering, National Taiwan University, Taipei, Taiwan, Republic of China and 2Department of
Dermatology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan,
Republic of China
Bioartificial skin containing keratinocytes and fibroblasts has been used to accelerate wound
healing and reduce scar contracture. However, the skin appendages including hair follicles
cannot be regenerated. Reconstitution of appropriate epithelial-mesenchymal interactions that
can elicit regeneration of arrays of hair follicles with desired distribution is essential for
regeneration of fully functional skin. Here, we developed a method for fast patterning of
keratinocytes, fibroblasts and trichogenic dermal papilla cells into desired topological
arrangement on a glass chip. The cell adhesivity of poly-(vinyl alcohol) (PVA) dynamically
varies in the presence of serum. Freshly PVA-coated glass is non-adherent to all three cells, but it
becomes adherent to fibroblasts and DP cells later in culture. We take this advantage as a surface
barrier for cell patterning through laser-assisted surface microfabrication. By varying carbon
dioxide laser parameters for ablation, we are able to create arrays of micro-domains of
controllable size, depth and spacing on PVA-coated glass chips. With the adjustment of cell
seeding, DP cells attach to these micro-domains, forming corresponding arrays of multicellular
aggregates of controllable size and cell number. Fibroblasts seeded later adhere to the cell-free
PVA domain as the substratum adhesivity increases. The finally seeded keratinocytes attach either
to fibroblasts or DP cells depending on the cell types they contact. The final organization is an
epithelial sheet on top of a mesenchymal layer of fibroblasts doped with arrays of DP islets.
Functionally, keratinocytes on top of DP islets, but not those on top of fibroblasts, show
differentiation toward HF. This method con be applied in the research of interactions between
heterotypic cells, and it also shows potential for generation of bioartificial skin with patternable
epithelial-mesenchymal interaction.
P232
Maintenance of hair-inducing capacity of cultured dermal cells by addition of cell
culture medium
Y Sung1, J Sung2, M Kim1 and J Kim1 1School of Medicine, Kyungpook National University,
Daegu, Republic of Korea and 2CHA University, Seoul, Republic of Korea
The neogenesis of the hair follicle through cultured cell implantation is a promising alternative for
the treatment of hair loss. Success of neogenesis of the hair follicle greatly depends on the ability
to expand hair-inductive dermal cells in vitro. However, cultured dermal cells lose their hair
follicle-inducing capacity (trichogenicity) during subculture. Therefore, to achieve successful hair
follicle neogenesis, identification of cell culture conditions that enable dermal cells to maintain
trichogenicity is an important matter. In this study, we show our data of maintenance of
trichogenicity of dermal cells by treatment with human follicular keratinocyte-conditioned media.
We also show enhancement of trichogenicity of dermal cells by UVB-irradiated adipose-derived
stem cell-conditioned media.
P233
Differences in the upregulation of inhibitor of apoptosis proteins (IAPs) in human
dermal fibroblasts derived from hair-bearing and non hair-bearing skin in a
scratch wound assay
O Kamala, A Graham and J Thornton Centre for Skin Sciences, University of Bradford, Bradford,
UK
Observational studies describe rapid donor site healing when scalp skin is used for split-thickness
skin grafting, suggesting that wounds heal better from hair-bearing skin. This has mainly been
attributed to the hair follicle, but studies also suggest that dermal fibroblasts from different regions
exhibit phenotypic differences. Recently the role of IAPs, a family of antiapoptotic proteins that
inhibit the activity of caspase proteins, in wound repair has been highlighted. Using matched
patient skin samples (n¼ 3), we cultured dermal fibroblasts from hair-bearing scalp skin and
adjacent skin that does not contain terminal follicles. In a comparison of fibroblasts derived from
the same patients, at the same passage number, those derived from hair-bearing skin grew at a
much slower rate over a 12 day period, compared to their adjacent counterparts. Using a scratch
wound assay we compared the expression of a panel of IAPs (NAIP, c-IAP2, XIAP and Apollon)
and their antagonists (XAF1 and SMAC/DIABLO) immediately after scratching and 24 hours later
using immunocytochemistry quantitated by ImageJ. Fibroblasts from hair-bearing skin demon-
strated an increase in the expression of NAIP, Apollon and SMAC/DIABLO immediately after
scratching; all returned to control levels after 24 h. In contrast, only an upregulation in the
expression of SMAC/DIABLO was observed in matching fibroblasts from non hair-bearing skin.
These results provide further evidence for important phenotypic differences in human dermal
fibroblasts from skin containing either terminal or vellus hair follicles. An immediate upregulation
of the expression of IAPs in fibroblasts from hair-bearing skin suggests that they have better
mechanisms in place for cell survival following wounding, which may contribute to the superior
wound healing observed in hairy skin. Further studies are required to determine if fibroblasts from
hair bearing skin significantly contribute to the wound healing response, which in turn may lead
to improved therapies for chronic non-healing wounds.
1430 Journal of Investigative Dermatology (2013), Volume 133
ABSTRACTS
P234
SOX2 expression in human scalp derived follicular progenitor cells correlates with
trichogenicity
B Marshall, K Watkins, X Wu, C Ingraham and K Stenn Aderans Research Institute, Marietta,
Georgia, USA
Hair follicle formation and growth is driven by stem cell populations in both the epidermal and
dermal compartments. SOX2 gene expression in mouse has been found in the dermal papilla of
guard, awl, and auchene, but not zig-zag, hairs. Moreover, SOX2 identifies skin derived precursor
cells, cells which have stem cell, trichogenic and homing properties. We have been interested in
defining the trichogenic dermal stem cell population of human scalp. In this study we focused on
the properties of SOX2 using immunohistochemistry, a triochogenic bioassay (Aderans HPA, Hair
Patch Assay, [Zheng et al. 2005]), enhanced culture conditions, and RT-PCR techniques. SOX2 is
expressed throughout morphogenesis starting with the dermal condensate. In adult occipital skin
follicles, SOX2 is expressed in the dermal papilla and sheath of all follicles and in all stages of
follicle cycling. To test the correlation between SOX2 expression and trichogenic potential, we
isolated dermal cells from adult occipital scalp and assessed cellular trichogenicity with a
bioassay (Aderans HPA). We found a correlation of bioassay response to level of SOX2
expression. To directly test the role of SOX2 in trichogenic potency of the cells we used siRNA to
knock down SOX2 expression in cultured cells. siRNA not only reduced SOX2 expression of the
transfected dermal cells (greater than two fold reduction) but also abrogated their trichogenicity.
This work convincingly links SOX2 gene expression to the dermal papilla and sheath cells of
human scalp follicles. SOX2 expression of scalp derived cells is maintained in culture and
correlates with trichogenicity.
TRICHOSCOPY
P235
Follicular red dots: a normal trichoscopy feature in patients with pigmentary
disorders?
R Pirmez and CT Sodre´ Dermatologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro,
Brazil
Follicular red dots (FRD) are erythematous structures regularly distributed around follicular ostia.
They were first described in patients with active discoid lupus erythematosus (DLE) of the scalp
and considered a specific trichoscopic feature of the disease. To our knowledge, no other scalp
disorders have been associated with FRD, since the initial description. We report four patients
with pigmentary disorders in whom FRD were detected during scalp examination. In two patients
with albinism and one patient with extensive vitiligo and no previous history of hair disorders,
FRD were identified in a homogenous pattern of distribution. In one patient with extensive vitiligo
and female pattern hair loss (FPHL), FRD were irregularly distributed. FRD were linked to the
presence of dilated vessels and red blood cell extravasation around the isthmus associated with an
atrophic epidermis, in active DLE lesions. Since three of our patients had no previous history of
hair loss and none of them had history of cicatricial alopecia, we believe that the red color
observed under trichoscopy is possibly related to the rich vasculature that naturally envelops the
normal hair follicle. FRD in these cases were probably easily identified due to the lack of
pigmentation of the overlying skin. Furthermore, we speculate that the irregular distribution
pattern of FRD in the patient with FPHL is a reflection of the disease process, with alopecic areas
where FRD are absent representing long-standing disease.
P236
Computer assisted image analysis after manual processing (CAIAMP) generates
more precise and less variable body hair counts than Trichoscan
DJJ Van Neste1,2 1Skinterface, Tournai, Belgium and 2Brussels’Hair Clinic, Brussels, Belgium
Body hair counts by Trichoscan and CAIAMP were compared to detect possible influences
of in-vivo procedures on naturally dark body hair. Six sites on the forearms of a
Caucasian male individual were imaged three times on the same day before and after application
of a hair dye and immediately after hair-length reduction. Trichoscan was used first and the
automatically defined target site in each individual image was subsequently used after
randomization for CAIAMP (blinding of technician as to site, time, and procedure). CAIAMP
has been validated (accuracy and precision after hair dye), and it detected a total of six thin
(20p+o40 mm) and 331 thick (+X40 mm) hair strands, whereas Trichoscans counted 63 thin
and 1066 thick hair strands (ANOVA, Po0.01). There was also a wider variation depending on
the procedures with Trichoscan (ANOVA, Po0.0001). The thick hair counts (averages of the 6
target sites) were 44 before dye, 73 after dye and 61 after hair length reduction with Trichoscan as
opposed to 18, 18 and 19 with CAIAMP. The range of variation was 4 to þ6 thick hair with
CAIAMP as opposed to 51 to þ 24.5 with Trichoscan. Thin hair counts were lower and less
variable with CAIAMP (range 1 to þ 1) as compared with Trichoscan (range 5.5 to þ 3;
ANOVA, Po0.0001). Furthermore, with CAIAMP it was possible to explain two aspects in
relation with variability:
(1) obviously hair dye did not improve hair detection, confirming the good natural contrast, and
(2) skin elasticity with minimal shifts in or out of the target site may result in CAIAMP variation of
a small number of hairs, unlike Trichoscan.
The present findings confirm previously published data (J Eur Acad Dermatol Venereol
2006;20:578–583) and suggest that the use of CAIAMP by a calibrated qualified technician is
preferable for body hair measurement, its reduction, or its removal.
P237
New trichoscopy findings in trichotillomania
A Rakowska1, M Slowinska1, M Olszewska2 and L Rudnicka1 1Dermatology Department, CSK
MSW, Warsaw, Poland and 2Dermatology Department, Medical University of Warsaw, Warsaw,
Poland
Aims: To determine if differential diagnosis between trichotillomania and other focal alopecias
can be performed by trichoscopy. To determine the trichoscopic features of trichotillomania.
Materials and methods: Trichoscopy was performed in 370 patients with focal alopecia. Forty-
four patients were diagnosed with the trichotillomania, 314 with alopecia areata, and 12 with
tinea capitis. Trichoscopic images were searched for specific trichoscopic features from hair shafts
and from interfollicular surface.
Results: The main and specific trichoscopic findings in trichotillomania patients were: irregularly
broken hairs (100% vs. 67% in alopecia areata vs. 83% in tinea capitis), v-sign (57% vs. 0.6% in
alopecia areata vs. 0% in tinea capitis), flame hairs (25% vs. 0% in alopecia areata vs. 0% in tinea
capitis), hook-hairs (25% vs. 0% in alopecia areata vs. 0% in tinea capitis), hair powder (16% vs.
0% in alopecia areata vs. 0% in tinea capitis), and coiled hairs (39% vs. 0.6% in alopecia aretata
vs. 0% in tinea capitis). All these differences were statistically significant.
Conclusions: Trichoscopy allows clinicians to easily diagnose trichotillomania. We describe new
trichoscopy findings, characteristic for trichotillomania, the flame hairs, and the V-sign.
P238
Broom hairs in trichoscopy provide different histological findings. What is the
meaning of broom hairs?
J Czuwara, A Rakowska, M Slowinska, M Jasinska and L Rudnicka Department of Dermatology,
CSK MSW, Warsaw, Poland
Dermoscopy of the hairs and scalp (trichoscopy) is a useful non-invasive technique facilitating the
diagnosis of alopecia, hair, and scalp disorders. Trichoscopic evaluation of the short, disrupted
hairs easily accessible to dermoscopy is characteristic for many diseases. Examples include
comma hairs in tinea capitis, microexclamation, and tulip hairs in alopecia areata, and Tosti hairs
in androgenetic alopecia (AGA) among others. Recently we noticed a peculiar type of short, dark
hairs protruding like a brush from one follicle opening on the scalp in alopecia cases. We called
them ‘‘broom hairs’’. Broom hairs were noticed on seven female patients referring to the clinic
with visible alopecia complaint. In all patients frontotemporal hairline recession with diffuse hair
loss in the central part of the scalp was observed with clinical and dermoscopic presentation
characteristic for AGA. One patient was suspected of overlapping scarring alopecia because of
characteristic dermoscopic findings. Frontal fibrosing alopecia was in differentiation. Trichoscopy
revealed two types of brooms, one of short, thick and frayed hairs, the second of thin, longer,
lighter, densely bundled hairs. Clinically their appearance was similar to pili multigemini and
trichostasis spinulosa. Biopsy oriented on broom hair was performed in four cases followed by
histological evaluation. The biopsies showed AGA features with abnormal infundibular
keratinization. Two cases presented features of scarring alopecia without inflammation;
longstanding AGA in such a scenario cannot be ruled out. In one case a typical picture of
trichostasis spinulosa was seen. In reflectance confocal microscopy compressed, abnormal
shapes of hair shafts and follicles were visible. In conclusion, broom hairs do not seem to be a
pathognomonic sign of particular entity. They may represent the dystrophic stage of terminal hairs
in diffuse, longstanding AGA, or in non-active scarring alopecia such as frontal fibrosing alopecia
overlapping with AGA.
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‘‘Normal’’ limits for caucasian scalp hair with contrast-enhanced-
phototrichogram method with exogen collection (CE-PTG-EC)
DJJ Van Neste1,2 1Skinterface, Tournai, Belgium and 2Brussels’ Hair Clinic, Brussels, Belgium
There is no information about normal values for scalp hair growth using CE-PTG-EC. Normal hair
values were evaluated on the top of the head during four repeat observations (two during summer
and two during winter) in young volunteers (16–20 years). Ethical approval was obtained before
enrollment and all participants declared to be in good health without excess hair shedding. Data
from 52 CE-PTG-EC on 14 males and 10 females are reported. Besides nano hair (+p20mm) that
were not included in total hair counts (THC), THC was split into thin (20o+p40 mm) and thick
(+440 mm) hair and anagen hair only if elongation exceeded 150 mm/24 h. Extensive descriptive
statistics reported no significant influence of session and season, but there were statistically
significant gender differences. Herein we report values of the most ‘‘robust’’ (applicable for M and
F) criteria that could serve to describe ‘‘extreme normal limits’’ of CE-PTG-EC data (either P5 or
P95).
Accordingly, in 1 cm2 scalp of a healthy subject one should find:
(1) less than 17 nano hair;
(2) more than 210 hair in total (THC);
(3) more than 170 thick hair (73% of THC) of which at least 76% are anagen;
(4) less than 88 thin hair (27% of THC);
(5) less than 7 exogen hair.
In our panel, 1 male and 1 female showed three parameters on one CE-PTG-EC session outside
the limits and it is unclear whether this might already reflect the incipient deficiency of hair
growth. Our preliminary data could help individual patients complaining about increased hair
shedding, insufficient growth, or incipient hair loss. Also, when three criteria at least would be
outside those limits, subjects might be given treatment at an early ‘‘preclinical stage’’ of the
condition.
P240
Usefulness of a handheld dermoscope for clinical diagnosis of alopecia in Koreans
J Park, J-I Kim, K-H Song, S-K Yun and H-U Kim Department of Dermatology, Chonbuk National
University Medical School, Jeonju, Republic of Korea
Trichoscopy, hair, and scalp dermoscopy is a noninvasive diagnostic technique performed with a
handheld dermoscope or videodermoscope focused on follicular and perifollicular pattern,
vascular pattern, and hair shaft characteristics. There have been many reports regarding the value
of the videodermoscope in clinical evaluation of alopecia; however, studies performed with a
more convenient handheld dermoscope are scarce and limited to a few disease entities.
Moreover, previous reports were mostly based on Caucasians and studies regarding Korean
alopecia patients, whose skin color as well as characteristics of hair is different from Caucasians,
have rarely been reported. We studied the characteristic trichoscopic features of normal scalp and
distinct types of alopecia in Koreans to assess the potential usefulness of a handheld dermoscope
in clinical diagnosis of alopecia. In all, 338 alopecia patients and 160 unaffected control subjects
of Koreans who visited the Department of Dermatology in Chonbuk National University Hospital
were enrolled in the study. Dermoscopic examination was performed by a polarized-light
handheld dermoscope with a 10-fold magnification. The images were obtained by a digital
camera with a 3-fold optical zoom.
P241
Contrast-enhanced phototrichogram with exogen collection (CE-PTG-EC)
documents 0% anagen: who has alopecia areata, telogen effluvium, or
trichotillomania? A challenging ‘‘biopsy-proven’’ (?) study!
DJJ Van Neste1,2 and N Renard3 1Skinterface, Tournai, Belgium; 2Brussels’ Hair Clinic, Brussels,
Belgium and 3CHWAPI, Tournai, Belgium
CE-PTG-EC was recorded in three subjects with clinically severe acute hair loss. All three had
medical history, extensive blood sampling, and two 4-mm punch scalp biopsies (double-check
reports with second opinion). A female nurse showed no improvement during ‘‘mesotherapy’’
and we unravelled 0% anagen predicting total hair loss within the next 3 months. Biopsy
confirmed clinical hypothesis of alopecia areata (AA). An Indonesian female with a history of
severe weight loss, chronic cough, and moderate chronic fever had 0% anagen on CE-PTG-EC
pointing to total hair loss in the near future. Global health status with severe anemia and
bronchial mycotic contamination appeared to be related to an active HIV infection. The biopsy
reported ‘‘acute telogen effluvium’’. Follow-up indicated total hair loss at 3 months with
satisfactory scalp hair regrowth as observed at 6 months after initial diagnosis in the absence of
the usual treatments used for AA. A 12-year-old boy experienced sudden diffuse hair loss during
the period of school tests. CE-PTG-EC showed 0% anagen. Biopsy reported aspects compatible
with ‘‘trichotillomania’’. Thorough explanation of the natural course of the process, including
total hair loss in the next 3 months, was understood and accepted by the young patient. Daily
application of topical steroid lotion resulted in total ‘‘vellus-like’’ hair regrowth by the fifth month.
Together with the clinical course favoring the diagnosis of AA totalis, the CE-PTG-EC was against
the histopathological diagnosis of trichotillomania. Information generated by the CE-PTG-EC and
histopathological diagnosis may be ‘‘convergent’’ (cases 1 and 2) or ‘‘divergent’’ (case 3). The
initial diagnosis may be modified according to the clinical course and the follow-up, but CE-PTG-
EC objectivates the seriousness of the hair loss process such that the patients can adjust to a
rapidly changing and dramatic situation.
P242
A multisite, double-blind, placebo-controlled clinical trial of a dietary supplement
containing marine proteins shows statistically significant benefits in reducing hair
shedding and an increase in vellus hair diameter in those with subclinical hair
thinning/loss
Herndon JH1, Sperber BR2, Stephens TJ1, Rizer RL2, Murphy J3 and Ablon G4 1Thomas J. Stephens
& Associates, Inc., Dallas Research Center, Carrollton, Texas, USA; 2Thomas J. Stephens &
Associates, Inc., Colorado Springs Research Center, Colorado Springs, Colorado, USA;
3Lifes2Good, 7 Racecourse Business Park, Ballybrit, Galway, Ireland and 4Ablon Skin Institute
Research Centre, University of California, Los Angeles, California, USA
Scalp hair growth is a very powerful social signal in humans. Thus, hair thinning and loss, even at
subclinical levels, can provoke profound psychoemotional anxiety. Poor nutrition has been
implicated in suboptimal hair growth, and although drugs are available to treat recognized
clinical causes of hair loss, those with subclinical hair thinning may seek benefits through
nutritional approaches. In order to formally evaluate a dietary supplement containing marine
proteins, a multisite, double-blind, placebo-controlled clinical study was conducted by the global
research organization, Stephens & Associates. A total of 72 adult women (age range 24–55 years,
mean; 44 years) were randomly and equally assigned to the test and placebo groups and a 6-
month-period study involving six evaluations was completed. Study participants underwent
physical and scalp assessment of their general health status to exclude pre-existing scalp
conditions. Hair growth was evaluated using a phototrichogram (tattooed test site 0.25 cm2; vellus
hair defined as p40mm; terminal hair defined 440 mm with) and hair shedding was assessed
using a validated shampooing protocol. Subjects also completed a quality-of-life questionnaire
and maintained a daily diary. Phototrichogram data revealed a statistically significant increase in
mean vellus hair caliber after 6 months in those subjects taking the marine peptide complex when
compared with those in the placebo control group. Moreover, hair counts revealed a statistically
significant lower shedding rate at month 3 in those in the oral supplement group compared with
those taking the placebo tablets. These data are, to the best of our knowledge, the first from a
multisite, double-blind, placebo-controlled clinical study to reveal statistically significant benefits
from an oral dietary supplement by decreasing hair shedding rate and by increasing mean vellus
hair fiber diameter, making these hairs more pronounced. Although the reduction in hair
shedding peaked at 3 months of supplementation, significant vellus hair fiber diameter increase
was seen after 6 months and could be envisaged to continue at least during the same anagen VI
stage of the hair cycle.
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PS1.1
Hair follicle stem cells in alopecia
L Garza1, G Cotsarelis2 1Johns Hopkins Medical School, Baltimore, Maryland, USA and
2Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
We originally localized hair follicle stem cells to the mouse and human hair follicle bulge. Much
progress has been made in understanding of mouse bulge cells, but the relevance of this information
to human hair follicle biology often is not studied. We evaluated the status of hair follicle stem cells
in androgenetic alopecia (AGA). We analyzed bald and non-bald scalp from men with AGA for the
presence of hair follicle stem and progenitor cells. Cells expressing cytokeratin15 (KRT15), CD200,
CD34, and a´6-integrin (ITGA6) were quantitated via flow cytometry. High levels of KRT15
expression correlated with stem cell properties of small cell size and quiescence. These KRT15hi
stem cells were maintained in bald scalp samples. However, CD200hi/ITGA6hi and CD34hi cell
populations—both of which possessed a progenitor phenotype, in that they localized closely to the
stem cell-rich bulge area but were larger and more proliferative than the KRT15hi stem cells—were
markedly diminished. These findings support the notion that a defect in conversion of hair follicle
stem cells to progenitor cells plays a role in the pathogenesis of AGA. We then showed that
prostaglandin D2 synthase (PTGDS) is elevated at the mRNA and protein levels in bald scalp
compared to haired scalp of men with AGA. The product of PTGDS enzyme activity, prostaglandin
D2 (PGD2), is similarly elevated in bald scalp. PGD2 inhibits hair growth in explanted human hair
follicles and when applied topically to mice. Hair growth inhibition requires the PGD2 receptor
(GPR44). Furthermore, we find that a transgenic mouse, K14-Ptgs2, demonstrates elevated levels of
PGD2 in the skin and develops alopecia, follicular miniaturization, and sebaceous gland
hyperplasia, which are all hallmarks of human AGA. These results define PGD2 as an inhibitor of
hair growth in AGA and suggest the PGD2–GPR44 pathway as a potential target for treatment.
PS1.2
Mechanisms of hair follicle aging and stem cell regulation
EK Nishimura Department of Stem Cell Biology, Medical Research Institute, Tokyo Medical
and Dental University, Bunkyo-ku, Tokyo, Japan
Multicellular organisms senesce with the expression of various aging phenotypes
characterized by functional tissue decline and organismal changes with decreased
regenerating capabilities. Hair loss and hair graying are typical aging phenotypes in
mammals, but the underlying mechanisms of aging are still largely elusive in most tissues. In
recent decades, some signaling pathways that determine organismal lifespan and molecules
responsible for progeroid syndromes have been identified in some organisms, but the
underlying cellular mechanisms of aging-associated tissue decline and diseases are still
largely unknown. We have studied the mechanisms of aging-associated hair graying and hair
loss by focusing on adult stem cells. We previously identified melanocyte stem cells (McSC)
within the bulge–subbulge area of mouse hair follicles. The population is cyclically activated
to self-renew and to provide mature melanocytes for hair pigmentation. Our chronological
analysis of McSCs and hair follicle stem cells (HFSCs), the niche for McSCs, demonstrated
that mouse hair follicles age through defective renewal of McSCs and HFSCs. McSCs
differentiate into pigment-producing melanocytes in the niche without renewing themselves
under excessive genomic stress or with aging. Strikingly, HFSCs with a sustained DNA
damage response also showed characteristic fate changes that are clearly distinguished from
cellular senescence. The stem cell fate changes with aging and the underlying mechanisms of
tissue aging will be illustrated and discussed.
PS1.3
Biological and translational potential of hair follicle mesenchymal cells
CAB Jahoda School of Biological and Biomedical Sciences, Durham University, Durham, UK
The recognition that hair follicle mesenchymal cells have potential stem cell or progenitor
activities now extends well beyond the original observations of regeneration within the follicle.
Both hair follicle dermal papilla (DP) and dermal sheath (DS) cells resemble other mesenchymal
stem cell populations in that they can be directed to differentiate down new lineages, and indeed
DP cells have been completely reprogrammed into iPS cells. Notwithstanding these findings, in
the broader translational sphere hair follicle mesenchymal cells may ultimately have a greater
role in maintaining other stem cell populations. In this and other contexts it is important to
consider DP and DS separately, since there are notable differences between them. One example
of the wider stem cell potential of hair follicle mesenchymal cells is exemplified by their capacity
to form skin-derived precursors (SKPs), where the dermal papilla has shown to be an enriched
niche. Intriguingly, this SKP-forming capacity is lost by DP cells after culture, and this may be a
result of the cells undergoing accelerated environmental reprogramming. In the context of skin,
we, like others, have postulated that hair follicle mesenchymal cells might serve as a superior
source of donor cells during skin wound healing. To investigate this question we have modified
and developed a number of three-dimensional skin models to incorporate cultured follicle
dermal cells in place of conventional dermal skin fibroblasts. We have shown that these models
elicit normal epidermal differentiation and that the hair follicle cells have potential for skin
replacement therapy. Three-dimensional reconstituted cell aggregations that incorporate follicle
mesenchymal cells may also represent a useful means of introducing and maintaining small
pieces of tissue in discrete locations for therapeutic applications.
PS1.4
Cellular and signaling mechanisms that regulate hair follicle stem cells by live
imaging
V Greco1,2 1Department of Genetics, Yale, New Haven, USA and 2Department of
Dermatology, Yale, New Haven, USA
Stem cells and their niches are critical for tissue development and regeneration. Yet, we still
lack knowledge of the sequential steps stem cells undertake to sustain regeneration.
Outstanding unanswered questions remain: (1) what is the behavior of stem cells?, (2) which
signals control stem cell behaviours?, and (3) what is the functional role of the niche during
physiological regeneration?. My laboratory has recently established an in vivo strategy to
visualize the components of the hair follicle stem cell niche, track them over time, and
manipulate them by two-photon microscopy in live mice. By these means, we have
uncovered that hair follicle growth relies on both spatial organization of cell divisions as well
as directional cell movements within the stem cell/progeny compartments. In order to
address which signaling controls the identified cellular behaviors, we have utilized genetic
approaches to perturb key regenerative signaling pathways that control hair follicle
regeneration and dissect in real time the mode of action of evolutionally conserved
pathways such as Wnt. Thus, we have established an in vivo approach that has led to the
discovery of unpredicted cellular mechanisms of growth regulation, and enabled us to
precisely investigate the functional requirements of stem cell niche components along with
key signaling pathways during the process of physiological regeneration. This work is
supported in part by NIH-NIAMS and ACS.
PLENARY SESSION 2
PS2.1
Genetics and immunology of alopecia areata
AM Christiano Department of Dermatology and Genetics, Columbia University, New York,
USA
We recently reported the identification of several susceptibility loci in alopecia areata (AA)
using genomewide association studies (GWAS), which have since been independently
confirmed in other cohorts. These studies identified the NKG2D axis as a central player in AA
pathogenesis, and invited therapeutic interventions along these targets. Using the C3H/HeJ
mouse model, we have shown that several rationally selected drugs can both prevent disease
onset as well as reverse established disease. These studies illustrate the rapid pace at which
GWAS studies can uncover new genetic pathways that are critical to a complex disease, and
lead to unanticipated therapeutic approaches guided by the underlying genetics.
PS2.2
Xenobiotic receptors in cicatricial alopecia: linking environment to disease
pathogenesis
P Karnik Department of Dermatology, Case Western Reserve University, Cleveland, Ohio,
USA
The aryl hydrocarbon receptor (AhR) is a transcription factor activated by xenobiotic ligands that
induce enzymes which metabolize environmental toxins such as dioxins and polycyclic aromatic
hydrocarbons. AhR is known to regulate diverse physiological processes and cellular functions in
the pathogenesis of cancer, cardiovascular disease, metabolic syndrome, and diabetes. The role of
AhR in the skin is not known, but the activation of AhR by xenobiotics or endogenous ligands
could interfere with normal skin functions, thereby triggering disease. We discovered that the
expression of AhR-target genes is increased in human primary cicatricial alopecia (PCA). This
suggests a correlation between AhR activation and PCA pathogenesis. Treatment of hair follicle
cells with xenobiotics showed increased expression of AhR-target genes, suggesting the activation
of this receptor in vitro. Based on this evidence, we hypothesized that overexpression of AhR in
the skin causes scarring alopecia. Indeed, keratinocyte-targeted overexpression of AhR in mice is
reported to cause hair loss due to unknown mechanisms. We have shown that the upregulation of
AhR-target genes causes progressive alopecia and whole-skin lesions including hyperkeratosis,
loss of sebaceous glands, dystrophic hair follicles, follicular plugging, inflammation, and scarring.
The loss of stem cells and sebaceous glands precedes the inflammatory response in this mouse
model. These data suggest that the AhR transgenic mouse is an excellent experimental model for
scarring alopecia. The human and animal studies taken together implicate AhR in the onset and
progression of PCA. Thus, targeting AhR activity with naturally occurring or synthetic antagonists
may provide an innovative therapeutic strategy for PCA. Our studies provide a novel link between
environmental factors and the etiology of primary cicatricial alopecia.
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PS2.3
The latest updates of the management of pattern hair loss
W-S Lee Department of Dermatology, Institute of Hair & Cosmetic Medicine, Yonsei
University Wonju College of Medicine, Wonju, Republic of Korea
Because of the social and psychological impact of pattern hair loss (PHL, androgenetic
alopecia), patients may seek inappropriate and unproven therapies that are available in
nonmedical settings, often at great expense to the consumer. The aim of treatment of PHL is
to increase scalp coverage or to retard the progression of hair thinning, or both. There are
effective medical treatments available currently for some men and women with PHL, but
clearly further treatment options are desired, particularly for women with FPHL. Agents used
to treat PHL may be nonspecific biologic response modifiers that enlarge suboptimal hair
follicles regardless of the underlying pathophysiology, androgen blockers to interrupt the
5a-reductase enzymes, or androgen receptor protein inhibitors to specifically block the
binding and transport of androgens to the cell nucleus. The purpose of this lecture is to
provide current information on an approach to the evaluation and medical treatment of
pattern hair loss. This lecture discusses therapeutic options with current and emerging new
treatment modalities. Also, management strategies for PHL will be covered in the setting of
an algorithmic evaluation of pattern hair loss based on a newly designed classification
system, named the Basic and Specific (BASP) classification.
PS2.4
The surgical management of cicatricial alopecias
RG Knudsen The Knudsen Clinic, Double Bay, Australia
It is well known that active cicatricial alopecias are unsuitable for surgical hair grafting
or excision. There is some debate, however, about the correct management of
cicatricial alopecias that no longer appear active. The current approaches relate to presumed
‘‘stability’’ of the condition. One approach is to wait for 12–24 months of stability post
cessation of medication management. In this approach there is no medication ‘‘cover’’
during the surgical process. The alternative approach is to proceed to surgery during
medication management if the patient has completed a successful ‘‘stable’’ period of 12
months on medication. Previous reports of re-activation of some cicatricial alopecias have
suggested there is some risk in pursuing surgery, particularly if the patient is not currently
using medication. My personal experience suggests there is greater risk of re-activation in
patients with frontal fibrosing alopecia (FFA) compared to other cicatricial alopecias. With
this in mind, it seems prudent to both warn all patients with cicatricial alopecia of the risk
and suggest some period of medication cover during the surgery and for at least 12 months
after. In patients with FFA, I would recommend that patients pursue lifetime medication, as
the re-activation risk is high and often considerably delayed. I will present case studies to
illustrate this problem.
KEYNOTE SPEAKERS
K1
Skin stem cells: in silence and in action
E Fuchs Howard Hughes Medical Institute, Rockefeller University, New York, USA
How stem cells balance self-renewal and differentiation is of fundamental importance to our
understanding of normal tissue maintenance and wound repair. Moreover, increasing
evidence suggests that the regulatory circuitry governing this balancing act is at the root of
some types of tumors both in mice and in humans. The hair follicle is an ideal model system
for exploring how stem cell behavior is controlled and how this process goes awry in tumor
progression. In the adult, hair follicles undergo cyclical bouts of tissue regeneration,
destruction, and rest. The hair cycle is fueled by stem cells located within a niche referred to
as the bulge. In the mouse, hair cycles are synchronous, making them an especially attractive
model to explore how quiescent stem cells become mobilized to actively regenerate tissue,
how they self-renew to maintain a pool of stem cells, and how they return to quiescence
following tissue production. This process is related to a challenge faced by many adult stem
cells, namely, to be able to respond quickly to injury, repair tissue, and then return again to a
quiescent state. Using the hair follicle as our paradigm, we’ve been dissecting the crosstalk
that takes place between a stem cell and its microenvironment (stem cell niche) that governs
when stem cells will be activated to make tissue in normal homeostasis and wound repair.
Our findings provide us with an understanding of how the hair cycle works, why the resting
phase gets longer as we age, and how hair follicle and melanocyte stem cells coordinate their
behavior and how this can be uncoupled in disease states. Our studies also provide new
insights into the process of stem cell activation, and in so doing have revealed mechanisms
that are also deregulated in squamous cell carcinomas (SCCs), among the most prevalent and
life-threatening cancers world-wide.
K2
Hair follicle: the root of the future. Clinical research, implications, and advances
U Blume-Peytavi Department of Dermatology and Allergy, Charite´-Universita¨tsmedizin
Berlin, Berlin, Germany
The human hair follicle, a highly developed biological autonomous machinery with
individual self-renewing capacities, produces keratin fibers possessing an incredible
symbolic power for attractiveness, strength, gender definition, as well as emotional and
physical well-being. Creating and maintaining life-long beautiful hair, which is easy to grow
or eliminate, pigment or depigment, newly create or replace, is the key interest to anyone
interested and involved in hair research and management of patients with hair loss, alopecia,
or excessive hair growth. Advances in understanding hair follicle physiology, hair growth
and cycling, hair genetics, innovative diagnostic techniques, hair care, hair removal, and
restoration have significantly contributed to an improvement in patient care and manage-
ment. Today, the pilosebaceous unit is exemplary in successful translational research, with
the human being still remaining the best model to study and investigate hair cycling and
growth behavior. Advances in the field of stem cell biology have led to direct clinical impact
in projects of hair follicle neogenesis and hair transplantation. Targeted follicular delivery,
using the unique role of hair follicle pathways in percutaneous penetration with drug delivery
systems, has opened a new dimension in the development of hair growth therapeutics and
adjacent indications such as transfollicular vaccination strategies. Advances in experimental
and clinical research enable us today to offer our patients innovative diagnostic tools and
new testing devices and procedures. These in turn enable us to validate and quantify
efficiently new candidate molecules for treating hair disorders. Trichology today incorporates
evidence-based guidelines established for the management of androgenetic alopecia,
alopecia areata, and hirsutism.
CONCLUDING PLENARY
CP1
What’s new in clinical hair research?
A Zlotogorski Department of Dermatology, Hadassah - Hebrew University Medical Center
and The Center for Genetic Diseases of the Skin and Hair, Jerusalem, Israel
This lecture will give a brief overview of the recent advances in clinical hair research. It will
cover the progress in the diagnosis and treatment of common hair disorders such as
androgenetic alopecia, alopecia areata, and scarring alopecia. Additionally, innovations in a
range of inherited, infectious, and structural disorders, as well as hirsutism, will be discussed.
Potential medical and surgical treatments will be reviewed too.
CP2
What’s new in basic science aspects of hair research?
SE Millar Departments of Dermatology and Cell and Developmental Biology, University of
Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
In this talk I will review recent exciting findings in basic hair research. I will cover the latest
studies of cell–cell signaling mechanisms; describe new approaches examining the functions
of regulatory factors at the genomic level; explore the roles of global chromatin regulators in
the hair follicle; present exciting new developments in live imaging techniques that permit
visualization of hair follicle formation and stem cell activity; and provide an update on
approaches to hair follicle regeneration. These striking advances have revealed new
molecular and cellular mechanisms that will impact therapeutic strategies.
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